Sorted by Divisions

Publications - Sorted by Divisions

• Sieghart W, Chiou LC, Ernst M, Fabjan J, M Savić M, Lee MT (2022) α6-Containing GABAA Receptors: Functional Roles and Therapeutic Potentials Pharmacol Rev, 74(1): 238-270

• Tzeng HR, Lee MT, Fan PC, Knutson DE, Lai TH, Sieghart W, Cook J, Chiou LC (2021) α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia Neurotherapeutics, 18(1): 569-585
• Golani LK, Platt DM, Rüedi-Bettschen D, Edwanker C, Huang S, Poe MM, Furtmüller R, Sieghart W, Cook JM, Rowlett JK (2021) 8-Substituted Triazolobenzodiazepines: In Vitro and In Vivo Pharmacology in Relation to Structural Docking at the α1 Subunit-Containing GABAA Receptor Front. Pharmacol., 12: 625233
• Belelli D, Hales TG, Lambert JJ, Luscher B, Olsen R, Peters JA, Rudolph U, Sieghart W (2021) GABAA receptors in GtoPdb v.2021.3 IUPHAR BPS Guide Pharm CITE, : Sep 2;2021(3):10.2218/gtopdb/F72/2021.3.

• Sperk G, Kirchmair E, Bakker J, Sieghart W, Drexel M, Kondova I (2020) Immunohistochemical distribution of 10 GABAA receptor subunits in the forebrain of the rhesus monkey Macaca mulatta. J Comp Neurol, 528(15): 2551-2568

• Kasugai Y, Vogel E, Hörtnagl H, Schönherr S, Paradiso E, Hauschild M, Göbel G, Milenkovic I, Peterschmitt Y, Tasan R, Sperk G, Shigemoto R, Sieghart W, Singewald N, Lüthi A, Ferraguti F (2019) Structural and Functional Remodeling of Amygdala GABAergic Synapses in Associative Fear Learning Neuron, 104(4): 781-794
• Stefanits H, Milenkovic I, Mahr N, Pataraia E, Baumgartner C, Hainfellner JA, Kovacs GG, Kasprian G, Sieghart W, Yilmazer-Hanke D, Czech T. (2019) Alterations in GABAA Receptor Subunit Expression in the Amygdala and Entorhinal Cortex in Human Temporal Lobe Epilepsy J Neuropath Exp Neurol, 78(11): 1022-1048
• Vasović D, Divović B, Treven M, Knutson D, Steudle F, Scholze P, Obradović A, Fabjan J, Brković B, Sieghart W, Ernst M, Cook J, Savić M (2019) Trigeminal neuropathic pain development and maintenance in rats are suppressed by a positive modulator of α6 GABA A receptors Eur. J. Pain, 23(5): 973-984

• Knutson D, Kodali R, Divović B, Treven M, Stephen M, Zahn N, Dobričić V, Huber A, Meirelles M, Verma R, Wimmer L, Witzigmann C, Arnold L, Chiou L, Ernst M, Mihovilovic M, Savić M, Sieghart W, Cook J (2018) Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABAAR) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability J Med Chem, 61 (6): 2422-2446
• Chiou L, Lee H, Ernst M, Huang W, Chou J, Chen H, Mouri A, Chen L, Treven M, Mamiya T, Fan P, Knutson D, Witzigmann C, Cook J, Sieghart W, Nabeshima T (2018) Cerebellar α6-subunit-containing GABAAreceptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders Br J Pharmacol, 175 (12): 2414-2427
• Duke A, Meng Z, Platt D, Atack J, Dawson G, Reynolds D, Tiruveedhula V, Li G, Stephen M, Sieghart W, Cook J, Rowlett J (2018) Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABAA Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys J Pharmacol Exp Ther, 366 (1): 145-157
• Fan P, Lai T, Hor C, Lee M, Huang P, Sieghart W, Ernst M, Knutson D, Cook J, Chiou L (2018) The α6 subunit-containing GABAA receptor: A novel drug target for inhibition of trigeminal activation Neuropharmacology, 140: 1-13

• Sieghart W, Savić MM. (2018) International Union of Basic and Clinical Pharmacology. CVI: GABAA Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans Pharmacol Rev, 70(4): 836-878

• Stefanits H, Milenkovic I, Mahr N, Pataraia E, Hainfellner J, Kovacs G, Sieghart W, Yilmazer-Hanke D, Czech T (2017) GABAA receptor subunits in the human amygdala and hippocampus: immunohistochemical distribution of 7 subunits J Comp Neurol, 526 (2): 324-348

• Klein A., Drexel C., Tan D., Matiasek J., Birkemeyer R., Trost H. (2009) Eingabe strukturierter Befunddaten mittels Spracherkennung: Ein Feldtest, Mensch & Computer 2009, : 233-242
• Rosipal R., Trejo L.J., Nunez P.L. (2009) Application of Multi-way EEG Decomposition for Cognitive Workload Monitoring. Proceedings of the 6th International Conference on Partial Least Squares and Related Methods, : 145-149
• Moser D., Anderer P., Gruber G., Parapatics S., Loretz E., Böck M., Klösch G., Heller E., Schmidt A., Danker-Hopfe H., Saletu B., Zeitlhofer J., Dorffner G. (2009) Sleep classification according to AASM and Rechtschaffen & Kales: effects on sleep scoring parameters. Sleep, 32(2): 139-149
• Danker-Hopfe H., Anderer P., Zeitlhofer J., Böck M., Dorn H., Gruber G., Heller E., Loretz E., Moser D., Parapatics S., Saletu B., Schmidt A., Dorffner G. (2009) Interrater reliability for sleep scoring according to the Rechtschaffen & Kales and the new AASM standard. Journal of Sleep Research, 18(1): 74-84
• Trost H., Jancsary J., Klein A., Matiasek J. (2009) Moving Automated Dictation from Speech Recognition to Structured Text Reproduction OEGAI Journal, 28(1): 2-13
• Matiasek J., Jancsary J., Klein A., Trost H. (2009) Identifying Segment Topics in Medical Dictations. SRSL 2009, held at the held at the 12th Conference of the European Chapter of the Association for Computational Linguistics (EACL-09), : 19-25

• Buchberger E. (2009) Arabic Computational Morphology. Knowledge-Based and Empirical Methods, by Abdelhadi Soudi, Antal van den Bosch and Günter Neumann, editors. Dordrecht, The Netherlands: Springer. Natural Language Engineering, 15: 309-310

• Jancsary, J., Matiasek, J., Trost, H. (2008) Revealing the structure of medical dictations with conditional random fields J Cell Sci., Proceedings of the 2008 Conference on Empirical Methods in Natural Language Processing: 1-10
• Ludl M.C., Lewandowski A., Dorffner G. (2008) Adaptive Machine Learning in Delayed Feedback Domains by Selective Relearning Appl.Artif.Intell., 22(6): 543-557
• Miazhynskaia T., Frühwirth-Schnatter S., Dorffner G. (2008) Neural network models for conditional distribution under bayesian analysis Neural Computation, 20(2): 504-22

• Rome E., Hertzberg J., Dorffner G. (2008) Towards Affordance-Based Robot Control. , Springer-Verlag

• Bandini S., Vizzari G., Petta P. (2007) Guest Editorial: Best of "Agent-Based Modeling and Simulation" (ABModSim) Cybernetics and Systems, 38(7): 627-630
• Rank S., Petta P. (2007) From ActAffAct to BehBehBeh: Increasing Affective Detail in a Story-World ICVS 2007, : 206-209
• Petta P., Omicini A., Payne T., McBurney P. (2007) Introduction to the special issue: The AgentLink III technical forums ACM Transactions on Autonomous and Adaptive Systems, 2(4): 121-126
• Rank S., Petta P. (2007) Basing artificial emotion on process and resource management Affective Computing and Intelligent Interaction, : 350-361
• Anderer P., Gruber G., Parapatics S., Dorffner G. (2007) Automatic sleep classification according to Rechtschaffen and Kales Proceedings of the 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, : 3994-3997
• Flexer A. (2007) Drum transcription in polyphonic music using non-negative matrix factorisation Proceedings of the 8th International Conference on Music Information Retrieval (ISMIR'07), : 353-354
• Flexer A. (2007) A closer look on artist filters for musical genre classification Proceedings of the 8th International Conference on Music Information Retrieval (ISMIR'07), : 341-344
• Flexer A., Makeig S. (2007) Independent Component Analysis of EEG recorded during two-person game playing Appl.Artif.Intell., 21(9): 883-894
• Trejo L.J., Knuth K., Prado R., Rosipal R., Kubitz K., Kochavi R., Matthews B., Zhang Y. (2007) EEG-based Estimation of Mental Fatigue: Convergent Evidence for a Three-State Model Foundations of Augmented Cognition, : 201-211
• Rosipal R., Peters B., Kecklund G. Akerstedt T., Gruber G., Wörtz M., Anderer P., Dorffner G. (2007) EEG-based drivers’ drowsiness monitoring using a hierarchical Gaussian mixture model Foundations of Augmented Cognition, 4565: 294-303
• Fritz G., Paletta L., Breithaupt R., Rome E., Dorffner G. (2007) Learning predictive features in affordance based robotic perception systems IEEE 6th International Conference on Development and Learning 2007, : 3642-3647
• Paletta L., Fritz G., Kintzler F., Irran J., Dorffner G. (2007) Perception and developmental learning of affordances in autonomous robots KI 2007, 4667: 235-250
• Paletta L., Fritz G., Kintzler F., Irran J., Dorffner G. (2007) Learning to perceive affordances in a framework of developmental embodied cognition IEEE 6th International Conference on Development and Learning 2007, : 110-115
• Jancsary J., Klein A., Matiasek J., Trost H. (2007) Semantics-based Automatic Literal Reconstruction Of Dictations SRSL7, : 67-74

• Petta P., Martinho C. (2007) Proceedings of the Systems Demonstrations. The Second International Conference on Affective Computing and Intelligent Interaction. , Lisbon, Portugal
• Petta P., Mueller J.P., Klusch M., Georgeff M. (2007) Multiagent System Technologies. 5th German Conference, MATES 2007. , Springer, Berlin
• Trappl R., Trost H. (2007) Wissenschaft und Medizin. , Facultas, Wien

• Trejo LJ, Rosipal R, Matthews B. (2006) Brain-Computer Interfaces for 1-D and 2-D Cursor Control: Designs using Volitional Control of the EEG Spectrum or Steady-State Visual Evoked Potentials IEEE Transactions on Neural Systems and Rehabilitation Engineering, 14(2): 225-229
• Paletta L., Fritz G., Rome E., Dorffner G. (2006) A computational model for visual learning of affordance-like cues ECVP06,
• Miazhynskaia T., Fruehwirth-Schnatter S., Dorffner G. (2006) Bayesian testing for non-linearity in volatility modeling Computational Statistics & Data Analysis, 51(3): 2029-2042
• Miazhynskaia T., Dorffner G. (2006) A Comparison of Bayesian Model Selection Based on MCMC with an Application to GARCH-type Models Statistical Papers, 47: 525-549
• Lewandowski A., Ludl M., Byrne G., Dorffner G. (2006) Applying the Yule-Nielsen Equation with Negative n Journal of the Optical Society of America A, 23: 1827-1834
• Kadlec P., Dorffner G. (2006) Learning of Dynamic Object Representations Cybernetics and Systems 2006, : 507-512
• Fritz G., Paletta L., Kumar M., Dorffner G., Breithaupt R., Rome E. (2006) Visual learning of affordance-based cues SAB 2006, LNAI 4095: 52-64
• Fritz G., Paletta L., Breithaupt R., Rome E., Dorffner G. (2006) Learning predictive features in affordance-based robotics IROS 2006, : 3642-3647
• Rami B., Popow C., Horn W., Waldhoer T., Schober E. (2006) Telemedical support to improve glycemic control in adolescents with type 1 diabetes mellitus Eur. J. Pediatr., 165(10): 701-705
• Buchberger E. (2006) Kann ein Computer Gedichte schreiben? ZEIT Online, 4/2006
• Huber M., Jancsary J., Klein A., Matiasek J., Trost H. (2006) Mismatch interpretation by semantics-driven alignment KONVENS 2006,

• Rosipal R, Krämer N. (2006) Overview and Recent Advances in Partial Least Squares. In: Saunders C, Grobelnik M, Gunn S, Shawe-Taylor J, Subspace, Latent Structure and Feature Selection Techniques Springer : 34-51
• Dorffner G., Rattenberger J., Hoertnagl E., Bercovitch J., Trappl R. (2006) Neural Computation for International Conflict Management. In: Trappl R., Programming for Peace: Computer-Aided Methods for International Conflict Resolution and Prevention Springer Academic Publishers, Dordrecht, NL
• Buchberger E. (2006) Warum spielen Computer so gut Schach, aber so schlecht Go?. In: <p>Ackerl I., Sachslehner J.</p>, Wissen! Antworten auf unsere großen Fragen Kremayr & Scheriau, Wien
• Buchberger E. (2006) Können Computer Gedichte schreiben?. In: <p>Ackerl I., Sachslehner J.</p>, Wissen! Antworten auf unsere großen Fragen Kremayr & Scheriau, Wien
• Buchberger E. (2006) Wieso verstehen Diktiersysteme, was wir sagen?. In: <p>Ackerl I., Sachslehner J.</p>, Wissen! Antworten auf unsere großen Fragen Kremayr & Scheriau, Wien
• Buchberger E. (2006) Wie funktionieren sprechende Computer?. In: <p>Ackerl I., Sachslehner J.</p>, Wissen! Antworten auf unsere großen Fragen Kremayr & Scheriau, Wien
• Buchberger E. (2006) Warum übersetzen Übersetzungscomputer so schlecht?. In: <p>Ackerl I., Sachslehner J.</p>, Wissen! Antworten auf unsere großen Fragen Kremayr & Scheriau, Wien

• Wallerius J, Trejo LJ, Matthews R, Rosipal R, and Caldwell JA (2005) Robust feature extraction and classification of EEG spectra for real-time classification of cognitive state Proceedings of the 11th International Conference on Human Computer Interaction,
• Trejo L.J., Kochavi R., Kubitz K, Montgomery LD, Rosipal R, Matthews B. (2005) Measures and models for predicting cognitive fatigue Proceedings of SPIE: Biomonitoring for Physiological and Cognitive Performance During Military Operations, Vol. 5797: 105-115
• Neumann C., Gschwendtner M., Karnel F., Mair J., Dorffner G., Dorffner R. (2005) Technical feasibility of the implantation of a monorail stent system into the renal arteries without pre-dilatation RoFo, 177: 84-88
• Flexer A., Gruber G., Dorffner G. (2005) A reliable probabilistic sleep stager based on a single EEG signal Artificial Intelligence in Medicine, 33(3): 199-207
• Flexer A., Bauer H., Pfripfl J., Dorffner G. (2005) Using ICA for removal of ocular artifacts in EEG recorded from blind subjects Neural Networks, 18(7): 998-1005
• Danker-Hopfe H., Schaefer M., Dorn H., Anderer P., Saletu B., Gruber G., Zeitlhofer J., Kunz D., Barbanoj M., Himanen S.L., Kemp B., Penzel T., Roeschke J., Dorffner G. (2005) Percentile reference charts for selected sleep parameters for 20- to 80-year-old healthy subjects from the SIESTA database Somnologie, 9(1): 3-14
• Anderer P., Gruber G., Parapatics S., Woertz M., Miazhynskaia T., Kloesch G., Saletu B., Zeitlhofer J., Barbanoj M., Danker-Hopfe H., Himanen S., Kemp B., Penzel T., Groezinger M., Kunz D., Rappelsber (2005) An E-Health Solution for Automatic Sleep Classification according to Rechtschaffen and Kales: Validation Study of the Somnolyzer 24 x 7 Utilizing the Siesta Database Neuropsychobiology, 51(3): 115-133
• Trost H., Matiasek J., Baroni M. (2005) The language component of the FASTY text prediction system Appl.Artif.Intell., 19: 743-781

• De Bie T., Cristianini N., Rosipal R. (2005) Eigenproblems in Pattern Recognition. In: Bayro-Corrochano, E., Handbook of Geometric Computing: Applications in Pattern Recognition, Computer Vision Springer: 129-170

• Findl O., Struhal W., Dorffner G., Drexler W. (2004) Analysis of non-linear systems to estimate the intraocular lens position after cataract surgery Journal of Cataract and Refractive Surgery, 30(4): 863-866
• Danker-Hopfe H., Kunz D., Gruber G., Kloesch G., Lorenzo J.L., Himanen S.L., Kemp B., Penzel T., Roeschke J., Dorn H., Schloegl A., Trenker E., Dorffner G. (2004) Interrater reliability between scorers from eight European sleep laboratories in subjects with different sleep disorders Journal of Sleep Research, 13(1): 63-69
• Urschitz M.S., Horn W., Seyfang A., Hallenberger A., Herberts T., Miksch S., Popow C., Mueller-Hansen I., Poets C.F. (2004) Automatic Control of the Inspired Oxygen Fraction in Preterm Infants. A Randomized Cross-over Trial Am. J. Respir. Crit. Care Med., 170(10): 1095-1100
• Klein A., Trost H. (2004) Context-based error correction for proper names in a large vocabulary domain KONVENS 2004, : 81-88
• Apel J., Neubarth F., Pirker H., Trost H. (2004) Have a break! Modelling pauses in German speech KONVENS 2004, : 5-12

• Buchberger E. (2004) KONVENS 2004. , &Ouml;sterreichische Gesellschaft f&uuml;r Artificial Intelligence, Vienna, Austria

• Rosipal R, Trejo LJ, Matthews B. (2003) Kernel PLS-SVC for Linear and Nonlinear Classification ICML'03, : 640-647
• Rosipal R, Trejo LJ, Matthews B, Wheeler K. (2003) Nonlinear Kernel-Based Chemometric Tools: a Machine Learning Approach PLS and Related Methods, : 249-260
• Trejo LJ, Wheeler KR, Jorgensen CC, Rosipal R, Clanton ST, Matthews B, Hibbs AD, Matthews R, Krupka M. (2003) Multimodal Neuroelectric Interface Development Neural Network World, 11(2): 199-204
• Rosipal R. (2003) Kernel Partial Least Squares for Nonlinear Regression and Discrimination Neural Network World, 13(3): 291-300
• Popow C., Horn W., Rami B., Schober E. (2003) VIE-DIAB: a Support Program for Telemedical Glycaemic Control AIME-2003,
• Klein A., Trost H. (2003) Using Corpus-Based Methods for Spoken Access to News Texts on the Web Eurospeech 2003, : 1037-1040

• Trost H. (2003) Morphology. In: Mitkov R., The Oxford Handbook of Computational Linguistics Oxford University Press, Oxford New York
• Trost H., Buchberger E. (2003) Sprachtechnologie. In: Seipel W., Der Turmbau zu Babel, Ausstellungskatalog, Schloss Eggenberg, Graz, 2003

• Horn W., Popow C., Miksch S., Kirchner L., Seyfang A. (2002) Development and Evaluation of VIE-PNN, a Knowledge-based System for Calculating the Parenteral Nutrition of Newborn Infants Artificial Intelligence in Medicine, 24(3): 207-218
• Horn W., Popow C., Miksch S., Seyfang A. (2002) Benefits of a Knowledge-based System for Parenteral Nutrition Support: a Report after 5 Years of Routine Daily Use ECAI 2002,
• Neubarth F., Pirker H., Trost H. (2002) Learning duration KONVENS 2002, : 123-130
• Klein A., Puig-Waldmueller E., Trost H. (2002) Robust Interpretation of User Requests for Text Retrieval in a Multimodal Environment COLING 2002, : 1233-1237
• Baroni M., Matiasek J., Trost H. (2002) Wordform- and Class-Based Prediction of the Components of German Nominal Compounds in an AAC System COLING 2002, : 57-63
• Baroni M., Matiasek J., Trost H. (2002) Predicting the Components of German Nominal Compounds ECAI 2002, : 470-474
• Baroni M., Matiasek J., Trost H. (2002) Unsupervised discovery of morphologically related words based on orthographic and semantic similarity Proceedings of the Workshop on Morpological and Phonological Learning of ACL 2002, : 48-57

• Matiasek J., Baroni M., Trost H. (2002) FASTY - A Multi-Lingual Approach to Text Prediction. In: Miesenberger K. et al., Computers Helping People with Special Needs Springer-Verlag Berlin Heidelberg New York

• Buchberger E. (2001) Ein Überblick des Gasteditors OEGAI Journal, 20: 2
• Buchberger E. (2001) 20 Jahre ÖGAI im Zeitraffer OEGAI Journal, 20: 6-9
• Seyfang A., Miksch S., Horn W., Urschitz M.S., Popow C., Poets C.F. (2001) Using Time-Oriented Data Abstraction Methods to Optimize Oxygen Supply for Neonates AIME-2001, : 217-226
• Horn W. (2001) AI in Medicine on its Way from Knowledge-intensive to Data-intensive Systems Artificial Intelligence in Medicine, 23(1): 5-12
• Horn W., Popow C., Unterasinger L. (2001) Support for Fast Comprehension of ICU Data: Visualization Using Metaphor Graphics Methods of Information in Medicine, 40: 421-424

• Horn W. (2000) Artificial Intelligence in Medicine and Medical Decision Making Europe Artificial Intelligence in Medicine, 20(1): 1-3

• Horn W. (2000) ECAI 2000. Proceedings of the 14th European Conference on Artificial Intelligence. , IOS, Amsterdam

• Miksch S., Seyfang A., Horn W., Popow C. (1999) Abstracting Steady Qualitative Descriptions over Time from Noisy, High-Frequency Data Artificial Intelligence in Medicine, : 281-290
• Horn W., Popow C., Stocker C., Miksch S. (1999) Neonatal Ventilation Tutor (VIE-NVT), a Teaching Program for the Mechanical Ventilation of Newborn Infants Artificial Intelligence in Medicine, : 148-152

• Horn W., Shahar Y., Lindberg G., Andreassen S., Wyatt J. (1999) Artificial Intelligence in Medicine. ,

• Buchberger E. (1998) Electronic NLP courses - facts and prospects ELSNET in Wonderland Proceedings,
• Horn W., Popow C., Miksch S., Seyfang A. (1998) Quicker, More Accurate Nutrition Plans for Newborn Infants IEEE Intelligent Systems, 13(1): 65-69

• Horn W., Miksch S., Egghart G., Popow C., Paky F. (1997) Effective Data Validation of High-Frequency Data: Time-Point-, Time-Interval-, and Trend-Based Methods Computers in Biology and Medicine, 27(5): 389-409
• Miksch S., Horn W., Popow C., Paky F. (1997) Time-Oriented Analysis of High- Frequency Data in ICU Monitoring Intelligent Data Analysis in Medicine and Pharmacology,
• Miksch S., Horn W., Shahar Y., Popow C., Paky F., Johnson P. (1997) Is Skeletal Planning in Real-World, High-Frequency Domains Possible? OFAI Technical Report, TR-97-08

• Alter K., Buchberger E., Matiasek J., Niklfeld G., Trost H. (1996) VIECTOS: The Vienna Concept-to-Speech System Natural Language Processing and Speech Technology,
• Miksch S., Horn W., Egghart G., Popow C., Paky F. (1996) Monitoring and Therapy Planning without Effective Data Validation are Ineffective 1996 AAAI Spring Symposium: AI in Medicine: Applications of Current Technologies,
• Miksch S., Horn W., Popow C., Paky F. (1996) Utilizing Temporal Data Abstraction for Data Validation and Therapy Planning for Artificially Ventilated Newborn Infants Artificial Intelligence in Medicine, 8(6): 543-576

• Buchberger E. (1995) Prosodic Cues for Inferring and Realizing Discourse Relations Proceedings of the XIIIth International Congress of Phonetic Sciences, Stockholm, Sweden, 2: 282-285
• Miksch S., Horn W., Popow C., Paky F. (1995) Therapy Planning Using Qualitative Trend Descriptions AIME-95, 934: 197-208
• Dobner M., Miksch S., Horn W., Popow C. (1995) VIE-PNN: Ein Expertensystem für die Berechnung der parenteralen Ernährung von intensiv behandelten Früh- und Neugeborenen Wiener Klinische Wochenschrift, 107(4): 128-132

• Horn W. (1994) A Perspective on the Use of Knowledge-Based Systems, Model-Based Diagnosis, and Interactive Multimedia Technology in Health Care Knowledge and Decisions in Health Telematics, : 121-125
• Miksch S., Horn W., Popow C., Paky F. (1994) Context-Sensitive Data Validation and Data Abstraction for Knowledge-Based Monitoring ECAI94, : 48-52
• Miksch S., Horn W., Popow C., Paky F. (1994) Intensive Care Monitoring and Therapy Planning for Newborns AAAI 1994 Spring Symposium: Artificial Intelligence in Medicine: Interpreting Clinical Data,

• Buchberger E. (1994) Form and substance: knowledge representation by thesauri. In: Best H et al. (eds.), Informations- und Wissensverarbeitung in den Sozialwissenschaften Westdeutscher Verlag, Opladen

• Buchberger E. (1993) Criteria in Natural Language Generation: Minimal Vriteria and Their Impacts GWAI-92, : 347-356
• Buchberger E., Trost H. (1993) GIST - generating Instructional text OEGAI Journal, 1-2: 13-15
• Miksch S., Horn W., Popow C., Paky F. (1993) VIE-VENT: Knowledge-Based Monitoring and Therapy Planning of the Artificial Ventilation of Newborn Infants AIME-93, : 218-229
• Miksch S., Dobner M., Horn W., Popow C. (1993) VIE-PNN: An Expert System for Parenteral Nutrition of Neonates CAIA-93, : 285-291
• Widmer G., Horn W., Nagele B. (1993) Automatic Knowledge Base Refinement: Learning from Examples and Deep Knowledge in Rheumatology Artificial Intelligence in Medicine, 5(3): 225-243
• Buchberger E. (1993) The Hidden Treasure Appl.Artif.Intell., 7(1): 29-38

• Buchberger E. (1993) Lexicalization: Introduction. In: Horacek, H., Zock M. (eds.), New Concepts in Natural Language Generation. Pinter, London

• Heinz W., Matiasek J., Trost H., Buchberger E. (1992) Comparison in NLIs - Habitability and Database Reality ECAI-92. Proceedings of the 10th European Conference on Artificial Intelligence,

• Buchberger E. (1992) Natural Language Markets: Commercial Strategies, by B. Engelien and R. McBryde Appl.Artif.Intell., 6(3): 385-386
• Buchberger E. (1992) Knowledge-Based Systems and Legal Applications, by Bench Capon, T. Appl.Artif.Intell., 6(2): 251-252

• Buchberger E., Garner H., Heinz W., Matiasek J., Pfahringer B. (1991) VIE-DU - Dialogue by Unification 7.Österreichische Artificial Intelligence-Tagung, : 42-51
• Horn W. (1991) The Challenge of Deep Models, Inference Structures, and Abstract Tasks Appl.Artif.Intell., 5(1): 47-56
• Horn W. (1991) Utilizing Detailed Anatomical Knowledge for Hypothesis Formation and Hypothesis Testing in Rheumatological Decision Support Artificial Intelligence in Medicine, 3(1): 21-39

• Trost H., Buchberger E. (1990) Datenbank-DIALOG: How to Communicate with your Database in German (and Enjoy it) Interacting with Computers, 2(3): 367-381
• Dorffner G., Buchberger E., Kommenda M. (1990) Integrating Stress and Intonation into a Concept-to-Speech System COLING 1990,
• Buchberger E. (1990) Impacts of Artificial Intelligence: A foreword Cybernetics and Systems '90, : 1019-1022

• Buchberger E. (1990) Sprachverarbeitung. In: Mertens P. et al. (eds.), Lexikon der Wirtschaftsinformatik Springer, Berlin

• Gottlob G., Fruehwirth T., Horn W. (1990) Expertensysteme. , Springer, Wien
• Horn W. (1990) Causal AI Models: Steps Toward Applications. , Hemisphere, Washington, DC

• Buchberger E., Trost H. (1989) Datenbank-DIALOG: Kommunikation mit Datenbanken in deutscher Sprache Künstliche Intelligenz, 4: 27-30
• Horn W. (1989) MESICAR - A Medical Expert System Integrating Causal and Associative Reasoning, in Special Issue on Causal Modeling Appl.Artif.Intell., 3(2-3): 305-336
• Horn W. (1989) Diagnostic Decision Support Based on Generic Disease Descriptions and Detailed Anatomical Knowledge AIME 89, : 299-308

• Dorffner G., Trost H., Buchberger E. (1988) Generating Spoken Output for an Expert System Interface OEGAI Journal, 3-4: 36-41

• Buchberger E., Horacek H. (1988) VIE-GEN: A Generator for German Texts. In: McDonald D.D., Bolc L., Natural Language Generation Systems Springer, Berlin/Heidelberg/New York: 166-204

• Trost, H., Buchberger, E., Heinz, W., Hörtnagl, C., Matiasek, J. (1987) Datenbank-Dialog: A German language interface for relational databases Appl.Artif.Intell., 1(2): 181-203

• Buchberger E., Retti J. (1987) 3.Österreichische Artificial Intelligence-Tagung. , Springer, Berlin
• Buchberger E. (1987) AI-Dictionary: Die Begriffswelt der Wissensverarbeitung und Künstlichen Intelligenz. , Schriftenreihe der Österreichischen Gesellschaft für Artificial Intellligence, Band 1

• Buchberger E. (1986) Sprachverstehen in der Artificial Intelligence. In: <p>Retti J. et al.</p>, Artificial Intelligence - Eine Einführung Teubner, Stuttgart: 2.Aufl.

• Trost H., Buchberger E. (1985) Knowledge acquisition in the system VIE-LANG Oesterreichische Artificial Intelligence-Tagung 1985,

• Horacek H., Buchberger E. (1984) On Generation of Anaphora and Gapping in German Cybernetics and Systems Research 2,
• Horn W., Ammer K. (1984) Causal and Anatomical Reasoning in a Two-Level Medical Expert System ECAI-84,

• Retti J., Bibel W., Buchberger B., Buchberger E., Horn W., Kobsa A., Steinacker I., Trappl R., Trost H. (1984) Artificial Intelligence - Eine Einführung. <p>Retti J. et al.</p>, Teubner, Stuttgart

• Trost H., Buchberger E., Steinacker I., Trappl R. (1983) VIE-LANG: A German language dialogue system Cybernetics and Systems, 14: 343-357
• Steinacker I., Buchberger E. (1983) Relating Syntax and Semantics: The Syntactico-Semantic Lexicon of the System VIE-LANG Proceedings of the 1st Conference of the EACL,

• Buchberger E., Steinacker I., Trappl R., Trost H., Leinfellner E. (1982) A natural language understanding system for medical applications SIGART Newsletter, 79: 146-147
• Buchberger E., Steinacker I., Trappl R., Trost H., Leinfellner E. (1982) VIE-LANG - A German Language Understanding System Cybernetics and Systems Research, : 851-856
• Buchberger E. (1982) Künstliche Intelligenz für natürliche Sprache OEGAI Journal, 1(3-4): 23-33
• Horn W., Buchberger E., Trost H. (1982) Database Access in LISP ECAI-82, : Discussion Papers

• Buchberger E., Steinacker I., Trost H. (1981) LAUS (Language Analyzing and Understanding System) - Ein sprachverstehendes System für die Anwendung in der Medizin KI-Rundbrief, 24/25
• Horn W., Buchstaller W., Trappl R. (1981) Knowledge Structure Definition for an Expert System in Primary Medical Care IJCAI-81, : 850-852

• Milenkovic I, Vasiljevic M, Maurer D, Höger H, Klausberger T, Sieghart W. (2013) The parvalbumin-positive interneurons in the mouse dentate gyrus express GABAA receptor subunits alpha1, beta2, and delta along their extrasynaptic cell membrane. Neuroscience, 254: 80-96
  | Weblink |
• Varagic Z, Ramerstorfer J, Huang S, Rallapalli S, Sarto-Jackson I, Cook J, Sieghart W, Ernst M (2013) Subtype selectivity of alpha+beta-site ligands of GABA-A receptors - identification of the first highly specific positive modulators at alpha6beta2/3gamma2 receptors Br J Pharmacol, 169(2): 384-399

• Berger ML, Pöhler T, Schadt O, Stanger M, Rebernik P, Scholze P, Noe CR (2012) Exploring the Polyamine Regulatory Site of the NMDA Receptor: a Parallel Synthesis Approach ChemMedChem, 8 (1): 82-94
  | Article (PDF) || Weblink |
• Maj M, Milenkovic I, Bauer J, Berggard T, Veit M, Ilhan-Mutlu A, Wagner L, Tretter V (2012) Novel insights into the distribution and functional aspects of the calcium binding protein Secretagogin from studies on rat brain and primary neuronal cell culture Front Mol Neurosci, 5: Article 84
  | Supplement |
• Seeger C, Christopeit T, Fuchs K, Grote K, Sieghart W, Danielson UH (2012) Histaminergic pharmacology of homo-oligomeric beta3 gamma-aminobutyric acid type A receptors characterized by surface plasmon resonance biosensor technology Biochem Pharmacol, 84: 341-355
• Tretter V, Mukherjee J, Maric HM, Schindelin H, Sieghart W, Moss SJ (2012) Gephyrin, the enigmatic organizer at GABAergic synapses Front Cell Neurosci, 6: 1-16
• Sarto-Jackson I, Milenkovic I, Smalla K-H, Gundelfinger ED, Kaehne T, Herrera-Molina R, Thomas S, Kiebler MA, Sieghart W (2012) The cell adhesion molecule neuroplastin-65 is a novel interaction partner of gamma-aminobutyric acid type A receptors J Biol Chem, 287: 14201-14214
  | Supplement |
• Richter L, de Graaf C, Sieghart W, Varagic Z, Mörzinger M, de Esch IJP, Ecker GF, Ernst M (2012) Diazepam-bound GABA-A receptor models identify new benzodiazepine binding site ligands Nature Chem Biol, 8: 455-464
• Sieghart W, Ramerstorfer J, Sarto-Jackson I, Varagic Z, Ernst M (2012) A novel GABA-A receptor pharmacology: drugs interacting with the alpha+beta-interface Br J Pharmacol, 166: 476-485
• Vasiljevic M, Heisler FF, Hausrat TJ, Fehr S, Milenkovic I, Kneussel M, Sieghart W (2012) Spatio-temporal expression analysis of the calcium-binding protein calumenin in the rodent brain Neuroscience, 202: 29-41

• Shrivastava AN, Triller A, Sieghart W (2011) GABA-A receptors: post-synaptic co-localization and cross-talk with other receptors Front Cell Neurosci, 5,7: Epub June 2011
• Maric HM, Mukherjee J, Tretter V, Moss SJ, Schindelin H (2011) Gephyrin-Mediated GABA(A) and Glycine Receptor Clustering Relies on a Common Binding Site J Biol Chem, 286 (49): 42105-14
• Mukherjee J, Kretschmannova K, Gouzier G, Maric H, Schindelin H, Ramsden S, Tretter V, Harvey K, Davies P, Triller A, Moss SJ (2011) The residence time of GABAARs at inhibitory synapses is determined by direct binding of the receptor alpha1 subunit to gephyrin J Neurosci, 31 (41): 14677-14687
• Tretter V, Kerschner B, Milenkovic I, Ramsden SL, Ramerstorfer J, Saiepour L, Maric HM, Moss SJ, Schindelin H, Harvey RJ, Sieghart W, Harvey K (2011) Molecular basis of the GABA-A receptor alpha3 subunit interaction with the clustering protein gephyrin J Biol Chem, 286 (43): 37702-37711
• Shrivastava AN, Triller A, Sieghart W, Sarto-Jackson I (2011) Regulation of GABA-A receptor dynamics by interaction with P2X-2 receptors J Biol Chem, 286: 14455-14468
• Ramerstorfer J, Furtmüller R, Sarto-Jackson I, Varagic Z, Sieghart W, Ernst M (2011) The GABA-A receptor alpha+beta-interface: a novel target for subtype-selective drugs J Neurosci, 31: 870-877
• Schosser A, Schloegelhofer M, Fuchs K, Stojanovic M, Mossaheb N, Kindler J, Cohen-Woods S, Hosang G, Farmer A, Craig I, McGuffin P, Aschauer H (2011) Bipolar disorder susceptibility region on chromosome 3q29 not confirmed in a case-control association study World J Biol Psychiat, 12: 309-315
• Kindler J, Bailer U, De Zwaan M, Fuchs K, Leisch F, Grün B, Strnad A, Stojanovic M, Windisch J, Lennkh-Wolfsberg, El-Giamal N, Sieghart W, Kasper S, Aschauer H (2011) No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with eating disorders Nordic Journal of Psychiatry, 65: 203-207

• Abramian AM, Comenencia-Ortiz E, Vithlani M, Tretter V, Sieghart W, Davies PA, Moss SJ (2010) Protein kinase C phosphorylation regulates membrane insertion of GABA-A receptor subtypes that mediate tonic inhibition J Biol Chem, 285: 41795-41805
• Fischer BD, Licata SC, Edwankar RV, Wang ZJ, Huang S, He X, Yu J, Zhou H, Johnson EM Jr, Cook JM, Furtmüller R, Ramerstorfer J, Sieghart W, Roth BL, Majumder S, Rowlett JK (2010) Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure Neuropharmacology, 59: 612-618
• Jurd R, Tretter V, Walker J, Brandon NJ, Moss SJ (2010) Fyn kinase contributes to tyrosine phosphorylation of the GABA-A receptor gamma2 subunit Mol Cell Neurosci, 44(2): 129-134
• Savic MM, Majumder S, Huang SM, Edwankar RV, Furtmüller R, Joksimovic S, Clayton T, Ramerstorfer J, Milinkovic MM, Roth BL, Sieghart W, Cook JM (2010) Novel positive allosteric modulators of GABA-A receptors: Do subtle differences in activity at alpha1 plus a5 versus a2 plus a3 subunits account for dissimilarities in behavioural effects in rats? Progr Neuro-Psychopharmacol & Biol Psychiat, 34: 376-386
  | Article (PDF) |
• Ramerstorfer J, Furtmüller R, Vogel E, Huck S, Sieghart W (2010) The point mutation gamma2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes Eur J Pharmacol, 636: 18-27
  | Article (PDF) |
• David R, Ciuraszkiewicz A, Simeone X, Orr-Urtreger A, Papke RL, McIntosh JM, Huck S, Scholze P (2010) Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes Eur J Neurosci, 6: 978-993
  | Article (PDF): 1 2 |

• Tretter V, Revilla-Sanchez R, Houston C, Terunuma M, Havekes R, Florian C, Jurd R, Vithlani M, Michels G, Couve A, Sieghart W, Brandon N, Abel T, Smart T, Moss S (2009) Deficits in spatial memory correlate with modified y-aminobutyric acid type A receptor tyrosine phosphorylation in the hippocampus Proc Natl Acad Sci USA, 106: 20039-20044
• Rivas FM, Stables JP, Murphree L, Edwankar RV, Edwankar CR, Huang S, Jain HD, Zhou H, Majumder S, Sankar S, Roth BL, Ramerstorfer J, Furtmüller R, Sieghart W, Cook JM (2009) Antiseizure activity of novel gamma-aminobutyric acid(A) receptor subtype-selective benzodiazepine analogues in mice and rat models J Med Chem, 52: 1795-1798
  | Article (PDF) |

• Savic MM, Clayton T, Furtmüller R, Gavrilovic I, Samardzic J, Savic S, Huck S, Sieghart W, Cook JM (2008) PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA-A receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats Brain Res, 1208: 150-159
  | Article (PDF) |
• Han D, Försterling FH, Li X, Deschamps JR, Parrish D, Cao H, Rallapalli S, Clayton T, Teng Y, Majumder S, Sankar S, Roth BL, Sieghart W, Furtmüller R, Rowlett J, Weed MR, Cook JM (2008) A study of the structure-activity relationship of GABA-A-benzodiazepine receptor bivalent ligands by conformational analysis with low temperature NMR and X-ray analysis Bioorg Med Chem, 16: 8853-8862
  | Article (PDF) |
• Furtmüller R, Furtmüller B, Ramerstorfer J, Paladini AC, Wasowski C, Marder M, Huck S, Sieghart W (2008) 6,3'-Dinitroflavone is a low efficacy modulator of GABA(A) receptors Eur J Pharmacol, 591: 142-146
  | Article (PDF) |

• Sarto-Jackson I, Sieghart W (2008) Assembly of GABA-A receptors Mol Membr Biol, 25: 302-310
  | Article (PDF) |

• Pytel M, Wojtowicz T, Mercik K, Sarto-Jackson I, Sieghart W, Ikonomidou C, Mozrzymas JW (2007) 17 beta-estradiol modulates GABAergic synaptic transmission and tonic currents during development in vitro Neuropharmacology, 52: 1342-1353
  | Article (PDF) |
• Sarto-Jackson I, Furtmüller R, Ernst M, Huck S, Sieghart W (2007) Spontaneous cross-link of mutated alpha1 subunits during GABA-A receptor assembly J Biol Chem, 282: 4354-4363
  | Article (PDF) |

• Urak L, Feucht M, Fathi N, Hornik K, Fuchs K (2006) A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity Hum Mol Genet, 15: 2533-2541
• Payne HL, Donoghue PS, Connelly WMK, Hinterreiter S, Tiwari P, Ives JH, Hann V, Sieghart W, Lees G, Thompson CL (2006) Aberrant GABA-A receptor expression in the dentate gyrus of the epileptic mutant mouse, stargazer J Neurosci, 26: 8600-8608
  | Article (PDF) |
• Sarto-Jackson I, Ramerstorfer J, Ernst M, Sieghart W (2006) Identification of amino acid residues important for assembly of GABA-A receptor alpha1 and gamma2 subunits J Neurochem, 96: 983-995
  | Article (PDF) |

• Ehya N, Sarto I, Wabnegger L, Klausberger T, and Sieghart W (2003) Identification of an amino acid sequence within GABAA receptor beta3 subunits that is important for receptor assembly J Neurochem, 84: 127-135
• Pirker S, Schwarzer C, T. Czech T, Baumgartner C, Pockberger H, Maier H, Hauer B, Sieghart W, Furtinger S, and Sperk G (2003) Increased expression of GABAA receptor beta-subunits in the hippocampus of patients with temporal lobe epilepsy J Neuropath Exp Neurol, 62: 820-834
• Pöltl A, Hauer B, Fuchs K, Tretter V, Sieghart W (2003) Subunit composition and quantitative importance of GABAA receptor subtypes in the cerebellum of mouse and rat. J Neurochem, 87: 1444-1455

• Sarto I, Wabnegger L, Dögl E, Sieghart W (2002) Homologous sites of GABA-A receptor alpha1, beta3 and gamma2 subunits are important for assembly Neuropharmacology, 43: 482-491
• Wisden W, Cope D, Klausberger T, Hauer B, Sinkkonen S T, Tretter V, Lujan R, Jones A, Korpi E R, Mody I, Sieghart W, Somogyi P, (2002) Ectopic expression of the GABA-A receptor alpha 6 subunit in hippocampal pyramidal neurons produces extrasynaptic receptors and an increased tonic inhibition. Neuropharmacology, 43: 530-549
• Sarto I, Klausberger T, Ehya N, Mayer B, Fuchs K, Sieghart W (2002) A novel site on gamma3 subunits important for assembly of GABA-A receptors J Biol Chem, 277: 30656-30664
• El Hadri A, Abouabdellah A, Thomet U, Baur R, Furtmüller R, Sigel E, Sieghart W, Dodd RH (2002) N-Substituted 4-amino-3,3-dipropyl-2(3H)-furanones: new positive allosteric modulators of the GABA-A receptor sharing electrophysiological properties with the anticonvulsant loreclezole J Med Chem, 45: 2824-2831
• Peng Z, Hauer B, Mihalek RM, Homanics GE, Sieghart W, Olsen RW, Houser CR (2002) GABA-A receptor changes in delta subunit-deficient mice: altered expression of alpha4 and gamma2 subunits in the forebrain J Comp Neurol, 446: 179-197
• Korpi ER, Mihalek RM, Sinkkonen ST, Hauer B, Hevers W, Homanics GE, Sieghart W, Lüddens H (2002) Altered receptor subtypes in the forebrain of GABA-A receptor delta subunit-deficient mice: recruitment of gamma2 subunits Neuroscience, 109: 733-743
• Furtmüller R, Schlag MG, Berger M L, Hopf R, Huck S, Sieghart W, Redl H (2002) Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid-A-receptor antagonistic effect J Pharmacol Exp Ther, 301: 168-173

• Sigel E, Baur R, Furtmüller R, Razet R, Dodd RH, Sieghart W (2001) Differential cross talk of ROD compounds with the benzodiazepine binding site Mol Pharmacol, 59: 1470-1477
• Klausberger T, Ehya N, Fuchs K, Fuchs T, Ebert V, Sarto I, Sieghart W (2001) Detection and binding properties of GABA-A receptor assembly intermediates J Biol Chem, 276: 16024-16032
• Tretter V, Hauer B, Nusser Z, Mihalek RM, Höger H, Homanics GE, Somogyi P, Sieghart W (2001) Targeted disruption of the GABA(A) receptor delta subunit gene leads to an upregulation of gamma 2 subunit containing receptors in cerebellar granule cells J Biol Chem, 276: 10532-10538
• Klausberger T, Sarto I, Ehya N, Fuchs K, Furtmüller R, Mayer B, Huck S, Sieghart W (2001) Alternate use of distinct intersubunit contacts controls GABA-A receptor assembly and stoichiometry J Neurosci, 21: 9124-9133

• Razet R, Thomet U, Furtmüller R, Chiaroni A, Sigel E, Sieghart W, Dodd RH (2000) 5-{1´-(2´,3´,4´-tetrahydroisoquinolyl)}-4,5-dihydro-2(3H)-furanones: positive allosteric modulators of the GABA-A receptor with a new mode of acion J Med Chem, 43: 4363-4366
• Meszaros K, Lenzinger E, Hornik K, Füreder T, Stompe T, Willinger U, Heiden A, Fathi N, Gerhard E, Fuchs K, Sieghart W, Kasper S, Aschauer HN (2000) Association study of schizophrenia spectrum disorders and dopamine D3 receptor gene: is schizoaffective disorder special? Psychiat Res, 96: 179-183
• Razet R, Thomet U, Furtmüller R, Jursky F, Sigel E, Sieghart W, Dodd RH (2000) Use of bicuculline, a GABA antagonist, as a template for the development of a new class of ligands showing positive allosteric modulation of the GABA-A receptor Bioorg Med Chem Lett, 10: 2579-2583
• Thomet U, Baur R, Razet R, Dodd RH, Furtmüller R, Sieghart W, Sigel E (2000) A novel positive allosteric modulator of the GABA-A receptor: the action of (+)-ROD188 Br J Pharmacol, 131: 843-850
• Uusi-Oukari M, Heikkila J, Sinkkonen ST, Makelä R, Hauer B, Homanics GE, Sieghart W, Wisden W, Korpi ER (2000) Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABA-A receptor beta2-alpha6-alpha1-gamma2 subunit gene cluster Mol Cell Neurosci, 16: 34-41
• Nicoletti D, Ghini AA, Furtmüller R, Sieghart W, Dodd RH, Burton G (2000) Synthesis and GABA-A receptor activity of 6-oxa-analogs of neurosteroids Steroids, 65: 349-356
• Jursky F, Fuchs K, Buhr A, Tretter V, Sigel E, Sieghart W (2000) Identification of aminoacid residues of GABA(A) receptor subunits contributing to the formation and affinity of the tert-butylbicyclophosphorothionate binding site J Neurochem, 74: 1310-1316

• Thomet U, Furtmüller R, Sieghart W, Le Hyaric-Almeida M, Rousseau JF, Dodd RH, Venault P, Chapouthier G, Sigel E (1999) EDPC: a novel high affinity ligand for the benzodiazepine site on rat GABA-A receptors Neurosci Lett, 269: 63-66
• Bencits E, Ebert V, Tretter V, Sieghart W, (1999) A significant part of native gamma-aminobutyric acid-A receptors containing alpha4 do not contain gamma or delta subunits J Biol Chem, 274: 19613-19616
• Nusser Z, Ahmad Z, Tretter V, Fuchs K, Wisden W, Sieghart W, Somogyi P (1999) Alterations in the expression of GABA-A receptor subunits in cerebellar granule cells after the disruption of the alpha6 subunit gene Eur J Neurosci, 11: 1685-1697
• Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi Z, Lagenaur C, Tretter V, Sieghart W, Anagnostaras SG, Sage JR, Fanselow MS, Guidotti A, DeLorey TM, Olsen RW, Homanics GE (1999) Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice PNAS, 96: 12905-12910

• Sieghart W, Fuchs K, Tretter V, Eber V, Jechlinger M, Höger H, Adamiker D (1999) Structure and subunit composition of GABA-A receptors Neurochem Internat, 34: 379-385

• Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K, Sieghart W, Meszaros K, Fathi N, Laurent C, Mallet J, Macciardi F, Pedrini S, Gill M, Hawi Z, Gibson S, Adolfsson R, Owen MJ (1998) European Multicentre Association Study of Schizophrenia: A study of the DRD2Ser311Cys and DRD3Ser9Gly Polymorphisms Am J Med Genet, 81: 24-28

• Tretter V, Ehya N, Fuchs K, Sieghart W (1997) Stoichiometry and assembly of a recombinant GABA-A receptor subtype J Neurosci, 17: 2728-2737

• Meszaros K, Lenzinger E, Füreder T, Hornik K, Willinger U, Stompe T, Heiden AH, Resinger E, Fathi N, Gerhard E, Fuchs K, Miller-Reiter E, Pfersmann V, Sieghart W, Aschauer HN, Kasper S (1996) Schizophrenia and the dopamine-beta-hydroxylase gene: results of a linkage and association study Psychiat Gen, 6: 17-22

• Singh M, Zhao Y, Gastaldi V, Wojcik S, Curto Y, Kawaguchi R, Merino RM, Garcia-Agudo L, Taschenberger H, Brose N, Geschwind D, Nave K, Ehrenreich H (2023) Erythropoietin re-wires cognition-associated transcriptional networks Nat Commun, 14 (1)
• Qin Y, Mahdavi A, Bertschy M, Anderson P, Kulikova S, Pinault D (2023) The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network Eur J Neurosci, 57 (3): 440-455
  | Weblink |
• Forro T, Klausberger T (2023) Differential behavior-related activity of distinct hippocampal interneuron types during odor-associated spatial navigation Neuron, 111: 1-15
  | Weblink |
• Malagon-Vina H, Ciocchi S, Klausberger T (2023) Firing patterns of ventral hippocampal neurons predict the exploration of anxiogenic locations eLife, 12
  | Article (PDF) || Weblink |
• Hanganu-Opatz I, Klausberger T, Sigurdsson T, Nieder A, Jacob S, Bartos M, Sauer J, Durstewitz D, Leibold C, Diester I (2023) Resolving the prefrontal mechanisms of adaptive cognitive behaviors: A cross-species perspective Neuron, 111 (7): 1020-1036
  | Article (PDF) || Weblink |
• Zakani M, Nigritinou M, Ponleitner M, Takai Y, Hofmann D, Hillebrand S, Höftberger R, Bauer J, Lasztoczi B, Misu T, Kasprian G, Rommer P, Bradl M (2023) Paths to hippocampal damage in neuromyelitis optica spectrum disorders Neuropathol Appl Neurobiol, 49 (2)
  | Article (PDF) || Weblink |

• Bernhard Hochreiter, Hugo Malagon-Vina, Johannes A. Schmid, Johannes Berger and Markus Kunze (2022) Studying the interaction between PEX5 and its full-length cargo proteins in living cells by a novel Förster´s resonance energy transfer-based competition assay Front Cell Dev Biol,
  | Weblink |
• Forro T, Volitaki E, Malagon-Vina H, Klausberger T, Nevian T, Ciocchi S (2022) Anxiety-related activity of ventral hippocampal interneurons Prog.Neurobiol., 219: 102368
  | Weblink |
• Sakalar E, Klausberger T, Lasztóczi B (2022) Neurogliaform cells dynamically decouple neuronal synchrony between brain areas Science, 377 (6603): 324-328
  | Article (PDF) || Weblink |

• Merino RM, Leon-Pinzon C, Stühmer W, Möck M, Staiger J, Wolf F, Neef A (2021) Theta activity paradoxically boosts gamma and ripple frequency sensitivity in prefrontal interneurons PNAS, 118 (51)

• Nestvogel D, Merino RM, Leon-Pinzon C, Schottdorf M, Lee C, Imig C, Brose N, Rhee J (2020) The Synaptic Vesicle Priming Protein CAPS-1 Shapes the Adaptation of Sensory Evoked Responses in Mouse Visual Cortex Cell Rep, 30 (10): 3261-3269.e4
• Anner P, Passecker J, Klausberger T, Dorffner G (2020) Ca2+ imaging of neurons in freely moving rats with automatic post hoc histological identification J. Neurosci. Methods, 341: 108765
  | Article (PDF) || Weblink |
• Katona L, Hartwich K, Tomioka R, Somogyi J, Roberts J, Wagner K, Joshi A, Klausberger T, Rockland K, Somogyi P (2020) Synaptic organisation and behaviour-dependent activity of mGluR8a-innervated GABAergic trilaminar cells projecting from the hippocampus to the subiculum Brain Struct Funct, 225 (2): 705-734
  | Article (PDF) || Weblink |
• Ozdemir AT, Lagler M, Lagoun S, Malagon-Vina H, Lasztóczi B, Klausberger T (2020) Unexpected Rule-Changes in a Working Memory Task Shape the Firing of Histologically Identified Delay-Tuned Neurons in the Prefrontal Cortex Cell Rep, 30 (5): 1613-1626.e4
  | Article (PDF) || Weblink |

• Guzman S, Schlögl A, Espinoza C, Zhang X, Suter B, Jonas P (2019) Fast signaling and focal connectivity of PV+ interneurons ensure efficient pattern separation by lateral inhibition in a full-scale dentate gyrus network model bioRxiv,
  | Article (PDF) || Supplement |
• Biró S, Lasztóczi B, Klausberger T (2019) A Visual Two-Choice Rule-Switch Task for Head-Fixed Mice Front Behav Neurosci, 13: 119
  | Weblink |
• Passecker J, Mikus N, Malagon-Vina H, Anner P, Dimidschstein J, Fishell G, Dorffner G, Klausberger T (2019) Activity of Prefrontal Neurons Predict Future Choices during Gambling Neuron, 101 (1): 152-164.e7
  | Weblink |

• Keppeler* D, Merino* RM, Lopez de la Morena* D, Bali B, Huet A, Gehrt A, Wrobel C, Subramanian S, Dombrowski T, Wolf F, Rankovic V, Neef A, Moser T (2018) Ultrafast optogenetic stimulation of the auditory pathway by targeting‐optimized Chronos Embo Journ, 37 (24)
• Kasper S, Sachs GM (2018) Österreichische Konsensus-Dokumente – Psychopharmakologie. Sammelband der ÖGPB 2005–2018 CliniCum neuropsy, Sonderausgabe 2018
• Espinoza C, Guzman S, Zhang X, Jonas P (2018) Parvalbumin+ interneurons obey unique connectivity rules and establish a powerful lateral-inhibition microcircuit in dentate gyrus Nat Commun, 9 (1)
  | Article (PDF) || Supplement |
• Unal G, Crump M, Viney T, Éltes T, Katona L, Klausberger T, Somogyi P (2018) Spatio-temporal specialization of GABAergic septo-hippocampal neurons for rhythmic network activity Brain Struct Funct, 223 (5): 2409-2432
  | Weblink |
• Valenti O, Mikus N, Klausberger T (2018) The cognitive nuances of surprising events: exposure to unexpected stimuli elicits firing variations in neurons of the dorsal CA1 hippocampus Brain Struct Funct, 223 (7): 3183-3211
  | Article (PDF) |
• Kőszeghy Á, Lasztóczi B, Forro T, Klausberger T (2018) Spike-Timing of Orbitofrontal Neurons Is Synchronized With Breathing Front Cell Neurosci, 12: 105
  | Weblink |
• Malagon-Vina H, Ciocchi S, Passecker J, Dorffner G, Klausberger T (2018) Fluid network dynamics in the prefrontal cortex during multiple strategy switching Nat Commun, 9 (1): 309
  | Weblink |

• Weidenauer A, Sauerzopf U, Bartova L, Bauer M, Praschak-Rieder N, Kasper S, Willeit M (2018) Sensibilisierung auf Amphetamine: Bedeutung für die Schizophrenie- und Suchtforschung Journal für Neurologie, Neurochirurgie und Psychiatrie, 19 (2): 66-der 71
  | Weblink |

• Katona L, Micklem B, Borhegyi Z, Swiejkowski D, Valenti O, Viney T, Kotzadimitriou D, Klausberger T, Somogyi P (2017) Behavior-dependent activity patterns of GABAergic long-range projecting neurons in the rat hippocampus Hippocampus, 27 (4): 359-377
  | Weblink |
• Lasztóczi B, Klausberger T (2017) Distinct gamma oscillations in the distal dendritic fields of the dentate gyrus and the CA1 area of mouse hippocampus Brain Struct Funct, 222 (7): 3355-3365
  | Article (PDF) |

• Kasper S (2017) Vorwort. In: , Forensische Psychodiagnostik und Psychotherapie im Strafvollzug Facultas Verlag

• Fuenzalida M, Espinoza C, Pérez M, Tapia-Rojas C, Cuitino L, Brandan E, Inestrosa N (2016) Wnt signaling pathway improves central inhibitory synaptic transmission in a mouse model of Duchenne muscular dystrophy Neurobiol Dis, 86: 109-120
  | Supplement |
• Lagler M, Ozdemir A, Lagoun S, Malagon-Vina H, Borhegyi Z, Hauer R, Jelem A, Klausberger T (2016) Divisions of Identified Parvalbumin-Expressing Basket Cells during Working Memory-Guided Decision Making Neuron, 91 (6): 1390-1401
  | Weblink |
• Lasztóczi B, Klausberger T (2016) Hippocampal Place Cells Couple to Three Different Gamma Oscillations during Place Field Traversal Neuron, 91 (1): 34-40
  | weblink |

• da Silva* M, Merino* RM, Mecawi A, Moraes D, Varanda W (2015) In vitro differentiation between oxytocin- and vasopressin-secreting magnocellular neurons requires more than one experimental criterion Mol Cell Endocrinol, 400: 102-111
• Elisa L. Hill-Yardin, Andrew Argyropoulos, Suzanne Hosie, Gil Rind, Paul Anderson, Anthony J.Hannan, Terence J.O’Brien (2015) Reduced susceptibility to induced seizures in the Neuroligin-3R451C mouse model of autism Neurosci Lett, 589: 57-61
• Vandael D, Espinoza C, Jonas P (2015) Excitement about Inhibitory Presynaptic Terminals Neuron, 85 (6): 1149-1151
  | Article (PDF) || Supplement |
• Forro T, Valenti O, Lasztoczi B, Klausberger T (2015) Temporal Organization of GABAergic Interneurons in the Intermediate CA1 Hippocampus During Network Oscillations Cereb. Cortex, 25 (5): 1228-1240
  | Weblink |
• Ciocchi S, Passecker J, Malagon-Vina H, Mikus N, Klausberger T (2015) Selective information routing by ventral hippocampal CA1 projection neurons Science, 348 (6234): 560-563
  | Weblink |

• Paul M. Anderson, Didier Pinault, Terence J. O'Brien, Nigel C. Jones (2014) Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical γ oscillations Int. J. Neuropsychopharmacol., 17: 1895–1904
• Arszovszki A, Borhegyi Z, Klausberger T (2014) Three axonal projection routes of individual pyramidal cells in the ventral CA1 hippocampus Front Neuroanat, 8
  | Weblink |
• Katona L, Lapray D, Viney T, Oulhaj A, Borhegyi Z, Micklem B, Klausberger T, Somogyi P. (2014) Sleep and Movement Differentiates Actions of Two Types of Somatostatin-Expressing GABAergic Interneuron in Rat Hippocampus Neuron, 82 (4): 872-886
  | Weblink |
• Lasztoczi B, Klausberger T. (2014) Layer-Specific GABAergic Control of Distinct Gamma Oscillations in the CA1 Hippocampus. Neuron, 81: 1126-1139
  | Weblink |
• Somogyi P, Katona L, Klausberger T, Lasztoczi B, Viney TJ. (2014) Temporal redistribution of inhibition over neuronal subcellular domains underlies state-dependent rhythmic change of excitability in the hippocampus. Phil. Trans. R. Soc., 369: 20120518

• Viney TJ, Lasztoczi B, Katona L, Crump MG, Tukker JJ, Klausberger T, Somogyi P. (2013) Network state-dependent inhibition of identified hippocampal CA3 axo-axonic cells in vivo. Nature Neurosci, 16: 1802-11
  | Weblink |
• Tukker JJ, Lasztóczi B, Katona L, Roberts JD, Pissadaki EK, Dalezios Y, Márton L, Zhang L, Klausberger T, Somogyi P. (2013) Distinct dendritic arborization and in vivo firing patterns of parvalbumin-expressing basket cells in the hippocampal area CA3. J Neurosci, 33 (16): 6809-25
• Milenkovic I, Vasiljevic M, Maurer D, Höger H, Klausberger T, Sieghart W. (2013) The parvalbumin-positive interneurons in the mouse dentate gyrus express GABAA receptor subunits alpha1, beta2, and delta along their extrasynaptic cell membrane. Neuroscience, 254: 80-96
  | Weblink |

• Nigel C. Jones, Maya Reddy, Paul Anderson, Michael R. Salzberg, Terence J. O'Brien, Didier Pinault (2012) Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power Int. J. Neuropsychopharmacol., 15: 657–668
• Massi L, Lagler M, Hartwich K, Borhegyi Z, Somogyi P, Klausberger T, (2012) Temporal Dynamics of Parvalbumin-Expressing Axo-axonic and Basket Cells in the Rat Medial Prefrontal Cortex In Vivo. J Neurosci, 32: 16496-16502
  | Weblink |
• Lapray D, Lasztoczi B, Lagler M, Viney TJ, Katona L, Valenti O, Hartwich K, Borhegyi Z, Somogyi P, Klausberger T, (2012) Behavior-dependent specialization of identified hippocampal interneurons. Nature Neurosci, 15: 1265-71
  | Weblink |
• Takács VT, Klausberger T, Somogyi P, Freund TF, Gulyás AI, (2012) Extrinsic and local glutamatergic inputs of the rat hippocampal CA1 area differentially innervate pyramidal cells and interneurons. Hippocampus, 22: 1379-91
  | Weblink |

• Lasztoczi B, Tukker JJ, Somogyi P, Klausberger T, (2011) Terminal Field and Firing Selectivity of Cholecystokinin-Expressing Interneurons in the Hippocampal CA3 Area. J Neurosci, 31: 18073-93
  | Weblink |

• Fuentealba P, Klausberger T, Karayannis T, Suen W Y, Huck J, Tomioka R, Rockland K, Capogna M, Studer M, Morales M, Somogyi P, (2010) Expression of COUP-TFII Nuclear Receptor in Restricted GABAergic Neuronal Populations in the Adult Rat Hippocampus. J Neurosci, 30: 1595-1609

• Hartwich K, Pollak T, Klausberger T, (2009) Distinct firing patterns of identified basket and dendrite-targeting interneurons in the prefrontal cortex during hippocampal theta and local spindle oscillations. J Neurosci, 29: 9563-9574

• Klausberger T, (2009) GABAergic interneurons targeting dendrites of pyramidal cells in the CA1 area of the hippocampus. Eur J Neurosci, 30: 947-957

• Fuentealba P, Tomioka R, Dalezios Y, Marton L, Studer M, Rockland K, Klausberger T, Somogyi P, (2008) Rhythmically active enkephalin-expressing GABAergic cells in the CA1 area of the hippocampus project to the subiculum and preferentially innervate interneurons. J Neurosci, 28: 10017-10022
• Fuentealba P, Begum R, Capogna M, Jinno S, Márton L F, Csicsvari J, Thomson A, Somogyi P, Klausberger T, (2008) Ivy cells: a population of nitric-oxide-producing, slow-spiking GABAergic neurons and their involvement in hippocampal network activity. Neuron, 57: 917-929

• Klausberger T, Somogyi P, (2008) Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science, 321: 53-57

• Tukker J, Fuentealba P, Hartwich K, Somogyi P, Klausberger T, (2007) Cell type-specific tuning of hippocampal interneuron firing during gamma oscillations in vivo. J Neurosci, 27: 8184-8189
• Jinno S, Klausberger T, Marton L F, Dalezios Y, Roberts J D B, Fuentealba P, Bushong E A, Henze D, Buzsáki G, Somogyi P, (2007) Neuronal diversity in GABAergic Long-range Projections from the Hippocampus. J Neurosci, 27: 8790-8804
• Baude A, Bleasdale C, Dalezios Y, Somogyi P, Klausberger T, (2007) Immunoreactivity for the GABA-A receptor alpha 1 subunit, somatostatin and connexin36 distinguishes axo-axonic, basket and bistratified interneurons of the rat hippocampus. Cereb. Cortex, 17: 2094-2107

• Ferraguti F, Klausberger T, Cobden P, Baude A, Roberts J D B, Szucs P, Kinoshita A, Shigemoto R, Somogyi P, Dalezios Y, (2005) Metabotropic glutamate receptor 8-expressing nerve terminals target subsets of GABAergic neurons in the hippocampus. J Neurosci, 25: 10520-10536
• Klausberger T, Marton L F, O’Neill J, Huck J H J, Dalezios Y, Fuentealba P, Suen W Y, Papp E, Kaneko T, Watanabe M, Csicsvari J, Somogyi P, (2005) Complementary roles of cholecystokinin and parvalbumin expressing GABAergic neurons in hippocampal network oscillations. J Neurosci, 25: 9782-9793

• Somogyi P, Klausberger T, (2005) Defined types of cortical interneuron structure space and spike timing in the hippocampus. J Physiol, 562: 9-26

• Klausberger T, Márton L F, Baude A, Roberts J.D.B, Magill P J, Somogyi P, (2004) Spike timing of dendrite-targeting bistratified cells during hippocampal network oscillations in vivo. Nature Neurosci, 7: 41-47

• Klausberger T, Magill P J, Márton L F, Roberts J.D.B, Cobden P M, Buzsáki G, Somogyi P, (2003) Brain state- and cell type-specific firing of hippocampal interneurons in vivo. Nature, 421: 844-848

• Ehya N, Sarto I, Wabnegger L, Klausberger T, Sieghart W (2002) Identification of an amino acid sequence within GABAA receptor β3 subunits that is important for receptor assembly J Neurochem, 84 (1): 127-135
  | Weblink |
• Wisden W, Cope D, Klausberger T, Hauer B, Sinkkonen S T, Tretter V, Lujan R, Jones A, Korpi E R, Mody I, Sieghart W, Somogyi P, (2002) Ectopic expression of the GABA-A receptor alpha 6 subunit in hippocampal pyramidal neurons produces extrasynaptic receptors and an increased tonic inhibition. Neuropharmacology, 43: 530-549
• Klausberger T, Roberts J.D.B, Somogyi P, (2002) Cell type and input specific differences in the number and subtypes of synaptic GABA-A receptors in the hippocampus. J Neurosci, 22: 2513-2521
• Sarto I, Klausberger T, Ehya N, Mayer B, Fuchs K, Sieghart W (2002) A novel site on gamma3 subunits important for assembly of GABA-A receptors J Biol Chem, 277: 30656-30664

• Klausberger T, Ehya N, Fuchs K, Fuchs T, Ebert V, Sarto I, Sieghart W (2001) Detection and binding properties of GABA-A receptor assembly intermediates J Biol Chem, 276: 16024-16032
• Klausberger T, Sarto I, Ehya N, Fuchs K, Furtmüller R, Mayer B, Huck S, Sieghart W (2001) Alternate use of distinct intersubunit contacts controls GABA-A receptor assembly and stoichiometry J Neurosci, 21: 9124-9133

• Klausberger T, Fuchs K, Mayer B, Ehya N, Sieghart W (2000) GABA-A receptor assembly: Identification and structure of gamma2 sequences forming the intersubunit contacts with alpha1 and beta3 subunits J Biol Chem, 275: 8921-8928

• Jechlinger M, Pelz R, Tretter V, Klausberger T, Sieghart W, (1998) Subunit composition and quantitative importance of heterooligomeric receptors: GABA-A receptors containing alpha 6 subunits. J Neurosci, 18: 2449-2457

• Garcia Moreno S, Limani F, Ludwig I, Gilbert C, Pifl C, Hnasko T, Steinkellner T (2024) Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration Exp. Neurol., 382: 114959
• Zifko U, Guendling K, Seet R, Kasper S (2024) Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care Front. Pharmacol., 15: 1338235
  | Weblink |
• Bartova L, Fugger G, Dold M, Kautzky A, Bairhuber I, Kloimstein P, Fanelli G, Zanardi R, Weidenauer A, Rujescu D, Souery D, Mendlewicz J, Zohar J, Montgomery S, Fabbri C, Serretti A, Kasper S (2024) The clinical perspective on late-onset depression in European real-world treatment settings Int. J. Neuropsychopharmacol., 84: 59-68
  | Weblink |
• Kasper S, Volz H, Möller H, Schläfke S, Klement S, Anghelescu I, Seifritz E (2024) Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial Eur Arch Psychiatry Clin Neurosci,
  | Weblink |
• Szodorai E, Hevesi Z, Wagner L, Hökfelt T, Harkany T, Schnell R (2024) A hydrophobic groove in secretagogin allows for alternate interactions with SNAP-25 and syntaxin-4 in endocrine tissues Proc Natl Acad Sci USA, 121: e2309211121
• Harkany T, Tretiakov E, Varela L, Jarc J, Rebernik P, Newbold S, Keimpema E, Verkhratsky A, Horvath T, Romanov R (2024) Molecularly stratified hypothalamic astrocytes are cellular foci for obesity Res Sq,
• Harkany T, Tretiakov E, Varela L, Jarc J, Rebernik P, Newbold S, Keimpema E, Verkhratsky A, Horvath T, Romanov R (2024) Molecularly stratified hypothalamic astrocytes are cellular foci for obesity Nature, preprint
• Benevento M, Alpár A, Gundacker A, Afjehi L, Balueva K, Hevesi Z, Hanics J, Rehman S, Pollak D, Lubec G, Wulff P, Prevot V, Horvath T, Harkany T (2024) A brainstem–hypothalamus neuronal circuit reduces feeding upon heat exposure Nature, online
• Hevesi Z, Bakker J, Tretiakov E, Adori C, Raabgrund A, Barde S, Caramia M, Krausgruber T, Ladstätter S, Bock C, Hökfelt T, Harkany T (2024) Transient expression of the neuropeptide galanin modulates peripheral‑to‑central connectivity in the somatosensory thalamus during whisker development in mice Nat Commun, 15 : 2762
• Oliva V, Martone A, Fanelli G, Domschke K, Minelli A, Gennarelli M, Martini P, Bortolomasi M, Maron E, Squassina A, Pisanu C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Baune B, Serretti A, Fabbri C, Potier M, van Westrhenen R, Rybakowski F, Mehta D, Dierssen M, Janzing J, Liò P (2024) Polygenic scores of subcortical brain volumes as possible modulators of treatment response in depression Neuroscience Applied, 3: 103937
  | Weblink |
• Kadriu B, Deng Z, Kraus C, Johnston J, Fijtman A, Henter I, Kasper S, Zarate C (2024) The impact of body mass index on the clinical features of bipolar disorder: A STEP-BD study Bipolar Disorders, 26: 160-175
  | Weblink |

• Lochmann van Bennekom M, IntHout J, Gijsman H, Akdede B, Yağcıoğlu A, Barnes T, Galling B, Gueorguieva R, Kasper S, Kreinin A, Nielsen J, Nielsen R, Remington G, Repo-Tiihonen E, Schmidt-Kraepelin C, Shafti S, Xiao L, Correll C, Verkes R (2024) Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data Schizophr Res, 272: 1-11
  | Weblink |

• Wirth U, Raabe K, Kalaba P, Keimpema E, Muttenthaler M, König B (2023) Photoswitchable Probes of Oxytocin and Vasopressin J Med Chem, 66 (21): 14853-14865
• Caramia M, Romanov R, Sideromenos S, Hevesi Z, Zhao M, Krasniakova M, Xu Z, Harkany T, Hökfelt T (2023) Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus coeruleus Proc Natl Acad Sci USA, 120 (31)
• Romanov R, Harkany T (2023) Grabbing neuropeptide signals in the brain Science, 382 (6672): 764-765
  | Weblink |
• Spies M, Silberbauer L, Kasper S (2023) Letter to the editor refers to “Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression” Decision making in treatment resistant depression: appeal for an individualized approach. N Engl J Med, 389 (10): 960
  | Weblink |
• Kasper S, Eckert A, Möller H, Volz H, Seifritz E (2023) Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan Int J Psychiatry Clin Pract, 27 (3): 285-291
  | Weblink |
• Wegener T, Edwards D, Kasper S (2023) The potential role of Rhodiola rosea L. extract WS® 1375 for patients with post-COVID-19 fatigue hb TIMES Schw Aerztej, 8 (1): 56-61
  | Weblink |
• Buchmayer F, Kasper S (2023) Overcoming the myths of esketamine administration: different and not difficult Front Psychiatry, 14
  | Weblink |
• Kasper S (2023) Cheers and a thank-you note from the founding chief-editor Int J Psychiatry Clin Pract, 27 (4): 319-322
  | Weblink |
• McIntyre R, Alsuwaidan M, Baune B, Berk M, Demyttenaere K, Goldberg J, Gorwood P, Ho R, Kasper S, Kennedy S, Ly‐Uson J, Mansur R, McAllister‐Williams R, Murrough J, Nemeroff C, Nierenberg A, Rosenblat J, Sanacora G, Schatzberg A, Shelton R, Stahl S, Trivedi M, Vieta E, Vinberg M, Williams N, Young A, Maj M (2023) Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions World Psychiatry, 22 (3): 394-412
  | Weblink |
• Kautzky A, Bartova L, Fugger G, Dold M, Souery D, Montgomery S, Zohar J, Mendlewicz J, Fabbri C, Serretti A, Rujescu D, Kasper S (2023) Age as a moderating factor of treatment resistance in depression Eur Psychiatry, 66: ahead of print
  | Weblink |
• Dold M, Bartova L, Volz H, Seifritz E, Möller H, Schläfke S, Kasper S (2023) Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials Eur Arch Psychiatry Clin Neurosci, 273 (7): 1615-1628
  | Weblink |
• Stöhrmann P, Godbersen G, Reed M, Unterholzner J, Klöbl M, Baldinger-Melich P, Vanicek T, Hahn A, Lanzenberger R, Kasper S, Kranz G (2023) Effects of bilateral sequential theta-burst stimulation on functional connectivity in treatment-resistant depression: first results J Affect Disord, 324: 660-669
  | Weblink |
• Murgaš M, Unterholzner J, Stöhrmann P, Philippe C, Godbersen G, Nics L, Reed M, Vraka C, Vanicek T, Wadsak W, Kranz G, Hahn A, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R, Baldinger-Melich P (2023) Effects of bilateral sequential theta-burst stimulation on 5-HT1A receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial Transl Psychiat, 13 (1)
  | Weblink |
• Kraus C, Kautzky A, Watzal V, Gramser A, Kadriu B, Deng Z, Bartova L, Zarate C, Lanzenberger R, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fanelli G, Serretti A, Kasper S (2023) Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database J Affect Disord, 335: 349-357
  | Weblink |
• Bartova L, Fugger G, Dold M, Kautzky A, Fanelli G, Zanardi R, Albani D, Weidenauer A, Rujescu D, Souery D, Mendlewicz J, Montgomery S, Zohar J, Fabbri C, Serretti A, Kasper S (2023) Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder J Affect Disord, 332: 105-114
  | Weblink |
• Zupančič M, Tretiakov E, Máté Z, Erdélyi F, Szabó G, Clotman F, Hökfelt T, Harkany T, Keimpema E (2023) Brain‐wide mapping of efferent projections of glutamatergic (Onecut3+) neurons in the lateral mouse hypothalamus Acta Physiol (Oxf)., 238 (3)
  | Weblink |
• Cinquina V, Keimpema E, Pollak D, Harkany T (2023) Adverse effects of gestational ω‐3 and ω‐6 polyunsaturated fatty acid imbalance on the programming of fetal brain development Neuroendocrinology,
  | https://pubmed.ncbi.nlm.nih.gov/37497857/ |
• Pifl C, Reither H, Attems J, Zecca L (2023) Dopamine and vesicular monoamine transport loss supports incidental Lewy body disease as preclinical idiopathic Parkinson npj Parkinson's Disease, Jun 15;9(1):89
• Bhat S, El-Kasaby A, Kasture A, Boytsov D, Reichelt J, Hummel T, Sucic S, Pifl C, Freissmuth M, Sandtner W (2023) A mechanism of uncompetitive inhibition of the serotonin transporter eLife, 12/e82641
• Petersen J, Englmaier L, Artemov A, Poverennaya I, Mahmoud R, Bouderlique T, Tesarova M, Deviatiiarov R, Szilvásy-Szabó A, Akkuratov E, Pajuelo Reguera D, Zeberg H, Kaucka M, Kastriti M, Krivanek J, Radaszkiewicz T, Gömöryová K, Knauth S, Potesil D, Zdrahal Z, Ganji R, Grabowski A, Buhl M, Zikmund T, Kavkova M, Axelson H, Lindgren D, Kramann R, Kuppe C, Erdélyi F, Máté Z, Szabó G, Koehne T, Harkany T, Fried K, Kaiser J, Boor P, Fekete C, Rozman J, Kasparek P, Prochazka J, Sedlacek R, Bryja V, Gusev O, Adameyko I (2023) A previously uncharacterized Factor Associated with Metabolism and Energy (FAME/C14orf105/CCDC198/1700011H14Rik) is related to evolutionary adaptation, energy balance, and kidney physiology Nat Commun, 14 (1): 3092
• Kasper S (2023) Fluch oder Segen von Benzodiazepinen: neu bewertet Jatros Neurologie & Psychiatrie , : 5
• Kasper S (2023) Evidenzbasis pflanzlicher Arzneimittel in der Psychopharmakotherapie Psychopharmakotherap, 30: 11-20
• Oliva V, Fanelli G, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Fabbri C, Serretti A (2023) Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns J Affect Disord, 320: 534-543
  | Weblink |

• Harkany T, Hökfelt T (2023) Neuroglia: Function and Pathology by Alexei Verkhratsky and Arthur M. Butt Acta Physiol (Oxf)., 239 (2)
• Pallanti S, Zohar J, Kasper S, Möller H, Hollander E (2023) Revisiting benzodiazepines (GABA Enhancers):A transdiagnostic and precision medicine approach Psychiat Gen, 170: 65-72
  | Weblink |
• Bartova L, Lanzenberger R, Rujescu D, Kasper S (2023) Reply to: “The serotonin theory of depression: a systematic umbrella review of the evidence” published by Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA in Molecular Psychiatry (2022 Jul 20. doi: 10.1038/s41380-022-01661-0) Mol Psychiatry, 28 (8): 3153-3154
  | Weblink |
• Himmerich H, Lewis Y, Conti C, Mutwalli H, Karwautz A, Sjögren J, Uribe Isaza M, Tyszkiewicz-Nwafor M, Aigner M, McElroy S, Treasure J, Kasper S, Bailer U, Bulik C, Conti C, Zwaan M, Favaro A, Fernandez-Aranda F, Fetissov S, Hilbert A, Himmerich H, Wijbrand Hoek H, Kan C, Karpenko O, Karwautz A, Kasper S, Kaye W, Lewis Y, McElroy S, Mitchell J, Monteleone P, Mörkl S, Müller D, Mutwalli H, Nazar B, Papežová H, Sjögren J, Steiger H, Stein D, Szabo C, Tyszkiewicz-Nwafor M, Voderholzer U, Uribe Isaza M, Wade T, Wranik W, Yoshiuchi K, (2023) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders World J Biol Psychiatry, 24: 643-706
  | Weblink |
• Bartova L, Dold M, Fugger G, Weidenauer A, Rujescu D, Kasper S (2023) Silexan for treatment of anxiety and depression in the context of COVID-19 Eur Neuropsychopharmacol, 70: 47-48
  | Weblink |

• Inada K, Yamawaki S, Kanba S, Shinozaki G, Kasper S (2023) General Principles of Pharmacologic Therapy. In: Springer Verlag, Springer Verlag Heidelberg, New York Springer Verlag, Heidelberg, New York: ahead of print
  | Weblink |

• Steffens S, Bakker J, Glat M, Keimpema E, Pollak D, Hökfelt T, Harkany T (2022) 3D‐printed design of a stereotaxic adaptor for the precision targeting of brain structures in infant mice Eur J Neurosci, 55 (3): 725-732
• Krassnitzer M, Boisvert B, Beiersdorf J, Harkany T, Keimpema E (2022) Resident Astrocytes can Limit Injury to Developing Hippocampal Neurons upon THC Exposure Neurochem Res, 48 (4): 1242-1253
• Korchynska S, Rebernik P, Pende M, Boi L, Alpár A, Tasan R, Becker K, Balueva K, Saghafi S, Wulff P, Horvath T, Fisone G, Dodt H, Hökfelt T, Harkany T, Romanov R (2022) A hypothalamic dopamine locus for psychostimulant-induced hyperlocomotion in mice Nat Commun, 13 (1)
• Seifritz E, Kasper S, Möller H, Volz H, Müller W, Eckert A, Hatzinger M (2022) Effect of anxiolytic drug silexan on sleep – a narrative review World J Biol Psychiatry, 23 (7): 493-500
  | Weblink |
• Pain O,..,the GSRD Consortium, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, McIntosh AM, Lewis CM (2022) Identifying the Common Genetic Basis of Antidepressant Response Biological Psychiatry GOS, 2 (2): 115-126
  | Weblink |
• Panariello F, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Serretti A, Fabbri C (2022) Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting World J Biol Psychiatry, 24 (5): 439-448
  | Weblink |
• Roca M, Bonelli A, Cattaneo A, Comandini A, Di Dato G, Heiman F, Pegoraro V, Kasper S, Volz H, Palao D (2022) Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain Int J Psychiatry Clin Pract, 27 (1): 59-68
  | Weblink |
• Silberbauer L, Rischka L, Vraka C, Hartmann A, Godbersen G, Philippe C, Pacher D, Nics L, Klöbl M, Unterholzner J, Stimpfl T, Wadsak W, Hahn A, Hacker M, Rujescu D, Kasper S, Lanzenberger R, Gryglewski G (2022) ABCB1 variants and sex affect serotonin transporter occupancy in the brain Mol Psychiatry, 27 (11): 4502-4509
  | Weblink |
• Bandelow B, Allgulander C, Baldwin D, Costa D, Denys D, Dilbaz N, Domschke K, Eriksson E, Fineberg N, Hättenschwiler J, Hollander E, Kaiya H, Karavaeva T, Kasper S, Katzman M, Kim Y, Inoue T, Lim L, Masdrakis V, Menchón J, Miguel E, Möller H, Nardi A, Pallanti S, Perna G, Rujescu D, Starcevic V, Stein D, Tsai S, Van Ameringen M, Vasileva A, Wang Z, Zohar J (2022) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders World J Biol Psychiatry, 24 (2): 79-117
  | Weblink |
• Bandelow B, Allgulander C, Baldwin D, Costa D, Denys D, Dilbaz N, Domschke K, Hollander E, Kasper S, Möller H, Eriksson E, Fineberg N, Hättenschwiler J, Kaiya H, Karavaeva T, Katzman M, Kim Y, Inoue T, Lim L, Masdrakis V, Menchón J, Miguel E, Nardi A, Pallanti S, Perna G, Rujescu D, Starcevic V, Stein D, Tsai S, Van Ameringen M, Vasileva A, Wang Z, Zohar J (2022) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD World J Biol Psychiatry, 24 (2): 118-134
  | Weblink |
• Ludwig B, Carlberg L, Kienesberger K, Swoboda P, Swoboda M, Bernegger A, Koller R, Inaner M, Fuxjäger M, Zotter M, Schmelzle N, Senft B, Meisner L, Fischer-Hansal D, Huber J, Schoenthaler S, Kapusta N, Haslacher H, Aigner M, Weinhaeusel A, Kasper S, Schosser A (2022) Oxytocin receptor gene methylation as a molecular marker for severity of depressive symptoms in affective disorder patients BMC Psychiatry, 22 (1): 1-8
  | Weblink |
• L. Bartova, G. Fugger, M. Dold, S. Kasper (2022) Therapieoptionen bei Angsterkrankungen unter Berücksichtigung der Phyto- Psychopharmakotherapie Journal für Neurologie, Neurochirurgie und Psychiatrie, 23: 124-130
• Vanicek T, Reed M, Seiger R, Godbersen G, Klöbl M, Unterholzner J, Spurny-Dworak B, Gryglewski G, Handschuh P, Schmidt C, Kraus C, Stimpfl T, Rupprecht R, Kasper S, Lanzenberger R (2022) Increased left dorsolateral prefrontal cortex density following escitalopram intake during relearning: a randomized, placebo-controlled trial in healthy humans Ther Adv Psychopharmacol, 12: 1-15
  | Weblink |
• Zhang B, Stöhrmann P, Godbersen G, Unterholzner J, Kasper S, Kranz G, Lanzenberger R (2022) Normal component of TMS-induced electric field is correlated with depressive symptom relief in treatment-resistant depression Brain Stimul, 15 (5): 1318-1320
  | Weblink |
• Bartova L, Fugger G, Dold M, Kautzky A, Rujescu D, Kasper S (2022) Psychotherapy’s Role for Treatment-Resistant Depression? Am J Psychiatry, 179 (9): 687-687
  | Weblink |
• Fallatah W, Cui W, Di Pietro E, Carter G, Pounder B, Dorninger F, Pifl C, Moser A, Berger J, Braverman N (2022) A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1 Front Cell Dev Biol, 10
  | Article (PDF) |
• Spurny-Dworak B, Godbersen GM, Reed MB, Unterholzner J, Vanicek T, Baldinger-Melich P, Hahn A, Kranz GS, Bogner W, Lanzenberger R, Kasper S (2022) The impact of theta-burst stimulation on cortical GABA and glutamate in treatment-resistant depression: A surface-based MRSI analysis approach. Front Mol Neurosci, : 913274
  | Weblink |
• Bartova L, Dold M, Volz HP, Seifritz E, Möller HJ, Kasper S (2022) Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders – randomized, placebo-controlled trials revisited. Eur Arch Psychiatry Clin Neurosci,
  | Weblink |
• Fanelli G, Domschke K, Minelli A, Gennarelli M, Martini P, Bortolomasi M, Maron E, Squassina A, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Baune BT, European College of Neuropsychopharmacology (ECNP) Pharmacogenomics & Transcriptomics Thematic Working Group, Serretti A, Fabbri C (2022) A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response. Eur Neuropsychopharmacol, 55: 86-95
  | Weblink |
• Oliva V, Fanelli G, Kasper S; Zohar J, Souery D; Montgomery S, Albani D; Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Kas M, De Ronchi D, Fabbri C, Serretti A (2022) Social withdrawal as a trans-diagnostic predictor of short-term remission. A meta-analysis of five clinical cohorts. Int Clin Psychopharmacol, 37: 38 – 45
  | Weblink |
• Fugger G, Bartova L, Dold M, Fabbri C, Fanelli G, Zanardi R, Kautzky A, Zohar J, Souery D, Mendlewicz J, Montgomery S, Rujescu D, Serretti A, Kasper S (2022) Evidence on Sociodemographic and Clinical Correlates of Antidepressant Combination or Augmentation with Second-Generation Antipsychotics in Major Depressive Disorder. Prog in Neuropsychopharmaco & Biolog. Psychiatry , 114: 110480
  | Weblink |
• Fugger G, Bartova L, Fabbri C, Fanelli G, Zanardi R, Dold M, Kautzky A, Rujescu D, Souery D, Mendlewicz J, Zohar J, Montgomery S, Serretti A, Kasper S (2022) The Sociodemographic and Clinical Phenotype of European Patients with Major Depressive Disorder Undergoing first-line Antidepressant Treatment with NaSSAs J Affect Disord, : 225-234
  | Weblink |
• Fugger G, Bartova L, Fabbri C, Fanelli G, Dold M, Swoboda MMM, Kautzky A, Zohar J, Souery D, Mendlewicz J, Montgomery S, Rujescu D, Serretti A, Kasper S (2022) The Sociodemographic and Clinical Profile of Patients with Major Depressive Disorder Receiving SSRIs as First-line Antidepressant Treatment in European Countries. Eur Arch Psychiatry Clin Neurosci,
  | Weblink |
• de Bardeci M, Greil W, Stassen H, Willms J, Köberle U, Bridler R, Hasler G, Kasper S, Rüther E, Bleich S, Toto S, Grohmann R, Seifert J (2022) Dear Doctor Letters regarding Citalopram and Escitalopram: Guidelines vs real world data. Eur Arch Psychiatry Clin Neurosci,
  | Weblink |
• Bartova L, Fugger G, Dold M, Kautzky A, Swoboda MMM, Rujescu D, Zohar J, Souery D, Mendlewicz J, Montgomery S, Fabbri C, Serretti A, Kasper S (2022) The Choice of either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients with Major Depressive Disorder. Int. J. Neuropsychopharmacol., 25: 118-127
  | Weblink |
• Calabrò M, Fabbri C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Serretti A, Crisafulli C (2022) Metabolizing status of CYP2C19 in response and side effects to medications for depression: results from a naturalistic study. Eur Neuropsychopharmacol, 56: 100-111
  | Weblink |
• Kasper S (2022) Initiating Antidepressant Medication: What is the Most Important Factor? Adv in Therapy, : S5-S12,
  | Weblink |
• Sarris J, Ravindran A, Yatham LN, Marx W, Rucklidge J, McIntyre RS, Akhondzadeh S, Benedetti F, Caneo C, Cramer H, Cribb L, de Manincor M, Dean O, Deslandes AC, Freeman MP, Gangadhar B, Harvey BH, Kasper S, Lake J, Lopresti A, Lu L, Metri NJ, Mischoulon D, Ng C, Nishi D, Rahimi R, Seedat S, Sincliar J, Su KP, Zhang ZJ, Berk M (2022) Clinician Guidelines for the Treatment of Psychiatric Disorders with Nutraceuticals and Phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. World J Biol Psychiatry, 23: 424-455
  | Weblink |
• Volz H, Bartečků E, Bartova L, Bessa J, De Berardis D, Dragasek J, Kozhuharov H, Ladea M, Lazáry J, Roca M, Usov G, Wichniak A, Godman B, Kasper S (2022) Sick leave duration as a potential marker of functionality and disease severity in depression Int J Psychiatry Clin Pract, 26 (4): 406-416
  | Weblink |
• Komorowski A, Murgas M, Vidal R, Singh A, Gryglewski G, Kasper S, Wiltfang J, Lanzenberger R, Goya-Maldonado R (2022) Regional gene expression patterns are associated with task-specific brain activation during reward and emotion processing measured with functional MRI Human Brain Mapping, 43: 5266-5280
  | Weblink |
• Fanelli G, Sokolowski M, Wasserman D, European College of Neuropsychopopharmacology (ECNP) Network on Suicide Research and Prevention, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Serretti A, Fabbri C (2022) Polygenic risk scores for neuropsychiatric, inflammatory, and cardio-metabolic traits highlight possible genetic overlap with suicide attempt and treatment-emergent suicidal ideation Am. J. Med. Genet. B Neuropsychiatr. Genet. , : 74-85
  | Weblink |
• Pain O, Hodgson K, Trubetskoy V, Ripke S, Marshe VS, Adams MJ, Byrne EM, Campos AI, Carillo-Roa T, Cattaneo A, Als TD, Souery D, Dernovsek MZ, Fabbri C, Hayward C, Jenigsberg N, Hauser J, Kennedy JL, Lenze EJ, Lewis G, Müller DJ, Martin NG, Mulsant BH, Mors O, Perroud N, Porteous DJ, Renteria ME, Reynolds III CF, Rietschel M, Uher R, Wigmore EM, Maier W, Wray NR, Aitchison KJ, Arolt V, Baune BT, Biernacka JM, Bondolfi G, Domschke K, Kato M, Li QS, Liu YL, Serretti A, Tsai SJ, Turecki G, Weinshilboum R, the GSRD Consortium, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, McIntosh AM, Lewis CM (2022) Identifying the common genetic basis of antidepressant response. Biol Psychiatry, 2: 115-126
  | Weblink |
• Generoso M, Taiar I, Cordeiro Q, Shiozawa P, Kasper S (2022) Cariprazine for treating psychosis: an updated meta-analysis Int J Psychiatry Clin Pract, 27 (1): 107-109
  | Weblink |
• Friedrich ME, Grohmann R, Rabl U, Winkler D, Konstantinidis A, Engel R, Seifert J, Toto S, Stübner S, Frey R, Kasper S (2022) Incidence of drug-induced delirium during treatment with antidepressants or antipsychotics – a drug surveillance report of German-speaking countries between 1993 and 2016. Int. J. Neuropsychopharmacol., 25: 556-566
  | Weblink |
• Vanicek T, Unterholzner J, Lanzenberger R, Naderi-Heiden A, Kasper S, Praschak-Rieder N (2022) Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder World J Biol Psychiatry, 23 (9): 715-718
  | Weblink |
• Zambon A, Rico L, Herman M, Gundacker A, Telalovic A, Hartenberger L, Kuehn R, Romanov R, Hussaini S, Harkany T, Pollak D (2022) Gestational immune activation disrupts hypothalamic neurocircuits of maternal care behavior Mol Psychiatry,

• Kasper S (2022) Rasch wirkende Antidepressiva bei Major Depression und therapieresistenter Depression Jatros Neurologie & Psychiatrie , 5: 38
• Kasper S, Sachs G, Erfurth A, Rujescu D, Bach M, Baldinger-Melich P, Bartova L, Conca A, Dold M, Frey R, Goessler R, Hausmann A, Lan-zenberger R, Lehofer M, Marksteiner J, Naderi-Heiden A, Plener P, Praschak-Rieder N, Rados C, Schosser A, Sperner-Unterweger B, Spies M, Winkler D (2022) Angststörungen Psychopharmakotherapie Jatros Neurologie & Psychiatrie ,
• Möller HJ, Kasper S (2022) Serotonin-Theorie der Depression in Umbrella-Review nicht bestätigt? Psychopharmakotherap, 29: 187-189
• Kasper S (2022) Suizidalität: Von einer psychiatrischen zu einer juristischen Sichtweise? Jatros Neurologie & Psychiatrie , : 24-25
• Kasper S. (2022) Suizidalität: Von einer psychiatrischen zu einer juristischen Sichtweise? Journal für Neurologie, Neurochirurgie und Psychiatrie, 23: 5-6
• Kasper S, Erfurth A, Sachs G, Aichhorn W, Bartova L, Bengesser S, Buchmayer F, Deisenhammer E, Di Pauli J, Dold M, Falkai P, Frey R, Glück K, Hofer A, Holsboer-Trachsler E, Kautzky A, Konstantinidis A, Kraus C, Lehofer M, Marksteiner J, Mitschek M, Mörkl S, Oberlerchner H, Plener P, Psota G, Rados C, Rainer M, Schosser A, Seifritz E, Silberbauer C, Winkler D, Wunsch C, Zwanzger P (2022) Treatment-resistant Depression: Diagnosis and Treatment, Konsensus-Statement Jatros Neurologie & Psychiatrie , : 1-31
• Fugger G, Bartova L, Dold M, Kasper S (2022) Die therapieresistente Depression (TRD) – Herausforderungen und praktisches Management. psychopraxis. neuropraxis, : 49 – 54
  | Weblink |
• Kasper S (2022) Is treatment-resistant depression really resistant? Eur Neuropsychopharmacol, : 44–46
  | Weblink |
• Volz HP, Stirnweiß J, Kasper S, Möller HJ, Seifritz E (2022) Subthreshold depression – concept, operationalization and epidemiological data. A scoping review. Int J Psychiatry Clin Pract, 27: 92-106
  | Weblink |

• Tortoriello G, Beiersdorf J, Romani S, Williams G, Cameron G, Mackie K, Williams M, Di Marzo V, Keimpema E, Doherty P, Harkany T (2021) Genetic Manipulation of sn-1-Diacylglycerol Lipase and CB1 Cannabinoid Receptor Gain-of-Function Uncover Neuronal 2-Linoleoyl Glycerol Signaling in Drosophila melanogaster Cannabis Cannabinoid Res, 6 (2): 119-136
• Mitschek M, Vanicek T, Unterholzner J, Kraus C, Weidenauer A, Naderi-Heiden A, Frey R, Silberbauer L, Gryglewski G, Papageorgiou K, Winkler D, Dold M, Kasper S, Praschak-Rieder N, Bartova L (2021) How to prevent and manage hyperammonemic encephalopathies in valproate therapy J Affect Disord, 5: 100186
  | Weblink |
• Möller H, Falkai P, Kasper S (2021) Obituary – Prof. Dr. Hanns Hippius Int. J. Neuropsychopharmacol., 24: 856-857
  | Weblink |
• Winkler D, Grohmann R, Friedrich ME, Toto S, Bleich S, Seifert J, Anastasios Konstantinidis A, Shariat SF, Kasper S, Pjrek E (2021) Urological adverse drug reactions of psychotropic medication in psychiatric inpatients – A drug surveillance report of German-speaking countries J Psychiatr Res, 144: 412–420
  | Weblink |
• Bartova L, Kasper S (2021) Chronobiologie der Depression Psychiatr Danub., 33: 446-453
  | Weblink |
• Sauerzopf U, Weidenauer A, Dajic I, Bauer M, Bartova L, Meyer B, Nics L, Philippe C, Pfaff S, Pichler V, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R, Pezawas L, Praschak-Rieder N, Willeit M (2021) Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia Neuroimage Clin, 32: 102813
  | Weblink |
• Gryglewski G, Lanzenberger R, Silberbauer LR, Pacher D, Kasper S, Rupprecht R, Frey R, Baldinger-Melich P (2021) Meta-analysis of brain structural changes after electroconvulsive therapy in depression Brain Stimul, 14: 927-937
  | Weblink |
• Kasper S, Bonelli A, Cattaneo A, Comandini A, Di Dato G, Heiman F, Pegoraro V, Palao D, Roca M, Volz HP (2021) Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany Int J Psychiatry Clin Pract, 24: 393-402
• Kasper S, Young AH, Vieta E, Goodwin G, Meyer-Lindenberg A (2021) Letter to BJPsych in response to Horowitz and Moncrieff (electronic response to Horowitz MA and Moncrieff J) Are we repeating mistakes of the past? A review of the evidence for esketamine. Br J Psychiatry, 219: 619-620
  | Weblink |
• Seifritz E, Möller HJ, Volz HP, Müller WE, Hopyan T, Wacker A, Schläfke S, Kasper S (2021) No abuse potential of Silexan in healthy recreational drug users: a randomised controlled trial Int. J. Neuropsychopharmacol., 24: 171-180
• Dold M, Bartova L, Fugger G, Mitschek MMM, Fabbri C, Serretti A, Mendlewicz J, Souery D, Zohar J, Montgomery S, Kasper S (2021) Pregabalin augmentation of antidepressants in major depression – results from a European multicenter study J Affect Disord, 296: 485-492
  | Weblink |
• da Silva SR, Kalaba P, Fabisikova A, Zehl M, Dragacevic V, Ribeiro dos Anjos L, Neill PJ, Wieder M, Prado-Roller A, Gajic N, Palaretti V, da Silva GVJ, Pifl C, Lubec G, Gonzalez ERP (2021) Synthesis and dopamine receptor binding of dihydrexidine and SKF 38393 catecholamine-based analogues Amino Acids, Published Online: 29 November 2021
• Volz H, Saliger J, Kasper S, Möller H, Seifritz E (2021) Subsyndromal generalised anxiety disorder: operationalisation and epidemiology – a systematic literature survey Int J Psychiatry Clin Pract,
  | Weblink |
• Bartova L, Dold M, Fugger G, Kautzky A, Mitschek M, Weidenauer A, Hienert M, Frey R, Mandelli L, Zohar J, Mendlewicz J, Souery D, Montgomery S, Fabbri C, Serretti A, Kasper S (2021) Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression Depress Anxiety,
  | Weblink |
• Rischka L, Godbersen G, Pichler V, Michenthaler P, Klug S, Klöbl M, Ritter V, Wadsak W, Hacker M, Kasper S, Lanzenberger R, Hahn A (2021) Reliability of task-specific neuronal activation assessed with functional PET, ASL and BOLD imaging Cereb Blood Flow Metab, : 0271678X2110205
  | Weblink |
• Ludwig B, Carlberg L, Kienesberger K, Swoboda P, Mitschek M, Bernegger A, Koller R, Inaner M, Senft B, Meisner L, Fischer-Hansal D, Affenzeller A, Huber J, Schoenthaler S, Kapusta N, Haslacher H, Aigner M, Weinhaeusel A, Kasper S, Schosser A (2021) Monoamino Oxidase a Gene Single-Nucleotide Polymorphisms and Methylation Status and the Risk of Violent Suicide Attempts in Affective Disorder Patients Front Psychiatry, 12
  | Weblink |
• Bartova L, Fugger G, Dold M, Swoboda M, Zohar J, Mendlewicz J, Souery D, Montgomery S, Fabbri C, Serretti A, Kasper S (2021) Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression J Psychiatr Res, 141: 167-175
  | Weblink |
• Lubec J, Kalaba P, Hussein A, Feyissa D, Kotob M, Mahmmoud R, Wieder O, Garon A, Sagheddu C, Ilic M, Dragačević V, Cybulska-Klosowicz A, Zehl M, Wackerlig J, Sartori S, Ebner K, Kouhnavardi S, Roller A, Gajic N, Pistis M, Singewald N, Leban J, Korz V, Malikovic J, Plasenzotti R, Sitte H, Monje F, Langer T, Urban E, Pifl C, Lubec G (2021) Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition Mol Psychiatry,
• Milenkovic I, Bartova L, Papageorgiou K, Kasper S, Traub-Weidinger T, Winkler D (2021) Case Report: Bupropion Reduces the [123I]FP-CIT Binding to Striatal Dopamine Transporter Front Psychiatry, 12: 631357
  | Weblink |
• Bhat S, Niello M, Schicker K, Pifl C, Sitte H, Freissmuth M, Sandtner W (2021) Handling of intracellular K+ determines voltage dependence of plasmalemmal monoamine transporter function eLife, 10
• Patthy �, Murai J, Hanics J, Pintér A, Zahola P, Hökfelt T, Harkany T, Alpár A (2021) Neuropathology of the Brainstem to Mechanistically Understand and to Treat Alzheimer’s Disease J Clin Med, 10 (8): 1555
• Höflich A, Kraus C, Pfeiffer R, Seiger R, Rujescu D, Zarate C, Kasper S, Winkler D, Lanzenberger R (2021) Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial Transl Psychiat, 11 (1): 200
  | Weblink |
• Dold M, Bartova L, Fugger G, Kautzky A, Mitschek M, Fabbri C, Montgomery S, Zohar J, Souery D, Mendlewicz J, Serretti A, Kasper S (2021) Melancholic features in major depression – a European multicenter study Prog Neuropsychopharmacol Biol Psychiatry, 110: 110285
  | Weblink |
• McIntyre R, Rosenblat J, Nemeroff C, Sanacora G, Murrough J, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu D, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee J, Lee Y, Lui L, Mansur R, Papakostas G, Subramaniapillai M, Thase M, Vieta E, Young A, Zarate C, Stahl S (2021) Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation Am J Psychiatry, 178 (5): 383-399
  | Weblink |
• von Känel R, Kasper S, Bondolfi G, Holsboer‐Trachsler E, Hättenschwiler J, Hatzinger M, Imboden C, Heitlinger E, Seifritz E (2021) Therapeutic effects of Silexan on somatic symptoms and physical health in patients with anxiety disorders: A meta‐analysis Brain and Behavior, 11 (4): e01997
  | Weblink |
• Bartova L, Dold M, Fugger G, Kautzky A, Mitschek M, Weidenauer A, Handschuh P, Frey R, Mandelli L, Zohar J, Mendlewicz J, Souery D, Montgomery S, Fabbri C, Serretti A, Kasper S (2021) The Role of Relationship Status in Major Depressive Disorder Results of the European Group for the Study of Resistant Depression J Affect Disord, 286: 149-157
  | Weblink |
• Seiger R, Gryglewski G, Klöbl M, Kautzky A, Godbersen G, Rischka L, Vanicek T, Hienert M, Unterholzner J, Silberbauer L, Michenthaler P, Handschuh P, Hahn A, Kasper S, Lanzenberger R (2021) The influence of acute SSRI administration on white matter microstructure in patients suffering from major depressive disorder and healthy controls Int J Neuropsychopharmacol, 24 (7): 542-550
  | Weblink |
• Sarris J, Marx W, Ashton M, Ng C, Galvao-Coelho N, Ayati Z, Zhang Z, Kasper S, Ravindran A, Harvey B, Lopresti A, Mischoulon D, Amsterdam J, Yatham L, Berk M (2021) Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d’essais randomisés contrôlés Can J Psychiatry, 6: 849-862
  | Weblink |
• McAllister-Williams R, Arango C, Blier P, Demyttenaere K, Falkai P, Gorwood P, Hopwood M, Javed A, Kasper S, Malhi G, Soares J, Vieta E, Young A, Papadopoulos A, Rush A (2021) Reconceptualising treatment-resistant depression as difficult-to-treat depression Lancet Psychiatry, 8 (1): 14-15
  | Weblink |
• Fabbri C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Serretti A, Lewis C (2021) Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression J Affect Disord, 279: 722-729
  | Weblink |
• Fabbri C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Riva M, Lewis C, Serretti A (2021) Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study Prog Neuropsychopharmacol Biol Psychiatry, 104: 110050
  | Weblink |
• Fanelli G, Benedetti F, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Serretti A, Fabbri C (2021) Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder Prog Neuropsychopharmacol Biol Psychiatry, : 110170
  | Weblink |
• Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, Hough D, Drevets WC, Manji H, Canuso CM (2021) Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II) Int J Neuropsychopharmacol, 24(1): 22-31
  | Weblink |
• Kautzky A, Möller H, Dold M, Bartova L, Seemüller F, Laux G, Riedel M, Gaebel W, Kasper S (2021) Combining machine learning algorithms for prediction of antidepressant treatment response Acta Psychiatr Scand, 143 (1): 36-49
  | Weblink |
• Möller H, Volz H, Seifritz E, Müller H, Kenntner-Mabiala R, Kaussner Y, Schoch S, Kasper S (2021) Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers J Psychiatr Res, 136: 543-551
  | Weblink |

• Cinquina V, Weidenauer A, Kasper S, Harkany T (2021) Cannabinoids in the brain: their mechanism of action in relation to neuropsychiatric disorders Jatros Neurologie & Psychiatrie , 6: 35-38
• Keimpema E, Di Marzo V, Harkany T (2021) Biological basis of cannabinoid medicines Science, 374 (6574): 1449-1450
• Kasper S, Erfurth A, Sachs G, Aichhorn W, Bartova L, Bengesser S, Buchmayer F, Deisenhammer E, Di Pauli J, Dold M, Falkai P, Frey R, Glück K, Hofer A, Holsboer-Trachsler E, Kautzky A, Konstantinidis A, Kraus C, Lehofer M, Marksteiner J, Mitschek M, Mörkl S, Oberlerchner H, Plener P, Psota G, Rados C, Rainer M, Schosser A, Seifritz E, Silberbauer C, Winkler D, Wunsch C, Zwanzger P (2021) Therapieresistente Depression: Diagnose und Behandlung, Konsensus-Statement Jatros Neurologie & Psychiatrie , Sonderheft 03/2021: 1-32
• Kasper S (2021) Neue Behandlungsperspektiven bei der sog. behandlungsresistenten Depression (TRD) Journal für Neurologie, Neurochirurgie und Psychiatrie, 1: 3-5
  | Weblink |
• Calabrò M, Fabbri C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Colombo R, De Ronchi D, Serretti A, Crisafulli C (2021) Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression Curr Med Chem, 28 (22): 4296-4320
  | Weblink |
• Dodd S, Bauer M, Carvalho A, Eyre H, Fava M, Kasper S, Kennedy S, Khoo J, Lopez Jaramillo C, Malhi G, McIntyre R, Mitchell P, Castro A, Ratheesh A, Severus E, Suppes T, Trivedi M, Thase M, Yatham L, Young A, Berk M (2021) A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough? World J Biol Psychiatry, 22 (7): 483-494
  | Weblink |
• Kasper S, Cubała W, Fagiolini A, Ramos-Quiroga J, Souery D, Young A (2021) Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance World J Biol Psychiatry,
  | Weblink |
• Zecca L, Pifl C, Fahn S, Sulzer D, Fariello R (2021) Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease npj Parkinson's Disease, 7 (1)

• Sachs G, Kasper S, Anditsch M, Erfurth A, Lehofer M, Marksteiner J, Rados C, Rujescu D, Sperner-Unterweger B (2021) Was in der Praxis zählt. Diagnostik und Therapie der generalisierten Angststörung. In: , Jatros Neurologie & Psychiatrie Universimed: 2-6
• Graf I, Willeit M, Kasper S, Praschak-Rieder (2021) The Impact of Genetic Polymorphisms on Neuroreceptor Binding: Results from PET and SPECT Neuroreceptor Imaging Studies. In: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, Lammertsma AA (Hrsg.) PET and SPECT of Neurobiological Systems. . In: , Springer Nature Springer: 153-190
• Dajić I, Praschak-Rieder N, Lanzenberger R, Spindelegger C, Kasper S, Willeit M (2021) Neuroimaging in Seasons and Winter Depression. In: Rudi A.J.O. Dierckx, Andreas Otte, Erik F. J. de Vries, Aren van Waarde, Iris E. Sommer, PET and SPECT in Psychiatry, Vol.2 Springer International Publishing: 245-259
  | Weblink |

• Beiersdorf J, Hevesi Z, Calvigioni D, Pyszkowski J, Romanov RA, Szodorai E, Lubec G, Shirran S, Botting CH, Kasper S, Guy GW, Gray R, Di Marzo V, Harkany T, Keimpema E (2020) Adverse effects of tetrahydrocannabinol on neuronal bioenergetics during postnatal brain development. JCI Insight, 5: e135418
  | Weblink |
• Calabrò M, Porcelli S, Crisafulli C, Albani D, Kasper S, Zohar J, Souery D, Montgomery S, Mantovani V, Mendlewicz J, Bonassi S, Vieta E, Frustaci A, Ducci G, Landi S, Boccia S, Bellomo A, Di Nicola M, Janiri L, Colombo R, Mandelli L, Fabbri C, Serretti A (2020) Genetic variants associated with psychotic symptoms across disorders psychotic symptoms. Neurosci Lett, 720: 134754
  | Weblink |
• Spurny B, Seiger R, Moser P, Vanicek T, Reed M, Heckova E, Michenthaler P, Basaran A, Gryglewski G, Klöbl M, Trattnig S, Kasper S, Bogner W, Lanzenberger R (2020) Hippocampal GABA levels correlate with retrieval performance in an associative learning paradigm Neuroimage, 204: 116244
  | Weblink |
• Friedrich ME, Winkler D, Konstantinidis A, Huf W, Engel RR, Toto S, Grohmann R, Kasper S (2020) Cardiovascular adverse reactions during antipsychotic treatment: Results of AMSP- A drug surveillance program between 1993 and 2013. Int. J. Neuropsychopharmacol., 23: 67-75
• Gryglewski G, Seiger R, Baldinger-Melich P, Unterholzner J, Spurny B, Vanicek T, Hahn, Kasper S, Frey R, Lanzenberger R (2020) Changes in white matter microstructure after electroconvulsive therapy in treatment resistant depression Int J Neuropsychopharmacol, 23: 20-25
  | Weblink |
• Orthofer M, Valsesia A, Mägi R, Wang Q, Kaczanowska J, Kozieradzki I, Leopoldi A, Cikes D, Zopf L, Tretiakov E, Demetz E, Hilbe R, Boehm A, Ticevic M, Nõukas M, Jais A, Spirk K, Clark T, Amann S, Lepamets M, Neumayr C, Arnold C, Dou Z, Kuhn V, Novatchkova M, Cronin S, Tietge U, Müller S, Pospisilik J, Nagy V, Hui C, Lazovic J, Esterbauer H, Hagelkruys A, Tancevski I, Kiefer F, Harkany T, Haubensak W, Neely G, Metspalu A, Hager J, Gheldof N, Penninger J (2020) Identification of ALK in Thinness Cell, 181 (6): 1246-1262.e22
  | Weblink |
• Stagkourakis S, Smiley K, Williams P, Kakadellis S, Ziegler K, Bakker J, Brown R, Harkany T, Grattan D, Broberger C (2020) A Neuro-hormonal Circuit for Paternal Behavior Controlled by a Hypothalamic Network Oscillation Cell, 182 (4): 960-975.e15
• Seifritz E, Möller H, Volz H, Müller W, Hopyan T, Wacker A, Schläfke S, Kasper S (2020) No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial Int J Neuropsychopharmacol, 24 (3): 171-180
  | Weblink |
• Kasper S, Möller H, Engberg G, Eriksson E, Hökfelt T (2020) Torgny Svensson, a superb mind and an inspiring colleague Int J Neuropsychopharmacol, 23 (8): 543-544
  | Weblink |
• Komorowski A, Weidenauer A, Murgaš M, Sauerzopf U, Wadsak W, Mitterhauser M, Bauer M, Hacker M, Praschak-Rieder N, Kasper S, Lanzenberger R, Willeit M (2020) Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain Neuroimage, 223: 117270
  | Weblink |
• Dold M, Bartova L, Kasper S (2020) Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment Int J Neuropsychopharmacol, 23 (7): 440-445
  | Weblink |
• Fugger G, Dold M, Bartova L, Mitschek M, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Fabbri C, Frey R, Kasper S (2020) Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression Int J Neuropsychopharmacol, 23 (9): 571-577
  | Weblink |
• Cinquina V, Calvigioni D, Farlik M, Halbritter F, Gernedl V, Shirran SL, Fuszard MA, Botting CH, Poullet P, Piscitelli F, Máté Z, Szabó G, Yanagawa Y, Kasper S, Di Marzo V, Mackie K, McBain CJ, Bock C, Keimpema E, Harkany T (2020) Life-long epigenetic programming of cortical architecture by maternal ‘Western’ diet during pregnancy Mol Psychiatry, 25 (1): 22-36
  | Weblink |
• Fagiolini A, Albert U, Ferrando L, Herman E, Muntean C, Pálová E, Cattaneo A, Comandini A, Di Dato G, Di Loreto G, Olivieri L, Salvatori E, Tongiani S, Kasper S (2020) A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder Int Clin Psychopharmacol, 35 (3): 137-146
  | Weblink |
• Dold M, Bartova L, Fugger G, Mitschek M, Kautzky A, Frey R, Montgomery S, Zohar J, Mendlewicz J, Souery D, Fabbri C, Serretti A, Kasper S (2020) Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study Eur Neuropsychopharmacol, 41: 70-80
  | Weblink |
• Fabbri C, Kasper S, Kautzky A, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Uher R, Lewis C, Serretti A (2020) A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping Transl Psychiat, 10 (1): 50
  | Weblink |
• Krivanek J, Soldatov R, Kastriti M, Chontorotzea T, Herdina A, Petersen J, Szarowska B, Landova M, Matejova V, Holla L, Kuchler U, Zdrilic I, Vijaykumar A, Balic A, Marangoni P, Klein O, Neves V, Yianni V, Sharpe P, Harkany T, Metscher B, Bajénoff M, Mina M, Fried K, Kharchenko P, Adameyko I (2020) Dental cell type atlas reveals stem and differentiated cell types in mouse and human teeth Nat Commun, 11 (1): 4816
• Pifl C, Sitte H (2020) A Tribute to Oleh Hornykiewicz (1926–2020) Trends Pharmacol Sci, 41 (8): 499-501
• Romanov R, Tretiakov E, Kastriti M, Zupancic M, Häring M, Korchynska S, Popadin K, Benevento M, Rebernik P, Lallemend F, Nishimori K, Clotman F, Andrews W, Parnavelas J, Farlik M, Bock C, Adameyko I, Hökfelt T, Keimpema E, Harkany T (2020) Molecular design of hypothalamus development Nature, 582(7811): 246-252

• Keimpema E, Harkany T, Alpár A (2020) The p(l)ot thickens: cannabinoid receptors on astroglial mitochondria coordinate animal behaviors by regulating lactate availability for neurons Signal Transduct Target Ther, 5 (1)
• Fountoulakis KN, Young A, Yatham L, Grunze H, Vieta E, Tohen M, Blier P, Moeller HJ, Kasper S (2020) The CINP guidelines on the definition and the evidence-based interventions for treatment-resistant Bipolar disorder. Invited Review. Int. J. Neuropsychopharmacol., 23: 230-256
  | Weblink |
• Bartova L, Mitschek MMM, Kasper S (2020) Das aktuelle Verständnis der sogenannten behandlungsresistenten Depression Jatros Neurologie & Psychiatrie , 06/2020: 44-49
• Kasper S, Bancher C, Eckert A, Förstl H, Frölich L, Hort J, Korczyn A, Kressig R, Levin O, Palomo M (2020) Management of mild cognitive impairment (MCI): The need for national and international guidelines World J Biol Psychiatry, 21 (8): 579-594
  | Weblink |

• Silberbauer L, James G, Spies M, Michenthaler P, Kranz GS, Kasper S, Lanzenberger R (2020) Molecular neuroimaging of the serotonergic system with PET. In: , Handbook of the Behavioral Neurobiology of Serotonin Elsevier: 175-194

• Daba Feyissa D, Sialana F, Keimpema E, Kalaba P, Paunkov A, Engidawork E, Höger H, Lubec G, Korz V (2019) Dopamine type 1- and 2-like signaling in the modulation of spatial reference learning and memory Behav Brain Res, 362: 173-180
• Korchynska S, Lutz M, Borók E, Pammer J, Cinquina V, Fedirko N, Irving A, Mackie K, Harkany T, Keimpema E (2019) GPR55 controls functional differentiation of self-renewing epithelial progenitors for salivation JCI Insight, 4 (4)
• Moeller HJ, Volz HP, Dienel A, Schlaefke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials Eur Arch Psychiatry Clin Neurosci,
• Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials. Eur Arch Psychiatry Clin Neurosci, 269: 183-193
• Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials. Eur Arch Psychiatry Clin Neurosci, 269: 183-193
  | Weblink |
• Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials. Eur Arch Psychiatry Clin Neurosci, 269: 183-193
  | Weblink |
• Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials. Eur Arch Psychiatry Clin Neurosci, 260: 183-193
  | Weblink |
• Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials. Eur Arch Psychiatry Clin Neurosci, 260: 183-193
  | Weblink |
• Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials. Eur Arch Psychiatry Clin Neurosci, 269: 183-193
  | Weblink |
• Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials. European Archives of Psychiatry and Clinical Neuroscience , 269: 183-193
  | Weblink |
• Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials. European Archives of Psychiatry and Clinical Neuroscience , 269: 183-193
  | Weblink |
• Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials. European Archives of Psychiatry and Clinical Neuroscience , 269: 183-180
  | Weblink |
• Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S (2019) Efficacy of Silexan in subthreshold anxiety: meta‑analysis of randomised, placebo‑controlled trials. Eur Arch Psychiatry Clin Neurosci, 269: 183-180
  | Weblink |
• Müller WE, Eckert A, Eckert G, Fink H, Friedland K, Gauthier S, Hoerr R, Ihl R, Kasper S, Möller HJ (2019) Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer’s disease. World J Biol Psychiatry, 20: 173-189
  | Weblink |
• Meyer BM, Rabl U, Huemer J, Bartova L, Kalcher K, Provenzano J, Brandner C, Sezen P, Kasper S, Schatzberg AF, Moser E, Chen G, Pezawas L (2019) Prefrontal Networks Dynamically Related to Recovery from Major Depressive Disorder: a Longitudinal Pharmacological fMRI Study. Transl Psychiat, 9: 46
  | Weblink |
• Kalaba P, Ilić M, Aher N, Dragačević V, Wieder M, Zehl M, Wackerlig J, Beyl S, Sartori S, Ebner K, Roller A, Lukic N, Beryozkina T, Gonzalez E, Neill P, Khan J, Bakulev V, Leban J, Hering S, Pifl C, Singewald N, Lubec J, Urban E, Sitte H, Langer T, Lubec G (2019) Structure–Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters J Med Chem, 63 (1): 391-417
• Abdo H, Calvo-Enrique L, Lopez J, Song J, Zhang M, Usoskin D, El Manira A, Adameyko I, Hjerling-Leffler J, Ernfors P (2019) Specialized cutaneous Schwann cells initiate pain sensation Science, 365 (6454): 695-699
• Hörtnagl H, Pifl C, Hörtnagl E, Reiner A, Sperk G (2019) Distinct gradients of various neurotransmitter markers in caudate nucleus and putamen of the human brain J Neurochem, 152 (6): 650-662
• Tesařová M, Heude E, Comai G, Zikmund T, Kaucká M, Adameyko I, Tajbakhsh S, Kaiser J (2019) An interactive and intuitive visualisation method for X-ray computed tomography data of biological samples in 3D Portable Document Format Sci Rep, 9 (1)
• Dorninger F, König T, Scholze P, Berger M, Zeitler G, Wiesinger C, Gundacker A, Pollak D, Huck S, Just W, Forss-Petter S, Pifl C, Berger J (2019) Disturbed Neurotransmitter Homeostasis in Ether Lipid Deficiency Hum Mol Genet, 28(12): 2046-2061

• Kaucka M, Adameyko I (2019) Evolution and development of the cartilaginous skull: From a lancelet towards a human face Semin Cell Dev Biol, 91: 2-12
• Pifl C (2019) The Time Delay Between In Vivo Imaging and Postmortem Data Poses a Caveat on “No Link” Findings Movement Disorders, 34: 1579-1580

• Tesařová M, Mancini L, Simon A, Adameyko I, Kaucká M, Elewa A, Lanzafame G, Zhang Y, Kalasová D, Szarowská B, Zikmund T, Novotná M, Kaiser J (2018) A quantitative analysis of 3D-cell distribution in regenerative muscle-skeletal system with synchrotron X-ray computed microtomography Sci Rep, 8 (1)
• Alpár A, Zahola P, Hanics J, Hevesi Z, Korchynska S, Benevento M, Pifl C, Zachar G, Perugini J, Severi I, Leitgeb P, Bakker J, Miklosi AG, Tretiakov E, Keimpema E, Arque G, Tasan RO, Sperk G, Malenczyk K, Máté Z, Erdélyi F, Szabó G, Lubec G, Palkovits M, Giordano A, Hökfelt TG, Romanov RA, Horvath TL, Harkany T. (2018) Hypothalamic CNTF volume transmission shapes cortical noradrenergic excitability upon acute stress EMBO J., 37: e100087
• Maier J, Mayer FP, Luethi D, Holy M, Jaentsch K, Reither H, Hirtler L, Hoener MC, Liechti ME, Pifl C, Brandt SD, Sitte HH (2018) The psychostimulant (±)-cis-4,4′-dimethylaminorex (4,4′-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters Neuropharmacology, 138: 282-291
• Treven M, Siebert D, Holzinger R, Bampali K, Fabjan J, Varagic Z, Wimmer L, Steudle F, Scholze P, Schnürch M, Mihovilovic M, Ernst M (2018) Towards Functional Selectivity for α6β3γ2 GABAA Receptors: A Series of Novel Pyrazoloquinolinones Br J Pharmacol, 175 (3): 419-428

• Milenkovic I, Stojanovic T, Aronica E, Fülöp L, Bozsó Z, Máté Z, Yanagawa Y, Adle-Biassette H, Lubec G, Szabó G, Harkany T, Kovács G, Keimpema E (2017) GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome Brain Struct Funct,
• Romanov R, Zeisel A, Bakker J, Girach F, Hellysaz A, Tomer R, Alpár A, Mulder J, Clotman F, Keimpema E, Hsueh B, Crow A, Martens H, Schwindling C, Calvigioni D, Bains J, Máté Z, Szabó G, Yanagawa Y, Zhang M, Rendeiro A, Farlik M, Uhlén M, Wulff P, Bock C, Broberger C, Deisseroth K, Hökfelt T, Linnarsson S, Horvath T, Harkany T (2017) Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes Nature Neurosci, 20 (2): 176-188
• Kaucka M, Zikmund T, Tesarova M, Gyllborg D, Hellander A, Jaros J, Kaiser J, Petersen J, Szarowska B, Newton P, Dyachuk V, Li L, Qian H, Johansson A, Mishina Y, Currie J, Tanaka E, Erickson A, Dudley A, Brismar H, Southam P, Coen E, Chen M, Weinstein L, Hampl A, Arenas E, Chagin A, Fried K, Adameyko I (2017) Oriented clonal cell dynamics enables accurate growth and shaping of vertebrate cartilage eLife, 6
• Furlan A, Dyachuk V, Kastriti M, Calvo-Enrique L, Abdo H, Hadjab S, Chontorotzea T, Akkuratova N, Usoskin D, Kamenev D, Petersen J, Sunadome K, Memic F, Marklund U, Fried K, Topilko P, Lallemend F, Kharchenko P, Ernfors P, Adameyko I (2017) Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla Science, 357 (6346): eaal3753
• Hornykiewicz O (2017) L-DOPA J Parkinson Dis, 7 (s1): S3-S10
• Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, Guttman M, Hornykiewicz O, Kish SJ (2017) Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders Brain, 140: 2460-2474
• Ghafari M, Falsafi S, Szodorai E, Kim E, Li L, Höger H, Berger J, Fuchs K, Sieghart W, Lubec G (2017) Formation of GABAA receptor complexes containing α1 and α5 subunits is paralleling a multiple T-maze learning task in mice Brain Struct Funct, 222 (1): 549-561
• Pifl C, Reither H, Lopez-Gonzalez del Rey N, Cavada C, Obeso JA, Blesa J (2017) Early paradoxical increase of dopamine: A neurochemical study of olfactory bulb in asymptomatic and symptomatic MPTP treated monkeys Front Neuroanat, 11: 46
• Rivetti di Val Cervo P, Romanov RA, Spigolon G, Masini D, Martín-Montañez E, Toledo EM, La Manno G, Feyder M, Pifl C, Ng YH, Sánchez SP, Linnarsson S, Wernig M, Harkany T, Fisone G, Arenas E (2017) Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model Nat Biotechnol, 35: 444-452

• Kasper S (2017) Phythotherapeutika bei Depression und Angst. Hilfe aus dem Pflanzenreich. Interview Jatros Neurologie & Psychiatrie , 06/2017: 39-40
• Krivanek J, Adameyko I, Fried K (2017) Heterogeneity and Developmental Connections between Cell Types Inhabiting Teeth Front Physiol, 8
• Kastriti M, Adameyko I (2017) Specification, plasticity and evolutionary origin of peripheral glial cells Curr Opin Neurobiol, 47: 196-202

• Calvigioni D, Máté Z, Fuzik J, Girach F, Zhang M, Varro A, Beiersdorf J, Schwindling C, Yanagawa Y, Dockray G, McBain C, Hökfelt T, Szabó G, Keimpema E, Harkany T (2016) Functional Differentiation of Cholecystokinin-Containing Interneurons Destined for the Cerebral Cortex Cereb. Cortex, : bhw094
• Li L, Newton P, Bouderlique T, Sejnohova M, Zikmund T, Kozhemyakina E, Xie M, Krivanek J, Kaiser J, Qian H, Dyachuk V, Lassar A, Warman M, Barenius B, Adameyko I, Chagin A (2016) Superficial cells are self‐renewing chondrocyte progenitors, which form the articular cartilage in juvenile mice FASEB J, 31 (3): 1067-1084
• Hoerbelt P, Ramerstorfer J, Ernst M, Sieghart W, Thomson JL, Hough LB, Fleck MW (2016) Mutagenesis and computational docking studies support the existence of a histamine binding site at the extracellular b3+b3- interface of homooligomeric b3 GABA-A receptors Neuropharmacology, 108: 252-263
• Jonas O, Calligaris D, Methuku K, Poe M, Francois J, Tranghese F, Changelian A, Sieghart W, Ernst M, Pomeranz Krummel D, Cook J, Pomeroy S, Cima M, Agar N, Langer R, Sengupta S (2016) First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development J Biomed Nanotech, 12 (6): 1297-1302
• Pifl C (2016) Problems with traffic ahead: Synaptic vesicles in Parkinson's disease Movement Disorders, 31: 1480
• Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O (2016) Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications Eur J Neurosci, 45: 192-197
• Furukawa Y, Rajput A, Tong J, Tomizawa Y, Hornykiewicz O, Kish S (2016) A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia: Table Neurology, 87 (10): 1060-1061
• Kaucka M, Ivashkin E, Gyllborg D, Zikmund T, Tesarova M, Kaiser J, Xie M, Petersen J, Pachnis V, Nicolis S, Yu T, Sharpe P, Arenas E, Brismar H, Blom H, Clevers H, Suter U, Chagin A, Fried K, Hellander A, Adameyko I (2016) Analysis of neural crest-derived clones reveals novel aspects of facial development Sci Adv, 2 (8): e1600060-e1600060
  | Article (PDF) || Weblink |
• Marques S, Zeisel A, Codeluppi S, van Bruggen D, Mendanha Falcao A, Xiao L, Li H, Haring M, Hochgerner H, Romanov R, Gyllborg D, Munoz-Manchado A, La Manno G, Lonnerberg P, Floriddia E, Rezayee F, Ernfors P, Arenas E, Hjerling-Leffler J, Harkany T, Richardson W, Linnarsson S, Castelo-Branco G (2016) Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system Science, 352 (6291): 1326-1329
  | Article (PDF) || Weblink |
• Peneder T, Bauer J, Pifl C (2016) Apoptosis-inducing factor in nigral dopamine neurons: Higher levels in primates than in mice Movement Disorders, 31: 1729-1733
• Zhang MD, Barde S, Szodorai E, Josephson A, Mitsios N, Watanabe M, Attems J, Lubec G, Kovacs GM, Uhlen M, Mulder J, Harkany T, Hökfelt T (2016) Comparative anatomical distribution of neuronal calcium-binding protein (NECAB) 1 and -2 in rodent and human spinal cord Brain Struct Funct, 221 (7): 3803-3823
  | Article (PDF) || Weblink |
• Berger ML (2016) Soaping the NMDA receptor: Various types of detergents influence differently [³H]MK-801 binding to rat brain membranes Biochim Biophys Acta, 1858: 116-122

• Kaucka M, Adameyko I (2016) Spotlight on the Schwann cells during the regeneration Stem Cell Investig, 3: 74-74
• Adameyko I (2016) Neural circuitry gets rewired Science, 354 (6314): 833-834
• Adameyko I, Fried K (2016) The Nervous System Orchestrates and Integrates Craniofacial Development: A Review Front Physiol, 7
  | Article (PDF) || Weblink |

• Pangratz-Fuehrer S, Sieghart W, Rudolph U, Parada I, Huguenard J (2015) Early postnatal switch in GABAAreceptor α-subunits in the reticular thalamic nucleus J. Neurophysiol., 115 (3): 1183-1195
• Ernst M, Sieghart W (2015) GABAA – Rezeptorsubtypen: Strukturelle Vielfalt gibt Hoffnung auf neue Therapiekonzepte Neuroforum, 21 (4): 144-151
• Ernst M, Sieghart W (2015) GABAA receptor subtypes: structural variety raises hope for new therapy concepts e-Neuroforum, 6 (4): 97-103
• Kudryavtsev D, Shelukhina I, Son L, Ojomoko L, Kryukova E, Lyukmanova E, Zhmak M, Dolgikh D, Ivanov I, Kasheverov I, Starkov V, Ramerstorfer J, Sieghart W, Tsetlin V, Utkin Y (2015) Neurotoxins from Snake Venoms and α-Conotoxin ImI Inhibit Functionally Active Ionotropic γ-Aminobutyric Acid (GABA) Receptors J Biol Chem, 290 (37): 22747-22758
• Sieghart W (2015) Allosteric Modulation of GABAA Receptors via Multiple Drug-Binding Sites Adv Pharmacol, : 53-96
• Rycek L, Puthenkalam R, Schnürch M, Ernst M, Mihovilovic M (2015) Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABAA receptor ligands Bioorg Med Chem Lett, 25 (2): 400-403
• Yocum GT, Gallos G, Zhang Y, Jahan R, Stephen MR, Varagic Z, Puthenkalam R, Ernst M, Cook JM, Emala CW (2015) Targeting the GABAA Receptor α4 Subunit in Airway Smooth Muscle to Alleviate Bronchoconstriction Am J Respir Cell Mol Biol, Sept 25: Epub ahead of print
• Ádori C, Glück L, Barde S, Yoshitake T, Kovacs G, Mulder J, Maglóczky Z, Havas L, Bölcskei K, Mitsios N, Uhlén M, Szolcsányi J, Kehr J, Rönnbäck A, Schwartz T, Rehfeld J, Harkany T, Palkovits M, Schulz S, Hökfelt T (2015) Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer’s disease Acta Neuropathol, 129 (4): 541-563
• Guggenhuber S, Alpar A, Chen R, Schmitz N, Wickert M, Mattheus T, Harasta AE, Purrio M, Kaiser N, Elphick MR, Monory K, Kilb W, Luhmann HJ, Harkany T, Lutz B, Klugmann M (2015) Cannabinoid receptor-interacting protein Crip 1a modulates CB1 receptor signaling in mouse hippocampus Brain Struct Funct, March 15: Epub ahead of print
• Penz O, Fuzik J, Kurek A, Romanov R, Larson J, Park T, Harkany T, Keimpema E (2015) Protracted brain development in a rodent model of extreme longevity Sci Rep, 5: 11592
  | Article (PDF): 1 2 |
• Valladolid-Acebes I, Daraio T, Brismar K, Harkany T, Ögren S, Hökfelt T, Bark C (2015) Replacing SNAP-25b with SNAP-25a expression results in metabolic disease PNAS, 112 (31): E4326-E4335
• Bitencourt R, Alpár A, Cinquina V, Ferreira S, Pinheiro B, Lemos C, Ledent C, Takahashi R, Sialana F, Lubec G, Cunha R, Harkany T, Köfalvi A (2015) Lack of presynaptic interaction between glucocorticoid and CB1 cannabinoid receptors in GABA- and glutamatergic terminals in the frontal cortex of laboratory rodents Neurochem Internat, 90: 72-84
• Malenczyk K, Keimpema E, Piscitelli F, Calvigioni D, Björklund P, Mackie K, Di Marzo V, Hökfelt T, Dobrzyn A, Harkany T (2015) Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture PNAS, 112 (45): E6185-E6194
• Alpár A, Di Marzo V, Harkany T (2015) At the Tip of an Iceberg: Prenatal Marijuana and Its Possible Relation to Neuropsychiatric Outcome in the Offspring Biol Psychiatry,
• Tesoriero C, Codita A, Zhang M, Cherninsky A, Karlsson H, Grassi-Zucconi G, Bertini G, Harkany T, Ljungberg K, Liljeström P, Hökfelt T, Bentivoglio M, Kristensson K (2015) H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep–wake regulatory neurons in mice PNAS, 113 (3): E368-E377
• Fuzik J, Zeisel A, Máté Z, Calvigioni D, Yanagawa Y, Szabó G, Linnarsson S, Harkany T (2015) Integration of electrophysiological recordings with single-cell RNA-seq data identifies neuronal subtypes Nat Biotechnol, 34 (2): 175-183
• Ivashkin E, Khabarova M, Melnikova V, Nezlin LP, Kharchenko O, Voronezhskaya EE, Adameyko I (2015) Serotonin Mediates Maternal Effects and Directs Developmental and Behavioral Changes in the Progeny of Snails Cell Rep, 12 (7): 1144-1158
  | Article (PDF) || Weblink |
• Hnat J, Berger ML (2015) Radioligand kinetics at the NMDA receptor channel revisited: an active part by Na+ and Tris Neurotransmitter, 2: e 945
• Hornykiewicz O (2015) 50 years of levodopa Movement Disorders, 30: 1008
• Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ (2015) Low levels of astroglial markers in Parkinson's disease: relationship to alpha-synuclein accumulation Neurobiol Dis, 82: 243-253
• Berger ML, Rebernik P (2015) Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers Bioorg Med Chem Lett, 25 (19): 4131-4135
  | Article (PDF) || Weblink |
• Karabacak Y, Sase S, Aher YD, Sase A, Saroja SR, Cicvaric A, Höger H, Berger M, Bakulev V, Sitte HH, Leban J, Monje FJ, Lubec G (2015) The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm maze Front Behav Neurosci, Epub August 2015
• Ramerstorfer J, Foppa V, Thiery H, Hermange P, Janody S, Berger M, Dodd R, Sieghart W (2015) GABAA Receptor Subtype-Selectivity of Novel Bicuculline Derivates Curr Med Chem, 22: 771-780
• Berger M, Maciejewska D, Vanden Eynde JJ, Mottamal M, Zabinski J, Kazmierczak P, Rezler M, Jarak I, Piantanida I, Karminski-Zamola G, Mayence A, Rebernik P, Kumar A, Ismail MA, Boykin DW, Huang TL (2015) Pentamidine analogs as iInhibitors of [3H]MK-801 and [3H]ifenprodil binding to rat brain NMDA receptors Bioorg Med Chem, 23 (15): 4489-4500
  | Article (PDF): 1 2 || Weblink |
• Pifl C, Reither H, Hornykiewicz O (2015) The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter Eur J Pharmacol, 755: 119-126
  | Article (PDF) |

• Keimpema E, Zheng K, Barde SS, Berghuis P, Dobszay MB, Schnell R, Mulder J, Luiten PG, Xu ZD, Runesson J, Langel Ü, Lu B, Hökfelt T, Harkany T (2014) GABAergic terminals are a source of galanin to modulate cholinergic neuron development in the neonatal forebrain Cereb. Cortex,
• Dyachuk V, Furlan A, Shahidi M, Giovenco M, Kaukua N, Konstantinidou C, Pachnis V, Memic F, Marklund U, Muller T, Birchmeier C, Fried K, Ernfors P, Adameyko I (2014) Parasympathetic neurons originate from nerve-associated peripheral glial progenitors Science, 345 (6192): 82-87
• Kaukua N, Shahidi M, Konstantinidou C, Dyachuk V, Kaucka M, Furlan A, An Z, Wang L, Hultman I, Ährlund-Richter L, Blom H, Brismar H, Lopes N, Pachnis V, Suter U, Clevers H, Thesleff I, Sharpe P, Ernfors P, Fried K, Adameyko I (2014) Glial origin of mesenchymal stem cells in a tooth model system Nature, 513 (7519): 551-554
• Obradović A, Joksimović S, Poe M, Ramerstorfer J, Varagic Z, Namjoshi O, Batinić B, Radulović T, Marković B, Roth B, Sieghart W, Cook J, Savić M (2014) Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: The approximated activation of receptor subtypes may explain behavioral effects Brain Res, 1554: 36-48
• Middendorp S, Puthenkalam R, Baur R, Ernst M, Sigel E (2014) Accelerated Discovery of Novel Benzodiazepine Ligands by Experiment-Guided Virtual Screening ACS Chem Biol, 9 (8): 1854-1859
• Carta V, Pangerl M, Baur R, Puthenkalam R, Ernst M, Trauner D, Sigel E (2014) A Pentasymmetric Open Channel Blocker for Cys-Loop Receptor Channels PLoS One, 9 (9): e106688
• Iannotti F, Silvestri C, Mazzarella E, Martella A, Calvigioni D, Piscitelli F, Ambrosino P, Petrosino S, Czifra G, Biro T, Harkany T, Taglialatela M, Di Marzo V (2014) The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels PNAS, 111 (24): E2472-E2481
• Parnia S, Spearpoint K, de Vos G, Fenwick P, Goldberg D, Yang J, Zhu J, Baker K, Killingback H, Beisteiner R, Berger M, Bullock S, Sutton J, Walmsley A, Deakin CD, Little P, Farber M, Greyson B, Schoenfeld ER (2014) AWARE-AWAREness during REsuscitation-A prospective study Resuscitation, 85: 1799-1805
• Romanov R, Alpar A, Zhang M, Zeisel A, Calas A, Landry M, Fuszard M, Shirran SL, Schnell R, Dobolyi A, Olah M, Spence L, Mulder J, Martens H, Palkovits M, Uhlen M, Sitte H, Botting CH, Wagner L, Linnarsson S, Hökfelt T, Harkany T (2014) A secretagonin locus of the mammalian hypothalamus controls stress hormon release EMBO J., 34 (1): 36-54
  | Article (PDF) |
• Maccarrone M, Guzman M, Mackie K, Doherty P, Harkany T (2014) Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies Nat. Rev. Neurosci., 15: 786-801
• Ferreira SG, Goncalves FQ, Marques JM, Tomé AR, Rodrigues RJ, Nunes-Correia I, Ledent C, Harkany T, Venance L, Cunha RA, Köfalvi A (2014) Presynaptic A2A adenosine receptors dampen CB1 cannabinoid receptor-mediated inhibition of corticostriatal glutamatergic transmission Br J Pharmacol, Oct 9
• Harkany T, Zeilhofer HU, Cattaneo A (2014) Neurotrophin and endocannabinoid interactions in the neurobiology of pain Eur J Neurosci, 39: 331-333
• Gati G, Lendvai D, Hökfelt T, Harkany T, Alpar A (2014) Revival of calcium-binding proteins for neuromorphology: secretagonin typifies distinct cell populations in the avian brain Brain Behav Evol, Epub April 24. 2014
• Iannotti FA, Silvestri C, Mazzarella E, Martella A, Calvigioni D, Piscitelli F, Ambrosino P, Petrosino S, Czifra G, Biro T, Harkany T, Taglialatela M, Di Marzo V (2014) The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels Proc Natl Acad Sci USA, Epub June 3, 2014
• Zhang M, Tortoriello G, Hsueh B, Tomer R, Ye L, Mitsios N, Borgius L, Grant G, Kiehn O, Watanabe M, Uhlen M, Mulder J, Deisseroth K, Harkany T, Hökfelt T (2014) Neuronal calcium-binding proteins 1/2 localize to dorsal root ganglia and excitatory spinal neurons and are regulated by nerve injury PNAS, 111 (12): E1149-E1158
• Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput AH, Hornykiewicz O (2014) Is Parkinson's Disease a Vesicular Dopamine Storage Disorder? Evidence from a Study in Isolated Synaptic Vesicles of Human and Nonhuman Primate Striatum J Neurosci, 24: 8210-8218
• Tortoriello G, Morris CV, Alpar A, Fuzik J, Shirran SL, Calvigioni D, Keimpema E, Botting CH, Reinecke K, Herdegen T, Courtney M, Hurd YL, Harkany T (2014) Miswiring the brain: delta9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway Embo Journ, 33: 668-85
• Mirheydari P, Ramerstorfer J, Varagic Z, Scholze P, Wimmer L, Mihovilovic MM, Sieghart W, Ernst M (2014) Unexpected properties of delta-containing GABA-A receptors in response to ligands interacting with the alpha+beta-site Neurochem Res, 39 (6): 1057-1067

• Keimpema E, Hökfelt T, Harkany T, Doherty P (2014) The molecular interplay between endocannabinoid and neurotrophin signals in the nervous system and beyond Eur J Neurosci, 39: 334-343
• Calvigioni D, Hurd YL, Harkany T, Keimpema E, (2014) Neuronal substrates and functional consequences of prenatal cannabis exposure Child Adolesc Psychiatry Ment Health, Epub May 3, 2014

• Sieghart W (2014) GABA-A receptors in the brain: exciting targets for the development of clinically important drugs. In: , Magyar Tudomanyos Akademia k.A.: k.A.

• Keimpema E, Alpár A, Howell F, Malenczyk K, Hobbs C, Hurd Y, Watanabe M, Sakimura K, Kano M, Doherty P, Harkany T (2013) Diacylglycerol lipase α manipulation reveals developmental roles for intercellular endocannabinoid signaling Sci Rep, 3 (1)
• Baur R, Kielar M, Richter L, Ernst M, Ecker G, Sigel E (2013) Molecular analysis of the site for 2-arachidonylglycerol (2-AG) on the β 2 subunit of GABA A receptors J Neurochem, 126 (1): 29-36
• Palangsuntikul R, Berner H, Berger ML,Wolschann P (2013) Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT-1A and 5HT-2A Receptors Molecules, 18: 8799-8811
• Hanada T, Weitzer S, Mair B, Bernreuther C, Wainger BJ, Ichida J, Hanada R, Orthofer M, Cronin SJ, Komnenovic V, Minis A, Mimata H, Yoshimura A, Tamir I, Herbst R, Martinez J, Penninger JM et al. (2013) CLP1 links tRNA metabolism to progressive motor-neuron loss Nature, 495 (7442): 474-480
  | Weblink |
• Keimpema E, Tortoriello G, Alpar A, Capsoni S, Arisi I, Calvigioni D, Hu S, Cattaneo A, Doherty P, Mackie K, Harkany T (2013) Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons PNAS, 110: 1935-1940
• Malenczyk K, Jazurek M, Keimpema E, Silvestri C, Janikiewicz J, Mackie K, Di Marzo V, Redowicz MJ, Harkany T, Dobrzyn A (2013) CB1 Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release J Biol Chem, 288: 32685-32699
• Joksimovic S, Varagic Z, Kovacevic J, Van Linn M, Milic M, Rallapali S, Timic T, Sieghart W, Cook JM, Savic MM (2013) Insights into functional pharmacology of alpha1 GABA-A receptors: how much does partial activation at the benzodiazepine site matter? Psychopharmycol, 230: 113-123
• Yip GM, Chen ZW, Edge CJ, Smith EH, Dickinson R, Hohenester E, Townsend RR, Fuchs K, Sieghart W, Evers AS, Fanks NP (2013) A propofol binding site on mammalian GABA-A receptors identified by photolabeling Nature Chem Biol, 9: 715-720
• Milenkovic I, Vasiljevic M, Maurer D, Höger H, Klausberger T, Sieghart W. (2013) The parvalbumin-positive interneurons in the mouse dentate gyrus express GABAA receptor subunits alpha1, beta2, and delta along their extrasynaptic cell membrane. Neuroscience, 254: 80-96
  | Weblink |
• Varagic Z, Ramerstorfer J, Huang S, Rallapalli S, Sarto-Jackson I, Cook J, Sieghart W, Ernst M (2013) Subtype selectivity of alpha+beta-site ligands of GABA-A receptors - identification of the first highly specific positive modulators at alpha6beta2/3gamma2 receptors Br J Pharmacol, 169(2): 384-399
• Varagic Z, Wimmer L, Schnuerch M, Mihovilovic MD, Huang S, Rallapalli S, Cook JM, Mirheydari P, Ecker GF, Sieghart W, Ernst M (2013) Identification of novel positive allosteric modulators and null modulators at the GABA-a receptor alpha+beta-interface Br J Pharmacol, 169(2): 371-383
• Hoertnagl H, Tasan RO, Wieselthaler A, Kirchmair E, Sieghart W, Sperk G (2013) Patterns of mRNA and protein expression for 12 GABA-A receptor subunits in the mouse brain Neuroscience, 236: 345-372
• Sieghart W (2013) Anxioselective anxiolytics: additional perspective Trends Pharmacol Sci, 34: 145-146
• Namjoshi OA, Wang Z-J, Rallapalli SK, Johnson EM Jr, Johnson Y-T, Ng H, Ramerstorfer J, Varagic Z, Sieghart W, Majumder S, Roth BL, Rowlett JK, Cook JM (2013) Search for alpha3beta2/3gamma2 subtype selective ligands that are stableon human liver microsomes Bioorg Med Chem, 21: 93-101
• Pifl C, Hornykiewicz O, Blesa J, Adanez R, Cavada C, Obeso JA (2013) Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of Parkinsonism J Neurochem, 125: 657-662
• Berger ML, Hammerschmidt F, Qian R, Hahner S, Schirbel A, Stichelberger M, Schibli R, Yu J, Arion VB, Woschek A, Öhler E, Zolle IM (2013) [3H]Metyrapol and 4-[131I]Iodometomidate Label Overlapping, but Not Identical, Binding Sites on Rat Adrenal Membranes Mol Pharmaceutics, 10: 1119-1130
  | Article (PDF) |
• Mark C, Bornatowicz B, Mitterhauser M, Hendl M, Nics L, Haeusler D, Lanzenberger R, Berger ML, Spreizer H, Wadsak W (2013) Development and automation of a novel NET-PET tracer: [11C]Me@APPI Nucl Med and Biol, 40: 295-303

• Keimpema E, Calvigioni D, Harkany T (2013) Endocannabinoid signals in the developmental programming of delayed-onset neuropsychiatric and metabolic illnesses Biochem. Soc. Trans., 41: 1569-1576

• Richter L, de Graaf C, Sieghart W, Varagic Z, Mörzinger M, de Esch IJP, Ecker GF, Ernst M (2012) Diazepam-bound GABA-A receptor models identify new benzodiazepine binding-site ligands Nature Chem Biol, 8: 455-464
• Spurny R, Ramerstorfer J, Price K, Brams M, Ernst M, Nury H, Verheij M, Legrand P, Bertrand D, Bertrand S, Dougherty DA, de Esch IJ, Corringer PJ, Sieghart W, Lummis SC, Ulens C (2012) Pentameric ligand-gated ion channel ELIC is activated by GABA and modulated by benzodiazepines Proc Natl Acad Sci USA, 109(44): E3028-34
• Berger ML, Pöhler T, Schadt O, Stanger M, Rebernik P, Scholze P, Noe CR (2012) Exploring the Polyamine Regulatory Site of the NMDA Receptor: a Parallel Synthesis Approach ChemMedChem, 8 (1): 82-94
  | Article (PDF) || Weblink |
• Pifl C, Stephen J, Kish SJ, Hornykiewicz O (2012) Thalamic noradrenaline in Parkinson's disease: Deficits suggest role in motor and non-motor symptoms Movement Disorders, 27: 1618-1624
• Maj M, Milenkovic I, Bauer J, Berggard T, Veit M, Ilhan-Mutlu A, Wagner L, Tretter V (2012) Novel insights into the distribution and functional aspects of the calcium binding protein Secretagogin from studies on rat brain and primary neuronal cell culture Front Mol Neurosci, 5: Article 84
  | Supplement |
• Berger ML, Palangsuntikul R, Rebernik P, Wolschann P, Berner H (2012) Screening of 64 tryptamines at NMDA, 5-HT1A, and 5-HT2A receptors: a comparative binding and modeling study Curr Med Chem, 19 (18): 3044-3057
  | Weblink |
• J. Blesa, C. Pifl, M.A. Sánchez-González, C. Juri, M.A. García-Cabezas, R. Adánez, E. Iglesias, M. Collantes, I. Peñuelas, J.J. Sánchez-Hernández, M.C. Rodríguez-Oroz, C. Avendaño, O. Hornykiewicz et (2012) The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study Neurobiol Dis, 48: 79-91
• Chen ZW, Manion B, Townsend RR, Reichert DE, Covey DF, Steinbach JH, Sieghart W, Fuchs K, Evers AS (2012) Neurosteroid analogue photolabeling of a site in the TM3 domain of the beta3 subunit of the GABA-A receptor Mol Pharmacol, 82: 408-419
• Utkin YN, Weise C, Kasheverov IE, Andreeva TV, Kyukova EV, Zhmak MN, Starkov VG, Anh HN, Bertrand D, Ramerstorfer J, Sieghart W, Lummis S, Tsetlin VI (2012) Azemiopsin from Azemiops feae viper venom, a new polypeptide ligand of nicotinic acetylcholine receptor J Biol Chem, 287: 27079-27086
• Joksimovic S, Divljakovic J, Van Linn ML, Varagic Z, Brajkovic G, Milinkovic MM, Yin W, Timic T, Sieghart W, Cook JM, Savic MM (2012) Benzodiazepine-induced spatial learning deficits in rats are regulated by the degree of modulation of a1 GABA-A receptors Eur Neuropsychopharmacol, 23: 390-399
  | Supplement |
• Seeger C, Christopeit T, Fuchs K, Grote K, Sieghart W, Danielson UH (2012) Histaminergic pharmacology of homo-oligomeric beta3 gamma-aminobutyric acid type A receptors characterized by surface plasmon resonance biosensor technology Biochem Pharmacol, 84: 341-355
• Radner S, Celie PH, Fuchs K, Sieghart W, Sixma TK, Stornaiuolo M (2012) Transient transfection coupled to baculovirus infection for rapid protein expression screening in insect cells J Struc Biol, 179: 46-55
• Tretter V, Mukherjee J, Maric HM, Schindelin H, Sieghart W, Moss SJ (2012) Gephyrin, the enigmatic organizer at GABAergic synapses Front Cell Neurosci, 6: 1-16
• Sieghart W (2012) Unraveling the role of GABA-A receptor subtypes in distinct neurons and behaviour J Physiol, 590: 2181-2182
• Sarto-Jackson I, Milenkovic I, Smalla K-H, Gundelfinger ED, Kaehne T, Herrera-Molina R, Thomas S, Kiebler MA, Sieghart W (2012) The cell adhesion molecule neuroplastin-65 is a novel interaction partner of gamma-aminobutyric acid type A receptors J Biol Chem, 287: 14201-14214
  | Supplement |
• Richter L, de Graaf C, Sieghart W, Varagic Z, Mörzinger M, de Esch IJP, Ecker GF, Ernst M (2012) Diazepam-bound GABA-A receptor models identify new benzodiazepine binding site ligands Nature Chem Biol, 8: 455-464
• Sieghart W, Ramerstorfer J, Sarto-Jackson I, Varagic Z, Ernst M (2012) A novel GABA-A receptor pharmacology: drugs interacting with the alpha+beta-interface Br J Pharmacol, 166: 476-485
• Chen ZW, Fuchs K, Sieghart W, Townsend RR, Evers AS (2012) Deep amino acid sequencing of native brain GABA-A receptors using high-resolution mass spectrometry Mol Cell Proteomics, 11.1, 10.1074/mcp.M111.011445-1: Epub Oct 2011
• Vasiljevic M, Heisler FF, Hausrat TJ, Fehr S, Milenkovic I, Kneussel M, Sieghart W (2012) Spatio-temporal expression analysis of the calcium-binding protein calumenin in the rodent brain Neuroscience, 202: 29-41
• Sperk G, Wieselthaler-Hölzl A, Pirker S, Tasan R, Strasser SS, Drexe M, Pifl C, Marschalek J, Ortler M, Trinka E, Haitmair-Wietzorrek K, Ciofi P, Feucht M, Baumgartner C, Czech T (2012) Glutamate decarboxylase67 is expressed in hippocampal mossy fibers of temporal lobe epilepsy patients Hippocampus, 22: 590-603
• Sommerauer C, Rebernik P, Reither H, Nanoff C, Pifl C (2012) The noradrenaline transporter as site of action for the anti-Parkinson drug amantadine. Neuropharmacology, 62 (4): 1708-1716
  | Article (PDF) || Weblink |

• Keimpema E, Straiker A, Mackie K, Harkany T, Hjerling‐Leffler J (2012) Sticking out of the crowd: the molecular identity and development of cholecystokinin‐containing basket cells Am J Physiol, 590 (4): 703-714

• Mulder J, Zilberter M, Pasquaré S, Alpár A, Schulte G, Ferreira S, Köfalvi A, Martín-Moreno A, Keimpema E, Tanila H, Watanabe M, Mackie K, Hortobágyi T, de Ceballos M, Harkany T (2011) Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease Brain, 134 (4): 1041-1060
• Yang AR, Liu J, Yi HS, Warnock KT, Wang M, June HL Jr, Puche AC, Elnabawi A, Sieghart W, Aurelian L, June HL Sr (2011) Binge drinking: in search of its molecular target via the GABA-A receptor Front Neurosci, 5:123: Epub Oct 2011
• Leppä E, Linden AM, Vekovischeva OY, Swinny JD, Rantanen V, Toppila E, Höger H, Sieghart W, Wulff P, Wisden W, Korpi ER (2011) Removal of GABA-A receptor gamma2 subunits from parvalbumin neurons causes wide-ranging behavioural alterations PLoS.ONE., 6 (9): e24159
• Shrivastava AN, Triller A, Sieghart W (2011) GABA-A receptors: post-synaptic co-localization and cross-talk with other receptors Front Cell Neurosci, 5,7: Epub June 2011
• Ouattara B, Gregoire L, Morissette M, Gasparini F, Vranesic I, Bilbe G, Johns DR, Rajput A, Hornykiewicz O, Rajput AH, Gomez-Mancilla B, Di PaoloT (2011) Metabotropic glutamate receptor type 5 in levodopa-induced motor complications Neurobiol Aging, 32: 1286-1295
• Tretter V, Kerschner B, Milenkovic I, Ramsden SL, Ramerstorfer J, Saiepour L, Maric HM, Moss SJ, Schindelin H, Harvey RJ, Sieghart W, Harvey K (2011) Molecular basis of the GABA-A receptor alpha3 subunit interaction with the clustering protein gephyrin J Biol Chem, 286 (43): 37702-37711
• Suryanarayanan A, Liang J, Meyer EM, Lindemeyer AK, Chandra D, Homanics GE, Sieghart W, Olsen RW, Spigelman I (2011) Subunit compensation and plasticity of synaptic GABA-A receptors induced by ethanol in alpha4 subunit knockout mice Front Neurosci, 5: Article 110
• Corteen NL, Cole TM, Sarna A, Sieghart W, Swinny JD (2011) Localisation of GABA-A receptor subunits on neurochemically distinct cell-types in the rat locus coeruleus Eur J Neurosci, 34: 260-262
• Shrivastava AN, Triller A, Sieghart W, Sarto-Jackson I (2011) Regulation of GABA-A receptor dynamics by interaction with P2X-2 receptors J Biol Chem, 286: 14455-14468
• Gross A, Sims RE, Swinny JD, Sieghart W, Bolam JP, Stanford IM (2011) Differential localization of GABA-A receptor subunits in relation to striato-pallidal and pallido-pallidal synapses Eur J Neurosci, 33: 868-878
• Liu J, Yang A, Kelly T, Puche A, Esoga C, June H, Jr., Elnabawi A, Merchenthaler I, Sieghart W, June H, Sr., Aurelian L (2011) Binge alcohol drinking is associated with GABA-A alpha2-regulated TLR4 expression in the central amygdala PNAS, 108: 4465-4470
• Shen Y, Lindemeyer KA, Spigelman I, Sieghart W, Olsen RW, Liang J (2011) Plasticity of GABA-A receptors following ethanol pre-exposure in cultured hippocampal neurons Mol Pharmacol, 79: 432-442
• Ramerstorfer J, Furtmüller R, Sarto-Jackson I, Varagic Z, Sieghart W, Ernst M (2011) The GABA-A receptor alpha+beta-interface: a novel target for subtype-selective drugs J Neurosci, 31: 870-877
• Schosser A, Schloegelhofer M, Fuchs K, Stojanovic M, Mossaheb N, Kindler J, Cohen-Woods S, Hosang G, Farmer A, Craig I, McGuffin P, Aschauer H (2011) Bipolar disorder susceptibility region on chromosome 3q29 not confirmed in a case-control association study World J Biol Psychiat, 12: 309-315
• Neuhaus W, Freidl M, Szkokan P, Berger M L, Wirth M, Winkler J, Gabor F, Pifl C, Noe CR (2011) Effects of NMDA receptor modulators on a blood-brain barrier in vitro model Brain Res, 1394: 49-61
• Tong J, Furukawa Y, Sherwin A, Hornykiewicz O, Kish SJ (2011) Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain Neurobiol Dis, 41: 458-468
• Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C (2011) Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice Neuroscience, 180: 280-292
• Kindler J, Bailer U, De Zwaan M, Fuchs K, Leisch F, Grün B, Strnad A, Stojanovic M, Windisch J, Lennkh-Wolfsberg, El-Giamal N, Sieghart W, Kasper S, Aschauer H (2011) No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with eating disorders Nordic Journal of Psychiatry, 65: 203-207

• Keimpema E, Mackie K, Harkany T (2011) Molecular model of cannabis sensitivity in developing neuronal circuits Trends Pharmacol Sci, 32 (9): 551-561

• Keimpema E, Barabas K, Morozov Y, Tortoriello G, Torii M, Cameron G, Yanagawa Y, Watanabe M, Mackie K, Harkany T (2010) Differential Subcellular Recruitment of Monoacylglycerol Lipase Generates Spatial Specificity of 2-Arachidonoyl Glycerol Signaling during Axonal Pathfinding J Neurosci, 30 (42): 13992-14007
• Abramian AM, Comenencia-Ortiz E, Vithlani M, Tretter V, Sieghart W, Davies PA, Moss SJ (2010) Protein kinase C phosphorylation regulates membrane insertion of GABA-A receptor subtypes that mediate tonic inhibition J Biol Chem, 285: 41795-41805
• Hornykiewicz O (2010) A brief history of levodopa J Neurol, 257: S249-S252
• Kasugai Y, Swinny J, Roberts D, Dalezios Y, Fukazawa Y, Sieghart W, Shigemoto R, Somogyi P (2010) Quantitative localisation of synaptic and extrasynaptic GABA-A receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabeling Eur J Neurosci, 32: 1868-1888
• Fischer BD, Licata SC, Edwankar RV, Wang ZJ, Huang S, He X, Yu J, Zhou H, Johnson EM Jr, Cook JM, Furtmüller R, Ramerstorfer J, Sieghart W, Roth BL, Majumder S, Rowlett JK (2010) Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure Neuropharmacology, 59: 612-618
• Savic MM, Majumder S, Huang SM, Edwankar RV, Furtmüller R, Joksimovic S, Clayton T, Ramerstorfer J, Milinkovic MM, Roth BL, Sieghart W, Cook JM (2010) Novel positive allosteric modulators of GABA-A receptors: Do subtle differences in activity at alpha1 plus a5 versus a2 plus a3 subunits account for dissimilarities in behavioural effects in rats? Progr Neuro-Psychopharmacol & Biol Psychiat, 34: 376-386
  | Article (PDF) |
• Ramerstorfer J, Furtmüller R, Vogel E, Huck S, Sieghart W (2010) The point mutation gamma2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes Eur J Pharmacol, 636: 18-27
  | Article (PDF) |
• Tong J, Wong H, Guttman M, Ang L, Forno L, Shimadzu M, Rajput A, Muenter M, Kish S, Hornykiewicz O, Furukawa Y (2010) Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson´s disease and progressive supranuclear palsy: a comparative investigation Brain, 133: 172-188
  | Article (PDF) |
• Schosser A, Fuchs K, Scharl T, Schloegelhofer M, Kindler J, Mossahed N, Kaufmann RM, Leisch F, Kasper S, Sieghart W, Aschauer HN (2010) Interaction between Serotonin 5-HT2A receptor gene and Dopamine Transporter (DAT1) gene polymorphisms influences personality trait of Persistence in Austrian Caucasians World J Biol Psychiat, 11: 417-424

• Keimpema E, Fokkens M, Nagy Z, Agoston V, Luiten P, Nyakas C, Boddeke H, Copray J (2009) Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats Neuropathol Appl Neurobiol, 35 (1): 89-102
• Kaufmann R, Kraft B, Frey R, Winkler D, Weiszenbichler S, Bäcker C, Kasper S, Kress H (2009) Acute Psychotropic Effects of Oral Cannabis Extract with a Defined Content of Δ 9 -Tetrahydrocannabinol (THC) in Healthy Volunteers Pharmacopsychiatry, 43 (01): 24-32
• Marchionni I, Kasap Z, Mozrzymas JW, Sieghart W, Cherubini E, Zacchi P (2009) New insights on the role of gephyrin in regulating both phasic and tonic GABAergic inhibitition in rat hippocampal neurons in culture Neuroscience, 164(2): 552 - 562
• de Kovel CGF, Trucks H, Helbig I, Rosenow F, Zimprich F, Urak L, Feucht M, Fuchs K, Schreiber S, Nürnberg P, Eichler E, Sander T (2009) Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies Brain, 133: 23-32
• Hanada R, Leibbrandt A, Hanada T, Kitaoka S, Furuyashiki T, Fujihara H, Trichereau J, Paolino M, Qadri F, Plehm R, Klaere S, Komnenovic V, Mimata H, Pifl C, Penninger J et al (2009) Central control of fever and female body temperature by RANKL/RANK Nature, 462: 505-509
• Tretter V, Revilla-Sanchez R, Houston C, Terunuma M, Havekes R, Florian C, Jurd R, Vithlani M, Michels G, Couve A, Sieghart W, Brandon N, Abel T, Smart T, Moss S (2009) Deficits in spatial memory correlate with modified y-aminobutyric acid type A receptor tyrosine phosphorylation in the hippocampus Proc Natl Acad Sci USA, 106: 20039-20044
• Kang SU, Fuchs K, Sieghart W, Pollak A, Csaszar E, Lubec G (2009) Gel-based mass spectrometric analysis of a strongly hydrophobic GABAA-receptor subunit containing four transmembrane domains Nat Protoc, 4: 1093-1102
  | Article (PDF) |
• Atucha E, Hammerschmidt F, Zolle I, Sieghart W, Berger M L (2009) Structure-activity relationship of etomidate derivatives at the GABA-A receptor: Comparison with binding to 11-beta-hydroxylase Bioorg Med Chem Lett, 19: 4284-4287
  | Article (PDF) |
• Rivas FM, Stables JP, Murphree L, Edwankar RV, Edwankar CR, Huang S, Jain HD, Zhou H, Majumder S, Sankar S, Roth BL, Ramerstorfer J, Furtmüller R, Sieghart W, Cook JM (2009) Antiseizure activity of novel gamma-aminobutyric acid(A) receptor subtype-selective benzodiazepine analogues in mice and rat models J Med Chem, 52: 1795-1798
  | Article (PDF) |
• Helbig I, Rosenow F, Urak L, Fuchs K, Feucht M, Franke A, Muhle H, Baker C, Klein KM, Wittig M, Nothnagel M, Schreiber S, Eichler EE, Sander T (2009) 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy Nature Genetics, 41(2): 160-162
• Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ (2009) Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson´s disease Brain, 132: 1366-1375
  | Article (PDF) |
• Berger M.L, Schweifer A, Rebernik P, Hammerschmidt F (2009) NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds Bioorg Med Chem, 17: 3456-3462
  | Article (PDF) |
• Samadi P, Rajput A, Calon F, Gregoire L, Hornykiewicz O, Rajput AH, Di Paolo T (2009) Metabotropic glutamate receptor II in the brains of Parkinsonian patients J Neuropath Exp Neurol, 68: 374-382
  | Article (PDF) |
• Pifl C, Wolf A, Rebernik P, Reither H, Berger M L (2009) Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner Neuropharmacology, 56: 531-540
  | Article (PDF) |

• Olsen RW, Sieghart W (2009) Subtypes provide diversity of function and pharmacology Neuropharmacology, 56: 141-148

• Mulder J, Aguado T, Keimpema E, Barabás K, Ballester Rosado C, Nguyen L, Monory K, Marsicano G, Di Marzo V, Hurd Y, Guillemot F, Mackie K, Lutz B, Guzmán M, Lu H, Galve-Roperh I, Harkany T (2008) Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning Proc Natl Acad Sci USA, 105 (25): 8760-8765
• Savic MM, Clayton T, Furtmüller R, Gavrilovic I, Samardzic J, Savic S, Huck S, Sieghart W, Cook JM (2008) PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA-A receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats Brain Res, 1208: 150-159
  | Article (PDF) |
• Han D, Försterling FH, Li X, Deschamps JR, Parrish D, Cao H, Rallapalli S, Clayton T, Teng Y, Majumder S, Sankar S, Roth BL, Sieghart W, Furtmüller R, Rowlett J, Weed MR, Cook JM (2008) A study of the structure-activity relationship of GABA-A-benzodiazepine receptor bivalent ligands by conformational analysis with low temperature NMR and X-ray analysis Bioorg Med Chem, 16: 8853-8862
  | Article (PDF) |
• Choi DS, Wei W, Deitchman JK, Kharazia VN, Lesscher HMB, McMahon T, Wang D, Qi ZH, Sieghart W, Zhang C, Shokat KM, Mody I, Messing RO (2008) Protein kinase C-delta regulates ethanol intoxication and enhancement of GABA-stimulated tonic current J Neurosci, 28: 11890-11899
• Baburin I, Khom S, Timin E, Hohaus A, Sieghart W, Hering S (2008) Estimating the efficiency of benzodiazepines on GABA-A receptors comprising gamma1 or gamma2 subunits Br J Pharmacol, 155: 424-433
• Kang SU, Fuchs K, Sieghart W, Lubec G (2008) Gel-based mass spectrometric analysis of recombinant GABA-A receptor subunits representing strongly hydrophobic transmembrane proteins J Proteome Res, 7: 3498-3506
  | Article (PDF) |
• Furtmüller R, Furtmüller B, Ramerstorfer J, Paladini AC, Wasowski C, Marder M, Huck S, Sieghart W (2008) 6,3'-Dinitroflavone is a low efficacy modulator of GABA(A) receptors Eur J Pharmacol, 591: 142-146
  | Article (PDF) |
• Harris D, Clayton T, Cook J, Sahbaie P, Halliwell RF, Furtmüller R, Huck S, Sieghart W, and DeLorey TM (2008) Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit J Med Chem, 51: 3788-3803
  | Article (PDF) |
• Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y (2008) Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease Brain, 131: 120-131
  | Article (PDF) |
• Terunuma M, Xu J, Vithlani M, Sieghart W, Kittler J, Pangalos M, Haydon PG, Coulter DA, Moss SJ (2008) Deficits in phosphorylation of GABA-A receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus J Neurosci, 28: 376-384
  | Article (PDF) |
• Payne HL, Ives JH, Sieghart W, Thompson CL (2008) AMPA and kainate receptors mediate mutually exclusive effects on GABA-A receptor expression in cultured mouse cerebellar granule neurons J Neurochem, 104: 173-186
  | Article (PDF) |
• Savic MM, Huang S, Furtmüller R, Clayton T, Huck S, Obradovic DI, Ugresic ND, Sieghart W, Bokonjic DR, Cook JM (2008) Are GABA(A) Receptors Containing alpha5 Subunits Contributing to the Sedative Properties of Benzodiazepine Site Agonists? Neuropsychopharm, 33: 332-339
  | Article (PDF) |
• Zolle IM, Berger ML, Hammerschmidt F, Hahner S, Schirbel A, Peric-Simov B (2008) New Selective Inhibitors of Steroid 11ß-Hydroxylation in the Adrenal Cortex. Synthesis and Structure–Activity Relationship of Potent Etomidate Analogues J Med Chem, 51: 2244-2253
  | Article (PDF) |
• Rajput A.H., Sitte H.H., Rajput A., Fenton M.E., Pifl C., Hornykiewicz O. (2008) Globus pallidus dopamine and Parkinson motor subtypes. Neurology, 70: 1403-1410
  | Article (PDF) |

• Harkany T, Keimpema E, Barabás K, Mulder J (2008) Endocannabinoid functions controlling neuronal specification during brain development Mol Cell Endocrinol, 286 (1-2): S84-S90
• Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit composition, pharmacology and function - update Pharmacol Rev, 60: 243-260
  | Article (PDF) |
• Sarto-Jackson I, Sieghart W (2008) Assembly of GABA-A receptors Mol Membr Biol, 25: 302-310
  | Article (PDF) |

• Nanoff C, Pifl C (2008) Neurotransmitter transporters. In: , Encyclopedia of Molecular Pharmacology Springer Berlin Heidelberg: 836-842

• Tong J, Hornykiewicz O, Furukawa Y, Kish SJ (2007) Marked dissociation between high noradrenaline vs. low noradrenaline transporter levels in human nucleus accumbens J Neurochem, 102: 1691-1702
• Schosser A, Fuchs K, Scharl T, Leisch F, Bailer U, Kasper S, Sieghart W, Hornik K, Aschauer HN (2007) Additional support for linkage of schizophrenia and bipolar disorder to chromosome 3q29 Eur Neuropsychopharmacol, 17: 501-505
  | Article (PDF) |
• Tan KR, Gonthier A, Baur R, Ernst M, Goeldner M, Sigel E (2007) Proximity-Accelerated chemical coupling reaction in the benzodiazepine-binding site of gamma-aminobutyric acid type A receptors: superposition of different allosteric modulators J Biol Chem, 282: 26316-26325
• Payne HL, Connelly WM, Ives JH, Lehner R, Furtmüller B, Sieghart W, Tiwari P, Lucocq JM, Lees G, Thompson CL (2007) GABA-A alpha6-containing receptors are selectively compromised in cerebellar granule cells of the ataxic mouse, stargazer. J Biol Chem, 282: 29130-29143
  | Article (PDF) |
• Wulff P, Goetz T, Leppä E, Linden AM, Renzi M, Swinny JD, Vekovischeva OY, Sieghart W, Somogyi P, Korpi ER, Farrant M, Wisden W (2007) From synapse to behaviour: rapid modulation of defined neuronal populations through engineered GABA-A receptors Nature Neurosci, 10: 923-929
  | Article (PDF) |
• Pytel M, Wojtowicz T, Mercik K, Sarto-Jackson I, Sieghart W, Ikonomidou C, Mozrzymas JW (2007) 17 beta-estradiol modulates GABAergic synaptic transmission and tonic currents during development in vitro Neuropharmacology, 52: 1342-1353
  | Article (PDF) |
• Sarto-Jackson I, Furtmüller R, Ernst M, Huck S, Sieghart W (2007) Spontaneous cross-link of mutated alpha1 subunits during GABA-A receptor assembly J Biol Chem, 282: 4354-4363
  | Article (PDF) |
• Pöhler T., Schadt O., Niepel D., Rebernik P., Berger M.L., Noe C.R. (2007) New polyamine-sensitive inhibitors of the NMDA receptor: Syntheses and pharmacological evaluation. Eur J Med Chem, 42: 175-197
  | Article (PDF) |

• Clayton T, Chen JL, Ernst M, Richter L, Cromer BA, Morton CJ, Ng H, Kaczorowski CC, Helmstetter FJ, Furtmüller R, Ecker G, Parker MW, Sieghart W, Cook JM (2007) An updated unified pharmacophore model of the benzodiazepine binding site of gamma-aminobutyric acid(a) receptors: correlation with comparative models Current Topics in Medicinal Chemistry, 14: 2755-2775
  | Article (PDF) |

• Sieghart W (2007) Neurobiologische Grundlagen psychischer Erkrankungen. In: , Krankheit, Krankheitsursachen und -bilder Marian B, Facultas Universit&auml;tsverlag: 380-384
• Sieghart W (2007) Subunit Composition and Structure of GABA-A receptor subtypes. In: , The GABA Receptors, 3rd edition (Enna SJ, M&ouml;hler H) Humana Press Inc.

• Tong J, Hornykiewicz O, Kish SJ (2006) Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline Arch Neurol, 63: 1724-1728
• Pifl C, Hornykiewicz O (2006) Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP treated rhesus monkeys. Neurochem Internat, 49: 519-524
• Tong J, Hornykiewicz O, Kish SJ (2006) Identification of a noradrenaline-rich subdivision of the human nucleus accumbens J Neurochem, 96: 349-354
• Urak L, Feucht M, Fathi N, Hornik K, Fuchs K (2006) A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity Hum Mol Genet, 15: 2533-2541
• Payne HL, Donoghue PS, Connelly WMK, Hinterreiter S, Tiwari P, Ives JH, Hann V, Sieghart W, Lees G, Thompson CL (2006) Aberrant GABA-A receptor expression in the dentate gyrus of the epileptic mutant mouse, stargazer J Neurosci, 26: 8600-8608
  | Article (PDF) |
• Hanchar HJ, Chutsrinopkun P, Meera P, Supavilai P, Sieghart W, Wallner M, Olsen R (2006) Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to alpha4/6beta3delta GABA-A receptors Proc Natl Acad Sci USA, 103: 8546-8551
  | Article (PDF) |
• Swanwick CC, Murthy NR, Mtchedlishvili Z, Sieghart W, Kapur J (2006) Development of GABAergic Synapses in Cultured Hippocampal Neurons J Comp Neurol, 495: 497-510
  | Article (PDF) |
• Sarto-Jackson I, Ramerstorfer J, Ernst M, Sieghart W (2006) Identification of amino acid residues important for assembly of GABA-A receptor alpha1 and gamma2 subunits J Neurochem, 96: 983-995
  | Article (PDF) |
• Ogris W, Lehner R, Fuchs K, Furtmüller B, Höger H, Homanics GE, Sieghart W (2006) Investigation of the abundance and subunit composition of GABA-A receptor subtypes in the cerebellum of alpha1-subunit-deficient mice J Neurochem, 96: 136-147
  | Article (PDF) |
• Khom S, Baburin I, Timin EN, Hohaus A, Sieghart W, Hering S (2006) Pharmacological properties of GABA-A receptors containing gamma1 subunits Mol Pharmacol, 69: 640-649
  | Article (PDF) |
• Berger M.L., Bitar A.Y., Waitner M.J., Rebernik P., O'Sullivan M.C. (2006) Polyamines and the NMDA receptor: modifying intrinsic activities with aromatic substituents. Bioorg Med Chem Lett, 16: 2837-2841
  | Article (PDF) |
• Buchstaller H.-P., Siebert C.D., Steinmetz R., Frank I., Berger M.L., Gottschlich R., Leibrock J., Krug M., Steinhilber D.,Noe C.R. (2006) Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the NMDA receptor. J Med Chem, 49: 864-871
  | Article (PDF) |

• Pifl C, Sperk G (2006) Current topics in brain dopamine research: a tribute to Professor Oleh Hornykiewicz Wiener Klinische Wochenschrift, 118: 563-565
• Hornykiewicz O (2006) The discovery of dopamine deficiency in the parkinsonian brain Neural Transm Suppl, 70: 9-15

• Sieghart W (2006) Structure, pharmacology and function of GABA-A receptor subtypes. In: , Advances in Pharmacology 54 (Enna SJ) Elsevier Inc: 231-263
  | Article (PDF) |

• Reiterer S., Hemmelmann C., Rappelsberger P., Berger M.L. (2005) Characteristic functional networks in high- versus low second language speakers detected also during native language processing: An explorative EEG coherence study in 6 frequency bands Cog Brain Res, 25: 566-578
  | Article (PDF) |
• Pifl C, Nagy G, Berényi S, Kattinger A, Reither H, Antus S (2005) Pharmacological characterization of ecstasy synthesis byproducts with recombinant human monoamine transporters J Pharmacol Exp Ther, 314: 346-354
• Xu J, Zhong N, Wang H, Elias JE, Kim CY, Woldman I, Pifl C, Gygi SP, Geula C, Yankner BA (2005) The Parkinson's Disease Associated DJ-1 Protein is a Transcriptional Co-Activator that Protects Against Neuronal Apoptosis Hum Mol Genet, 14: 1231-1241
• Woldman I, Reither H, Kattinger A, Hornykiewicz O, Pifl C (2005) Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase Neuropharmacology, 48: 525-537
• Ernst M, Bruckner S, Boresch S, Sieghart W (2005) Comparative models of GABA-A receptor extracellular and transmembrane domains: important insights in pharmacology and function Mol Pharmacol, 68: 1291-1300
  | Article (PDF) |
• Mangan PS, Sun C, Carpenter M, Goodkin HP, Sieghart W, Kapur J (2005) Cultured hippocampal pyramidal neurons express two kinds of GABAA receptors. Mol Pharmacol, 67: 775-788
  | Article (PDF) |
• Bailer U, Wiesegger G, Leisch F, Fuchs K, Leitner I, Letmaier M, Konstantinidis A, Stastny J, Sieghart W, Hornik K, Mitterauer B, Kasper S, Aschauer HN (2005) No association of clock gene T3111C polymorphism and affective disorders Eur Neuropsychopharmacol, 15: 51-55
  | Article (PDF) |
• Cope DW, Halbsguth C, Karayannis T, Wulff P, Ferraguti F, Hoeger H, Leppä E, Linden AM, Oberto A, Ogris W, Korpi ER, Sieghart W, Somogyi P, Wisden W, Capogna M (2005) Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor gamma2 F77I point mutation Eur J Neurosci, 21: 3002-3016
  | Article (PDF) |
• Reiterer S., Berger M.L., Hemmelmann C., Rappelsberger, P. (2005) Decreased EEG coherence between prefrontal electrodes: a correlate of high language proficiency? Exp Brain Res, 163: 109-113
  | Article (PDF) |

• Sieghart W, Ernst M (2005) Heterogeneity of GABA-A receptors: revived interest in the development of subtype-selective drugs Curr Med Chem - Centr Nervous Syst, 5: 217-242
  | Article (PDF) |

• Klein N, Wiesegger G, Attarbaschi T, Winkler D, Mossaheb N, Kasper S, Tauscher J (2004) A naturalistic observational study of escitalopram in the treatment of depression and anxiety disorder in adult outpatients Rom J Psychopharma, 4: 1-9
• Mitterhauser M, Wadsak W, Wabnegger L, Mien L-K, Tögel S, Langer O, Sieghart W, Viernstein H, Kletter K, Dudczak R (2004) Biological evaluation of 2'-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET Nucl Med and Biol, 31: 291-295
  | Article (PDF) |
• Calon F, Dridi M, Hornykiewicz O, Bédard PJ, Rajput AH, Di Paolo T (2004) Increased adenosine A2A receptors in the brain of Parkinson’s disease patients with dyskinesias. Brain, 127: 1075-1084
• Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, Giaveri G, Arosio P, Santambrogio P, Fariello RG, Karatekin E, Kleinman MH, Turro N, Hornykiewicz O, and Zucca FA (2004) The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci USA, 101: 9843-9848
• Rajput AH, Fenton ME , Di Paolo T, Sitte H, Pifl C Hornykiewicz O (2004) Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off Parkinsonism & Related Disorders, 10: 221-226
• Pifl C, Khorchide M, Kattinger A, Reither H, Hardy J, Hornykiewicz O (2004) alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter Neurosci Lett, 354: 34-37
• Pifl C, Rebernik P, Kattinger A, Reither H (2004) Zn2+ modulates currents generated by the dopamine transporter: parallel effects on amphetamine-induced charge transfer and release Neuropharmacology, 46: 223-231
  | Article (PDF) |
• Schosser A, Fuchs K, Leisch F, Bailer U, Meszaros K, Lenzinger E, Willinger U, Strobl R, Heiden A, Gebhardt C, Kasper S, Sieghart W, Hornik K, Aschauer HN (2004) Possible linkage of schizophrenia and bipolar affective disorders to chromosome 3q29; a follow-up. J Psychiatr Res, 38: 357-364
• Cope DW, Wulff P, Oberto A, Aller MI, Capogna M, Ferraguti F, Halbsguth C, Höger H, Jolin HE, Jones A, Mckenzie ANJ, Ogris W, Pöltl A, Sinkkonen ST, Vekovischeva OY, Korpi ER, Sieghart W, et al (2004) Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor gamma2 subunit Neuropharmacology, 47: 17-34
  | Article (PDF) |
• Ogris W, Pöltl A, Hauer B, Ernst M, Oberto A, Wulff P, Höger H,Wisden W, Sieghart W (2004) Affinity of various benzodiazepine site ligands in mice with a point mutation in the GABAA receptor gamma2 subunit Biochem Pharmacol, 68: 1621-1629
  | Article (PDF) |
• Petrini EM, Marchionni I, Zacchi P, Sieghart W, Cherubini E (2004) Clustering of extrasynaptic GABAA receptors modulates tonic inhibition in cultured hippocampal neurons J Biol Chem, 279: 45833-45843
  | Article (PDF) |
• Sinkkonen ST, Vekovischeva OY, Möykkynen T, Ogris W, Sieghart W, Wisden W, Korpi E (2004) Behavioral correlates of an altered balance between synaptic and extrasynaptic GABAAergic inhibition in a mouse model Eur J Neurosci, 20: 2168-2178
  | Article (PDF) |
• Sun C, Sieghart W, Kapur J (2004) Distribution of alpha1, alpha4, gamma2 and delta subunits of GABA A receptors in hippocampal granule cells Brain Res, 1029: 207-216
  | Article (PDF) |
• Schirbel A., Zolle I., Hammerschmidt F., Berger M.L., Schiller D., Kvaternik H., Reiners C. (2004) [123/131I]Iodometomidate as a radioligand for functional diagnosis of adrenal disease: synthesis, structural requirements and biodistribution. Radiochim Acta, 92: 297-303
  | Article (PDF) |

• Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonucelli U, Damier P, de Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E (2004) Levodopa in the treatment of Parkinson’s disease: current controversies Movement Disorders, 19: 997-1005
• Yamamoto K, Hornykiewicz O (2004) Proposal for a noradrenaline hypothesis of schizophrenia. Progr Neuro-Psychopharmacol & Biol Psychiat, 28: 913-922

• Sieghart W (2004) Laboruntersuchungen in der Psychiatrie. In: , Psychische Funktionen in Gesundheit und Krankheit Springer-Kremser M, L&ouml;ffler-Stastka H, Facultas Universit&auml;tsverlag: 374-381

• Ehya N, Sarto I, Wabnegger L, Klausberger T, and Sieghart W (2003) Identification of an amino acid sequence within GABAA receptor beta3 subunits that is important for receptor assembly J Neurochem, 84: 127-135
• Ernst M, Brauchart D, Boresch S, and Sieghart W (2003) Comparative modeling of GABAA receptors: limits, insights, future developments Neuroscience, 119: 933-943
• Mitterhauser M, Wadsak W, Wabnegger L, Sieghart W, Viernstein H, Kletter K, Dudczak R (2003) In vivo and in vitro evaluation of [18F]FETO with respect to the adrenocortical and GABAergic system in rats Eur J Nucl Med Mol Imaging, 30: 1398-1401
• Pirker S, Schwarzer C, T. Czech T, Baumgartner C, Pockberger H, Maier H, Hauer B, Sieghart W, Furtinger S, and Sperk G (2003) Increased expression of GABAA receptor beta-subunits in the hippocampus of patients with temporal lobe epilepsy J Neuropath Exp Neurol, 62: 820-834
• Willeit M, Praschak-Rieder N, Neumeister A, Zill P, Leisch F, Stastny J, Hilger E, Thierry N, Konstantinidis A, Winkler D, Fuchs K , Sieghart W, Aschauer H, Ackenheil M, et al (2003) A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder Mol Psychiatry, 8: 942-946
• Pöltl A, Hauer B, Fuchs K, Tretter V, Sieghart W (2003) Subunit composition and quantitative importance of GABAA receptor subtypes in the cerebellum of mouse and rat. J Neurochem, 87: 1444-1455
• Li X, Cao H, Zhang C, Furtmüller R, Fuchs K, Huck S, Sieghart W, Deschamps J, Cook JM (2003) Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazol[1,5a]- [1,4]benzo-diazepine analogue, the first bivalent alpha5 subtype selective BzR/GABAA antagonist J Med Chem, 46: 5567-5570

• Sieghart W (2003) Benzodiazepines, benzodiazepine receptors, and endogenous ligands. In: Boer, J.A., Ad Sitsen, J.M, Handbook of Depression and Anxiety eds. Marcel Dekker, Inc. New York, Basel: 415-442
• Berger, M.L., Noe, C.R. (2003) Polyamine regulation of the NMDA receptor complex as a target in drug development. In: Ramchandran, U., Current Topics in Medicinal Chemistry Research Trends, Trivandrum: 51-64
  | Article (PDF) |

• Sarto I, Wabnegger L, Dögl E, Sieghart W (2002) Homologous sites of GABA-A receptor alpha1, beta3 and gamma2 subunits are important for assembly Neuropharmacology, 43: 482-491
• Wisden W, Cope D, Klausberger T, Hauer B, Sinkkonen S T, Tretter V, Lujan R, Jones A, Korpi E R, Mody I, Sieghart W, Somogyi P, (2002) Ectopic expression of the GABA-A receptor alpha 6 subunit in hippocampal pyramidal neurons produces extrasynaptic receptors and an increased tonic inhibition. Neuropharmacology, 43: 530-549
• Kumar S, Sieghart W, Morrow AL (2002) Association of protein kinase C with GABA-A receptors containing alpha1 and alpha4 subunits in the cerebral cortex: selective effects of chronic ethanol consumption J Neurochem, 82: 110-117
• Bailer U, Leisch F, Meszaros K, Lenzinger E, Willinger U, Strobl R, Heiden A, Gebhardt C, Dögl E, Fuchs K, Sieghart W, Kasper S, Hornik K, Aschauer HN (2002) Genome scan for susceptibility loci for schizophrenia and bipolar disorder Biol Psychiatry, 52: 40-52
• Sarto I, Klausberger T, Ehya N, Mayer B, Fuchs K, Sieghart W (2002) A novel site on gamma3 subunits important for assembly of GABA-A receptors J Biol Chem, 277: 30656-30664
• El Hadri A, Abouabdellah A, Thomet U, Baur R, Furtmüller R, Sigel E, Sieghart W, Dodd RH (2002) N-Substituted 4-amino-3,3-dipropyl-2(3H)-furanones: new positive allosteric modulators of the GABA-A receptor sharing electrophysiological properties with the anticonvulsant loreclezole J Med Chem, 45: 2824-2831
• Peng Z, Hauer B, Mihalek RM, Homanics GE, Sieghart W, Olsen RW, Houser CR (2002) GABA-A receptor changes in delta subunit-deficient mice: altered expression of alpha4 and gamma2 subunits in the forebrain J Comp Neurol, 446: 179-197
• Korpi ER, Mihalek RM, Sinkkonen ST, Hauer B, Hevers W, Homanics GE, Sieghart W, Lüddens H (2002) Altered receptor subtypes in the forebrain of GABA-A receptor delta subunit-deficient mice: recruitment of gamma2 subunits Neuroscience, 109: 733-743
• Furtmüller R, Schlag MG, Berger M L, Hopf R, Huck S, Sieghart W, Redl H (2002) Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid-A-receptor antagonistic effect J Pharmacol Exp Ther, 301: 168-173
• Pifl C, Kattinger A, Reither H, Hornykiewicz O (2002) Cellular effects of dopamine - beyond oxidative mechanisms Parkinsonism & Related Disorders, 8: 433-437
• Kristufek D, Rudorfer W, Pifl C, Huck S (2002) Organic cation transporter mRNA and function in the rat superior cervical ganglion J Physiol, 543: 117-134

• Sieghart, W and Sperk, G (2002) Subunit composition, distribution and function of GABA-A receptor subtypes Current Topics in Medicinal Chemistry, 2: 795-816
  | Article (PDF) |

• Pifl C, Caron MG (2002) The dopamine transporter: molecular biology, pharmacology and genetics. In: , Handbook of Experimental Pharmacology Springer Berlin Heidelberg New York: 257-297

• Saha S, Sieghart W, Fritschy JM, McWilliam PN, Batten TF (2001) gamma-aminobutyric acid receptor (GABA-A) subunits in rat nucleus tractus solitarii (NTS) revealed by polymerase chain reaction (PCR) and immunohistochemistry Mol Cell Neurosci, 17: 241-257
• Buhr A, Wagner C, Fuchs K, Sieghart W, Sigel E (2001) Two novel residues in M2 of the GABA-A receptor affecting gating by GABA and picrotoxin affinity J Biol Chem, 276: 7775-7781
• Maric D, Liu QY, Maric I, Chaudry S, Chang YH, Smith SV, Sieghart W, Fritschy JM, Barker JL (2001) GABA expression dominates neuronal lineage progression in the embryonic rat neocortex and facilitates neurite outgrowth via GABA-A autoreceptor/Cl-channels J Neurosci, 21: 2343-2360
• Sigel E, Baur R, Furtmüller R, Razet R, Dodd RH, Sieghart W (2001) Differential cross talk of ROD compounds with the benzodiazepine binding site Mol Pharmacol, 59: 1470-1477
• Schwarzer C, Berresheim U, Pirker S, Wieselthaler A, Fuchs K, Sieghart W, Sperk G (2001) Distribution of the major gamma-aminobutyric acid(A) receptor subunits in the basal ganglia and associated limbic brain areas of the adult rat J Comp Neurol, 433: 526-549
• Klausberger T, Ehya N, Fuchs K, Fuchs T, Ebert V, Sarto I, Sieghart W (2001) Detection and binding properties of GABA-A receptor assembly intermediates J Biol Chem, 276: 16024-16032
• Tretter V, Hauer B, Nusser Z, Mihalek RM, Höger H, Homanics GE, Somogyi P, Sieghart W (2001) Targeted disruption of the GABA(A) receptor delta subunit gene leads to an upregulation of gamma 2 subunit containing receptors in cerebellar granule cells J Biol Chem, 276: 10532-10538
• Sitte H.H., Wanschitz J., Budka H., Berger M.L. (2001) Autoradiography with [3H]PK11195 of spinal tract degeneration in amyotrophic lateral sclerosis Acta Neuropathol, 101: 75-78
  | Article (PDF) |
• Dellovade TL, Davis AM, Ferguson C, Sieghart W, Homanics GE, Tobet SA (2001) GABA influences the development of the ventromedial nucleus of the hypothalamus J Neurobiol, 49: 264-276
• Klausberger T, Sarto I, Ehya N, Fuchs K, Furtmüller R, Mayer B, Huck S, Sieghart W (2001) Alternate use of distinct intersubunit contacts controls GABA-A receptor assembly and stoichiometry J Neurosci, 21: 9124-9133
• Willeit M, Stastny J, Pirker W, Praschak-Rieder N, Neumeister A, Asenbaum S, Tauscher J, Fuchs K, Sieghart W, Hornik K, Aschauer HN, Brücke T, Kasper S (2001) No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism Biol Psychiatry, 50: 8-12
• Sitte HH, Hiptmair B, Zwach J, Pifl C, Singer EA, Scholze P (2001) Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion Mol Pharmacol, 59: 1129-1137
  | Article (PDF) |
• Pifl C, Zezula J, Spittler A, Kattinger A, Reither H, Caron MG, Hornykiewicz O (2001) Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter FASEB J, 15: 1607-1609
• Krapfenbauer K., Berger M.L., Lubec G., Fountoulakis M. (2001) Changes in the levels of low-abundance brain proteins induced by kainic acid. Eur J Biochem, 268: 3532-3537
• Krapfenbauer K., Berger M.L., Lubec G., Fountoulakis M. (2001) Changes in the brain protein levels following administration of kainic acid. Electrophoresis, 22: 2086-2091

• Pifl C, Sitte HH, Reither H, Singer EA (2000) The mechanism of the releasing action of amphetamine. Uptake, superfusion and electrophysiological studies on transporter-transfected cells Pure Appl Chem, 72: 1045-1050
• Razet R, Thomet U, Furtmüller R, Chiaroni A, Sigel E, Sieghart W, Dodd RH (2000) 5-{1´-(2´,3´,4´-tetrahydroisoquinolyl)}-4,5-dihydro-2(3H)-furanones: positive allosteric modulators of the GABA-A receptor with a new mode of acion J Med Chem, 43: 4363-4366
• Bailer U, Leisch F, Meszaros K, Lenzinger E, Willinger U, Strobl R, Gebhardt C, Gerhard E, Fuchs K, Sieghart W, Kasper S, Hornik K, Aschauer HN on behalf of the European Science Foundation Programme (2000) Genome scan for Susceptibility Loci for Schizophrenia Neuropsychobiology, 42: 175-182
• Meszaros K, Lenzinger E, Hornik K, Füreder T, Stompe T, Willinger U, Heiden A, Fathi N, Gerhard E, Fuchs K, Sieghart W, Kasper S, Aschauer HN (2000) Association study of schizophrenia spectrum disorders and dopamine D3 receptor gene: is schizoaffective disorder special? Psychiat Res, 96: 179-183
• Razet R, Thomet U, Furtmüller R, Jursky F, Sigel E, Sieghart W, Dodd RH (2000) Use of bicuculline, a GABA antagonist, as a template for the development of a new class of ligands showing positive allosteric modulation of the GABA-A receptor Bioorg Med Chem Lett, 10: 2579-2583
• Do-Rego JL, Mensah-Nyagan GA, Beaujean D, Vaudry D, Sieghart W, Luu-The V, Pelletier G, Vaudry H (2000) gamma-Aminobutyric acid, acting through gamma-aminobutyric acid type A receptors, inhibits the biosynthesis of neurosteroids in the frog hypothalamus PNAS, 97: 13925-13930
• Simonian SX, Skynner MJ, Sieghart W, Essrich C, Lüscher B, Herbison AE (2000) Role of the GABA-A receptor gamma2 subunit in the development of gonadotropin-releasing hormone neurons in vivo Eur J Neurosci, 12: 3488-3496
• Thomet U, Baur R, Razet R, Dodd RH, Furtmüller R, Sieghart W, Sigel E (2000) A novel positive allosteric modulator of the GABA-A receptor: the action of (+)-ROD188 Br J Pharmacol, 131: 843-850
• Brandon NJ, Delmas P, Kittler JT, McDonald BJ, Sieghart W, Brown DA, Smart TG, Moss SJ (2000) GABA-A receptor phosphorylation and functional modulation in cortical neurons by a protein kinase C-dependent pathway J Biol Chem, 275: 38856-38862
• Uusi-Oukari M, Heikkila J, Sinkkonen ST, Makelä R, Hauer B, Homanics GE, Sieghart W, Wisden W, Korpi ER (2000) Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABA-A receptor beta2-alpha6-alpha1-gamma2 subunit gene cluster Mol Cell Neurosci, 16: 34-41
• Nicoletti D, Ghini AA, Furtmüller R, Sieghart W, Dodd RH, Burton G (2000) Synthesis and GABA-A receptor activity of 6-oxa-analogs of neurosteroids Steroids, 65: 349-356
• Sassoe-Pognetto M, Panzanelli P, Sieghart W, Fritschy JM (2000) Colocalization of multiple GABA-A receptor subtypes with gephyrin at postsynaptic sites J Comp Neurol, 420: 481-498
• Klausberger T, Fuchs K, Mayer B, Ehya N, Sieghart W (2000) GABA-A receptor assembly: Identification and structure of gamma2 sequences forming the intersubunit contacts with alpha1 and beta3 subunits J Biol Chem, 275: 8921-8928
• Louiset E, McKernan R, Sieghart W, Vaudry H (2000) Subunit composition and pharmacological characterization of gamma-aminobutyric acid type A receptors in frog pituitary melanotrophs Endocrinology, 141: 1083-1092
• Okada M, Onodera K, Van Reterghem C, Sieghart W, Takahashi T (2000) Functional correlation of GABA-A receptor a subunits expression with the properties of IPSCs in the developing thalamus J Neurosci, 20: 2202-2208
• Gebhardt C, Leisch F, Schüssler P, Fuchs K, Stompe T, Sieghart W, Hornik K, Kasper S, Aschauer HN (2000) Non-association of dopamine D4 and D2 receptor genes with personality in healthy individuals Psychiat Gen, 10: 131-137
• Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G (2000) GABA-A receptors: immunocytochemical distribution of 13 subunits in the adult rat brain Neuroscience, 101: 815-850
• Heiden A, Schüssler P, Itzlinger U, Leisch F, Scharfetter J, Gebhardt C, Fuchs K, Willeit M, Nilsson L, Miller-Reiter E, Meszaros K, Sieghart W, Hornik K, Kasper S, Aschauer HN (2000) Association studies of candidate genes in bipolar disorders Neuropsychobiology, 42: 18-21
• Jursky F, Fuchs K, Buhr A, Tretter V, Sigel E, Sieghart W (2000) Identification of aminoacid residues of GABA(A) receptor subunits contributing to the formation and affinity of the tert-butylbicyclophosphorothionate binding site J Neurochem, 74: 1310-1316
• Sitte HH, Scholze P, Schloss P, Pifl C, Singer EA (2000) Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study J Neurochem, 74: 1317-1324
• Scholze P, Zwach J, Kattinger A, Pifl V, Singer EA, Sitte HH (2000) Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter J Pharmacol Exp Ther, 293: 870-878p
• Berger M L (2000) Tryptamine derivatives as non-competitive N-methyl-D-aspartate receptor blockers: studies using [3H]MK-801 binding in rat hippocampal membranes Neurosci Lett, 296: 29-33
  | Article (PDF) |

• Sieghart W (2000) Unraveling the function of GABA-A receptor subtypes Trends Pharmacol Sci, 21: 411-413

• Scharfetter J, Chaudhry HR, Hornik K, Fuchs K, Sieghart W, Kasper S, Aschauer HN (1999) Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients Eur Neuropsychopharmacol, 10: 17-20
• Kapitany T, Schindl M, Schindler SD, Heßelmann B, Füreder T, Barnas C, Sieghart W, Kasper S (1999) The citalopram challenge test in patients with major depression and in healthy controls Psychiat Res, 88: 75-88
• Nusser Z, Sieghart W, Mody I (1999) Differential regulation of synaptic GABA-A receptors by cAMP-dependent protein kinase in mouse cerebellar and olfactory bulb neurons J Physiol, 521: 421-435
• Feucht M, Fuchs K, Pichlbauer E, Hornik K, Scharfetter J, Goessler R, Füreder T, Cvetkovic N, Sieghart W, Kasper S, Aschauer H (1999) Possible association between childhood absence epilepsy and the gene encoding GABRB3 Biol Psychiatry, 46: 997-1002
• Gustincich S, Feigenspan A, Sieghart W, Raviola E (1999) Composition of the GABA-A receptors of retinal dopaminergic neurons J Neurosci, 19: 7812-7822
• Thomet U, Furtmüller R, Sieghart W, Le Hyaric-Almeida M, Rousseau JF, Dodd RH, Venault P, Chapouthier G, Sigel E (1999) EDPC: a novel high affinity ligand for the benzodiazepine site on rat GABA-A receptors Neurosci Lett, 269: 63-66
• Levi S, Chesnoy-Marchais D, Sieghart W, Triller A (1999) Synaptic control of glycine-, GABA-A receptors and gephyrin expression in cultured motoneurons J Neurosci, 19: 7434-7449
• Kannenberg K, Schaerer MT, Fuchs K, Sieghart W, Sigel E (1999) A novel serine kinase with specificity for beta3 subunits is tightly associated with GABA-A receptors J Biol Chem, 274: 21257-21264
• Thomet U, Baur R, Scholze P, Sieghart W, Sigel E (1999) Dual mode of stimulation by the beta-carboline ZK91085 of recombinant GABA-A receptor currents: molecular determinants affecting its action Br J Pharmacol, 127: 1231-1239
• Chen S, Huang Z, Zeng XJ, Sieghart W, Tietz EI (1999) Benzodiazepine-mediated regulation of alpha1, alpha2, beta1-3 and gamma2 GABA-A receptor subunit proteins in the rat brain hippocampus and cortex Neuroscience, 93: 33-44
• Maric D, Maric I, Wen X, Fritschy JM, Sieghart W, Barker JL, Serafini R (1999) GABA-A receptor subunit and composition and functional properties of Cl-channels with differential sensitivity to zolpidem in embryonic rat hippocampal cells J Neurosci, 19: 4921-4937
• Lenzinger E, Neumeister A, Praschak-Rieder N, Fuchs K, Gerhard E, Willeit M, Sieghart W, Kasper SF, Hornik K, Aschauer HN (1999) Behavioral effects of tryptophan depletion in seasonal affective disorder associated with the serotonin transporter gene? Psychiat Res, 22: 241-246
• Ebert V, Scholze P, Fuchs K, Sieghart W (1999) Identification of subunits mediating clustering of GABA-A receptors by rapsyn Neurochem Internat, 34: 453-463
• Kannenberg K, Sieghart W, Reuter H (1999) Clusters of GABA-A receptors on cultured hippocampal cells correlate only partially with functional synapses Eur J Neurosci, 11: 1256-1264
• Tobet SA, Henderson RG, Whiting PJ, Sieghart W (1999) Special relationship of gamma-aminobutyric acid to the ventromedial nucleus of the hypothalamus during embryonic development J Comp Neurol, 405: 88-98
• Bencits E, Ebert V, Tretter V, Sieghart W, (1999) A significant part of native gamma-aminobutyric acid-A receptors containing alpha4 do not contain gamma or delta subunits J Biol Chem, 274: 19613-19616
• Nusser Z, Ahmad Z, Tretter V, Fuchs K, Wisden W, Sieghart W, Somogyi P (1999) Alterations in the expression of GABA-A receptor subunits in cerebellar granule cells after the disruption of the alpha6 subunit gene Eur J Neurosci, 11: 1685-1697
• Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi Z, Lagenaur C, Tretter V, Sieghart W, Anagnostaras SG, Sage JR, Fanselow MS, Guidotti A, DeLorey TM, Olsen RW, Homanics GE (1999) Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice PNAS, 96: 12905-12910
• Pifl C, Agneter E, Drobny H, Sitte HH, Singer EA (1999) Amphetamine reverses or blocks the operation of the human noradrenaline transporter depending on its concentration: superfusion studies on transfected cells Neuropharmacology, 38: 157-165
• Pifl C, Singer EA (1999) Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of faciliated exchange diffusion Mol Pharmacol, 56: 1047-1054
• Furukawa Y, Nygaard TG, Gutlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ (1999) Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia Neurology, 53: 1032-1041
• Berger M L, Rebernik P (1999) Zinc and Ifenprodil Allosterically Inhibit Two Separate Polyamine-Sensitive Sites at N-Methyl-D-Aspartate Receptor Complex J Pharmacol Exp Ther, 289: 1584-1591
  | Article (PDF) || Weblink |

• Sieghart W, Fuchs K, Tretter V, Eber V, Jechlinger M, Höger H, Adamiker D (1999) Structure and subunit composition of GABA-A receptors Neurochem Internat, 34: 379-385

• Kapitany T, Meszaros K, Lenzinger E, Schindler SD, Barnas C, Fuchs K, Sieghart W, Aschauer HN, Kasper S (1998) Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia Schizophr Res, 32: 101-106
• Serafini R, Ma W, Maric D, Maric I, Lahjouji F, Sieghart W, Barker JL (1998) Initially expressed early embryonic GABA-A receptor Cl- ion channels exhibit heterogeneous channel properties Eur J Neurosci, 10: 1771-1783
• Mitsuyama H, Little KY, Sieghart W, Devaud LL, Morrow AL (1998) GABA-A receptor alpha1, alpha4 and beta3 subunit mRNA and protein expression in the frontal cortex of human alcoholics Alcohol Clin Exp Res, 22: 815-822
• Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K, Sieghart W, Meszaros K, Fathi N, Laurent C, Mallet J, Macciardi F, Pedrini S, Gill M, Hawi Z, Gibson S, Adolfsson R, Owen MJ (1998) European Multicentre Association Study of Schizophrenia: A study of the DRD2Ser311Cys and DRD3Ser9Gly Polymorphisms Am J Med Genet, 81: 24-28
• Matthews DB, Devaud LL, Fritschy JM, Sieghart W, Morrow AL (1998) Differential regulation of GABA-A receptor gene expression by ethanol in the rat hippocampus versus cerebral cortex J Neurochem, 70: 1160-1166
• Nusser Z, Sieghart W, Somogyi P (1998) Segregation of different GABA-A receptors to synaptic and extrasynaptic membranes of cerebellar granule cells J Neurosci, 18: 1693-1703
• Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C (1998) Carrier-mediated release, transport rates and charge transfer induced by amphetamine, tyramine and dopamine in mammalian cells transfected with the human dopamine transporter J Neurochem, 71: 1289-1297
• Berger M.L, Schödl C, Noe CR (1998) Inverse agonists at the polyamine-sensitive modulatory site of the NMDA receptor: 50-fold increase in potency by insertion of an aromatic ring into an alkanediamine chain Eur J Med Chem, 33: 3-14
  | Article (PDF) |

• Barnard EA, Skolnick P, Olsen RW, Möhler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ (1998) International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acid-A receptors: classification on the basis of subunit structure and receptor function Pharmacol Rev, 50: 291-313

• Maric D, Maric I, Ma W, Lahojuji F, Somogyi R, Wen X, Sieghart W, Fritschy JM, Barker JL (1997) Anatomical gradients in proliferation and differentiation of embryonic rat CNS accessed by buoyant density fractionation: alpha3, beta3 and gamma2 GABA-A receptor subunit co-expression by postmitotic Eur J Neurosci, 9: 507-522
• Tretter V, Ehya N, Fuchs K, Sieghart W (1997) Stoichiometry and assembly of a recombinant GABA-A receptor subtype J Neurosci, 17: 2728-2737
• Jones A, Korpi ER, McKernan RM, Nusser Z, Pelz R, Mäkelä R, Mellor JR, Pollard S, Bahn S, Stephenson RA, Randall AD, Sieghart W, Somogyi P, Smith AJH, Wisden W (1997) Ligand-gated ion channel subunit partnerships: GABA-A receptor alpha6 subunit gene inactivation inhibits delta subunit expression J Neurosci, 17: 1350-1362
• Pifl C, Agneter E, Drobny H, Reither H, Singer EA (1997) Induction by low Na+ or Cl- of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters Br J Pharmacol, 121: 205-212

• Meszaros K, Lenzinger E, Füreder T, Hornik K, Willinger U, Stompe T, Heiden AH, Resinger E, Fathi N, Gerhard E, Fuchs K, Miller-Reiter E, Pfersmann V, Sieghart W, Aschauer HN, Kasper S (1996) Schizophrenia and the dopamine-beta-hydroxylase gene: results of a linkage and association study Psychiat Gen, 6: 17-22

• Berger M L (1995) On the true affinity of glycine for its binding site at the NMDA receptor complex J Pharmacol Tox Meth, 34: 79-88
  | Article (PDF) |

• Sieghart W, Item C, Buchstaller A, Fuchs K, Höger H, Adamiker D (1993) Evidence for the existence of differential O-glycosylated alpha5-subunits of the gamma-aminobutyric acid-A receptor in the rat brain J Neurochem, 60: 93-98

• Ruhrmann S, Kasper S, Danos P, Höflich G, Möller HJ (1993) Angst bei saisonal-abhängiger Depression (SAD) und Lichttherapie. In: Baumann P (Hrsg.), Biologische Psychiatrie der Gegenwart Wien, New York, Springer : pp. 264-267

• Kasper S (1992) Antidepressant medication and therapeutic sleep deprivation in depressed patients. In: Macher J.P., Crocq M.A. (Hrsg), New prospects in psychiatry, The bio-clinical interface I, Developments in psychiatry Amsterdam, London, New York, Tokyo, Elsevier : pp. 215-222

• Lewis E, Al Khazal F, Wilbanks B, Gades N, Ortega‐Sáenz P, López‐Barneo J, Adameyko I, Maher L (2024) Mouse developmental defects, but not paraganglioma tumorigenesis, upon conditional Complex II loss in early Sox10⁺ cells FASEB Bioadv, 6 (9): 327-336
• Boutou A, Roufagalas I, Politopoulou K, Tastsoglou S, Abouzeid M, Skoufos G, Verdu de Juan L, Ko J, Kyrargyri V, Hatzigeorgiou A, Barnum C, Tesi R, Bauer J, Lassmann H, Johnson M, Probert L (2024) Microglia regulate cortical remyelination via TNFR1-dependent phenotypic polarization Cell Rep, 43 (11): 114894
• Winklehner M, Wickel J, Gelpi E, Brämer D, Rauschenberger V, Günther A, Bauer J, Serra A, Jauk P, Villmann C, Höftberger R, Geis C (2024) Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor and GAD65 Antibodies Neurol Neuroimmunol Neuroinflamm, 11 (6): e200298
• Bien C, Rada A, Mertens M, Bien C, Bauer J, Hagemann A, Woermann F (2024) LGI1 encephalitis: potentially complement-activating anti-LGI1-IgG subclasses 1/2/3 are associated with the development of hippocampal sclerosis J Neurol, 271 (9): 6325-6335
• Roll W, Bauer J, Dik A, Mueller C, Backhaus P, Räuber S, Zinnhardt B, Gallus M, Wimberley C, Körtvelyessy P, Schindler P, Stenzel W, Elger C, Becker A, Lewerenz J, Wiendl H, Meuth S, Schäfers M, Melzer N (2024) 18F-DPA-714-PET-MRI reveals pronounced innate immunity in human anti-LGI1 and anti-CASPR2 limbic encephalitis J Neurol, 271 (6): 3653-3659
• Beliën J, Swinnen S, D’hondt R, de Juan L, Dedoncker N, Matthys P, Bauer J, Vens C, Moylett S, Dubois B (2024) CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis Nat Commun, 15 (1): 5013
• Yu W, Kastriti M, Ishan M, Choudhary S, Rashid M, Kramer N, Do H, Wang Z, Xu T, Schwabe R, Ye K, Adameyko I, Liu H (2024) The duct of von Ebner’s glands is a source of Sox10+ taste bud progenitors and susceptible to pathogen infections Front Cell Dev Biol, 12: 12:1460669
• Olsen T, Otte J, Mei S, Embaie B, Kameneva P, Cheng H, Gao T, Zachariadis V, Tsea I, Björklund ?, Kryukov E, Hou Z, Johansson A, Sundström E, Martinsson T, Fransson S, Stenman J, Fard S, Johnsen J, Kogner P, Adameyko I, Enge M, Kharchenko P, Baryawno N (2024) Joint single-cell genetic and transcriptomic analysis reveal pre-malignant SCP-like subclones in human neuroblastoma Mol Cancer, 23 (1): 180
• Erickson A, Motta A, Kastriti M, Edwards S, Coulpier F, Théoulle E, Murtazina A, Poverennaya I, Wies D, Ganofsky J, Canu G, Lallemend F, Topilko P, Hadjab S, Fried K, Ruhrberg C, Schwarz Q, Castellani V, Bonanomi D, Adameyko I (2024) Motor innervation directs the correct development of the mouse sympathetic nervous system Nat Commun, 15 (1): 7065
• Kaneko K, Kuroda H, Matsumoto Y, Sakamoto N, Yamazaki N, Yamamoto N, Umezawa S, Namatame C, Ono H, Takai Y, Takahashi T, Fujimori J, Nakashima I, Harigaya Y, Lassmann H, Fujihara K, Misu T, Aoki M (2024) Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD Neurol Neuroimmunol Neuroinfl, 11 (5): e200293
• Kibalnyk Y, Afanasiev E, Noble R, Watson A, Poverennaya I, Dittmann N, Alexiou M, Goodkey K, Greenwell A, Ussher J, Adameyko I, Massey J, Graf D, Bourque S, Stratton J, Voronova A (2024) The chromatin regulator Ankrd11 controls cardiac neural crest cell-mediated outflow tract remodeling and heart function Nat Commun, 15 (1): 4632
• Jevans B, Cooper F, Fatieieva Y, Gogolou A, Kang Y, Restuadi R, Moulding D, Vanden Berghe P, Adameyko I, Thapar N, Andrews P, De Coppi P, Tsakiridis A, McCann C (2024) Human enteric nervous system progenitor transplantation improves functional responses in Hirschsprung disease patient-derived tissue Gut, 73(9): 1441-1453
• Xie M, Kaiser M, Gershtein Y, Schnyder D, Deviatiiarov R, Gazizova G, Shagimardanova E, Zikmund T, Kerckhofs G, Ivashkin E, Batkovskyte D, Newton P, Andersson O, Fried K, Gusev O, Zeberg H, Kaiser J, Adameyko I, Chagin A (2024) The level of protein in the maternal murine diet modulates the facial appearance of the offspring via mTORC1 signaling Nat Commun, 15 (1): 2367
• Guo Y, Endmayr V, Zekeridou A, McKeon A, Leypoldt F, Hess K, Kalinowska-Lyszczarz A, Klang A, Pakozdy A, Höftberger E, Hametner S, Haider C, De Simoni D, Peters S, Gelpi E, Röcken C, Oberndorfer S, Lassmann H, Lucchinetti C, Höftberger R (2024) New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis Acta Neuropathol, 147 (1): 31
• Avloniti M, Evangelidou M, Gomini M, Loupis T, Emmanouil M, Mitropoulou A, Tselios T, Lassmann H, Gruart A, Delgado-García J, Probert L, Kyrargyri V (2024) IKKβ deletion from CNS macrophages increases neuronal excitability and accelerates the onset of EAE, while from peripheral macrophages reduces disease severity J Neuroinflammation, 21 (1): 34
• Steinmaurer A, Riedl C, König T, Testa G, Köck U, Bauer J, Lassmann H, Höftberger R, Berger T, Wimmer I, Hametner S (2024) The relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis Brain Pathol, 34(5): e13240

• Geraldes R, Arrambide G, Banwell B, Rovira A, Cortese R, Lassmann H, Messina S, Rocca M, Waters P, Chard D, Gasperini C, Hacohen Y, Mariano R, Paul F, DeLuca G, Enzinger C, Kappos L, Leite M, Sastre-Garriga J, Yousry T, Ciccarelli O, Filippi M, Barkhof F, Palace J, (2024) The influence of MOGAD on diagnosis of multiple sclerosis using MRI Nat Rev Neurol, 20(10): 620-635
• Kaiser M, Zikmund T, Vora S, Metscher B, Adameyko I, Richman J, Kaiser J (2024) 3D atlas of the human fetal chondrocranium in the middle trimester Sci Data, 11 (1): 626
• Filippi M, Preziosa P, Barkhof F, Ciccarelli O, Cossarizza A, De Stefano N, Gasperini C, Geraldes R, Granziera C, Haider L, Lassmann H, Margoni M, Pontillo G, Ropele S, Rovira ?, Sastre-Garriga J, Yousry T, Rocca M, Rocca M, Sastre-Garriga J, Barkhof F, Ciccarelli O, de Stefano N, Filippi M, Gasperini C, Kappos L, De Luca G, Enzinger C, Rovira ?, Schoonheim M, Yousry T, (2024) The ageing central nervous system in multiple sclerosis: the imaging perspective Brain, 47(11): 3665-3680
• Schmierer K, Lassmann H (2024) The shoulders we keep standing on: remembering Otto Marburg, a big brain in neurology and multiple sclerosis, at 150 Acta Neuropathol, 147 (1): 81
• Calabrese M, Preziosa P, Scalfari A, Colato E, Marastoni D, Absinta M, Battaglini M, De Stefano N, Di Filippo M, Hametner S, Howell O, Inglese M, Lassmann H, Martin R, Nicholas R, Reynolds R, Rocca M, Tamanti A, Vercellino M, Villar L, Filippi M, Magliozzi R (2024) Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis Ann Neurol, 96(1): 1-20
• Rommer P, Puchhammer‐Stöckl E, Lassmann H, Berger T, Vietzen H (2024) Ineffective control of Epstein–Barr virus infection is seen in MS: What is next? Clin Transl Med, 14 (2): :e1596
• Kameneva P, Taschner-Mandl S (2024) In preprints: recapitulation of development and wound healing shapes the spatial organization of glioblastoma Development, 151 (1): dev202618

• Jacob T, Annusver K, Czarnewski P, Dalessandri T, Kalk C, Levra Levron C, Campamà Sanz N, Kastriti ME, Mikkola ML, Rendl M, Lichtenberger MB, Donati G , Björklund AK, Kasper M (2023) Molecular and spatial landmarks of early mouse skin development Development, 58(20) : 2140-2162.e5.
• Gerschenfeld G, Coulpier F, Gresset A, Pulh P, Job B, Topilko T, Siegenthaler, Ph.D. J, Kastriti M, Brunet I, Charnay P, Topilko P (2023) Neural tube-associated boundary caps are a major source of mural cells in the skin eLife, 12
• Mathias S, Adameyko I, Hellander A, Kursawe J (2023) Contributions of cell behavior to geometric order in embryonic cartilage PloS Computational Biology, 19 (11): e1011658
• Gao T, Kastriti M, Ljungström V, Heinzel A, Tischler A, Oberbauer R, Loh P, Adameyko I, Park P, Kharchenko P (2023) A pan-tissue survey of mosaic chromosomal alterations in 948 individuals Nature Genetics, 55(11): )1901-1911
• Samadzadeh S, Olesen M, Wirenfeldt M, Möller S, Misu T, Soelberg K, Frederiksen J, Heegaard S, Mariotto S, Fujihara K, Ruprecht K, Andersen T, Marignier R, Lillevang S, Flanagan E, Pittock S, Kim H, Bennett J, Paul F, Sorensen G, Weinshenker B, Lassmann H, Asgari N (2023) Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects Mult Scler, 29(14): 1721-1735
• Laddach A, Chng S, Lasrado R, Progatzky F, Shapiro M, Erickson A, Sampedro Castaneda M, Artemov A, Bon-Frauches A, Amaniti E, Kleinjung J, Boeing S, Ultanir S, Adameyko I, Pachnis V (2023) A branching model of lineage differentiation underpinning the neurogenic potential of enteric glia Nat Commun, 14 (1): 5904
• Krupenko D, Miroliubov A, Kryukov E, Faure L, Minemizu R, Haag L, Lundgren M, Kameneva P, Kastriti M, Adameyko I (2023) Polymorphic parasitic larvae cooperate to build swimming colonies luring hosts Curr Biol., 33(20)4524-4531: 4524-4531
• Gallus M, Roll W, Dik A, Barca C, Zinnhardt B, Hicking G, Mueller C, Naik V, Anstötz M, Krämer J, Rolfes L, Wachsmuth L, Pitsch J, van Loo K, Räuber S, Okada H, Wimberley C, Strippel C, Golombeck K, Johnen A, Kovac S, Groß C, Backhaus P, Seifert R, Lewerenz J, Surges R, Elger C, Wiendl H, Ruck T, Becker A, Faber C, Jacobs A, Bauer J, Meuth S, Schäfers M, Melzer N (2023) Translational imaging of TSPO reveals pronounced innate inflammation in human and murine CD8 T cell–mediated limbic encephalitis Sci Adv, 9 (23): eabq7595.
• Krajnc N, Schmidbauer V, Leinkauf J, Haider L, Bsteh G, Kasprian G, Leutmezer F, Kornek B, Rommer P, Berger T, Lassmann H, Dal-Bianco A, Hametner S (2023) Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosis Mult Scler, 29(11-12): 1406-1417
• Martinović K, Bauer J, Kunze M, Berger J, Forss-Petter S (2023) Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy Acta Neuropathologica Communications, 11 (1): 98
• Sunadome K, Erickson A, Kah D, Fabry B, Adori C, Kameneva P, Faure L, Kanatani S, Kaucka M, Dehnisch Ellström I, Tesarova M, Zikmund T, Kaiser J, Edwards S, Maki K, Adachi T, Yamamoto T, Fried K, Adameyko I (2023) Directionality of developing skeletal muscles is set by mechanical forces Nat Commun, 14 (1): 3060
• Petersen J, Englmaier L, Artemov A, Poverennaya I, Mahmoud R, Bouderlique T, Tesarova M, Deviatiiarov R, Szilvásy-Szabó A, Akkuratov E, Pajuelo Reguera D, Zeberg H, Kaucka M, Kastriti M, Krivanek J, Radaszkiewicz T, Gömöryová K, Knauth S, Potesil D, Zdrahal Z, Ganji R, Grabowski A, Buhl M, Zikmund T, Kavkova M, Axelson H, Lindgren D, Kramann R, Kuppe C, Erdélyi F, Máté Z, Szabó G, Koehne T, Harkany T, Fried K, Kaiser J, Boor P, Fekete C, Rozman J, Kasparek P, Prochazka J, Sedlacek R, Bryja V, Gusev O, Adameyko I (2023) A previously uncharacterized Factor Associated with Metabolism and Energy (FAME/C14orf105/CCDC198/1700011H14Rik) is related to evolutionary adaptation, energy balance, and kidney physiology Nat Commun, 14 (1): 3092
• Geeraerts T, Guilbeau-Frugier C, Garcia C, Memier V, Raposo N, Bonneville F, Gales C, Darcourt J, Voisin S, Ribes A, Piel-Julian M, Bounes F, Albucher J, Roux F, Izopet J, Telmon N, Olivot J, Sié P, Bauer J, Payrastre B, Liblau R (2023) Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia Neurol Neuroimmunol Neuroinfl, 10 (4): e200127
• Pegoretti V, Bauer J, Fischer R, Paro I, Douwenga W, Kontermann R, Pfizenmaier K, Houben E, Broux B, Hellings N, Baron W, Laman J, Eisel U (2023) Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS J Neuroinflammation, 20 (1): 106
• Gonzalez-Fierro C, Fonte C, Dufourd E, Cazaentre V, Aydin S, Engelhardt B, Caspi R, Xu B, Martin-Blondel G, Spicer J, Trapani J, Bauer J, Liblau R, Bost C (2023) Effects of a Small-Molecule Perforin Inhibitor in a Mouse Model of CD8 T Cell–Mediated Neuroinflammation Neurol Neuroimmunol Neuroinfl, 10 (4): e200117
• Li X, Andrusivova Z, Czarnewski P, Langseth C, Andersson A, Liu Y, Gyllborg D, Braun E, Larsson L, Hu L, Alekseenko Z, Lee H, Avenel C, Kallner H, Åkesson E, Adameyko I, Nilsson M, Linnarsson S, Lundeberg J, Sundström E (2023) Profiling spatiotemporal gene expression of the developing human spinal cord and implications for ependymoma origin Nature Neurosci, 26(5): 891-901
• Schwab J, Haider C, Kopp M, Zrzavy T, Endmayr V, Ricken G, Kubista H, Haider T, Liebscher T, Lübstorf T, Blex C, Serdani-Neuhaus L, Curt A, Cinelli P, Scivoletto G, Fehlings M, May C, Guntermann A, Marcus K, Meisel C, Dirnagl U, Martus P, Prüss H, Popovich P, Lassmann H, Höftberger R (2023) Lesional Antibody Synthesis and Complement Deposition Associate With De Novo Antineuronal Antibody Synthesis After Spinal Cord Injury Neurol Neuroimmunol Neuroinfl, 10 (3): e200099
• Mader S, Ho S, Wong H, Baier S, Winklmeier S, Riemer C, Rübsamen H, Fernandez I, Gerhards R, Du C, Chuquisana O, Lünemann J, Lux A, Nimmerjahn F, Bradl M*, Kawakami N*, Meinl E* (* shared senior authorship) (2023) Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein PNAS, 120 (13): e2300648120
• Dorninger F, Kiss A, Rothauer P, Stiglbauer-Tscholakoff A, Kummer S, Fallatah W, Perera-Gonzalez M, Hamza O, König T, Bober M, Cavallé-Garrido T, Braverman N, Forss-Petter S, Pifl C, Bauer J, Bittner R, Helbich T, Podesser B, Todt H, Berger J (2023) Overlapping and Distinct Features of Cardiac Pathology in Inherited Human and Murine Ether Lipid Deficiency Int J Mol Sci, 24 (3): 1884
• Zakani M, Nigritinou M, Ponleitner M, Takai Y, Hofmann D, Hillebrand S, Höftberger R, Bauer J, Lasztoczi B, Misu T, Kasprian G, Rommer P, Bradl M (2023) Paths to hippocampal damage in neuromyelitis optica spectrum disorders Neuropathol Appl Neurobiol, 49 (2)
  | Article (PDF) || Weblink |
• Kalinowska‐Lyszczarz A, Tillema J, Tobin W, Guo Y, Weigand S, Metz I, Brück W, Lassmann H, Giraldo‐Chica M, Port J, Lucchinetti C (2023) Long‐term clinical, imaging and cognitive outcomes association with MS immunopathology Ann Clin Transl Neurol, 26(5): 891-901
• Tröscher A, Mair K, de Juan L, Köck U, Steinmaurer A, Baier H, Becker A, Blümcke I, Finzel M, Geis C, Höftberger R, Mawrin C, von Oertzen T, Pitsch J, Surges R, Voges B, Weis S, Winklehner M, Woermann F, Bauer J, Bien C (2023) Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex Brain, 146(4): 1436-1452
• Zhou C, Häneke T, Rohner E, Sohlmér J, Kameneva P, Artemov A, Adameyko I, Sahara M (2023) STRA6 is essential for induction of vascular smooth muscle lineages in human embryonic cardiac outflow tract development Cardiovascular Res, 119(5): 1202-1217
• Krajnc N, Dal-Bianco A, Leutmezer F, Kasprian G, Pemp B, Kornek B, Berger T, Rommer P, Hametner S, Lassmann H, Bsteh G (2023) Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis Mult Scler, 29(3): 374-384
• Faure L, Soldatov R, Kharchenko P, Adameyko I (2023) scFates: a scalable python package for advanced pseudotime and bifurcation analysis from single-cell data Bioinformatics, : 39(1):btac746
• Licht‐Mayer S, Campbell G, Mehta A, McGill K, Symonds A, Al‐Azki S, Pryce G, Zandee S, Zhao C, Kipp M, Smith K, Baker D, Altmann D, Anderton S, Kap Y, Laman J, t’Hart B, Rodriguez M, Franklin R, Chandran S, Lassmann H, Trapp B, Mahad D (2023) Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis Neuropathol Appl Neurobiol, 49(1): e12851

• Kameneva P (2023) Pathway to Independence – an interview with Polina Kameneva Development, 150 (17): dev202261
• Murtazina A, Adameyko I (2023) The peripheral nervous system Development, 150 (9): dev201164
• Erickson A, Adameyko I (2023) hPSCs-derived Schwann cells serve for disease modeling and drug discovery Cell Stem Cell, 30 (5): 501-502
• Adameyko I (2023) Evolutionary origin of the neural tube in basal deuterostomes Curr Biol., 33 (8): R319-R331
• Bien C, Bauer J (2023) What neuropathology teaches us about autoimmune encephalitides, autoimmune epilepsies, and encephalomyelitides Clin Neuropathol, 42(3): 87-92
• Krivanek J, Buchtova M, Fried K, Adameyko I (2023) Plasticity of Dental Cell Types in Development, Regeneration, and Evolution J Dent Res, 102(6): 589-598
• Erickson A, Kameneva P, Adameyko I (2023) The transcriptional portraits of the neural crest at the individual cell level Semin Cell Dev Biol, : 138:68-80

• Artemov A, Zhenilo S, Kaplun D, Starshin A, Sokolov A, Mazur A, Szpotan J, Gawronski M, Modrzejewska M, Gackowski D, Prokhortchouk E (2022) An IDH-independent mechanism of DNA hypermethylation upon VHL inactivation in cancer Epigenetics, 17 (8): 894-905
• Lomov N, Viushkov V, Ulianov S, Gavrilov A, Alexeyevsky D, Artemov A, Razin S, Rubtsov M (2022) Recurrent Translocations in Topoisomerase Inhibitor-Related Leukemia Are Determined by the Features of DNA Breaks Rather Than by the Proximity of the Translocating Genes Int J Mol Sci, 23 (17): 9824
• Kaucka M, Joven Araus A, Tesarova M, Currie J, Boström J, Kavkova M, Petersen J, Yao Z, Bouchnita A, Hellander A, Zikmund T, Elewa A, Newton P, Fei J, Chagin A, Fried K, Tanaka E, Kaiser J, Simon A, Adameyko I (2022) Altered developmental programs and oriented cell divisions lead to bulky bones during salamander limb regeneration Nat Commun, 13 (1): 14;13(1):6949
• Hametner S, Silvaieh S, Thurnher M, Dal-Bianco A, Cetin H, Ponleitner M, Zebenholzer K, Pemp B, Trattnig S, Rössler K, Berger T, Lassmann H, Hainfellner J, Bsteh G (2022) A case of primary optic pathway demyelination caused by oncocytic oligodendrogliopathy of unknown origin Acta Neuropathologica Communications, 10 (1): 160
• Akkuratova N, Faure L, Kameneva P, Kastriti M, Adameyko I (2022) Developmental heterogeneity of embryonic neuroendocrine chromaffin cells and their maturation dynamics Front Endocrinol, 13: 1020000.
• Weinhofer I, Buda A, Kunze M, Palfi Z, Traunfellner M, Hesse S, Villoria-Gonzalez A, Hofmann J, Hametner S, Regelsberger G, Moser A, Eichler F, Kemp S, Bauer J, Kühl J, Forss-Petter S, Berger J (2022) Peroxisomal very long-chain fatty acid transport is targeted by herpesviruses and the antiviral host response Commun Biol, 5 (1): 944
• Winklehner M, Bauer J, Endmayr V, Schwaiger C, Ricken G, Motomura M, Yoshimura S, Shintaku H, Ishikawa K, Tsuura Y, Iizuka T, Yokota T, Irioka T, Höftberger R (2022) Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies Neurol Neuroimmunol Neuroinfl, 9 (4): e200006
• Chuquisana O, Strippel C, Tröscher A, Baumgartner T, Rácz A, Keller C, Elger C, Melzer N, Kovac S, Wiendl H, Bauer J, Lünemann J (2022) Complement activation contributes to GAD antibody-associated encephalitis Acta Neuropathol, 144 (2): 381-383
• Krajnc N, Bsteh G, Kasprian G, Zrzavy T, Kornek B, Berger T, Leutmezer F, Rommer P, Lassmann H, Hametner S, Dal-Bianco A (2022) Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis Front Neurol, 13: 928582
• Kastriti M, Faure L, Von Ahsen D, Bouderlique T, Boström J, Solovieva T, Jackson C, Bronner M, Meijer D, Hadjab S, Lallemend F, Erickson A, Kaucka M, Dyachuk V, Perlmann T, Lahti L, Krivanek J, Brunet J, Fried K, Adameyko I (2022) Schwann cell precursors represent a neural crest‐like state with biased multipotency Embo Journ, : 41(17):e108780
• Petitpré C, Faure L, Uhl P, Fontanet P, Filova I, Pavlinkova G, Adameyko I, Hadjab S, Lallemend F (2022) Single-cell RNA-sequencing analysis of the developing mouse inner ear identifies molecular logic of auditory neuron diversification Nat Commun, 13 (1): 3878
• Sriha J, Louis-Brennetot C, Pierre-Eugène C, Baulande S, Raynal V, Kramdi A, Adameyko I, Ernsberger U, Deller T, Delattre O, Janoueix-Lerosey I, Rohrer H (2022) BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells Cancers, 14 (11): 2755
• Yizhou Hu, Yiwen Jiang, Jinan Behnan, Mariana Messias Ribeiro, Chrysoula Kalantzi, Ming-Dong Zhang, Daohua Lou, Martin Häring, Nilesh Sharma, Satoshi Okawa, Antonio Del Sol, Igor Adameyko, Mikael Svensson, Oscar Persson, Patrik Ernfors (2022) Neural network learning defines glioblastoma features to be of neural crest perivascular or radial glia lineages Sci Adv, : 8(23):eabm6340
• Bernard-Valnet R, Frieser D, Nguyen X, Khajavi L, Quériault C, Arthaud S, Melzi S, Fusade-Boyer M, Masson F, Zytnicki M, Saoudi A, Dauvilliers Y, Peyron C, Bauer J, Liblau R (2022) Influenza vaccination induces autoimmunity against orexinergic neurons in a mouse model for narcolepsy Brain, : 145(6):2018-2030
• Kameneva P, Melnikova V, Kastriti M, Kurtova A, Kryukov E, Murtazina A, Faure L, Poverennaya I, Artemov A, Kalinina T, Kudryashov N, Bader M, Skoda J, Chlapek P, Curylova L, Sourada L, Neradil J, Tesarova M, Pasqualetti M, Gaspar P, Yakushov V, Sheftel B, Zikmund T, Kaiser J, Fried K, Alenina N, Voronezhskaya E, Adameyko I (2022) Serotonin limits generation of chromaffin cells during adrenal organ development Nat Commun, 13 (1): 2901
• Matula J, Polakova V, Salplachta J, Tesarova M, Zikmund T, Kaucka M, Adameyko I, Kaiser J (2022) Resolving complex cartilage structures in developmental biology via deep learning-based automatic segmentation of X-ray computed microtomography images Sci Rep, 12 (1): 8728
• Bouderlique T, Petersen J, Faure L, Abed-Navandi D, Bouchnita A, Mueller B, Nazarov M, Englmaier L, Tesarova M, Frade P, Zikmund T, Koehne T, Kaiser J, Fried K, Wild C, Pantos O, Hellander A, Bythell J, Adameyko I (2022) Surface flow for colonial integration in reef-building corals Curr Biol., : 32(12):2596-2609
• Steinkellner H, Kempaiah P, Beribisky A, Pferschy S, Etzler J, Huber A, Sarne V, Neuhaus W, Kuttke M, Bauer J, Arunachalam J, Christodoulou J, Dressel R, Mildner A, Prinz M, Laccone F (2022) TAT-MeCP2 protein variants rescue disease phenotypes in human and mouse models of Rett syndrome Int J Biol Macromol, 209: 972-983
• Frieser D, Pignata A, Khajavi L, Shlesinger D, Gonzalez-Fierro C, Nguyen X, Yermanos A, Merkler D, Höftberger R, Desestret V, Mair K, Bauer J, Masson F, Liblau R (2022) Tissue-resident CD8+ T cells drive compartmentalized and chronic autoimmune damage against CNS neurons Sci Transl Med, 14 (640)
• Tesařová M, Mancini L, Mauri E, Aljančič G, Năpăruş-Aljančič M, Kostanjšek R, Bizjak Mali L, Zikmund T, Kaucká M, Papi F, Goyens J, Bouchnita A, Hellander A, Adameyko I, Kaiser J (2022) Living in darkness: Exploring adaptation of Proteus anguinus in 3 dimensions by X-ray imaging GigaScience, 11: giac030
• Rauschmeier R, Reinhardt A, Gustafsson C, Glaros V, Artemov AV, Dunst J, Taneja R, Adameyko I, Månsson R, Busslinger M, Kreslavsky T.exp (2022) Bhlhe40 function in activated B and TFH cells restrains the GC reaction and prevents lymphomagenesis J Exp Med, 219(2): e20211406
• Westerhout EM, Hamdi M, Stroeken P, Nowakowska NE, Lakeman A, van Arkel J, Hasselt NE, Bleijlevens B, Akogul N, Haneveld F, Chan A, van Sluis P, Zwijnenburg D, Volckmann R, van Noesel CJ, Adameyko I, van Groningen T, Koster J, Valentijn LJ, van Nes J, Versteeg R. (2022) Mesenchymal type neuroblastoma cells escape ALK inhibitors Cancer Res, 82(3): 484-496

• Faure L, Techameena P, Hadjab S (2022) Emergence of neuron types Curr Opin Cell Biol, 79: 102133
• Ineichen BV , Okar SV , Proulx ST, Engelhardt B , Lassmann H , Reich DS (2022) Perivascular spaces and their role in neuroinflammation Neuron, 110(21): 3566-3581
• Giovannoni G, Vanderdonckt P, Hartung H, Lassmann H, Comi G (2022) EBV and multiple sclerosis: Setting the research agenda Mult Scler Relat Disord., 67: 104158
• Höftberger R, Lassmann H, Berger T, Reindl M (2022) Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a complex concept Nat Rev Neurol, : 18(11):681-688
• Bradl M (2022) From astrocyte destruction to axon injury: watching lesion evolution in experimental neuromyelitis optica Brain, 145(5): 1581-1583
• Vanderdonckt P, Aloisi F, Comi G, de Bruyn A, Hartung H, Huitinga I, Kuhlmann T, Lucchinetti C, Metz I, Reynolds R, Lassmann H (2022) Tissue donations for multiple sclerosis research: current state and suggestions for improvement Brain Commun, 4 (2)
• Lassmann H (2022) The Contribution of Neuropathology to Multiple Sclerosis Research Eur J Neurol, : 29(9):2869-2877
• Lassmann H (2022) Tumefactive Multiple Sclerosis or Inflammatory Demyelinating Disease with Large Lesions? Eur J Neurol, 29(3): 687-688

• Colin A, Micali G, Faure L, Cosentino Lagomarsino M, van Teeffelen S (2021) Two different cell-cycle processes determine the timing of cell division in Escherichia coli eLife, 10: e67495
• Aschauer C, Jelencsics K, Hu K, Heinzel A, Gregorich M, Vetter J, Schaller S, Winkler S, Weinberger J, Pimenov L, Gualdoni G, Eder M, Kainz A, Troescher A, Regele H, Reindl-Schwaighofer R, Wekerle T, Huppa J, Sykes M, Oberbauer R (2021) Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts Front Immunol, 12: 750005
• Dal-Bianco A, Schranzer R, Grabner G, Lanzinger M, Kolbrink S, Pusswald G, Altmann P, Ponleitner M, Weber M, Kornek B, Zebenholzer K, Schmied C, Berger T, Lassmann H, Trattnig S, Hametner S, Leutmezer F, Rommer P (2021) Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study Front Neurol, 12: 632749
• Förster M, Nelke C, Räuber S, Lassmann H, Ruck T, Sormani MP, Signori A, Hartung HP, Küry P, Meuth SG, Kremer D (2021) Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-Analysis Biomedicines, 9(12): 1899
• Uçar M, Kamenev D, Sunadome K, Fachet D, Lallemend F, Adameyko I, Hadjab S, Hannezo E (2021) Theory of branching morphogenesis by local interactions and global guidance Nat Commun, 12 (1): 6830
• Krivanek J, Lavicky J, Bouderlique T, Adameyko I (2021) Rapid Isolation of Single Cells from Mouse and Human Teeth J Vis Exp, (176)
• Tröscher A, Sakaraki E, Mair K, Köck U, Racz A, Borger V, Cloppenborg T, Becker A, Bien C, Bauer J (2021) T cell numbers correlate with neuronal loss rather than with seizure activity in medial temporal lobe epilepsy Epilepsia, 62 (6): 1343-1353
• Papazian I, Tsoukala E, Boutou A, Karamita M, Kambas K, Iliopoulou L, Fischer R, Kontermann R, Denis M, Kollias G, Lassmann H, Probert L (2021) Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKKβ promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice J Neuroinflammation, 18 (1): 222.
• Zrzavy T, Endmayr V, Bauer J, Macher S, Mossaheb N, Schwaiger C, Ricken G, Winklehner M, Glatter S, Breu M, Wimmer I, Kovacs G, Risser D, Klupp N, Simonitsch‐Klupp I, Roetzer T, Rommer P, Berger T, Gelpi E, Lassmann H, Graus F, Dalmau J, Höftberger R (2021) Neuropathological variability within a spectrum of NMDAR‐encephalitis. Ann Neurol, : 2021 Sep 25. doi: 10.1002/ana.26223. Online ahead of print.
• Glaros V, Rauschmeier R, Artemov A, Reinhardt A, Ols S, Emmanouilidi A, Gustafsson C, You Y, Mirabello C, Björklund, Perez L, King N, Månsson R, Angeletti D, Loré K, Adameyko I, Busslinger M, Kreslavsky T (2021) Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response Immunity, 54 (9): 2005-2023.e10
• Tobin W, Kalinowska-Lyszczarz A, Weigand S, Guo Y, Tosakulwong N, Parisi J, Metz I, Frischer J, Lassmann H, Brück W, Linbo L, Lucchinetti C (2021) Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes Neurology, 97(19): e1906-e1913
• Bedoya-Reina O, Li W, Arceo M, Plescher M, Bullova P, Pui H, Kaucka M, Kharchenko P, Martinsson T, Holmberg J, Adameyko I, Deng Q, Larsson C, Juhlin C, Kogner P, Schlisio S (2021) Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors Nat Commun, 12 (1): 5309
• Fleischer V, Gonzalez-Escamilla G, Ciolac D, Albrecht P, Küry P, Gruchot J, Dietrich M, Hecker C, Müntefering T, Bock S, Oshaghi M, Radetz A, Cerina M, Krämer J, Wachsmuth L, Faber C, Lassmann H, Ruck T, Meuth SG, Muthuraman M, Groppa S. (2021) Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans Proc Natl Acad Sci USA, 118(36): e2025000118
• Marignier R, Hacohen Y, Cobo-Calvo A, Pröbstel A, Aktas O, Alexopoulos H, Amato M, Asgari N, Banwell B, Bennett J, Brilot F, Capobianco M, Chitnis T, Ciccarelli O, Deiva K, De Sèze J, Fujihara K, Jacob A, Kim H, Kleiter I, Lassmann H, Leite M, Linington C, Meinl E, Palace J, Paul F, Petzold A, Pittock S, Reindl M, Sato D, Selmaj K, Siva A, Stankoff B, Tintore M, Traboulsee A, Waters P, Waubant E, Weinshenker B, Derfuss T, Vukusic S, Hemmer B (2021) Myelin-oligodendrocyte glycoprotein antibody-associated disease Lancet Neurol, 20 (9): 762-772
• Petersen MA, Tognatta R, Meyer-Franke A, Bushong EA, Mendiola AS, Yan Z, Muthusamy A, Merlini M, Meza-Acevedo R, Cabriga B, Zhou Y, Thomas R, Ryu JK, Lassmann H, Ellisman MH, Akassoglou K. (2021) BMP receptor blockade overcomes extrinsic inhibition of remyelination and restores neurovascular homeostasis. Brain, 144(8): .2291-2301
• Kaucka M, Szarowska B, Kavkova M, Kastriti M, Kameneva P, Schmidt I, Peskova L, Joven Araus A, Simon A, Kaiser J, Adameyko I (2021) Nerve-associated Schwann cell precursors contribute extracutaneous melanocytes to the heart, inner ear, supraorbital locations and brain meninges Cell Mol Life Sci, : 2021 Jul 18. doi: 10.1007/s00018-021-03885-9. Online ahead of print. PMID: 34274976
• Metz I, Gavrilova R, Weigand S, Frischer J, Popescu B, Guo Y, Gloth M, Tobin W, Zalewski N, Lassmann H, Tillema J, Erickson B, Parisi J, Becker S, König F, Brück W, Lucchinetti C (2021) MRI Correlates of Multiple Sclerosis Immunopathological Patterns Ann Neurol, 90(3): 440-454
• Kamenev D, Sunadome K, Shirokov M, Chagin A, Singh A, Irion U, Adameyko I, Fried K, Dyachuk V (2021) Schwann cell precursors generate sympathoadrenal system during zebrafish development J Neurosci Res, : 99(10)
• Rodríguez-Pascau L, Vilalta A, Cerrada M, Traver E, Forss-Petter S, Weinhofer I, Bauer J, Kemp S, Pina G, Pascual S, Meya U, Musolino P, Berger J, Martinell M, Pizcueta P (2021) The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy Sci Transl Med, 13 (596): eabc0555
• Häusler D, Akgün K, Stork L, Lassmann H, Ziemssen T, Brück W, Metz I. (2021) CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study Brain Pathol, 31(6): e12969
• Kameneva P, V.Artemov A, Kastriti M, Sundström E, Kharchenko P, Adameyko I (2021) Evolutionary switch in expression of key markers between mouse and human leads to mis-assignment of cell types in developing adrenal medulla Cancer Cell, 39(5): 590-591
• Kameneva P, Artemov A, Kastriti M, Faure L, Olsen T, Otte J, Erickson A, Semsch B, Andersson E, Ratz M, Frisén J, Tischler A, de Krijger R, Bouderlique T, Akkuratova N, Vorontsova M, Gusev O, Fried K, Sundström E, Mei S, Kogner P, Baryawno N, Kharchenko P, Adameyko I (2021) Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin Nature Genetics, : 53(5)
• Takai Y, Misu T, Suzuki H, Takahashi T, Okada H, Tanaka S, Okita K, Sasou S, Watanabe M, Namatame C, Matsumoto Y, Ono H, Kaneko K, Nishiyama S, Kuroda H, Nakashima I, Lassmann H, Fujihara K, Itoyama Y, Aoki M (2021) Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders Brain, 144: 2401-2415
• Doss P, Umair M, Baillargeon J, Fazazi R, Fudge N, Akbar I, Yeola A, Williams J, Leclercq M, Joly-Beauparlant C, Beauchemin P, Ruda G, Alpaugh M, Anderson A, Brennan P, Droit A, Lassmann H, Moore C, Rangachari M (2021) Male sex chromosomal complement exacerbates the pathogenicity of Th17 cells in a chronic model of central nervous system autoimmunity Cell Rep, 34 (10): 108833
• Hamminger P, Marchetti L, Preglej T, Platzer R, Zhu C, Kamnev A, Rica R, Stolz V, Sandner L, Alteneder M, Kaba E, Waltenberger D, Huppa J, Trauner M, Bock C, Lyck R, Bauer J, Dupré L, Seiser C, Boucheron N, Engelhardt B, Ellmeier W (2021) Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases J Autoimmun, 119: 102610
• Matula J, Tesarova M, Zikmund T, Kaucka M, Adameyko I, Kaiser J (2021) X-ray microtomography–based atlas of mouse cranial development GigaScience, 10 (3)
• Cubas-Núñez L, Gil-Perotín S, Castillo-Villalba J, López V, Solís Tarazona L, Gasqué-Rubio R, Carratalá-Boscá S, Alcalá-Vicente C, Pérez-Miralles F, Lassmann H, Casanova B (2021) Potential Role of CHI3L1+ Astrocytes in Progression in MS Neurol Neuroimmunol Neuroinfl, 8 (3): e972
• Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Kornek B, Kasprian G, Berger T, Leutmezer F, Rommer P, Trattnig S, Lassmann H, Hametner S (2021) Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI Brain, 144(3): 833-847
• Zrzavy T, Schwaiger C, Wimmer I, Berger T, Bauer J, Butovsky O, Schwab J, Lassmann H, Höftberger R (2021) Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury Brain, 144(1): 144-161
• Tham M, Frischer J, Weigand S, Fitz‐Gibbon P, Webb S, Guo Y, Adiele R, Robinson C, Brück W, Lassmann H, Furber K, Pushie M, Parisi J, Lucchinetti C, Popescu B (2021) Iron heterogeneity in early active multiple sclerosis lesions Ann Neurol, 89(3): 498-510
• Beltrán E+, Paunovic M+, Gebert D, Cesur E, Jeitler M, Höftberger R, Malotka J, Mader S, Kawakami N, Meinl E, Bradl M*, Dornmair K*, Lassmann H* + sharing co-first; *sharing senior authorship (2021) Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis Acta Neuropathol, 141(1): 67-83
• Wimmer I, Scharler C, Kadowaki T, Hillebrand S, Scheiber‐Mojdehkar B, Ueda S, Bradl M, Berger T, Lassmann H, Hametner S (2021) Iron accumulation in the choroid plexus, ependymal cells and CNS parenchyma in a rat strain with low‐grade haemolysis of fragile macrocytic red blood cells Brain Pathol, 31(2): 333-345
  | Weblink |
• Zhao J, Faure L, Adameyko I, Sharpe PT (2021) Stem cell contributions to cementoblast differentiation in healthy periodontal ligament and periodontitis Stem Cells, 39(1): 92-102

• Wiendl H, Gross C, Bauer J, Merkler D, Prat A, Liblau R (2021) Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases Nat Rev Neurol, 17 (7): 433-447
• Schwabenland M, Brück W, Priller J, Stadelmann C, Lassmann H, Prinz M (2021) Analyzing microglial phenotypes across neuropathologies: a practical guide Acta Neuropathol, 142(6): 923-936.
• Baert L, Marignier R, Lassmann H, Huard B (2021) Case Report: In Situ Expression of a Proliferation-Inducing Ligand in Neuromyelitis Optica Front Neurol, 12: e721877
• Dal-Bianco A, Höftberger R, Lassmann H, Berger T (2021) Kurt Jellinger 90: his contribution to neuroimmunology J Neural Transm, 128(10): 1545-1550
• Cree B, Arnold D, Chataway J, Chitnis T, Fox R, Ramajo A, Murphy N, Lassmann H (2021) Secondary Progressive Multiple Sclerosis: New Insights Neurology, 97(8): 378-388
• Comi G, Bar‐Or A, Lassmann H, Uccelli A, Hartung H, Montalban X, Sørensen P, Hohlfeld R, Hauser S, Absinta M, Battistini L, Bennet J, Bergman J, Calabrese M, Correale J, Dornmair K, Moiola L, Edan G, Fujihara K, Gastaldi M, Ghezzi A, Gommerman J, Hausler D, Hoftberger R, Kappos L, Sörensen P, Klotz L, Leocani L, Magliozzi R, Michel L, Meinl E, Misu T, Palace J, Prat A, Rocca M, Selmaj K, (2021) The role of B cells in Multiple Sclerosis and related disorders Ann Neurol, 89(1): 13-23
• Kameneva P, Kastriti M, Adameyko I (2021) Neuronal lineages derived from the nerve-associated Schwann cell precursors Cell Mol Life Sci, 78(2): 513-529

• Lassmann, Hans (2021) Pathophysiological Bases of Autoimmune-Initiated/Mediated Neurodegeneration. In: Sergiu Groppa and Sven G. Meuth: , Translational Methods for Multiple Sclerosis Research Springer Nature, Cham Switzerland: 3-12

• Albergante L, Mirkes E, Bac J, Chen H, Martin A, Faure L, Barillot E, Pinello L, Gorban A, Zinovyev A (2020) Robust and Scalable Learning of Complex Intrinsic Dataset Geometry via ElPiGraph Entropy, 22 (3): 296
• Dagkonaki A, Avloniti M, Evangelidou M, Papazian I, Kanistras I, Tseveleki V, Lampros F, Tselios T, Jensen L, Möbius W, Ruhwedel T, Androutsou M, Matsoukas J, Anagnostouli M, Lassmann H, Probert L (2020) Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions Front Immunol, 11: 575451
• Gerhards R, Pfeffer L, Lorenz J, Starost L, Nowack L, Thaler F, Schlüter M, Rübsamen H, Macrini C, Winklmeier S, Mader S, Bronge M, Grönlund H, Feederle R, Hsia H, Lichtenthaler S, Merl-Pham J, Hauck S, Kuhlmann T, Bauer I, Beltran E, Gerdes L, Mezydlo A, Bar-Or A, Banwell B, Khademi M, Olsson T, Hohlfeld R, Lassmann H, Kümpfel T, Kawakami N, Meinl E (2020) Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS Acta Neuropathologica Communications, 8 (1): 207
• Xie M, Gol'din P, Herdina AN, Estefa J, Medvedeva EV, Li L, Newton PT, Kotova S, Shavkuta B, Saxena A, Shumate LT, Metscher BD, Großschmidt K, Nishimori S, Akovantseva A, Usanova AP, Kurenkova AD, Kumar A, Arregui IL, Tafforeau P, Fried K, Carlström M, Simon A, Gasser C, Kronenberg HM, Bastepe M, Cooper KL, Timashev P, Sanchez S, Adameyko I, Eriksson A, Chagin AS. (2020) Secondary ossification center induces and protects growth plate structure eLife, 9: e55212
• Krivanek J, Soldatov R, Kastriti M, Chontorotzea T, Herdina A, Petersen J, Szarowska B, Landova M, Matejova V, Holla L, Kuchler U, Zdrilic I, Vijaykumar A, Balic A, Marangoni P, Klein O, Neves V, Yianni V, Sharpe P, Harkany T, Metscher B, Bajénoff M, Mina M, Fried K, Kharchenko P, Adameyko I (2020) Dental cell type atlas reveals stem and differentiated cell types in mouse and human teeth Nat Commun, 11 (1): 4816
• Faure L, Wang Y, Kastriti M, Fontanet P, Cheung K, Petitpré C, Wu H, Sun L, Runge K, Croci L, Landy M, Lai H, Consalez G, de Chevigny A, Lallemend F, Adameyko I, Hadjab S (2020) Single cell RNA sequencing identifies early diversity of sensory neurons forming via bi-potential intermediates Nat Commun, 11 (1): 4175
• Eggers C, Kopatz V, Dörr W, Lassmann H, Geinitz H (2020) Localised multiple sclerosis-like disease after irradiation of the cervicothoracic spinal cord Mult Scler Relat Disord., 45: 102443
• Klimovich A, Giacomello S, Björklund A, Faure L, Kaucka M, Giez C, Murillo-Rincon A, Matt A, Willoweit-Ohl D, Crupi G, de Anda J, Wong G, D’Amato M, Adameyko I, Bosch T (2020) Prototypical pacemaker neurons interact with the resident microbiota Proc Natl Acad Sci USA, 117(30): 17854-17863
• Licht-Mayer S, Campbell G, Canizares M, Mehta A, Gane A, McGill K, Ghosh A, Fullerton A, Menezes N, Dean J, Dunham J, Al-Azki S, Pryce G, Zandee S, Zhao C, Kipp M, Smith K, Baker D, Altmann D, Anderton S, Kap Y, Laman J, Hart B, Rodriguez M, Watzlawick R, Schwab J, Carter R, Morton N, Zagnoni M, Franklin R, Mitchell R, Fleetwood-Walker S, Lyons D, Chandran S, Lassmann H, Trapp B, Mahad D (2020) Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis Acta Neuropathol, 140(2): 143-167
• Zhang Y, Kameneva P, Annusver K, Kasper M, Chagin A, Adameyko I, Xie M (2020) Cruciate ligament, patellar tendon, and patella formation involves differential cellular sources and dynamics as joint cavitation proceeds Dev Dyn, 249(6): 711-722
• Zierfuss B, Weinhofer I, Kühl J, Köhler W, Bley A, Zauner K, Binder J, Martinović K, Seiser C, Hertzberg C, Kemp S, Egger G, Leitner G, Bauer J, Wiesinger C, Kunze M, Forss-Petter S, Berger J (2020) Vorinostat in the acute neuroinflammatory form of X-linked adrenoleukodystrophy Ann Clin Transl Neurol, 7 (5): 639-652
• Kuehn J, Scheuerle A, Bauer J, Becker A, Wirtz R, Lewerenz J (2020) A 64‐Year‐Old Patient With a Mesiotemporal Mass and Symptomatic Epilepsy Brain Pathol, 30 (2): 413-414
• Malviya M, Saoudi A, Bauer J, Fillatreau S, Liblau R (2020) Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells J Autoimmun, 108: 102401
• Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, Nishida H, Komori T, Seki M, Komatsu T, Nakamagoe K, Ikeda T, Yoshida M, Takahashi T, Ono H, Nishiyama S, Kuroda H, Nakashima I, Suzuki H, Bradl M, Lassmann H, Fujihara K, Aoki M; Japan MOG-antibody Disease Consortium. (2020) Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study Brain, 143(5):: 1431-1446
• Zhang Y, Annusver K, Sunadome K, Kameneva P, Edwards S, Lei G, Kasper M, Chagin A, Adameyko I, Xie M (2020) Epiphyseal Cartilage Formation Involves Differential Dynamics of Various Cellular Populations During Embryogenesis Front Cell Dev Biol, 8: 22
• Romanov R, Tretiakov E, Kastriti M, Zupancic M, Häring M, Korchynska S, Popadin K, Benevento M, Rebernik P, Lallemend F, Nishimori K, Clotman F, Andrews W, Parnavelas J, Farlik M, Bock C, Adameyko I, Hökfelt T, Keimpema E, Harkany T (2020) Molecular design of hypothalamus development Nature, 582(7811): 246-252
• Sierra R, Gómez Bustillo S, Kameneva P, Fiore E, Mazzone G, Borda M, Blanco M, Usuardi C, Furlan A, Ernfors P, Alaniz L, Montaner A, Adameyko I, Aquino J (2020) Contribution of neural crest and GLAST + Wnt1 + bone marrow pericytes with liver fibrogenesis and/or regeneration Liver Int, 40 (4): 977-987
• Tsymala I, Nigritinou M, Zeka B, Schulz R, Niederschick F, Matković M, Bauer I, Szalay M, Schanda K, Lerch M, Misu T, Fujihara K, Bennett J, Dahle C, Pache F, Rommer P, Leutmezer F, Illes Z, Leite M, Palace J, Scholze P, Reindl M, Lassmann H, Bradl M (2020) Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes Acta Neuropathologica Communications, 15; 8 (1)
  | Supplement |
• Gödel C, Kunkel B, Kashani A, Lassmann H, Arumugam M, Krishnamoorthy G (2020) Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease J Neuroinflammation, 17 (1): 79
• Höftberger R, Guo Y, Flanagan E, Lopez-Chiriboga A, Endmayr V, Hochmeister S, Joldic D, Pittock S, Tillema J, Gorman M, Lassmann H, Lucchinetti C (2020) The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody Acta Neuropathol, 139(5): 875-892
• Klinger M, Zugmaier G, Nägele V, Goebeler M, Brandl C, Stelljes M, Lassmann H, von Stackelberg A, Bargou R, Kufer P (2020) Adhesion of T cells to endothelial cells facilitates blinatumomab-associated neurologic adverse events Cancer Res, 80 (1) : 91-101

• Kastriti M, Kameneva P, Adameyko I (2020) Stem cells, evolutionary aspects and pathology of the adrenal medulla: A new developmental paradigm Mol Cell Endocrinol, 518: 110998
• Filippi M, Preziosa P, Langdon D, Lassmann H, Paul F, Rovira A, Schoonheim M, Solari A, Stankoff B, Rocca M (2020) Identifying Progression In Multiple Sclerosis: New Perspectives Ann Neurol, 88(3): 438-452
• Absinta M, Lassmann H, Trapp B (2020) Mechanisms underlying progression in multiple sclerosis Curr Opin Neurol, 33(3): 277-285.
• Lassmann H (2020) Pathology of inflammatory diseases of the nervous system: Human disease versus animal models Glia, 68 (4): 830-844

• Adameyko, I and Eames, BF (2020) Evolving Neural Crest Cells: Hopes for Present and Future Understanding. In: Brian F. Eames, Daniel Meulemans Medeiros and Igor Adameyko, Evolving Neural Crest Cells; CRC Press - Taylor & Francis Group, Boca Raton, London, New York : 265-274
• Adameyko, I (2020) Elaboration of Fates in Neural Crest Lineage. In: Brian F. Eames, Daniel Meulemans Medeiros and Igor Adameyko, Evolving Neural Crest Cells; CRC Press - Taylor & Francis Group, Boca Raton, London, New York : 157-183
• Höftberger R, Lassmann H (2020) Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalomyelitis. In: Fabrice Chretien, Infections of the Central Nervous System: Pathology and Genetics John Wiley & Sons, Inc; Oxford, UK, Hoboken, USA: 251-257

• Prakash V, Carson B, Feenstra J, Dass R, Sekyrova P, Hoshino A, Petersen J, Guo Y, Parks M, Kurylo C, Batchelder J, Haller K, Hashimoto A, Rundqivst H, Condeelis J, Allis C, Drygin D, Nieto M, Andäng M, Percipalle P, Bergh J, Adameyko I, Farrants A, Hartman J, Lyden D, Pietras K, Blanchard S, Vincent C (2019) Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease Nat Commun, 10 (1)
• Newton P, Li L, Zhou B, Schweingruber C, Hovorakova M, Xie M, Sun X, Sandhow L, Artemov A, Ivashkin E, Suter S, Dyachuk V, El Shahawy M, Gritli-Linde A, Bouderlique T, Petersen J, Mollbrink A, Lundeberg J, Enikolopov G, Qian H, Fried K, Kasper M, Hedlund E, Adameyko I, Sävendahl L, Chagin A (2019) A radical switch in clonality reveals a stem cell niche in the epiphyseal growth plate Nature, 567 (7747): 234-238
• Soldatov R, Kaucka M, Kastriti M, Petersen J, Chontorotzea T, Englmaier L, Akkuratova N, Yang Y, Häring M, Dyachuk V, Bock C, Farlik M, Piacentino M, Boismoreau F, Hilscher M, Yokota C, Qian X, Nilsson M, Bronner M, Croci L, Hsiao W, Guertin D, Brunet J, Consalez G, Ernfors P, Fried K, Kharchenko P, Adameyko I (2019) Spatiotemporal structure of cell fate decisions in murine neural crest Science, 364 (6444): eaas9536
• Anaby D, Morozov D, Seroussi I, Hametner S, Sochen N, Cohen Y (2019) Single‐ and double‐Diffusion encoding MRI for studying ex vivo apparent axon diameter distribution in spinal cord white matter NMR Biomed, 32 (12): e4170
• Bergner C, Meer F, Winkler A, Wrzos C, Türkmen M, Valizada E, Fitzner D, Hametner S, Hartmann C, Pfeifenbring S, Stoltenburg‐Didinger G, Brück W, Nessler S, Stadelmann C (2019) Microglia damage precedes major myelin breakdown in X‐linked adrenoleukodystrophy and metachromatic leukodystrophy Glia, 67 (6): 1196-1209
• Gross C, Meyer C, Bhatia U, Yshii L, Kleffner I, Bauer J, Tröscher A, Schulte-Mecklenbeck A, Herich S, Schneider-Hohendorf T, Plate H, Kuhlmann T, Schwaninger M, Brück W, Pawlitzki M, Laplaud D, Loussouarn D, Parratt J, Barnett M, Buckland M, Hardy T, Reddel S, Ringelstein M, Dörr J, Wildemann B, Kraemer M, Lassmann H, Höftberger R, Beltrán E, Dornmair K, Schwab N, Klotz L, Meuth S, Martin-Blondel G, Wiendl H, Liblau R (2019) CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome Nat Commun, 10 (1): 5779
• Magliozzi R, Hametner S, Facchiano F, Marastoni D, Rossi S, Castellaro M, Poli A, Lattanzi F, Visconti A, Nicholas R, Reynolds R, Monaco S, Lassmann H, Calabrese M (2019) Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis Ann Clin Transl Neurol, 6(11): 2150-2163
• Konjevic Sabolek M, Held K, Beltrán E, Niedl A, Meinl E, Hohlfeld R, Lassmann H, Dornmair K (2019) Communication of CD 8 + T cells with mononuclear phagocytes in multiple sclerosis Ann Clin Transl Neurol, 6(7): 1151-1164
• Hernández-Torres E, Wiggermann V, Machan L, Sadovnick A, Li D, Traboulsee A, Hametner S, Rauscher A (2019) Increased mean R2* in the deep gray matter of multiple sclerosis patients: Have we been measuring atrophy? J Magn Reson Imaging, 50 (1): 201-208
• Wimmer I, Tietz S, Nishihara H, Deutsch U, Sallusto F, Gosselet F, Lyck R, Muller W, Lassmann H, Engelhardt B (2019) PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation Front Immunol, 10: 711
  | Weblink |
• Yshii L, Pignolet B, Mauré E, Pierau M, Brunner-Weinzierl M, Hartley O, Bauer J, Liblau R (2019) IFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration JCI Insight, 4 (7)
• Bernard-Valnet R, Cobo-Calvo A, Siegfried A, Marasescu R, Bonnan M, Ballan G, Ellie E, Bauer J, Uro-Coste E, Marignier R, Brassat D (2019) Paraneoplastic neuromyelitis optica and ovarian teratoma: A case series Mult Scler Relat Disord., 31: 97-100
• Wimmer I, Scharler C, Zrzavy T, Kadowaki T, Mödlagl V, Rojc K, Tröscher A, Kitic M, Ueda S, Bradl M, Lassmann H (2019) Microglia pre-activation and neurodegeneration precipitate neuroinflammation without exacerbating tissue injury in experimental autoimmune encephalomyelitis Acta Neuropathologica Communications, 7 (1): 14
  | Weblink |
• Haindl M, Köck U, Zeitelhofer-Adzemovic M, Fazekas F, Hochmeister S (2019) The formation of a glial scar does not prohibit remyelination in an animal model of multiple sclerosis Glia, 67 (3): 467-481
• Tröscher A, Wimmer I, Quemada-Garrido L, Köck U, Gessl D, Verberk S, Martin B, Lassmann H, Bien C, Bauer J (2019) Microglial nodules provide the environment for pathogenic T cells in human encephalitis Acta Neuropathol, 137(4): 137(4):619-635
• Baert L, Benkhoucha M, Popa N, Ahmed M, Manfroi B, Boutonnat J, Sturm N, Raguenez G, Tessier M, Casez O, Marignier R, Ahmadi M, Broisat A, Ghezzi C, Rivat C, Sonrier C, Hahne M, Baeten D, Vives R, Lortat-Jacob H, Marche P, Schneider P, Lassmann H, Boucraut J, Lalive P, Huard B (2019) APRIL-mediated anti-inflammatory response of astrocytes in multiple sclerosis Ann Neurol, 85(3): 406-420
• Hillebrand S, Schanda K, Nigritinou M, Tsymala I, Böhm D, Peschl P, Takai Y, Fujihara K, Nakashima I, Misu T, Reindl M, Lassmann H, Bradl M (2019) Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat Acta Neuropathol, 137(3): 467-485
• Heckova E, Strasser B, Hangel G, Považan M, Dal-Bianco A, Rommer P, Bednarik P, Gruber S, Leutmezer F, Lassmann H, Trattnig S, Bogner W (2019) 7 T Magnetic Resonance Spectroscopic Imaging in Multiple Sclerosis Invest Radiol, 54(4): 247-254
• Kau T, Hametner S, Endmayr V, Deistung A, Prihoda M, Haimburger E, Menard C, Haider T, Höftberger R, Robinson S, Reichenbach J, Lassmann H, Traxler H, Trattnig S, Grabner G (2019) Microvessels may Confound the “Swallow Tail Sign” in Normal Aged Midbrains: A Postmortem 7 T SW-MRI Study J Neuroimaging, 29(1): 65-69
• Zrzavy T, Höftberger R, Berger T, Rauschka H, Butovsky O, Weiner H, Lassmann H (2019) Pro-inflammatory Activation of Microglia in the Brain of Patients with Sepsis Neuropathol Appl Neurobiol, 45(3): 278-290

• Zrzavy T, Kollaritsch H, Rommer P, Boxberger N, Loebermann M, Wimmer I, Winkelmann A, Zettl U (2019) Vaccination in Multiple Sclerosis: Friend or Foe? Front Immunol, 10
• Titulaer M, Irani S, Lassmann H (2019) PDE10A antibodies in autoimmune encephalitis Neurology, 93(8): 327-328
• Lassmann H (2019) The changing concepts in the neuropathology of acquired demyelinating central nervous system disorders. Curr Opin Neurol, 32(3): 313-319
• Lassmann H (2019) Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis Front Immunol, 9: 3116
• Ciccarelli O, Cohen J, Reingold S, Weinshenker B, Amato M, Banwell B, Barkhof F, Bebo B, Becher B, Bethoux F, Brandt A, Brownlee W, Calabresi P, Chatway J, Chien C, Chitnis T, Ciccarelli O, Cohen J, Comi G, Correale J, De Sèze J, De Stefano N, Fazekas F, Flanagan E, Freedman M, Fujihara K, Galetta S, Goldman M, Greenberg B, Hartung H, Hemmer B, Henning A, Izbudak I, Kappos L, Lassmann H, Laule C, Levy M, Lublin F, Lucchinetti C, Lukas C, Marrie R, Miller A, Miller D, Montalban X, Mowry E, Ourselin S, Paul F, Pelletier D, Ranjeva J, Reich D, Reingold S, Rocca M, Rovira A, Schlaerger R, Soelberg Sorensen P, Sormani M, Stuve O, Thompson A, Tintoré M, Traboulsee A, Trapp B, Trojano M, Uitdehaag B, Vukusic S, Waubant E, Weinshenker B, Wheeler-Kingshott C, Xu J (2019) Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders Lancet Neurol, 18 (2): 185-197

• Kap Y, Bus-Spoor C, van Driel N, Dubbelaar M, Grit C, Kooistra S, Fagrouch Z, Verschoor E, Bauer J, Eggen B, Harmsen H, Laman J, ’t Hart B (2018) Targeted Diet Modification Reduces Multiple Sclerosis–like Disease in Adult Marmoset Monkeys from an Outbred Colony J Immunol, 201 (11): 3229-3243
• Reinthaler E, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky C, Pferschy S, Schmied C, Leutmezer F, Keilani M, Lill C, Hoffjan S, Epplen J, Zettl U, Hecker M, Deutschländer A, Meuth S, Ahram M, Mustafa B, El-Khateeb M, Vilariño-Güell C, Sadovnick A, Zimprich F, Tomkinson B, Strom T, Kristoferitsch W, Lassmann H, Zimprich A (2018) TPP2 mutation associated with sterile brain inflammation mimicking MS Neurol Genet, 4 (6): e285
• Rubino S, Mayo L, Wimmer I, Siedler V, Brunner F, Hametner S, Madi A, Lanser A, Moreira T, Donnelly D, Cox L, Rezende R, Butovsky O, Lassmann H, Weiner H (2018) Acute microglia ablation induces neurodegeneration in the somatosensory system Nat Commun, 9 (1): 4578
• Martin N, Nawrocki A, Molnar V, Elkjaer M, Thygesen E, Palkovits M, Acs P, Sejbaek T, Nielsen H, Hegedus Z, Sellebjerg F, Molnar T, Barbosa E, Alcaraz N, Gallyas F, Svenningsen A, Baumbach J, Lassmann H, Larsen M, Illes Z (2018) Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes PlosOne, 13 (8): e0202530
• Spadaro M, Winklmeier S, Beltrán E, Macrini C, Höftberger R, Schuh E, Thaler F, Gerdes L, Laurent S, Gerhards R, Brändle S, Dornmair K, Breithaupt C, Krumbholz M, Moser M, Kirshnamoorthy G, Kamp F, Jenne D, Hohlfeld R, Kümpfel T, Lassmann H, Kawakami N, Meinl E (2018) Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein Ann Neurol, 84(2): 315-328
• Hametner S, Endmayr V, Deistung A, Palmrich P, Prihoda M, Haimburger E, Menard C, Feng X, Haider T, Leisser M, Köck U, Kaider A, Höftberger R, Robinson S, Reichenbach JR, Lassmann H, Traxler H, Trattnig S, Grabner G. (2018) The influence of brain iron and myelin on magnetic susceptibility and effective transverse relaxation - A biochemical and histological validation study Neuroimage, 179: 117-133.
• Weinhofer I, Zierfuss B, Hametner S, Wagner M, Popitsch N, Machacek C, Bartolini B, Zlabinger G, Ohradanova-Repic A, Stockinger H, Köhler W, Höftberger R, Regelsberger G, Forss-Petter S, Lassmann H, Berger J (2018) Impaired plasticity of macrophages in X-linked adrenoleukodystrophy Brain, 141: 2329-2342
  | Article (PDF) |
• Machado-Santos J, Saji E, Tröscher A, Paunovic M, Liblau R, Gabriely G, Bien C, Bauer J, Lassmann H (2018) The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells Brain, 141(7): 2066-2082
• Blaabjerg M, Hemdrup A, Drici L, Ruprecht K, Garred P, Höftberger R, Kristensen B, Kondziella D, Sejbaek T, Hansen S, Nielsen H, Jensen P, Meyer M, Paul F, Lassmann H, Larsen M, Illes Z (2018) Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) Front Immunol, 9: 741
• Wimmer I, Tröscher A, Brunner F, Rubino S, Bien C, Weiner H, Lassmann H, Bauer J (2018) Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples Sci Rep, 8 (1): 6351
  | Weblink |
• Bagnato F, Hametner S, Franco G, Pawate S, Sriram S, Lassmann H, Gore J, Smith S, Dortch R (2018) Selective Inversion Recovery Quantitative Magnetization Transfer Brain MRI at 7T: Clinical and Postmortem Validation in Multiple Sclerosis J Neuroimaging, 28(4) : 380-388
• Martin N, Molnar V, Szilagyi G, Elkjaer M, Nawrocki A, Okarmus J, Wlodarczyk A, Thygesen E, Palkovits M, Gallyas F, Larsen M, Lassmann H, Benedikz E, Owens T, Svenningsen A, Illes Z (2018) Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice Front Immunol, 9: 490
• Bagnato F, Hametner S, Boyd E, Endmayr V, Shi Y, Ikonomidou V, Chen G, Pawate S, Lassmann H, Smith S, Welch E (2018) Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla PlosOne, 13 (3): e0193839
• Schweser F, Raffaini Duarte Martins A, Hagemeier J, Lin F, Hanspach J, Weinstock-Guttman B, Hametner S, Bergsland N, Dwyer M, Zivadinov R (2018) Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality Neuroimage, 167: 438-452
• Zrzavy T, Machado-Santos J, Christine S, Baumgartner C, Weiner H, Butovsky O, Lassmann H (2018) Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts Brain Pathol, 28(6): 791-805
• Lemke A, Ferguson J, Gross K, Penzenstadler C, Bradl M, Mayer R, Gerner C, Redl H, Wolbank S (2018) Transplantation of human amnion prevents recurring adhesions and ameliorates fibrosis in a rat model of sciatic nerve scarring Acta Biomater, 66: 335–349

• Lassmann H (2018) Multiple Sclerosis Pathology and its Reflection by Imaging Technologies: Introduction Brain Pathol, 28 (5): 721-722
• Wimmer I, Zrzavy T, Lassmann H (2018) Neuroinflammatory responses in experimental and human stroke lesions J Neuroimmunol, 323: 10-18
• Hametner S, Bianco AD, Trattnig S, Lassmann H. (2018) Iron related changes in MS lesions and their validity to characterize MS lesion types and dynamics with Ultra-high field magnetic resonance imaging Brain Pathol, 28(5): 743-749
• Bradl M, Reindl M, Lassmann H (2018) Mechanisms for lesion localization in neuromyelitis optica spectrum disorders Curr Opin Neurol, 31(3): 325-333
• O’Loughlin E, Madore C, Lassmann H, Butovsky O (2018) Microglial Phenotypes and Functions in Multiple Sclerosis Cold Spring Harb Perspect Med., 8 (2): a028993
• Lassmann H (2018) Multiple Sclerosis Pathology Cold Spring Harb Perspect Med., 8(3): a028936

• Furlan A, Dyachuk V, Kastriti M, Calvo-Enrique L, Abdo H, Hadjab S, Chontorotzea T, Akkuratova N, Usoskin D, Kamenev D, Petersen J, Sunadome K, Memic F, Marklund U, Fried K, Topilko P, Lallemend F, Kharchenko P, Ernfors P, Adameyko I (2017) Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla Science, 357 (6346): eaal3753
• Gebauer C, Pignolet B, Yshii L, Mauré E, Bauer J, Liblau R (2017) CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse model Oncoimmunology, 6 (2): e1260212
• Dunham J, van de Vis R, Bauer J, Wubben J, van Driel N, Laman J, ‘t Hart B, Kap Y (2017) Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey PlosOne, 12 (11): e0188013
• Wiggermann V, Hametner S, Hernández-Torres E, Kames C, Endmayr V, Kasprian G, Höftberger R, Li D, Traboulsee A, Rauscher A (2017) Susceptibility-sensitive MRI of multiple sclerosis lesions and the impact of normal-appearing white matter changes NMR Biomed, 30 (8): e3727
• Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Höftberger R, Berger T, Auff E, Leutmezer F, Trattnig S, Lassmann H, Bagnato F, Hametner S (2017) Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging Acta Neuropathol, 133 (1): 25-42
• Petersen M, Ryu J, Chang K, Etxeberria A, Bardehle S, Mendiola A, Kamau-Devers W, Fancy S, Thor A, Bushong E, Baeza-Raja B, Syme C, Wu M, Rios Coronado P, Meyer-Franke A, Yahn S, Pous L, Lee J, Schachtrup C, Lassmann H, Huang E, Han M, Absinta M, Reich D, Ellisman M, Rowitch D, Chan J, Akassoglou K (2017) Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage Neuron, 96(5): 1003-1012
• Peschl P, Schanda K, Zeka B, Given K, Böhm D, Ruprecht K, Saiz A, Lutterotti A, Rostásy K, Höftberger R, Berger T, Macklin W, Lassmann H, Bradl M, Bennett J, Reindl M (2017) Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination J Neuroinflammation, 14 (1): 208
• Tröscher A, Klang A, French M, Quemada-Garrido L, Kneissl S, Bien C, Pákozdy A, Bauer J (2017) Selective Limbic Blood–Brain Barrier Breakdown in a Feline Model of Limbic Encephalitis with LGI1 Antibodies Front Immunol, 8: 1364
• Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O’Loughlin E, Xu Y, Fanek Z, Greco D, Smith S, Tweet G, Humulock Z, Zrzavy T, Conde-Sanroman P, Gacias M, Weng Z, Chen H, Tjon E, Mazaheri F, Hartmann K, Madi A, Ulrich J, Glatzel M, Worthmann A, Heeren J, Budnik B, Lemere C, Ikezu T, Heppner F, Litvak V, Holtzman D, Lassmann H, Weiner H, Ochando J, Haass C, Butovsky O (2017) The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases Immunity, 47 (3): 566-581.e9
• Gabriely G, da Cunha A, Rezende R, Kenyon B, Madi A, Vandeventer T, Skillin N, Rubino S, Garo L, Mazzola M, Kolypetri P, Lanser A, Moreira T, Faria A, Lassmann H, Kuchroo V, Murugaiyan G, Weiner H (2017) Targeting latency-associated peptide promotes antitumor immunity Sci Immunol, 2 (11): eaaj1738
• Kitic M, Karram K, Israel N, Yogev N, Lacher S, Tang Y, Yigit H, Bauer J, Wanke F, Knezovic A, Trotter J, Kurschus F, Waisman A (2017) NG2 plays a role in neuroinflammation but is not expressed by immune cells Acta Neuropathol, 134 (2): 325-327
• Popkirov S, Ayzenberg I, Hahn S, Bauer J, Denno Y, Rieckhoff N, Radzimski C, Hans V, Berg S, Roghmann F, Noldus J, Bien C, Skodda S, Wellmer J, Stöcker W, Krogias C, Gold R, Schlegel U, Probst C, Komorowski L, Miske R, Kleiter I (2017) Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis Acta Neuropathologica Communications, 5 (1)
  | Supplement |
• Lemke A, Penzenstadler C, Ferguson J, Lidinsky D, Hopf R, Bradl M, Redl H, Wolbank S, Hausner T (2017) A novel experimental rat model of peripheral nerve scarring: reliably mimicking post-surgical complications and recurring adhesions Dis Model Mech, 10(8): 1015-1025
• Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner H, Lassmann H (2017) Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis Brain, 140 (7): 1900-1913
• Dunham J, Bauer J, Campbell G, Mahad D, van Driel N, van der Pol S, ‘t Hart B, Lassmann H, Laman J, van Horssen J, Kap Y (2017) Oxidative Injury and Iron Redistribution Are Pathological Hallmarks of Marmoset Experimental Autoimmune Encephalomyelitis J Neuropath Exp Neurol, 76(6): 467-478
• Karamita M, Barnum C, Möbius W, Tansey M, Szymkowski D, Lassmann H, Probert L (2017) Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia JCI Inside, 2 (8): e87455
• Körtvélyessy P, Breu M, Pawlitzki M, Metz I, Heinze H, Matzke M, Mawrin C, Rommer P, Kovacs G, Mitter C, Reindl M, Brück W, Wandinger K, Lassmann H, Höftberger R, Leypoldt F (2017) ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports Neurol Neuroimmunol Neuroinfl, 4 (3): e335
• Popescu B, Frischer J, Webb S, Tham M, Adiele R, Robinson C, Fitz-Gibbon P, Weigand S, Metz I, Nehzati S, George G, Pickering I, Brück W, Hametner S, Lassmann H, Parisi J, Yong G, Lucchinetti C (2017) Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions Acta Neuropathol, 134 (1): 45-64
• Espitia Pinzon N, Sanz-Morello B, Brevé J, Bol J, Drukarch B, Bauer J, Baron W, van Dam A (2017) Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination Sci Rep, 7: 40995
• Laukoter S, Rauschka H, Tröscher A, Köck U, Saji E, Jellinger K, Lassmann H, Bauer J (2017) Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis Acta Neuropathol, 133(4): 613-627
• Michailidou I, Naessens D, Hametner S, Guldenaar W, Kooi E, Geurts J, Baas F, Lassmann H, Ramaglia V (2017) Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis Glia, 65(2): 264-277

• Lassmann H (2017) Targets of therapy in progressive MS Mult Scler, 23 (12): 1593-1599
• ’t Hart B, Dunham J, Faber B, Laman J, van Horssen J, Bauer J, Kap Y (2017) A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model Front Immunol, 8: 804-
• Bauer J, Becker A, Elyaman W, Peltola J, Rüegg S, Titulaer M, Varley J, Beghi E (2017) Innate and adaptive immunity in human epilepsies Epilepsia, 58: 57-68
• Peschl P, Bradl M, Höftberger R, Berger T, Reindl M (2017) Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases Front Immunol, 8: 529
• Türkoğlu R, Lassmann H, Aker F, Tzartos J, Tzartos S, Tüzün E (2017) Recurrent tumefactive demyelinating lesions: a pathological study Clin Neuropathol, 36(4): 195-198
• Zeka B., Lassmann H., Bradl M. (2017) Müller cells and retinal axons can be primary targets in experimental neuromyelitis optica spectrum disorder Clinical and Experimental Neuroimmunology, 8: 3-7
• Kuhlmann T, Ludwin S, Prat A, Antel J, Brück W, Lassmann H. (2017) An updated histological classification system for multiple sclerosis lesions Acta Neuropathol, 133(1): 13-24
• Zurawski J, Lassmann H, Bakshi R. (2017) Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review. Jama Neurol, 74(1): 100-109
• Lassmann H, Bradl M. (2017) Multiple sclerosis: experimental models and reality Acta Neuropathol, 133(2): 223-244
• Kawachi I, Lassmann H (2017) Neurodegeneration in multiple sclerosis and neuromyelitis optica J Neurol Neurosurg Psychiatry, 88(2):: 137-145

• Finsterer, J; Pakozdy, A; Bradl, M (2017) Epilepsy in Humans and Animals: From Patients to Disease Models. In: Jensen-Jarolim, E., Comparative Medicine: disorders linking humans with their animals Springer-Verlag : 13-25
• Höftberger R, Lassmann H (2017) Immune-mediated disorders. In: , Handbook of Clinical Neurology : 285-299
• Höftberger R, Lassmann H (2017) Inflammatory demyelinating diseases of the central nervous system. In: , Handbook of Clinical Neurology : 263-283

• Adzemovic M, Zeitelhofer M, Leisser M, Köck U, Kury A, Olsson T (2016) Immunohistochemical Analysis in the Rat Central Nervous System and Peripheral Lymph Node Tissue Sections J Vis Exp, (117)
• Bernard-Valnet R, Yshii L, Quériault C, Nguyen X, Arthaud S, Rodrigues M, Canivet A, Morel A, Matthys A, Bauer J, Pignolet B, Dauvilliers Y, Peyron C, Liblau R (2016) CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice PNAS, 113 (39): 10956-10961
• Yshii L, Gebauer C, Pignolet B, Mauré E, Quériault C, Pierau M, Saito H, Suzuki N, Brunner-Weinzierl M, Bauer J, Liblau R (2016) CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model Brain, 139 (11): 2923-2934
• Peneder T, Bauer J, Pifl C (2016) Apoptosis-inducing factor in nigral dopamine neurons: Higher levels in primates than in mice Movement Disorders, 31: 1729-1733
• Burm S, Peferoen L, Zuiderwijk-Sick E, Haanstra K, ‘t Hart B, van der Valk P, Amor S, Bauer J, Bajramovic J (2016) Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself J Neuroinflammation, 13 (1)
• Alidzanovic L, Starlinger P, Schauer D, Maier T, Feldman A, Buchberger E, Stift J, Koeck U, Pop L, Gruenberger B, Gruenberger T, Brostjan C (2016) The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance Oncotarget, 7(35): 57197-57212
• Zeka B, Hastermann M, Kaufmann N, Schanda K, Pende M, Misu T, Rommer P, Fujihara K, Nakashima I, Dahle C, Leutmezer F, Reindl M, Lassmann H, Bradl M (2016) Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD Acta Neuropathologica Communications, 4 (1): 82
• Wiedermann U, Sitte HH, Burgmann H, Eser A, Falb P, Holzmann H, Kitchen M, Köller M, Kollaritsch H, Kundi M, Lassmann H, Mutz I, Pickl WF, Riedl E, Sibilia M, Thalhammer F, Tucek B, Zenz W, Zwiauer K. (2016) Guidelines for vaccination of immunocompromised individuals Wiener Klinische Wochenschrift, 128 (S4): 337-376
• Allan D, Fairlie-Clarke K, Elliott C, Schuh C, Barnett S, Lassmann H, Linnington C, Jiang H (2016) Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system Acta Neuropathologica Communications, 4 (1): 75
• Schuh E, Berer K, Mulazzani M, Feil K, Meinl I, Lahm H, Krane M, Lange R, Pfannes K, Subklewe M, Gurkov R, Bradl M, Hohlfeld R, Kumpfel T, Meinl E, Krumbholz M (2016) Features of Human CD3+CD20+ T Cells J Immunol, 197 (4): 1111-1117
• Mayo L, Cunha AP, Madi A, Beynon V, Yang Z, Alvarez JI, Prat A, Sobel RA, Kobzik L, Lassmann H, Quintana FJ, Weiner HL (2016) IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation Brain, 139 (7): 1939-1957
• Blaabjerg M, Ruprecht K, Sinnecker T, Kondziella D, Niendorf T, Kerrn-Jespersen B, Lindelof M, Lassmann H, Kristensen B, Paul F, Illes Z (2016) Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI Neurol Neuroimmunol Neuroinflamm, 3 (3): e226-e226
• Ramadan A, Lucca L, Carrié N, Desbois S, Axisa P, Hayder M, Bauer J, Liblau R, Mars L (2016) In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS Brain, : aww032
  | Article (PDF) |
• Oji S, Nicolussi E, Kaufmann N, Zeka B, Schanda K, Fujihara K, Illes Z, Dahle C, Reindl M, Lassmann H, Bradl M (2016) Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord PLoS One, 11 (3): e0151244
• Haider L, Zrzavy T, Hametner S, Höftberger R, Bagnato F, Grabner G, Trattnig S, Pfeifenbring S, Brück W, Lassmann H (2016) The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain Brain, 139 (3): 807-815
• Dunham J, Lee L, van Driel N, Laman J, Ni I, Zhai W, Tu G, Lin J, Bauer J, ‘t Hart B, Kap Y (2016) Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis J Neuroimmune Pharmacol, 11 (1): 73-83

• Lassmann H (2016) Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia Ann Neurol, 79 (4): 520-521
• Valent P, Groner B, Schumacher U, Superti-Furga G, Busslinger M, Kralovics R, Zielinski C, Penninger J, Kerjaschki D, Stingl G, Smolen J, Valenta R, Lassmann H, Kovar H, Jäger U, Kornek G, Müller M, Sörgel F (2016) Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine J Innate Immun, 8(2): 111-120
• Martin-Blondel G, Brassat D, Bauer J, Lassmann H, Liblau R (2016) CCR5 blockade for neuroinflammatory diseases — beyond control of HIV Nat Rev Neurol, 12(2): 95-105
• Lassmann H, van Horssen J. (2016) Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions Biochim Biophys Acta, 1862(3): 506-510
• Bauer J, Lassmann H. (2016) Neuropathological Techniques to Investigate Central Nervous System Sections in Multiple Sclerosis Methods Mol Biol, 1304: 211-229

• Bauer J, Bien C (2016) Neuropathology of autoimmune encephalitides. In: , Handbook of Clinical Neurology : 107-120
• Bradl M, Lassmann H (2016) Neurologic autoimmunity mechanisms revealed by animal models. In: , Handbook of Clinical Neurology : 121-143

• Zeka B, Hastermann M, Hochmeister S, Kögl N, Kaufmann N, Schanda K, Mader S, Misu T, Rommer P, Fujihara K, Illes Z, Leutmezer F, Sato D, Nakashima I, Reindl M, Lassmann H, Bradl M (2015) Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS Acta Neuropathol, 130 (6): 783-798
• Aboulenein-Djamshidian F, Höftberger R, Waters P, Krampla W, Lassmann H, Budka H, Vincent A, Kristoferitsch W (2015) Reduction in Serum Aquaporin-4 Antibody Titers During Development of a Tumor-Like Brain Lesion in a Patient With Neuromyelitis Optica: A Serum Antibody–Consuming Effect? J Neuropath Exp Neurol, 74 (3): 194-197
• Dal-Bianco A, Hametner S, Grabner G, Schernthaner M, Kronnerwetter C, Reitner A, Vass C, Kircher K, Auff E, Leutmezer F, Vass K, Trattnig S (2015) Veins in plaques of multiple sclerosis patients – a longitudinal magnetic resonance imaging study at 7 Tesla – Eur Radiol, 25 (10): 2913-2920
• Jagessar S, Heijmans N, Blezer E, Bauer J, Weissert R, ‘t Hart B (2015) Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund’s adjuvant J Neuroinflammation, 12 (1): 169
• Höftberger R, Leisser M, Bauer J, Lassmann H (2015) Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ? Acta Neuropathologica Communications, 3 (1): 80
• Di Pauli F, Hoftberger R, Reindl M, Beer R, Rhomberg P, Schanda K, Sato D, Fujihara K, Lassmann H, Schmutzhard E, Berger T (2015) Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology Neurol Neuroimmunol Neuroinflamm, 2 (6): e175-e175
• Hernández-Torres E, Wiggermann V, Hametner S, Baumeister T, Sadovnick A, Zhao Y, Machan L, Li D, Traboulsee A, Rauscher A (2015) Orientation Dependent MR Signal Decay Differentiates between People with MS, Their Asymptomatic Siblings and Unrelated Healthy Controls PLoS One, 10 (10): e0140956
• Ryu JK, Petersen MA, Murray SG, Baeten KM, Meyer-Franke A, Chan JP, Vagena E, Bedard C, Machado MR, Coronado PE, Prod'homme T, Charo IF, Lassmann H, Degen JL, Zamvil SS, Akassoglou K (2015) Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation Nat Commun, 6: 8164
• Kortvelyessy P, Bauer J, Stoppel C, Bruck W, Gerth I, Vielhaber S, Wiedemann F, Heinze H, Bartels C, Bien C (2015) Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis Neurol Neuroimmunol Neuroinflamm, 2 (2): e75-e75. PK and JB share first authorship
• Haanstra K, Dijkman K, Bashir N, Bauer J, Mary C, Poirier N, Baker P, Scobie L, 't Hart B, Vanhove B (2015) Selective Blockade of CD28-Mediated T Cell Costimulation Protects Rhesus Monkeys against Acute Fatal Experimental Autoimmune Encephalomyelitis J Immunol, 194 (4): 1454-1466
• Frischer J, Weigand S, Guo Y, Kale N, Parisi J, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti C (2015) Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque Ann Neurol, 78(5): 710-721
• Licht-Mayer S, Wimmer I, Traffehn S, Metz I, Brück W, Bauer J, Bradl M, Lassmann H. (2015) Cell type-specific Nrf2 expression in multiple sclerosis lesions Acta Neuropathol, 130 (2): 263-277
• Kaushansky N, Eisenstein M, Boura-Halfon S, Hansen BE, Nielsen CH, Milo R, Zeilig G, Lassmann H, Altmann DM, Ben-Nun A. (2015) Role of a novel HLA-DQA1*01:02;DRB1*15:01 mixed-isotype heterodimer in the pathogenesis of 'humanized' multiple sclerosis-like disease J Biol Chem, 290 (24): 15260-15278
• Lindner M, Thümmler K, Arthur A, Brunner S, Elliott C, McElroy D, Mohan H, Williams A, Edgar JM, Schuh C, Stadelmann C, Barnett SC, Lassmann H, Mücklisch S, Mudaliar M, Schaeren-Wiemers N, Meinl E, Linington C (2015) Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9 Brain, 138 (7): 1875-1893
• Bagnato F, Hametner S, Pennell D, Dortch R, Dula A, Pawate S, Smith S, Lassmann H, Gore J, Welch E (2015) 7T MRI-Histologic Correlation Study of Low Specific Absorption Rate T2-Weighted GRASE Sequences in the Detection of White Matter Involvement in Multiple Sclerosis J Neuroimaging, 25 (3): 370-378
• Spadaro M, Gerdes LA, Mayer MC, Ertl-Wagner B, Laurent S, Krumbholz M, Breithaupt C, Högen T, Straube A, Giese A, Hohlfeld R, Lassmann H, Meinl E, Kümpfel T. (2015) Histopathology and clinical course of MOG-antibody-associated encephalomyelitis Ann Clin Transl Neurol, 2(3: 295-301
• Martin-Blondel G, Bauer J, Uro-Coste E, Biotti D, Averseng-Peaureaux D, Fabre N, Dumas H, Bonneville F, Lassmann H, Marchou B, Liblau RS, Brassat D. (2015) Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome Acta Neuropathol, 129(3): 463-465
• Tseveleki V, Tselios T, Kanistras I, Koutsoni O, Karamita M, Vamvakas S, Apostolopoulos V, Dotsika E, Matsoukas J, Lassmann H, Probert L (2015) Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis Exp. Neurol., 267: 254-267
• Butovsky O, Jedrychowski M, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, Greco D, Wu P, Doykan C, Kiner O, Lawson R, Frosch M, Pochet N, Fatimy R, Krichevsky A, Gygi S, Lassmann H, Berry J, Cudkowicz M, Weiner H (2015) Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice Ann Neurol, 77(1): 75-99
• Skliris A, Papadaki O, Kafasla P, Karakasiliotis I, Hazapis O, Reczko M, Grammenoudi S, Bauer J, Kontoyiannis D (2015) Neuroprotection requires the functions of the RNA-binding protein HuR Cell Death Differ, 22(5): 703-718
  | Article (PDF) |

• Lassmann H (2015) Spinal cord pathology in multiple sclerosis Lancet Neurol, 14 (4): 348-349
• Bauer J, Gold R, Adams O, Lassmann H. (2015) Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS) Acta Neuropathol, 130(6): 751-764
• Haider L (2015) Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis Oxid Med Cell Longev, 2015: 1-10
• Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis Lancet Neurology, 14: 183–93
• Weier K, Banwell B, Cerasa A, Collins DL, Dogonowski AM, Lassmann H, Quattrone A, Sahraian MA, Siebner HR, Sprenger T. (2015) The Role of the Cerebellum in Multiple Sclerosis Cerebellum, 14(3): 364-74

• Lassmann H (2015) Immune Response in the Human Central Nervous System in Multiple Sclerosis and Stroke. In: Wiley-Blackwell, Neuroinflammation - New Insights into Beneficial and Detrimental Functions Wiley-Blackwell: 3-19

• Mohan H, Friese A, Albrecht S, Krumbholz M, Elliott CL, Arthur A, Menon R, Farina C, Junker A, Stadelmann C, Barnett SC, Huitinga I, Wekerle H, Hohlfeld R, Lassmann H, Kuhlmann T, Linington C, Meinl E. (2014) Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination Acta Neuropathologica Communications, 2(1): 178
• Hochmeister S, Pekar T, Lindner M, Kitic M, Haindl M, Storch M, Fazekas F, Linington C (2014) Maternal Neurofascin-Specific Autoantibodies Bind to Structures of the Fetal Nervous System during Pregnancy, but Have No Long Term Effect on Development in the Rat PLoS One, 9 (1): e85393
• Nijland PG, Witte ME, van Het Hof B, van der Pol S, Bauer J, Lassmann H, van der Valk P, de Vries HE, van Horssen J. (2014) Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis Acta Neuropathologica Communications, 2(1): 170
• Yao B, Hametner S, van Gelderen P, Merkle H, Chen C, Lassmann H, Duyn J, Bagnato F (2014) 7 Tesla Magnetic Resonance Imaging to Detect Cortical Pathology in Multiple Sclerosis PLoS One, 9 (10): e108863
• Marlatt M, Bauer J, Aronica E, van Haastert E, Hoozemans J, Joels M, Lucassen P (2014) Proliferation in the Alzheimer Hippocampus Is due to Microglia, Not Astroglia, and Occurs at Sites of Amyloid Deposition Neural Plast, 2014: 1-12
• Espitia Pinzon N, Stroo E, ‘t Hart B, Bol J, Drukarch B, Bauer J*, van Dam A* (2014) Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter PLoS One, 9 (6): e100574. *JB and AvD share senior authorship
• Castelo-Branco G, Stridh P, Guerreiro-Cacais A, Adzemovic M, Falcão A, Marta M, Berglund R, Gillett A, Hamza K, Lassmann H, Hermanson O, Jagodic M (2014) Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats Neurobiol Dis, 71: 220-233
• Taieb G, Uro-Coste E, Clanet M, Lassmann H, Benouaich-Amiel A, Laurent C, Delisle M, Labauge P, Brassat D (2014) A central nervous system B-cell lymphoma arising two years after initial diagnosis of CLIPPERS J Neurol Sci, 344 (1-2): 224-226
• Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, Lassmann H, Parisi JE, Pittock SJ, Stefoski D, Balabanov R, Lucchinetti CF (2014) Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum Jama Neurol, 71 (8): 1025
• Haider L, Simeonidou C, Steinberger G, Hametner S, Grigoriadis N, Deretzi G, Kovacs G, Kutzelnigg A, Lassmann H, Frischer J (2014) Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron J Neurol Neurosurg Psychiatry, 85(12): 1386-1395
• Metz Imke, Weigand Stephen D, Popescu Bogdan F.G., Frischer Josa M, Parisi Joseph E, Guo Yong, Lassmann Hans, Brück Wolfgang, Lucchinetti Claudia F. (2014) Pathologic heterogeneity persists in early active multiple sclerosis lesions Ann Neurol, 75 (5): 728-738
• Mars Lennart T., Mas Magali, Beaudoin Lucie, Bauer Jan, Leite-de-Moraes Maria, Lehuen Agnès, Bureau Jean-Francois, Liblau Roland S. (2014) Invariant NKT Cells Regulate the CD8 T Cell Response during Theiler's Virus Infection PLoS.ONE., 9 (1): e87717
• Klang Andrea, Schmidt Peter, Kneissl Sibylle, Bagó Zoltán, Vincent Angela, Lang Bethan, Moloney Teresa, Bien Christian G., Halász Péter, Bauer Jan*, Pákozdy Ákos* (2014) IgG and Complement Deposition and Neuronal Loss in Cats and Humans With Epilepsy and Voltage-Gated Potassium Channel Complex Antibodies J Neuropath Exp Neurol, 73 (5): 403-413. *JB and AP share senior authorship
• Kitic Maja, Wimmer Isabella, Adzemovic Milena, Kögl Nikolaus, Rudel Antonia, Lassmann Hans, Bradl Monika (2014) Thymic stromal lymphopoietin is expressed in the intact central nervous system and upregulated in the myelin-degenerative central nervous system Glia, 62 (7): 1066-1074
• Schuh C, Wimmer I, Hametner S, Haider L, Van Dam AM, Liblau RS, Smith KJ, Probert L, Binder CJ, Bauer J, Bradl M, Mahad D, Lassmann H. (2014) Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models Acta Neuropathol, 128 (2): 247-266
• Frischer J, Reindl M, Künz B, Berger T, Schmidt S, Milford E, Knosp E, Lassmann H, Utku N. (2014) TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis Mult Scler, 20(9) : 1171 –1181
• Hagelkruys A, Lagger S, Krahmer J, Leopoldi A, Artaker M, Pusch O, Zezula J, Weissmann S, Xie Y, Schöfer C, Schlederer M, Brosch G, Matthias P, Selfridge J, Lassmann H, Knoblich JA, Seiser C. (2014) A single allele of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralog Development, 141(3): 604-616
• Grabner G, Dal-Bianco A, Hametner S, Lassmann H, Trattnig S. (2014) Group specific vein-atlasing: An application for analyzing the venous system under normal and multiple sclerosis conditions J Magn Reson Imaging, 40 (3): 655-661

• Lassmann H (2014) CNS neuroimmunology seen by a neuropathologist Rev Neurol (Paris), 170(10): 561-563
• Lassmann H (2014) Genetic Control of Nerve Conduction Velocity May Influence Multiple Sclerosis Phenotype Am.J.Pathol., 184 (9): 2369-2370
• Bradl M, Kanamori Y, Nakashima I, Misu T, Fujihara K, Lassmann H, Sandkühler J. (2014) Pain in neuromyelitis optica-prevalence, pathogenesis and therapy Nat Rev Neurol, 10 (9): 529-536
  | Article (PDF) |
• Filippi M, Rocca M, Lassmann H (2014) KIR4.1: another misleading expectation in multiple sclerosis? Lancet Neurol, 13(8): 753-755
• Bien C, Bauer J (2014) Autoimmune Epilepsies Neurotherapeutics, 11 (2): 311-318
• Varadkar Sophia, Bien Christian G, Kruse Carol A, Jensen Frances E, Bauer Jan, Pardo Carlos A, Vincent Angela, Mathern Gary W, Cross J Helen (2014) Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances Lancet Neurology, 13 (2): 195-205
• Lassmann H (2014) Mechanisms of white matter damage in multiple sclerosis Glia, 62(11): 1816-1830
• Bradl M, Lassmann H (2014) Experimental models of neuromyelitis optica Brain Pathol, : 24(1):74-82
• Witte ME, Mahad DJ, Lassmann H, van Horssen J. (2014) Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis Trends Mol Med, 20(3): 179-187

• Bauer J, Lang B, Irani S, Vezzani A (2014) Immune Responses in the CNS in Epilepsy. In: Nicola Woodroofe and Sandra Amor, Neuroinflammation and CNS Disorders John Wiley & Sons, Ltd: 289-315
• Kutzelnigg A, Lassmann H. (2014) Pathology of multiple sclerosis and related inflammatory demyelinating diseases. In: , Handbook of Clinical Neurology : 15-58

• Haanstra KG, Jagessar SA, Bauchet AL, Doussau M, Fovet CM, Heijmans N, Hofman SO, van Lubeek-Veth J, Bajramovic JJ, Kap YS, Laman JD, Touin H, Watroba L, Bauer J, Lachapelle F, Serguera C, 't Hart BA (2013) Induction of experimental autoimmune encephalomyelitis with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant in three non-human primate species J Neuroimmune Pharmacol, 8(5): 1251-1264
• Pohl M, Kawakami N, Kitic M, Bauer J, Martins R, Fischer MT, Machado-Santos J, Mader S, Ellwart JW, Misu T, Fujihara K, Wekerle H, Reindl M, Lassmann H, Bradl M (2013) T cell-activation in neuromyelitis optica lesions plays a role in their formation Acta Neuropathologica Communications, : 1(1):85
• Dauvilliers Y, Bauer J, Rigau V, Lalloyer N, Labauge P, Carlander B, Liblau R, Peyron C, Lassmann H. (2013) Hypothalamic Immunopathology in Anti-Ma-Associated Diencephalitis With Narcolepsy-Cataplexy Jama Neurol, 70(10): 1305-1310
• Martin-Blondel G, Bauer J, Cuvinciuc V, Uro-Coste E, Debard A, Massip P, Delisle MB, Lassmann H, Marchou B, Mars LT, Liblau RS (2013) In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection Neurology, 81(11): 964-970
• Hametner S, Wimmer I, Haider L, Pfeifenbring S, Brück W, Lassmann H. (2013) Iron and Neurodegeneration in the Multiple Sclerosis Brain Ann Neurol, 74: 848–861
• Fischer MT, Wimmer I, Höftberger R, Gerlach S, Haider L, Zrzavy T, Hametner S, Mahad D, Binder CJ, Krumbholz M, Bauer J, Bradl M, Lassmann H. (2013) Disease-specific molecular events in cortical multiple sclerosis lesions Brain, 136(Pt 6): 1799-1815
  | Weblink |
• Kitic M, Hochmeister S, Wimmer I, Bauer J, Misu T, Mader S, Reindl M, Fujihara K, Lassmann H, Bradl M (2013) Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats Acta Neuropathologica Communications, 1(1) : 5
• Misu T, Höftberger R, Fujihara K, Wimmer I, Takai Y, Nishiyama S, Nakashima I, Konno H, Bradl M, Garzuly F, Itoyama Y, Aoki M, Lassmann H (2013) Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica Acta Neuropathol, 125(6): 815-827
• Haanstra KG, Hofman SO, Lopes Estêvão DM, Blezer EL, Bauer J, Yang LL, Wyant T, Csizmadia V, 't Hart BA, Fedyk ER (2013) Antagonizing the a4b1 integrin, but not a4b7, inhibits leukocytic infiltration of the central nervous system in rhesus monkey experimental autoimmune encephalomyelitis J Immunol, 190(5): 1961-1973
• Jagessar SA, Fagrouch Z, Heijmans N, Bauer J, Laman JD, Oh L, Migone T, Verschoor EJ, 't Hart BA. (2013) The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of -Herpesvirus Infected B Cells in the Marmoset EAE Model J Neuroimmune Pharmacol, 8(3): 727-738
• Pakozdy A, Halasz P, Klang A, Bauer J, Leschnik M, Tichy A, Thalhammer JG, Lang B, Vincent A. (2013) Suspected Limbic Encephalitis and Seizure in Cats Associated with Voltage-Gated Potassium Channel (VGKC) Complex Antibody J Vet Intern Med, 27(1): 212-214
• Berghoff AS, Lassmann H, Preusser M, Höftberger R. (2013) Characterization of the inflammatory response to solid cancer metastases in the human brain Clin Exp Metastasis, 30(1): 69-81
• Filippi M, Preziosa P, Pagani E, Copetti M, Mesaros S, Colombo B, Horsfield M, Falini A, Comi G, Lassmann H, Rocca M. (2013) Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis Mult Scler, 19(4): 418-426

• Lassmann H (2013) Multiple sclerosis: Lessons from molecular neuropathology Exp. Neurol., 262 Pt A: 2-7
• Lassmann H (2013) Pathology and disease mechanisms in different stages of multiple sclerosis J Neurol Sci, 333 (1-2): 1-4
• Bien CG, Bauer J (2013) Pathophysiologie antikörperassoziierter ZNS-Erkrankungen Nervenarzt, 84: 466–470
• Filippi M, Rocca MA, Horsfield MA, Hametner S, Geurts JJ, Comi G, Lassmann H. (2013) Imaging Cortical Damage and Dysfunction in Multiple Sclerosis Jama Neurol, 70(5): 556-564
• Lassmann H (2013) Relapsing-remitting and primary progressive MS have the same cause(s) - the neuropathologist's view: 1 Mult Scler, Mar;19(3): 266-267
• Bagnato F, Hametner S, Welch EB (2013) Visualizing iron in multiple sclerosis Magn Reson Imaging, 31(3): 376-384
• Lassmann H (2013) Henry de Forest Webster (1927-2012) Acta Neuropathol, 125(2): 311-312

• Jagessar SA, Heijmans N, Bauer J, Blezer EL, Laman JD, Migone TS, Devalaraja MN, 't Hart BA. (2012) Antibodies against human BLyS and APRIL attenuate EAE development in marmoset monkeys J Neuroimmune Pharmacol, 7(3): 557-570
• Jagessar SA, Heijmans N, Bauer J, Blezer EL, Laman JD, Hellings N, 't Hart BA. (2012) B-cell depletion abrogates T cell-mediated demyelination in an antibody-nondependent common marmoset experimental autoimmune encephalomyelitis model J Neuropath Exp Neurol, 71(8): 716-728
• Hochmeister S, Romauch M, Bauer J, Seifert-Held t, Weissert R, Linington C, Hartung HP, Fazekas F, Storch MK (2012) Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination Exp. Neurol., 237: 70-77
• Davalos D, Ryu JK, Merlini M, Baeten KM, Le Moan N, Petersen MA, Deerinck TJ, Smirnoff DS, Bedard C, Hakozaki H, Gonias Murray S, Ling JB, Lassmann H, Degen JL, Ellisman MH, Akassoglou K. (2012) Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation Nat Commun, 3: 1227
• Rigau V, Mania A, Béfort P, Carlander B, Jonquet O, Lassmann H, Camu W, Thouvenot E. (2012) Lethal Multiple Sclerosis Relapse after Natalizumab withdrawal Neurology, 79(22): 2214-2216
• Maj M, Milenkovic I, Bauer J, Berggard T, Veit M, Ilhan-Mutlu A, Wagner L, Tretter V (2012) Novel insights into the distribution and functional aspects of the calcium binding protein Secretagogin from studies on rat brain and primary neuronal cell culture Front Mol Neurosci, 5: Article 84
  | Supplement |
• Adzemovic MZ, Ockinger J, Zeitelhofer M, Hochmeister S, Beyeen AD, Paulson A, Gillett A, Hedreul MT, Covacu R, Lassmann H, Olsson T, Jagodic M. (2012) Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats PLoS.ONE., : 7(7):e39794
• Campbell GR, Kraytsberg Y, Krishnan KJ, Ohno N, Ziabreva I, Reeve A, Trapp BD, Newcombe J, Reynolds R, Lassmann H, Khrapko K, Turnbull DM, Mahad DJ. (2012) Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis Acta Neuropathol, 124(2): 209-220
• Preusser M, Hassler M, Birner P, Rudas M, Acker T, Plate H, Widhalm G, Knosp E, Breitschopf H, Berger J, Marosi C. (2012) Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches Clin Neuropathol, 31(5): 352-360
• Bien CG, Vincent A, Barnett MH, Becker AJ, Blümcke I, Graus F, Jellinger KA, Reuss DE, Ribalta T, Schlegel J, Sutton I, Lassmann H, Bauer J. (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis Brain, 135(Pt 5): 1622-1638
  | Article (PDF) |
• Scheikl T, Pignolet B, Dalard C, Desbois S, Raison D, Yamazaki M, Saoudi A, Bauer J, Lassmann H, Hardin-Pouzet H, Liblau RS. (2012) Cutting Edge: Neuronal Recognition by CD8 T Cells Elicits Central Diabetes Insipidus J Immunol, 188 (10): 4731-4735
• Lax NZ, Campbell GR, Reeve AK, Ohno N, Zambonin J, Blakely EL, Taylor RW, Bonilla E, Tanji K, Dimauro S, Jaros E, Lassmann H, Turnbull DM, Mahad DJ. (2012) Loss of myelin-associated glycoprotein in kearns-sayre syndrome Arch Neurol, 69(4): 490-499.
• Kaushansky N, Altmann DM, David CS, Lassmann H, Ben-Nun A. (2012) DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP). J Neuroinflammation, 9(1): 29
• Jagessar SA, Heijmans N, Blezer EL, Bauer J, Blokhuis JH, Wubben JA, Drijfhout JW, van den Elsen PJ, Laman JD, Hart BA (2012) Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG(34-56) peptide in incomplete adjuvant Eur. J. Immunol., 42(1): 217-227
• Jagessar SA, Gran B, Heijmans N, Bauer J, Laman JD, 't Hart BA, Constantinescu CS (2012) Discrepant Effects of Human Interferon-gamma on Clinical and Immunological Disease Parameters in a Novel Marmoset Model for Multiple Sclerosis J Neuroimmune Pharmacol, 7(1): 253-265
• Fischer MT, Sharma R, Lim J, Haider L, Frischer J, Drexhage J, Mahad D, Bradl M, van Horssen J, Lassmann H (2012) NADPH Oxidase Expression in Active Multiple Sclerosis Lesions in Relation to Oxidative Tissue Damage and Mitochondrial Injury Brain, 135: 886-899
  | Article (PDF) |
• Eisele S, Krumbholz M, Fischer M-T, Mohan H, Junker A, Arzberger T, Hohlfeld R, Bradl M, Lassmann H, Meinl E (2012) Prospects of transcript profiling for mRNAs and microRNAs using formalin fixed paraffin embedded dissected autoptic multiple sclerosis lesions Brain Pathol, 22(5): 607-618

• Lassmann H (2012) Targeting intracerebral inflammation in multiple sclerosis: is it feasible? Acta Neuropathol, 124(3): 395-396
• Berger T, Lassmann H (2012) Karl Vass, 1958-2012 Mult Scler, 18(12): 1666-1667
• Fujihara K, Misu T, Nakashima I, Takahashi T, Bradl M, Lassmann H, Takano R, Nishiyama S, Takai Y, Suzuki C, Sato D, Kuroda H, Nakamura M, Fujimori J, Narikawa K, Sato S, Itoyama Y, Aoki M (2012) Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease Clinical and Experimental Neuroimmunology, 3: 58-73
• Lassmann H (2012) Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration Brain, 135(Pt 10): 2904-2905
• Lassmann H, van Horssen J, Mahad D (2012) Progressive multiple sclerosis: pathology and pathogenesis Nat Rev Neurol, 8(11): 647-656
• Rathinam C, Lassmann H, Mengel M, Klein C. (2012) Retraction: transcription factor gfi1 restricts B cell-mediated autoimmunity J Immunol, : 189(7):3777
• Lassmann H (2012) The birth of oligodendrocytes in the anatomical and neuropathological literature: the seminal contribution of Pío del Río-Hortega. Clin Neuropathol, 31(6): 435-436
• Bauer J, Vezzani A, Bien CG (2012) Epileptic encephalitis: the role of the innate and adaptive immune system Brain Pathol, 22(3): 412-421
  | Article (PDF) |
• Filippi M, Rocca MA, Barkhof F, Brück W, Chen JT, Comi G, Deluca G, De Stefano N, Erickson BJ, Evangelou N, Fazekas F, Geurts JJ, Lucchinetti C, Miller DH, Pelletier D, Popescu BF, Lassmann H (2012) Association between pathological and MRI findings in multiple sclerosis Lancet Neurology, 11(4): 349-360
  | Article (PDF) |
• Bradl M, Lassmann H. (2012) Microarray analysis on archival multiple sclerosis tissue: Pathogenic authenticity outweighs technical obstacles Neuropathology, 32(4): 463-466

• Bradl M and Lassmann H (2012) Multiple Sclerosis. In: Kettenmann H and Ransom B, Neuroglia, Third Edition Oxford University Press, Oxford New York: 785-797

• Kap YS, Bauer J, Driel N, Bleeker WK, Parren PW, Kooi EJ, Geurts JJ, Laman JD, Craigen JL, Blezer E, 't Hart BA (2011) B-cell depletion attenuates white and gray matter pathology in marmoset experimental autoimmune encephalomyelitis J Neuropath Exp Neurol, 70(11): 992-1005
• Bagnato F, Hametner S, Yao B, van Gelderen P, Merkle H, Cantor FK, Lassmann H, Duyn JH. (2011) Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla Brain, 134(Pt 12): 3602-3615.
• Lucchinetti CF, Popescu BFG, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Brück W, Parisi JE, Scheithauer BW, Giannini C, Weigand SD, Mandrekar J, Ransohoff RM (2011) Inflammatory Cortical Demyelination in Early Multiple Sclerosis N Engl J Med, 365(23): 2188-2197.
  | Article (PDF) |
• Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, Szymkowski DE, Probert L. (2011) Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-{kappa}B Brain, 134(Pt 9): 2722-2735
• Van Strien ME, Baron W, Bakker EN, Bauer J, Bol JG, Brevé JJ, Binnekade R, Van Der Laarse WJ, Drukarch B, Van Dam AM (2011) Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination Glia, 59(11): 1622-1634
• Deckert M, Engert A, Brück W, Ferreri AJ, Finke J, Illerhaus G, Klapper W, Korfel A, Küppers R, Maarouf M, Montesinos-Rongen M, Paulus W, Schlegel U, Lassmann H, Wiestler OD, Siebert R, Deangelis LM. (2011) Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma Leukemia, 25(12): 1797-807.
• Zambonin JL, Zhao C, Ohno N, Campbell GR, Engeham S, Ziabreva I, Schwarz N, Lee SE, Frischer JM, Turnbull DM, Trapp BD, Lassmann H, Franklin RJ, Mahad DJ. (2011) Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis Brain, 134(Pt 7):: 1901-1913.
• Haider L, Fischer MT, Frischer JM, Bauer J, Höftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H. (2011) Oxidative damage in multiple sclerosis lesions Brain, 134(Pt 7):: 1914-1924
• Serbecic N, Aboul-Enein F, Beutelspacher SC, Vass C, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U. (2011) High Resolution Spectral Domain Optical Coherence Tomography (SD-OCT) in Multiple Sclerosis: The First Follow Up Study over Two Years PLoS.ONE., : 6(5):e19843
• Grabner G, Dal-Bianco A, Schernthaner M, Vass K, Lassmann H, Trattnig S (2011) Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI J Magn Reson Imaging, 33(3): 543-549
• Lichtenbergová L, Lassmann H, Jones MK, Kolá&#345;ová L, Horák P (2011) Trichobilharzia regenti: Host immune response in the pathogenesis of neuroinfection in mice Exp Parasitol, 128(4): 328-335
• Pohl M, Fischer MT, Mader S, Schanda K, Kitic M, Sharma R, Wimmer I, Misu T, Fujihara K, Reindl M, Lassmann H, Bradl M. (2011) Pathogenic T cell responses against aquaporin 4 Acta Neuropathol, 122(1): 21-34
• Grigoriadis N, Lourbopoulos A, Lagoudaki R, Frischer JM, Polyzoidou E, Touloumi O, Simeonidou C, Deretzi G, Kountouras J, Spandou E, Kotta K, Karkavelas G, Tascos N, Lassmann H. (2011) Variable behavior of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis Exp. Neurol., 230(1): 78-89
• Serbecic N, Beutelspacher SC, Geitzenauer W, Kircher K, Lassmann H, Reitner A, Khan A, Schmidt-Erfurth U. (2011) RNFL thickness in MS-associated acute optic neuritis using SD-OCT: critical interpretation and limitations Acta Ophtalmol, 89(5): e451-460
• Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C (2011) Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice Neuroscience, 180: 280-292
• Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O, Lassmann H, Turnbull DM, Mahad DJ. (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis Ann Neurol, 69(3): 481-492

• Lassmann H, van Horssen J. (2011) The molecular basis of neurodegeneration in multiple sclerosis FEBS Letters, 585(23): 3715-3723
• Bien CG, Bauer J. (2011) Which pathomechanism damages the brain in antibody-associated CNS disease? Neurology, 77(5): 414-415
• Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM; the NeuroproMiSe EBV Working Group (2011) Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria Brain, 134(Pt 9) : 2772-2786
• Lassmann H (2011) A dynamic view of the blood-brain barrier in active multiple sclerosis lesions Ann Neurol, 70(1): 1-2
• Lassmann H (2011) The Architecture of Inflammatory Demyelinating Lesions: Implications for Studies on Pathogenesis Neuropathol Appl Neurobiol, 37(7): 698-710
• Lassmann H, Bancher C, Attems J, Paulus W. (2011) In honor of the 80th birthday of Kurt Jellinger: a living legend in neuropathology Acta Neuropathol, 121(5): 565-568
  | Article (PDF) |
• Lassmann H (2011) Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease J Neural Transm, 118(5): 747-752
• Lassmann H. (2011) Pathophysiology of inflammation and tissue injury in multiple sclerosis: What are the targets for therapy J Neurol Sci, 306(1-2): 167-169
  | Article (PDF) |

• Málaga-Diéguez L, Yang Q, Bauer J, Pankevych H, Freissmuth M, Nanoff C. (2010) Pharmacochaperoning of the A1 adenosine receptor is contingent on the endoplasmic reticulum Mol Pharmacol, 77(6): 940-952
• Domingues HS, Mues M, Lassmann H, Wekerle H, Krishnamoorthy G. (2010) Functional and pathogenic differences of Th1 and th17 cells in experimental autoimmune encephalomyelitis PLoS.ONE., 5(11): e15531
• Serbecic N, Aboul-Enein F, Beutelspacher SC, Graf M, Kircher K, Geitzenauer W, Brannath W, Lang P, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U. (2010) Heterogeneous Pattern of Retinal Nerve Fiber Layer in Multiple Sclerosis. High Resolution Optical Coherence Tomography: Potential and Limitations PLoS.ONE., 5(11): e13877
• Beyeen AD, Adzemovic MZ, Ockinger J, Stridh P, Becanovic K, Laaksonen H, Lassmann H, Harris RA, Hillert J, Alfredsson L, Celius EG, Harbo HF, Kockum I, Jagodic M, Olsson T. (2010) IL-22RA2 Associates with Multiple Sclerosis and Macrophage Effector Mechanisms in Experimental Neuroinflammation. J Immunol, 185(11): 6883-6890
  | Article (PDF) |
• Boucheron N, Sharif O, Schebesta A, Croxford A, Raberger J, Schmidt U, Vigl B, Bauer J, Bankoti R, Lassmann H, Epstein MM, Knapp S, Waisman A, Ellmeier W. (2010) The Protein Tyrosine Kinase Tec Regulates a CD44highCD62L- Th17 Subset J Immunol, 185(9):5111-5119
  | Article (PDF) |
• Stridh P, Thessen Hedreul M, Beyeen AD, Adzemovic MZ, Laaksonen H, Gillett A, Ockinger J, Marta M, Lassmann H, Becanovic K, Jagodic M, Olsson T. (2010) Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat PLoS.ONE., 5(9): e12716
  | Article (PDF) |
• Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS, Laursen H (2010) Demyelination versus remyelination in progressive multiple sclerosis Brain, 133(10): 2983-2998
  | Article (PDF) |
• Höftberger R, Fink S, Aboul-Enein F, Botond G, Olah J, Berki T, Ovadi J, Lassmann H, Budka H, Kovacs GG. (2010) Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis Glia, 58(15):1847-1857
  | Article (PDF) |
• Höftberger R, Kunze M, Voigtländer T, Unterberger U, Regelsberger G, Bauer J, Aboul-Enein F, Garzuly F, Forss-Petter S, Bernheimer H, Berger J, Budka H (2010) Peroxisomal Localization of the Proopiomelanocortin-Derived Peptides β-Lipotropin and β-Endorphin Endocrinology, 151 (10): 4801-4810
  | Article (PDF) |
• Ziabreva I, Campbell G, Rist J, Zambonin J, Rorbach J, Wydro MM, Lassmann H, Franklin RJ, Mahad D. (2010) Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes Glia, 58(15):1827-37
  | Article (PDF) |
• Prevot N, Briet C, Lassmann H, Tardivel I, Roy E, Morin J, Mak TW, Tafuri A, Boitard C. (2010) Abrogation of icos/icosl costimulation in nod mice results in autoimmune deviation towards the neuromuscular system Eur. J. Immunol., 40(8): 2267-2276
  | Article (PDF) |
• Sharma R, Fischer MT, Bauer J, Felts PA, Smith KJ, Misu T, Fujihara K, Bradl M, Lassmann H. (2010) Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination Acta Neuropathol, 120(2): 223-236
  | Article (PDF) |
• Mohan H, Krumbholz M, Sharma R, Eisele S, Junker A, Sixt M, Newcombe J, Wekerle H, Hohlfeld R, Lassmann H, Meinl E. (2010) Extracellular Matrix in Multiple Sclerosis Lesions: Fibrillar Collagens, Biglycan and Decorin are Upregulated and Associated with Infiltrating Immune Cells Brain Pathol, 20(5): 966-975
  | Article (PDF) |
• Rémi J, Pfefferkorn T, König FB, Lassmann H, Brück W, Holtmannspötter M, Straube A, Kretzschmar HA, Schüller U (2010) A 76-year-old woman with paraplegia Brain Pathol, 20(2): 507-510
  | Article (PDF) |
• Khan O, Filippi M, Freedman MS, Barkhof F, Dore-Duffy P, Lassmann H, Trapp B, Bar-Or A, Zak I, Siegel MJ, Lisak R. (2010) Chronic cerebrospinal venous insufficiency and multiple sclerosis Ann Neurol, 67(3): 286-290
  | Article (PDF) |
• Veto S, Acs P, Bauer J, Lassmann H, Berente Z, Setalo G Jr, Borgulya G, Sumegi B, Komoly S, Gallyas F Jr, Illes Z. (2010) Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death Brain, 133(Pt 3):: 822-834
  | Article (PDF) |

• Pollak D, Rey C, Monje F (2010) Rodent models in depression research: Classical strategies and new directions Ann Med, 42 (4): 252-264
• Misu T, Fujihara K, Takahashi T, Takano R, Nishiyama S, Takai Y, Nakashima I, Sato S, Lassmann H, Itoyama Y (2010) Pathogenesis of Neuromyelitis Optica aquaporin 4 autoimmunity and astrocytopathy Rinsho Shinkeigaku, 50(11): 872
• Lassmann H (2010) Reply: Non-multiple sclerosis recurrent demyelinating disorders: an ongoing debate Brain, 133(8): E151
• Grois N, Fahrner B, Arceci RJ, Henter JI, McClain K, Lassmann H, Nanduri V, Prosch H, Prayer D; for the Histiocyte Society CNS LCH Study Group. (2010) Central Nervous System Disease in Langerhans Cell Histiocytosis J Pediatr, 156(6): 873-881
  | Article (PDF) |
• Lassmann H (2010) Acute disseminated encephalomyelitis and multiple sclerosis Brain, 133(2): 317-319
  | Article (PDF) |
• Bradl M, Lassmann H (2010) Oligodendrocytes: biology and pathology Acta Neuropathol, 119(1): 37-53
  | Article (PDF): 1 1 |
• Lassmann H (2010) Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models Exp. Neurol., 225(1): 2-8
  | Article (PDF) |

• Bien CC, Bauer J (2010) Rasmussen Encephalitis. In: Dale, Russell C. and Vincent, Angela, Inflammatory and Autoimmune Disorders of the nervous system in children MacKeith Press, London / Clinics in Developmental Medicine No.184-185: 207-226

• Emmanouil M, Taoufik E, Tseveleki V, Vamvakas SS, Tselios T, Karin M, Lassmann H, Probert L. (2009) Neuronal I{kappa}B Kinase {beta} Protects Mice from Autoimmune Encephalomyelitis by Mediating Neuroprotective and Immunosuppressive Effects in the Central Nervous System J Immunol, 183(12): 7877-89
  | Article (PDF) |
• Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E. (2009) Micro-ribonucleic acid profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47 Brain, 132(Pt 12): 3342-52
  | Article (PDF) |
• Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H. (2009) Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo Ann Neurol, 66(5): 630-643
  | Article (PDF) |
• Kaushansky N, Altmann DM, Ascough S, David CS, Lassmann H, Ben-Nun A. (2009) HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice J Immunol, 183(5): 3531-41
  | Article (PDF) |
• Isaksson M, Ardesjö B, Rönnblom L, Kämpe O, Lassmann H, Eloranta ML, Lobell A. (2009) Plasmacytoid dendritic cells promote priming of autoimmune Th17 cells and experimental autoimmune encephalomyelitis Eur. J. Immunol., 39(10): 2925-35
  | Article (PDF) |
• Fuchs P, Zorer M, Reipert S, Rezniczek GA, Propst F, Walko G, Fischer I, Bauer J, Leschnik MW, Luscher B, Thalhammer JG, Lassmann H, Wiche G. (2009) Targeted inactivation of a developmentally regulated neural plectin isoform (plectin 1C) in mice leads to reduced motor nerve conduction J Biol Chem, 284(39): 26502-9
  | Article (PDF) |
• Owens GP, Bennett JL, Lassmann H, O'Connor KC, Ritchie AM, Shearer A, Lam C, Yu X, Birlea M, Dupree C, Williamson RA, Hafler DA, Burgoon MP, Gilden D. (2009) Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid Ann Neurol, 65(6): 639-649
  | Article (PDF) |
• Schoderboeck L, Adzemovic M, Nicolussi EM, Crupinschi C, Hochmeister S, Fischer MT, Lassmann H, Bradl M. (2009) The 'window of susceptibility' for inflammation in the immature central nervous system is characterized by a leaky blood-brain barrier and the local expression of inflammatory chemokines Neurobiol Dis, 35(3): 368-75
  | Supplement |
• Pöllinger B, Krishnamoorthy G, Berer K, Lassmann H, Bösl MR, Dunn R, Domingues HS, Holz A, Kurschus FC, Wekerle H. (2009) Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells J Exp Med, 206(6): 1303-1316
  | Article (PDF) |
• Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, Lassmann H, Dornmair K, Kurschus FC, Liblau RS, Wekerle H. (2009) Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis Nat Med, 15(6): 626-632
  | Article (PDF) |
• Derfuss T, Parikh K, Velhin S, Braun M, Mathey E, Krumbholz M, Kümpfel T, Moldenhauer A, Rader C, Sonderegger P, Pöllmann W, Tiefenthaller C, Bauer J, Lassmann H, Wekerle H, Karagogeos D et al (2009) Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals Proc Natl Acad Sci USA, 106(20): 8302-8307
  | Article (PDF) |
• Nicolussi EM, Huck S, Lassmann H, Bradl M (2009) The cholinergic anti-inflammatory system limited T cell infiltration into the neurodegenerative CNS, but can not counteract complex CNS inflammation Neurobiol Dis, 35: 24-31
• Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains Brain, 132 (Pt. 5): 1175-1189
  | Article (PDF) |
• Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, Lassmann H, Turnbull DM (2009) Mitochondial changes within axons in multiple sclerosis Brain, 132 (Pt. 5): 1161-1174
  | Article (PDF) |
• Hochmeister S, Bittner RE, Höger H, Lassmann H, Bradl M (2009) The susceptibility to experimental autoimmune encephalomyelitis is not related to dysferlin-deficiency Autoimmunity, 42(3): 235-241

• Bauer J, Bien CG (2009) Encephalitis and epilepsy Semin Immunopathol, 31(4) : 537-544
  | Article (PDF) |
• Lassmann H (2009) Clinical and pathological topics of multiple sclerosis Rinsho Shinkeigaku, 49(11): 715-718
• Lassmann H (2009) Experimental models of neuromyelitis optica Rinsho Shinkeigaku, 49(11): 900-901
• Bradl M, Lassmann H (2009) Progressive multiple sclerosis Semin Immunopathol, 31(4): 455-465
  | Article (PDF) |

• Dal Bianco A, Bradl M, Frischer J, Kutzelnigg A, Jellinger K, Lassmann H. (2008) Multiple sclerosis and Alzheimer's disease. Ann Neurol, 63 (2): 174-83
• Multiple Sclerosis Therapeutic Consensus Group (MSTCG; u.a. Lassmann H), Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R (2008) Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations J Neurol, 255(10): 1449-1463
• Kap YS, Smith P, Jagessar SA, Remarque E, Blezer E, Strijkers GJ, Laman JD, Hintzen RQ, Bauer J, Brok HP, 't Hart BA (2008) Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cy J Immunol, 180(3): 1326-1337
• Jagessar SA, Smith PA, Blezer E, Delarasse C, Pham-Dinh D, Laman JD, Bauer J, Amor S, 't Hart B (2008) Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets J Neuropath Exp Neurol, 67(4): 326-40.
• Bajramovic JJ, Brok HP, Ouwerling B, Jagessar SA, van Straalen L, Kondova I, Bauer J, Amor S, 't Hart BA, Ben-Nun A. (2008) Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve Eur. J. Immunol., 38(5): 1452-1464
• Stavrou I, Baumgartner C, Frischer JM, Trattnig S, Knosp E (2008) Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery, 63(5): 888-896
• Hochmeister S, Zeitelhofer M, Bauer J, Nicolussi EM, Fischer MT, Heinke B, Selzer E, Lassmann H, Bradl M (2008) After injection into the striatum, in vitro-differentiated microglia- and bone marrow-derived dendritic cells can leave the central nervous system via the blood stream Am.J.Pathol., 173(6): 1669-1681
  | Article (PDF) || Supplement |
• Rathinam C, Lassmann H, Mengel M, Klein C (2008) Transcription factor Gfi1 restricts B cell-mediated autoimmunity J Immunol, 181(9): 6222-6229
• Aharonowiz M, Einstein O, Fainstein N, Lassmann H, Reubinoff B, Ben-Hur T (2008) Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis PLoS.ONE., 3(9): e3145
• Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, Wallström E, Lobell A, Brundin L, Lassmann H, Harris RA (2008) Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis J Leukoc Biol, 84(5): 1248-1255
• Saxena A*, Bauer J*, Scheikl T, Zapulla J, Audebert M, Desbois S, Waisman A, Lassmann H, Liblau RS, Mars LT (2008) Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes J Immunol, 181(3): 1617-1621. *AS and JB share first authorship
• Bramow S, Faber-Rod JC, Jacobsen C, Kutzelnigg A, Patrikios P, Sorensen PS, Lassmann H, Laursen H (2008) Fatal neurogenic pulmonary edema with progressive multiple sclerosis Mult Scler, 14(5): 711-715
• Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, Thomsen K, Mandrekar J, Altintas A, Erickson BJ, König F, Giannini C, Lassmann H, Linbo L, Pittock SJ, Brück W. (2008) Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis Brain, 131(Pt 7): 1759-1775
  | Article (PDF) |
• Mahad D, Ziabreva I, Lassmann H, Turnbull D (2008) Mitochondrial defects in acute multiple sclerosis lesions. Brain, 131(Pt 7): 1722-1735
  | Article (PDF) |
• Aboul-Enein F, Höftberger R, Buxhofer-Ausch V, Drlicek M, Lassmann H, Budka H, Kristoferitsch W. (2008) Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome Neuropathol Appl Neurobiol, 34(2): 248-252
  | Article (PDF) |
• Frischer JM, Pipp I, Stavrou I, Trattnig S, Hainfellner JA, Knosp E (2008) Cerebral cavernous malformations: congruency of histopathological features with the current clinical definition J Neurol Neurosurg Psych, 79(7): 783-788
  | Article (PDF) |
• Dal Bianco A, Bradl M, Frischer J, Kutzelnigg A, Jellinger K, Lassmann H (2008) Multiple sclerosis and Alzheimer's disease Ann Neurol, 63(2): 174-183
  | Article (PDF) |

• Lassmann H (2008) The pathological substrate of magnetic resonance alterations in multiple sclerosis Neuroimaging Clin N Am, 18(4): 563-576
• Mahad D, Lassmann H, Turnbull D (2008) Mitochondria and disease progression in multiple sclerosis Neuropathol Appl Neurobiol, 34(6): 577-589
  | Article (PDF) |
• Kutzelnigg A, Lassmann H (2008) Neuropathology of cognitive dysfunction in multiple sclerosis Handb Clin Neurol, 89: 719-723
• Zivadinov R, Reder AT, Filippi M, Minagar A, Stüve O, Lassmann H, Racke MK, Dwyer MG, Frohman EM, Khan O (2008) Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis Neurology, 71(2): 136-144
• Lassmann H (2008) Mechanisms of inflammation induced tissue injury in multiple sclerosis. J Neurol Sci, 274(1-2): 45-47
• Lassmann H (2008) Model of multiple sclerosis: new insights into pathopysiology and repair Curr Opin Neurol, 21(3): 242-247
• Lassmann H, Lucchinetti CF (2008) Cortical Demyelination ín CNS inflammatory demyelinating disease (Editorial) Neurology, 70(5): 332-333
• Kuhlmann T, Lassmann H, Brück W (2008) Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach Acta Neuropathol, 115(3): 275-287

• Bradl M, Dornmair K, Hohlfeld R (2008) New tools for investigating the immuno-pathogenesis of MS: principles and applications. In: Raine C, McFarland HF, Hohlfeld R (ed.), Multiple Sclerosis: a comprehensive text Elsevier, Philadelphia, USA: 284-299

• Mars LT, Bauer J, Gross DA, Bucciarelli F, Firat H, Hudrisier D, Lemonnier F, Kosmatopoulos K, Liblau RS (2007) CD8 T Cell Responses to Myelin Oligodendrocyte Glycoprotein-Derived Peptides in Humanized HLA-A*0201-Transgenic Mice J Immunol, 179: 5090-5098
• Brok HP, Boven L, van MM, Kerlero de RN, Celebi-Paul L, Kap YS, Jagessar A, Hintzen RQ, Keir G, Bajramovic J, Ben-Nun A, Bauer J, Laman JD, Amor S, 't Hart BA (2007) The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys J Neuroimmunol, 182: 135-152
• Blezer EL, Bauer J, Brok HP, Nicolay K, 't Hart BA (2007) Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis. NMR Biomed, 20: 90-103
• Seifert T, Bauer J, Weissert R, Fazekas F, Storch MK (2007) Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination Acta Neuropathol, 113: 195-203
• Rauschka H, Aboul-Enein F, Bauer J, Nobis H, Lassmann H, Schmidbauer M (2007) Acute cerebral white matter damage in lethal salicylate intoxication Neurotoxicology, 28: 33-37
• Einstein O, Fainstein N, Vaknin I, Mizrachi-Kol R, Reihartz E, Grigoriadis N, Lavon I, Baniyash M, Lassmann H, Ben-Hur T (2007) Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression Ann Neurol, 61(3): 209-218
• Müller GJ, Lassmann H, Johansen FF (2007) Anti-apoptotic signaling and failure of apoptosis in the ischemic rat hippocampus Neurobiol Dis, 25(3): 582-593
• Odoardi F, Kawakami N, Li Z, Cordiglieri C, Streyl K, Nosov M, Klinkert WE, Ellwart JW, Bauer J, Lassmann H, Wekerle H, Flügel A (2007) Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis Proc Natl Acad Sci USA, 104(3): 920-925
• Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis Brain, 130 (Pt 5): 1194-1205
• Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinetti CF (2007) Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations Mult Scler, 13(1): 7-16
  | Article (PDF) |
• Adams RA, Bauer J, Flick MJ, Sikorski SL, Nuriel T, Lassmann H, Degen JL, Akassoglou K (2007) The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease J Exp Med, 204(3): 571-582
• Eltayeb S, Berg AL, Lassmann H, Wallström E, Nilsson M, Olsson T, Ericsson-Dahlstrand A, Sunnemark D (2007) Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE J Neuroinflammation, 4: Art. 14
• Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, Stadelmann C, Brück W, Rauschka H, Schmidbauer M, Lassmann H (2007) Widespread demyelination in the cerebellar cortex in multiple sclerosis Brain Pathol, 17(1): 38-44
• Bauer J, Elger CE, Hans VH, Schramm J, Urbach H, Lassmann H, Bien CG (2007) Astrocytes are a specific immunological target in Rasmussen's encephalitis Ann Neurol, 62(1): 67-80
• Schmidt WM, Kraus C, Höger H, Hochmeister S, Oberndorfer F, Branka M, Bingemann S, Lassmann H, Müller M, Macedo-Souza LI, Vainzof M, Zatz M, Reis A, Bittner RE (2007) Mutation in the Scyl1 gene encoding amino-terminal kinase-like protein causes a recessive form of spinocerebellar neurodegeneration EMBO Rep, 8(7): 691-697
• Taoufik E, Valable S, Müller GJ, Roberts ML, Divoux D, Tinel A, Voulgari-Kokota A, Tseveleki V, Altruda F, Lassmann H, Petit E, Probert L (2007) FLIP(L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death J Neurosci, 27(25): 6633-6646
• Dumser M, Bauer J, Lassmann H, Berger J, Forss-Petter S (2007) Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency Acta Neuropathol, 114;6: 573-586
• Grundtner R, Dornmair K, Dahm R, Flügel A, Kawakami N, Zeitelhofer M, Schoderboeck L, Nosov M, Selzer E, Willheim M, Kiebler M, Wekerle H, Lassmann H, Bradl M (2007) Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system Neurobiol Dis, 28;3: 261-275
• Junker A, Ivanidze J, Malotka J, Eiglmeier I, Lassmann H, Wekerle H, Meinl E, Hohlfeld R, Dornmair K (2007) Multiple sclerosis: T-cell receptor expression in distinct brain regions Brain, 130;11: 2789-2799
  | Article (PDF) |
• Metz I, Lucchinetti CF, Openshaw H, Garcia-Merino A, Lassmann H, Freedman MS, Azzarelli B, Kolar OJ, Atkins HL, Brück W (2007) Autologous hematopoietic stem cell transplantation: the glass seems to be half full for aggressive, early forms of MS and half empty for advanced MS Brain, 130;5: 1254-1262
• Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain, 130;11: 2800-2815
  | Article (PDF) |
• Höftberger R, Garzuly F, Dienes HP, Grubits J, Rohonyi B, Fischer G, Hanzely Z, Lassmann H, Budka H (2007) Fulminant central nervous system demyelination associated with interferon-{alpha} therapy and hepatitis C virus infection Mult Scler, 13(9): 1100-1106
  | Article (PDF) |

• Lassmann H (2007) Cortical, subcortical and spinal alterations in neuroimmunological diseases J Neurol, 254 (Suppl 2): II/15-II/17
  | Article (PDF) |
• Lassmann H (2007) Experimental models in multiple sclerosis Rev Neurol (Paris), 163(6-7): 651-655
• Lassmann H (2007) Multiple sclerosis: is there neurodegeneration independent from inflammation? J Neurol Sci, 259 (1-2): 1-3
  | Article (PDF) |
• Lassmann H, Brück W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview Brain Pathol, 17(2): 210-218
• Lassmann H (2007) New concepts on progressive multiple sclerosis Curr Neurol Neurosci Rep, 7(3): 239-244

• Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H (2006) The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurological Sciences, 27 Suppl 1: 1-7
• Krishnamoorthy G, Lassmann H, Wekerle H, Holz A (2006) Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation J Clin Invest, 116(9): 2385-2392
• Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H (2006) Remyelination is extensive in a subset of multiple sclerosis patients Brain, 129(Pt.12): 3165-3172
• van Loo G, De Lorenzi R, Schmidt H, Huth M, Mildner A, Schmidt-Supprian M, Lassmann H, Prinz MR, Pasparakis M (2006) Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice Nature Immunol, 7(9): 954-961
• Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, Olsson T (2006) Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis J Immunol, 176(10): 6055-6064
• Spazierer D, Fuchs P, Reipert S, Fischer I, Schmuth M, Lassmann H, Wiche G (2006) Epiplakin is dispensable for skin barrier function and for integrity of keratin network cytoarchitecture in simple and stratified epithelia Mol Cell Biol, 26(2): 559-568
• Storch MK, Bauer J, Linington C, Olsson T, Weissert R, Lassmann H (2006) Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatability complex (MHC) haplotype-related J Neuropath Exp Neurol, 65(12): 1137-1142
• Kaushansky N, Zhong MC, Kerlero de Rosbo N, Hoeftberger R, Lassmann H, Ben-Nun A (2006) Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice J Immunol, 15;177(10): 7364-7376
• Aboul-Enein F., Weiser, P., Höftberger, R., Lassmann, H., and Bradl, M. (2006) Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis Acta Neuropathol, 111: 539-547
• Fraisl P., Tanaka H., Forss-Petter S, Lassmann H., Nishimune Y., Berger J (2006) A novel mammalian bubblegum-related acyl-CoA synthetase restricted to testes and possibly involved in spermatogenesis Arch Biochem Biophys, 451: 23-33
• Hochmeister S., Grundtner R., Bauer J., Engelhardt B., Lyck R., Gordon G., Korosec T., Kutzelnigg A., Berger J., Bradl M., Bittner R.E., Lassmann H (2006) Dysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis J Neuropath Exp Neurol, 65: 855-865

• Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain, 129(Pt. 8): 1953-1971
• Lassmann H (2006) Genetic predisposition for autoimmunity in multiple sclerosis? Lancet, 5(11): 897-898
• Kutzelnigg A, Lassmann H (2006) Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits? J Neurol Sci, 15;245(1-2): 123-126

• Bradl M. (2006) Progenitors and precursos of neurons and glial cells. In: Janigro D., Cell cycle in CNS development Humana Press, Totowa, NJ, USA: 23-29

• Compston A, Confavreux C, Lassmann H, McDonald I, Miller D, Noseworthy J, Smith K and Wekerle H (2006) McAlpine's Multiple Sclerosis, 4th Edition. , Churchill Livingstone, Elsevier, Philadelphia

• Kovacs,-G-G; Hoftberger,-R; Majtenyi,-K; Horvath,-R; Barsi,-P; Komoly,-S; Lassmann,-H; Budka,-H; Jakab,-G (2005) Neuropathology of white matter disease in Leber's hereditary optic neuropathy Brain, 128(Pt. 1): 35-41
• Miletic,-H; Utermohlen,-O; Wedekind,-C; Hermann,-M; Stenzel,-W; Lassmann,-H; Schluter,-D; Deckert,-M (2005) P0(106-125) is a neuritogenic epitope of the peripheral myelin protein P0 and induces autoimmune neuritis in C57BL/6 mice J Neuropath Exp Neurol, 64(1): 66-73
• Bien,-C-G; Granata,-T; Antozzi,-C; Cross,-J-H; Dulac,-O; Kurthen,-M; Lassmann,-H; Mantegazza,-R; Villemure,-J-G; Spreafico,-R; Elger,-C-E (2005) Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement Brain, 128 (Pt. 3): 454-471
• Mahad,-D-J; Staugaitis,-S; Ruggieri,-P; Parisi,-J; Kleinschmidt-Demasters,-B-K; Lassmann,-H; Ransohoff,-R-M (2005) Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination J Neurol Sci, 228(1): 3-5
• Grois N, Prayer D, Prosch H, Lassmann H and the CNS LCH Co-operative Group (2005) Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain, 128 (Pt. 4): 829-838
• Pittock SJ, McClelland RL, Achenbach SJ, Konig F, Bitsch A, Bruck W, Lassmann H, Parisi JE, Scheithauer BW, Rodriguez M, Weinshenker BG, Lucchinetti CF (2005) Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psych, 76 (12): 1693-1697
• Hovelmeyer N, Hao Z, Kranidioti K, Kassiotis G, Buch T, Frommer F, von Hoch L, Kramer D, Minichiello L, Kollias G, Lassmann H, Waisman A (2005) Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J Immunol, 175(9): 5875-5884
• Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain, 128 (Pt .11): 2705-2712
• Kantarci OH, Morales Y, Ziemer PA, Hebrink DD, Mahad DJ, Atkinson EJ, Achenbach SJ, De Andrade M, Mack M, Ransohoff RM, Lassmann H, Bruck W, Weinshenker BG, Lucchinetti CF (2005) CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis J Neuroimmunol, 169 (1-2): 137-143
• Gies U, Gruia D, Lassmann H, Bergmann M (2005) A case of rapidly progressive Rosai-Dorfman disease restricted to the central nervous system Zentralbl Neurochir, 66(3): 142-146
• Ali S, King GD, Curtin JF, Candolfi M, Xiong W, Liu C, Puntel M, Cheng Q, Prieto J, Ribas A, Kupiec-Weglinski J, van Rooijen N, Lassmann H, Lowenstein PR, Castro MG (2005) Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model Cancer Res, 65(16): 7194-7204
• Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange Lancet, 366(9485): 579-582
• Sunnemark D, Eltayeb S, Nilsson M, Wallstrom E, Lassmann H, Olsson T, Berg AL, Ericsson-Dahlstrand A (2005) CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin J Neuroinflammation, 2: 17
• Perron H, Lazarini F, Ruprecht K, Pechoux-Longin C, Seilhean D, Sazdovitch V, Creange A, Battail-Poirot N, Sibai G, Santoro L, Jolivet M, Darlix JL, Rieckmann P, Arzberger T, Hauw JJ, Lassmann H (2005) Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions J Neurovirol, 11(1): 23-33
• Stadelmann C, Ludwin S, Tabira T, Guseo A, Lucchinetti CF, Leel-Ossy L, Ordinario AT, Bruck W, Lassmann H (2005) Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis Brain, 128(Pt. 5): 979-987
• Sosnová, M., Bradl, M., and Forrester, J.V (2005) CD34+ corneal stromal cells are haematopoietic stem cells Stem Cells, 23: 507-515
• Bradl, M., Bauer, J., Flügel A., Wekerle H., and Lassmann, H (2005) Complementary contribution of CD4 and CD8 T lymphocytes to T cell infiltration of the intact and the degenerative spinal cord Am.J.Pathol., 166: 1441-1450
• Kawakami, N., Odoardi, F., Ziemssen, T., Bradl, M., Ritter, T., Neuhaus, O., Lassmann, H., Wekerle, H., and Flügel, A. (2005) Autoimmune CD4+ T cell memory: Life long persistence of encephalitogenic T cell clones in healthy immune repertoires J Neuroimmunol, 175: 69-81

• Bien CG, Bauer J. (2005) T-cells in human encephalitis Neuromolecular Med., : 7(3):243-53
• Aboul-Enein,-F; Lassmann,-H (2005) Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? Acta Neuropathol, 109(1): 49-55
• Lassmann H (2005) Multiple sclerosis pathology: evolution of pathogenetic concepts. Brain Pathol, 15(3): 217-222
• Lassmann H (2005) Stem cell and progenitor cell transplantation in multiple sclerosis: the discrepancy between neurobiological attraction and clinical feasibility. J Neurol Sci, 233(1-2): 83-86
• Kutzelnigg A, Lassmann H (2005) Cortical lesions and brain atrophy in MS J Neurol Sci, 233(1-2): 55-59

• Lassmann H (2005) Pathology of Neurons in Multiple Sclerosis. In: S. Waxman, Multiple Sclerosis as a Neuronal Disease Elsevier, Academic Press, Amsterdam: 153-164
• Bradl M, Lassmann H (2005) The role of autoimmunity in multiple sclerosis. In: Zouali, M., Molecular Autoimmunity Springer Science & Business Media, New York, USA: 209-225

• Muller,-G-J; Stadelmann,-C; Bastholm,-L; Elling,-F; Lassmann,-H; Johansen,-F-F (2004) Ischemia leads to apoptosis--and necrosis-like neuron death in the ischemic rat hippocampus Brain Pathol, 14(4): 415-424
• Tseveleki,-V; Bauer,-J; Taoufik,-E; Ruan,-C; Leondiadis,-L; Haralambous,-S; Lassmann,-H; Probert,-L (2004) Cellular FLIP (long isoform) overexpression in T cells drives Th2 effector responses and promotes immunoregulation in experimental autoimmune encephalomyelitis J Immunol, 173(11): 6619-6926
• Preusser,-M; Strobel,-T; Birner,-P; Marosi,-C; Dieckmann,-K; Rossler,-K; Budka,-H; Lassmann,-H; Hainfellner,-J-A (2004) Presence of D110 antigen expressing immunocompetent cells in glioblastoma associates with prolonged survival Neuropathol Appl Neurobiol, 30(6): 608-614
• Loers,-G; Aboul-Enein,-F; Bartsch,-U; Lassmann,-H; Schachner,-M (2004) Comparison of myelin, axon, lipid, and immunopathology in the central nervous system of differentially myelin-compromised mutant mice: a morphological and biochemical study Mol Cell Neurosci, 27(2): 175-189
• Lucchinetti,-C-F; Bruck,-W; Lassmann,-H (2004) Evidence for pathogenic heterogeneity in multiple sclerosis Ann Neurol, 56(2): 308
• Mead,-R-J; Neal,-J-W; Griffiths,-M-R; Linington,-C; Botto,-M; Lassmann,-H; Morgan,-B-P (2004) Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis Lab Invest, 84(1): 21-28
• Tschachler,-E; Reinisch,-C-M; Mayer,-C; Paiha,-K; Lassmann,-H; Weninger,-W (2004) Sheet preparations expose the dermal nerve plexus of human skin and render the dermal nerve end organ accessible to extensive analysis J Invest Dermatol, 122(1): 177-182
• Hoftberger,-R; Aboul-Enein,-F; Brueck,-W; Lucchinetti,-C; Rodriguez,-M; Schmidbauer,-M; Jellinger,-K; Lassmann,-H (2004) Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions Brain Pathol, 14(1): 43-50
• Cabarrocas,-J; Piaggio,-E; Zappulla,-J-P; Desbois,-S; Mars,-L-T; Lassmann,-H; Liblau,-R-S (2004) A transgenic mouse model for T-cell ignorance of a glial autoantigen J Autoimmun, 22(3): 179-189
• Mahad,-D-J; Trebst,-C; Kivisakk,-P; Staugaitis,-S-M; Tucky,-B; Wei,-T; Lucchinetti,-C-F; Lassmann,-H; Ransohoff,-R-M (2004) Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions J Neuropath Exp Neurol, 63(3): 262-273
• Aszmann,-O-C; Winkler,-T; Korak,-K; Lassmann,-H; Frey,-M (2004) The influence of GDNF on the timecourse and extent of motoneuron loss in the cervical spinal cord after brachial plexus injury in the neonate Neurol Res, 26(2): 211-217
• Kivisakk,-P; Mahad,-D-J; Callahan,-M-K; Sikora,-K; Trebst,-C; Tucky,-B; Wujek,-J; Ravid,-R; Staugaitis,-S-M; Lassmann,-H; Ransohoff,-R-M (2004) Expression of CCR7 in multiple sclerosis: implications for CNS immunity Ann Neurol, 55 (5): 627-638
• Akassoglou,-K; Adams,-R-A; Bauer,-J; Mercado,-P; Tseveleki,-V; Lassmann,-H; Probert,-L; Strickland,-S (2004) Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis Proc Natl Acad Sci USA, 101(17): 6698-6703
• de-Rosbo,-N-K; Kaye,-J-F; Eisenstein,-M; Mendel,-I; Hoeftberger,-R; Lassmann,-H; Milo,-R; Ben-Nun,-A (2004) The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-as J Immunol, 172(2): 1426-1435
• Pellkofer,-H; Schubart,-A-S; Hoftberger,-R; Schutze,-N; Pagany,-M; Schuller,-M; Lassmann,-H; Hohlfeld,-R; Voltz,-R; Linington,-C (2004) Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat Brain, 127 (Pt. 8): 1822-1830
• Xanthoulea,-S; Pasparakis,-M; Kousteni,-S; Brakebusch,-C; Wallach,-D; Bauer,-J; Lassmann,-H; Kollias,-G (2004) Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases J Exp Med, 200 (3): 367-376
• Kawakami, N., Lassmann, S., Li, Z., Odoardi, F., Ritter, T., Ziemssen, T., Klinkert, W.E.F., Ellwart, J.W., Bradl, M., Krivacic, K., Lassmann, H., Ransohoff, R.M., Volk, H.-D., Wekerle, H., Linington (2004) The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis J Exp Med, 199: 185-197
• Aboul-Enein, F., Bauer, J., Klein, M., Schubart, A., Flügel, A., Ritter, T., Kawakami, N., Siedler, F., Linington, C., Wekerle, H., Lassmann, H., Bradl, M (2004) Selective and antigen dependent effects of myelin degeneration on central nervous system inflammation J Neuropath Exp Neurol, 63: 1284-1296

• Lassmann,-H; Ransohoff,-R-M (2004) The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal Trends Immunol, 25(3): 132-137
  | Article (PDF) |
• Lassmann,-H (2004) Recent neuropathological findings in MS-implications for diagnosis and therapy. J Neurol, 251 Suppl 4: IV2-5
• Rieckmann,-P; Toyka,-K-V; Bassetti,-C; Beer,-K; Beer,-S; Buettner,-U; Chofflon,-M; Gotschi-Fuchs,-M; Kappos,-L; Kesselring,-J;...........Lassmann H et al (Multiple-Sclerosis-Therapy-Consensus-Group) (2004) Escalating immunotherapy of multiple sclerosis-new aspects and practical application J Neurol, 251(11): 1329-1339

• Lazzarini RA, Griffin JW, Lassmann H, Nave KA, Miller RH, Trapp BD (Eds.) (2004) Myelin Biology and Disorders. , Elsevier, Academic Press, Amsterdam

• Becanovic K, Wallstrom E, Kornek B, Glaser A, Broman KW, Dahlman I, Olofsson P, Holmdahl R, Luthman H, Lassmann H, Olsson T (2003) New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis J Immunol, 170(2): 1062-1069
• Lobell A, Weissert R, Eltayeb S, de Graaf KL, Wefer J, Storch MK, Lassmann H, Wigzell H, Olsson T (2003) Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response J Immunol, 170(4): 1806-1813
• Trebst C, Staugaitis SM, Kivisakk P, Mahad D, Cathcart MK, Tucky B, Wei T, Rani MR, Horuk R, Aldape KD, Pardo CA, Lucchinetti CF, Lassmann H, Ransohoff RM (2003) CC Chemokine Receptor 8 in the Central Nervous System Is Associated with Phagocytic Macrophages Am.J.Pathol., 162(1): 427-438
• Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H (2003) Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases J Neuropath Exp Neurol, 62(1): 25-33
• Akassoglou K, Douni E, Bauer J, Lassmann H, Kollias G, Probert L (2003) Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice Proc Natl Acad Sci USA, 100(2): 709-714
• Eltayeb,-S; Sunnemark,-D; Berg,-A-L; Nordvall,-G; Malmberg,-A; Lassmann,-H; Wallstrom,-E; Olsson,-T; Ericsson-Dahlstrand,-A (2003) Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease J Neuroimmunol, 142(1-2): 75-85
• Schroeter,-M; Stoll,-G; Weissert,-R; Hartung,-H-P; Lassmann,-H; Jander,-S (2003) CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destruction Am.J.Pathol., 163(4): 1517-1524
• Abdul-Majid,-K-B; Wefer,-J; Stadelmann,-C; Stefferl,-A; Lassmann,-H; Olsson,-T; Harris,-R-A (2003) Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4(-/-) and CD8(-/-) DBA/1 mice defines qualitative roles of different T cell subsets J Neuroimmunol, 141 (1-2): 10-19
• Rauschka,-H; Jellinger,-K; Lassmann,-H; Braier,-F; Schmidbauer,-M (2003) Guillain-Barre syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of di Eur J Neurol, 10(5): 479-486
• Wanschitz,-J; Maier,-H; Lassmann,-H; Budka,-H; Berger,-T (2003) Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome. Brain, 126(Pt.9): 2034-2042
• Kivisakk,-P; Mahad,-D-J; Callahan,-M-K; Trebst,-C; Tucky,-B; Wei,-T; Wu,-L; Baekkevold,-E-S; Lassmann,-H; Staugaitis,-S-M; Campbell,-J-J; Ransohoff,-R-M (2003) Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin Proc Natl Acad Sci USA, 100(14): 8389-8394
• Becanovic,-K; Backdahl,-L; Wallstrom,-E; Aboul-Enein,-F; Lassmann,-H; Olsson,-T; Lorentzen,-J-C (2003) Paradoxical effects of arthritis-regulating chromosome 4 regions on myelin oligodendrocyte glycoprotein-induced encephalomyelitis in congenic rats Eur. J. Immunol., 33(7): 1907-1916
• Cabarrocas,-J; Bauer,-J; Piaggio,-E; Liblau,-R; Lassmann,-H (2003) Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes Eur. J. Immunol., 33(5): 1174-1182
• Aszmann,-O-C; Korak,-K-J; Rab,-M; Grunbeck,-M; Lassmann,-H; Frey,-M (2003) Neuroma prevention by end-to-side neurorraphy: an experimental study in rats J Hand Surg, 28(6): 1022-1028
• Trebst,-C; Staugaitis,-S-M; Tucky,-B; Wei,-T; Suzuki,-K; Aldape,-K-D; Pardo,-C-A; Troncoso,-J; Lassmann,-H; Ransohoff,-R-M (2003) Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS) Neuropathol Appl Neurobiol, 29(6): 584-595
• Carboni,-S; Aboul-Enein,-F; Waltzinger,-C; Killeen,-N; Lassmann,-H; Pena-Rossi,-C (2003) CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis J Neuroimmunol, 145: 1-11
• Sunnemark,-D; Eltayeb,-S; Wallstrom,-E; Appelsved,-L; Malmberg,-A; Lassmann,-H; Ericsson-Dahlstrand,-A; Piehl,-F; Olsson,-T (2003) Differential expression of the chemokine receptors CX3CR1 and CCR1 by microglia and macrophages in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis Brain Pathol, 13(4): 617-629
• Lassmann H., Reindl M., Rauschka H., Berger J., Aboul-Enein F., Berger T., Zurbriggen A., Luterotti A., Brück W., Weber JR., Ullrich R., Schmidbauer M., Jellinger K., Vanddevelde M. (2003) A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions Brain, 126: 1347-1357

• Kornek,-B; Lassmann,-H (2003) Neuropathology of multiple sclerosis-new concepts Brain Res Bull, 61(3): 321-326
• Bradl, M.,Hohlfeld, R (2003) Neuroscience for Neurologists: molecular pathogenesis of neuroinflammation J Neurol Neurosurg Psych, 74: 1364-1370

• Storch MK, Weissert R, Stefferl A, Birnbacher R, Wallstrom E, Dahlman I, Ostensson CG, Linington C, Olsson T, Lassmann H (2002) MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury Brain Pathol, 12(3): 287-299
• Svensson L, Abdul-Majid KB, Bauer J, Lassmann H, Harris RA, Holmdahl R (2002) A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination Eur. J. Immunol., 32(7): 1939-1946
• Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica Brain, 125: 1450-1461
• Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, Van Kaer L, Lassmann H, Herbelin A, Lehuen A, Liblau RS (2002) Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice J Immunol, 15;168(12): 6007-6011
• Sorensen TL, Trebst C, Kivisakk P, Klaege KL, Majmudar A, Ravid R, Lassmann H, Olsen DB, Strieter RM, Ransohoff RM, Sellebjerg F (2002) Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system J Neuroimmunol, 127(1-2): 59-68
• Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R (2002) CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation Nat Med, 8(6): 620-624
• Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, Schramm J, Elger CE, Lassmann H (2002) Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis Ann Neurol, 51(3): 311-318
• Abdul-Majid KB, Stefferl A, Bourquin C, Lassmann H, Linington C, Olsson T, Kleinau S, Harris RA (2002) Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis Scand J Immunol, 55(1): 70-81
• Schobesberger M, Zurbriggen A, Doherr MG, Weissenbock H, Vandevelde M, Lassmann H, Griot C (2002) Demyelination precedes oligodendrocyte loss in canine distemper virus-induced encephalitis Acta Neuropathol, 103(1): 11-19
• Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain, 125: 75-85
• Holzfeind PJ, Grewal PK, Reitsamer HA, Kechvar J, Lassmann H, Hoeger H, Hewitt JE, Bittner RE (2002) Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle - eye – Hum Mol Genet, 11(21): 2673-2687
• Bien CG, Urbach H, Deckert M, Schramm J, Wiestler OD, Lassmann H, Elger CE (2002) Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology Neurology, 2: 250-257
• Mead RJ, Singhrao SK, Neal JW, Lassmann H, Morgan BP (2002) The membrane attack complex of complement causes severe demyelination associated with acute axonal injury J Immunol, 168(1): 458-465
• Neumann H, Medana IM, Bauer J, Lassmann H (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases Trends Neurosci, 25(6): 313-319
• Bauer, J., Bradl, M., Klein, M., Leisser, M., Deckwerth, T.I., Wekerle, H. and Lassmann, H (2002) Endoplasmic reticulum stress in PLP overexpressing transgenic rats: Gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes J Neuropath Exp Neurol, 61: 12-22

• Bruck W, Lucchinetti C, Lassmann H (2002) The pathology of primary progressive multiple sclerosis Mult Scler, 8(2): 93-97
• Bauer J, Bien CG, Lassmann H (2002) Rasmussen's encephalitis: a role for autoimmune cytotoxic T lymphocytes Curr Opin Neurol, 15(2): 197-200
• Schwerer B (2002) Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome Microbes Infect, 4: 373-384

• Bradl M, Flügel A. (2002) The role of T-cells in brain pathology. In: Richt J, Dietzschold B, Protective and pathological immune responses in the CNS. Current Topics in Microbiology and Immunology Springer Verlag, Heidelberg, Germany: 141-162

• Flugel A, Matsumoro K, Neumann H, Klinkert WE, Birnbacher R, Lassmann H, Otten U, Wekerle H (2001) Anti inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendeothelial migration Eur. J. Immunol., 31: 11-22
• Kornek B, Storch MK, Bauer J, Djamshidian A, Weissert R, Wallstrom E, Stefferl A, Zimprich F, Olsson T, Linington C, Schmidbauer M, Lassmann H (2001) Distribution of calcium channel subunit in dystrophic axons in multiple sclerosis and experiemntal autoimmune encephalomyelitis Brain, 124: 1114-1124
• Flugel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, Li Z, Ellwart JW, Willem M, Lassmann H, Wekerle H (2001) Migratory activity and functional changes of green fluorescent effector cells before and during experiemntal autoimmune encephalomyelitis Immunity, 14: 547-560
• Weissert R, de Graaf KL, Storch MK, Barth S, Linington C, Lassmann H, Olsson T (2001) MHC Class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune J Immunol, 166: 7588-7599
• Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Bruck W (2001) A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions Ann Neurol, 49: 793-796
• Stadelmann C, Mews I, Srinivasan A, Deckwerth TL, Lassmann H, Bruck W (2001) Expression of cell death-associated proteins in neuronal apoptosis associated with pontosubicular neuron necrosis Brain Pathol, 11: 273-281
• Stefferl A, Storch MK, Linington C, Stadelmann C, Lassmann H, Pohl T, Holsboer F, Tilders FJ, Reul JM (2001) Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone Endocrinology, 142: 3616-3624
• Eugster HP, Frei K, Winkler F, Koedel U, Pfister W, Lassmann H, Fontana A (2001) Superantigen overcomes resistance of Il-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway Eur. J. Immunol., 31: 2302-2312
• Jagodic M, Kornek B, Weissert R, Lassmann H, Olsson T, Dahlman I (2001) Congenic mapping confirms a locus on rat chromosome 10 conferring strong protection against myelin oligodendrocyte glycoprotein-induced experiemntal autoimmune encephalomyelitis Immunogenetics, 53: 410-415
• Gerber J, Bruck W, Stadelmann C, Bunkowski S, Lassmann H, Nau R (2001) Expression of cell death proteins in dentate granule cells in human bacterial meningitis Brain Pathol, 11: 422-431
• Cornet A, Savidge TC, Cabarrocas J, Dend WL, Colombel JF, Lassmann H, Desreumaux P, Liblau RS (2001) Enterocolitis induced by autoimmune targeting of enteric glia cells: a possible mechanism in Crohn’s disease? Proc Natl Acad Sci USA, 98: 13306-13311
• Trebst C, Sorensen TL, Kivisakk P, Cathcart MK, Hesselgesser J, Horuk R, Selleberg F, Lassmann H, Ransohoff RM (2001) CCR1+/CCR5+ mononuclear phagocates accumulate in the central nervous system of patients with multiple sclerosis Am.J.Pathol., 159: 1701-1710
• Flügel, A., Bradl, M., Kreutzberg, G.W. and Graeber, M.B. (2001) Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy J Neurosci Res, 66: 74-82

• Lassmann H (2001) Classification of demyelinating diseases at the interface between etiology and pathogenesis Curr Opin Neurol, 14: 253-258
• Flügel, A. and Bradl, M (2001) New tools to trace populations of inflammatory cells in the CNS Glia, 36: 125-136

• Kornek B, Storch M, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive and remyelinated lesions Am.J.Pathol., 157: 267-276
• Meixner A, Haverkamp S, Wassle H, Fuhrer S, Thalhammer J, Kropf N, Bittner RE, Lassmann H, Wiche G, Propst F (2000) MAP1B is reqired for axon guidance and is involved in the development of the central and peripheral nervous system J Cell Biol, 151: 1169-1178
• Abdul-Majid K, Jirholt J, Stadelmann C, Stefferl A, Kjellen P, Wallstrom E, Holmdahl R, Lassmann H, Olsson T, Harris RA (2000) Screeining of several H-2 congenic mouse strains identified H-2q mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement J Neuroimmunol, 111: 23-33
• Probert L, Eugster HP, Akassoglou K, Bauer J, Frei K, Lassmann H, Fontana A (2000) TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune mediated CNS disease Brain, 123: 2005-2019
• Stefferl A, Schubart A, Storch M, Amini A, Mather I, Lassmann H, Linington C (2000) Butyrophylin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis J Immunol, 165: 2859-2865
• Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schroder R, Deckert M, Schmidt S, Ravid R, Rajewsky K (2000) Clonal expansion of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction J Exp Med, 192: 393-404
• Neisser A., Schwerer B., Bernheimer H., Moran A.P (2000) Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome J Neuroimmunol, 102: 85-88

• Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination Ann Neurol, 47: 707-717
• Stadelmann C, Lassmann H (2000) Detection of apoptosis in tissue sections Cell Tissue Res, 301: 19-31
• Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H (2000) The neuroprotective effect of inflammation: implications for the pathogenesis of demyelination J Neuroimmunol, 107: 161-166

• Eugster HP, Frei K, Bachmann R, Bluethmann H, Lassmann H, Fontana A (1999) Severity of symptoms and demyelination depends in MOG induced EAE depends on TNFR1 Eur. J. Immunol., 29: 626-632
• Bachmann R, Eugster HP, Frei K, Fontana A, Lassmann H (1999) Impaiment of TNF-receptor 1 signalling but not Fas-signalling diminishes T-cell apoptosis in MOG-peptide induced chronic demyelinating autoimmune encephalomyelitis in mice Am.J.Pathol., 154: 1417-1422
• Kerschensteiner M, Gallmeier E, Behrens L, Klinkert WEF, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R (1999) Activated human T cells, B cells and monocytes produce brain-derived neurotrophic factor (BDNF) in vitr and in brain lesions: A neuroprotective role of inflammation ? J Exp Med, 189: 865-870
• Weerth S, Berger T, Lassmann H, Linington C (1999) Encephalitogenic and neuritogenic T-cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat J Neuroimmunol, 95: 157-164
• Bauer J, Stadelmann C, Bancher C, Jellinger K, Lassmann H (1999) Apoptosis of T-lymphocytes in acute disseminated encephalomyelitis Acta Neuropathol, 97: 543-546
• Kassiotis G, Bauer J, Akassoglou K, Lassmann H, Kollias G, Probert L (1999) A tumor necrosis factor-induced model of human primary demyelinating disease develops in immunodeficient backgrounds Eur. J. Immunol., 29: 912-917
• Bradl M, Bauer J, Inomata T, Zielasek J, Nave KA, Toyka K, Lassmann H, Wekerle H (1999) Transgenic Lewis rats overexpressing the proteolipid protein gene : myelin degeneration and its effects on T-cell mediated experimental autoimmune encephalomyelitis Acta Neuropathol, 97: 595-606
• Schmidt S, Hertfelder HJ, von Spiegel T, Hering R, Harzheim M, Lassmann H, Deckert-Schlüter M, Schlegel U (1999) Lethal capillary leak syndrome following a single administration of interferon beta-1b Neurology, 53: 220-222
• Kuhlmann T, Lucchinetti CF, Zettl UK, Bitsch A, Lassmann H, Brück W (1999) Bcl-2 expressing oligodendrocytes in multiple sclerosis Glia, 28: 34-39
• Bittner R, Anderson LVB, Burkhardt E, Bashir R, Vafiadaki E, Raffelsberger T, Maerk I, Höger H, Jung M, Karbasiyan M, Storch M, Lassmann H, Moss JA, Davison K, Harrison R, Bushby KMD, Reis A (1999) Dysferlin gene-deletion in the SJL mouse (dysf/sjl) defines a naturally occuring model for limb girdle muscular dystrophy 2B (LGMD 2B) and Miyoshi Myopathy Nature Genetics, 23: 141-142
• Stefferl A, Brehm U, Storch M, Lambracht-Washington D, Bourquin C, Wonigeit K, Lassmann H, Linington C (1999) Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the resistant Brown Norway rat: Disease susceptibility is determined by MHC and MHC-linked effects on the B-cel J Immunol, 163: 40-49
• Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 117 cases Brain, 122: 2279-2295
• Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Brück W, Jellinger K, Lassmann H (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer’s disease Am.J.Pathol., 155: 1459-1466
• Dewey RA, Morrissey G, Coswill CM, Stone D, Bolognami F, Dodd NJF, Southgate TD, Klatzmann D, Lassmann H, Castro MG, Löwenstein PR (1999) Chronic brain inflammation and persistent HSV1-TK expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials Nat Med, 5: 1256-1263
• Schwerer B., Neisser A., Bernheimer H (1999) Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection Infect Immun, 67: 2414-2420
• Finsterer J., Schwerer B., Bittner R.E., Mamoli B (1999) Cerebrospinal fluid filtration and immunoglobulins in multifocal motor neuropathy Clin Neuropathol, 18: 31-36

• Bradl M (1999) Myelin dysfunction/degradation in the central nervous system: Why are myelin sheaths susceptible to damage? J Neural Transm, Suppl 55: 9-17

• Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H (1998) Multiple sclerosis: in situ evidence for antibody and complement mediated demyelination. Ann Neurol, 43: 465-471
• Stadelmann C, Brück W, Bancher C, Jellinger K, Lassmann H (1998) Alzheimer’s disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis J Neuropath Exp Neurol, 86: 213-217
• Lassmann H, Raine CS, Antel J, Prineas JW (1998) Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology of the University of Vienna J Neuroimmunol, 86: 213-217
• Storch MK, Stefferl A, Brehm U, Weissert R, Wallström E, Kerschensteiner M, Olsson T, Linington C, Lassmann H (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology Brain Pathol, 8: 681-694
• Laman JD, Meurs KV, Schellekens MM, DeBoer M, Melchers B, Massacesi L, Lassmann H, Claassen E, t’Hart B (1998) Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (callizhrix jacchus) J Neuroimmunol, 86: 30-45
• Andrä K, Lassmann H, Bittner R, Shorny S, Fässler R, Probst F, Wiche G (1998) Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle and heart cytoarchitecture Genes and Development, 11: 3143-3156
• Lobell A, Weissert R, Storch MK, Svanholm C, DeGraaf KL, Lassmann H, Andersson R, Olsson T, Wigzell H (1998) Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of IgG suppresses experimental autoimmune encephalomyelitis J Exp Med, 187: 1543-1548
• Eugster HP, Frei K, Lassmann H, Fontana A (1998) Il-6 deficient mice resist myelin oligodendrocyte glycoprotein induced autoimmune encephalomyelitis despite intact T and B cell responses Eur. J. Immunol., 28: 2178-2187
• Sahrbacher UC, Lechner F, Eugster HP, Frei K, Lassmann H, Fontana A (1998) Mice with an inactivation of the inducible nitric oxide sythase gene are susceptible to experimental autoimmune encephalomyelitis Eur. J. Immunol., 28: 1332-1338
• Litzenburger T, Fässler R, Bauer J, Lassmann H, Linington C, Wekerle H, Iglesias A (1998) B lymphocytes producing demyelinating antibodies: Development and function in gene-trageted transgenic mice J Exp Med, 188: 169-180
• Akassoglou K, Bauer J, Kassiotis G, Pasparakis M, Lassmann H, Kollias G, Probert L (1998) Oligodendrocyte apoptosis and primary demyelination induced by TNF/p55TNF receptor signaling in the CNS of transgenic mice models of chronic and acute multiple sclerosis Am.J.Pathol., 153: 801-813
• t’Hart B, Bauer J, Muller HJ, Melchers B, Nicolay K, Brok H, Bontrop RE, Lassmann H, Massacesi L (1998) Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis. A correlative study in the experimental autoimmune ence Am.J.Pathol., 153: 649-663
• Weissert R, Wallström E, Storch MK, Stefferl A, Lorentzen J, Lassmann H, Linington C, Olsson T (1998) MHC haplotype dependent regulation of MOG-induced EAE in rats J Clin Invest, 102: 1265-1273
• Kääb, G., Haarmann, I., Wekerle, H., and Bradl, M (1998) The myelin basic protein-specific T cell repertoire in Lewis rats: T cell receptor diversity is influenced both by intrathymic milieu and by extrathymic peptide presentation Eur. J. Immunol., 28: 1499-1506
• Bauer, J., Bradl, M., Hickey, W.F., Forss-Petter, S., Breitschopf, H., Linington, C., Wekerle, H., and Lassmann, H (1998) T cell apoptosis in inflammatory brain lesions. Destruction of T cells does not depend on antigen recognition Am.J.Pathol., 153: 715-724

• Gatterbauer B., Neisser A., Bernheimer H., Schwerer B (1998) Antiglycosphingolipid immune responses in neurology: The Vienna experience with isotypes, subclasses, and disease Ann New York Acad Sci, 845: 353-362

• Compston A, Ebers G, Lassmann H, McDonald I, Matthews B and Wekerle H (eds.) (1998) McAlpine's Multiple Sclerosis, 3rd Edition. , Churchill Livingstone, Philadelphia

• Rinner W, Pifl C, Lassmann H, Hörtnagl H (1997) Induction of apoptosis in vitro and in vivo by the cholinergic neurotoxin ethylcholine aziridinium Neuroscience, 79: 535-542
• Stühler A, Flory E, Wege H, Lassmann H, Wege H (1997) No evidence for quasispezies populations during persistence of coronavirus mouse hepatitis virus JHM: sequence conservation within the surface glycoprotein gene S in Lewis rats J Gen Virol, 78: 747-756
• Kojima K, Reindl M, Lassmann H, Wekerle H, Linington C (1997) The thymus and self-tolerance: co-existence of encephalitogenic S-100ß-specific T cells and their nominal autoantigen in normal adult rat thymus. Int Immunol, 9: 897-904
• Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H (1997) Experimental autoimmune encephalomyelitis: The antigen specificity of T-lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest, 76: 355-364
• Bajramovic JJ, Lassmann H, VanNoort JM (1997) Expression of alphaB-crystallin in glia cells during lesional development in multiple sclerosis. J Neuroimmunol, 78: 143-151
• Gold R, Hartung HP, Lassmann H (1997) T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci, 20: 399-404
• Pouly S, Storch MK, Matthieu JM, Lassmann H, Monnet.Tschudi F, Honegger P (1997) Demyelination induced by protein kinase C-activating tumor promotors in aggregating brain cell cultures. J Neurosci Res, 49: 121-132
• Brück W, Bitsch A, Kolenda H, Brück Y, Stiefel M, Lassmann H (1997) Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol, 42: 783-793
• Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, Bernheimer H, Zimmermann F, Nave KA (1997) Targeted inactivation of the X-linked adrenoleucodystrophy gene in mice. J Neurosci Res, 50: 829-843
• Malpiero U, Frei K, Spanaus KS, Agresti C, Lassmann H, Hahne M, Tschopp J, Eugster HP, Fontana A (1997) Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic relapsing in perforin knockout mice, but monophasic in Fas and Fas ligand-deficient lpr and gld mice. Eur. J. Immunol., 27: 3151-3160
• Neisser A., Bernheimer H., Berger T., Moran A.P., Schwerer B (1997) Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome Infect Immun, 65: 4038-4042

• Klinkert WEF, Kojima K, Lesslauer W, Rinner W, Lassmann H, Wekerle H (1997) TNF-alpha receptor fusion protein prevents experimental autoimmune encephalomyelitis and demyelination in Lewis rats: an overview J Neuroimmunol, 72: 163-168
• Lassmann H, Brück W, Lucchinetti C, Rodriguez M (1997) Remyelination in multiple sclerosis Mult Scler, 3: 133-136

• Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu JM, Gardinier MV, Dornmair K, Linington C (1996) The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat J Neuroimmunol, 63: 17-27
• Schlüter D, Chahoud S, Lassmann H, Schumann A, Hof H, Dekert-Schlüter M (1996) The intracerebral lesions in murine listeria monocytogenes meningoencephalitis J Neuropath Exp Neurol, 55: 14-24
• Simonova Z, Svoboda J, Orkand P, Bernard CCA, Lassmann H, Sykova E (1996) Changes in extracellular space volume and tortuosity in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis Physiol Res, 45: 11-22
• Brück Y, Brück W, Kretschmar HA, Lassmann H (1996) Evidence of neuronal apotosis in pontosubicular neuronal necrosis Neuropathol Appl Neurobiol, 22: 23-29
• Storch MK, Fischer-Colbrie R, Smith T, Rinner WA, Hickey WF, Cuzner ML, Winkler H, Lassmann H (1996) Co-localization of secretoneurin imunoreactivity and macrophage infiltration in the lesions of experimental autoimmune encephalomyelitis Neuroscience, 71: 885-893
• Storch MK, Fischer-Colbrie R, Smith T, Rinner WA, Hickey WF, Cuzner ML, Winkler H, Lassmann H (1996) Co-localization of secretoneurin imunoreactivity and macrophage infiltration in the lesions of experimental autoimmune encephalomyelitis J Cell Sci., 71: 885-893
• Morrissey SP, Stodal H, Zettl U, Simonis C, Jung S, Kiefer R, Lassmann H, Hartung HP, Haase A, Toyka KV (1996) In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema Brain, 119: 239-248
• Gold R, Schmied M, Tontsch U, Hartung H P, Wekerle H, Toyka K V, Lassmann H (1996) Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death: a model for T cell apoptosis in vivo Brain, 119: 651-659
  | Article (PDF) |
• Smith T, Schmied M, Hewson AK, Lassmann H, Cuzner ML (1996) Apoptosis of T-cells and macrophages in the nervous system of intact and adrenalectomized Lewis rats during experimental allergic encephalomyelitis J Autoimmun, 9: 167-174
• Brück W, Sommermeier N, Bergmann M, Zettl U, Goebel HH, Kretschmar HA, Lassmann H (1996) Macrophages in multiple sclerosis Immunobiology, 195: 588-600
• Hainfellner JA, Kristoferitsch W, Lassmann H, Bernheimer H, Neisser A, Drlicek M, Beer F, Budka H (1996) T cell mediated ganglionitis associated with acute sensory neuronopathy Ann Neurol, 39: 543-547
• Lucchinetti CF, Brück W, Rodriguez M, Lassmann H (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis Brain Pathol, 6: 259-274
• Trieb K, Ransmayr G, Sgonc R, Lassmann H, Grubeck-Loebenstein B (1996) APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer’s disease. Neurobiol Aging, 17: 541-547
• Meinl E, Hoch RM, Dornmair K, Malefyt R de W, Bontrop RE, Jonker M, Lassmann H, Hohlfeld R, Wekerle H, ‘t Hart BA (1996) Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques Am.J.Pathol., 150: 445-453
• Schneider C, Gold R, Dalakas MC, Schmied M, Lassmann H, Toyka KV, Hartung HP (1996) MHC Class-I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: Studies in patients with polymyositis, dermatomyositis and inclusion body myositis J Neuropath Exp Neurol, 55: 1205-1209
• Salvati S, Sanchez M, Campeggi LM, Suchanek G, Breitschopf H, Lassmann H (1996) Accelerated myelinogenesis by dietary lipids in rat brain J Neurochem, 67: 1744-1750
• Barac-Latas V, Suchanek G, Breitschopf H, Stuehler A, Wege H, Lassmann H (1996) Patterns of oligodendroglia pathology in coronavirus induced subacute demyelinating encephalomyelitis in the Lewis rat Glia, 19: 1-12
• Lassmann H, Bartsch U, Montag D, Schachner M (1996) Dying-back oligodendrogliopathy: a late sequel of myelin-associated glycoprotein deficiency Glia, 19: 104-110
• Jaquet V, Gow A, Tosic M, Suchanek G, Breitschopf H, Lassmann H, Lazzarini RA, Matthieu JM (1996) An antisense strategy to inhibit the myelin oligodendrocyte glycoprotein synthesis Mol Brain Res, 43: 333-337
• Morrissey SP, Deichmann R, Syha J, Simonis C, Zettl U, Archelos JJ, Jung S, Stodahl H, Lassmann H, Toyka KV, Haase A, Hartung HP (1996) Partial inhibition of AT-EAE by an antibody to ICAM-1: clinico-histological and MRI studies J Neuroimmunol, 69: 85-93
• Kääb, G., Brandl, G., Marx, A., Wekerle, H., and Bradl, M (1996) The myelin basic protein specific T cell repertoire in (transgenic) Lewis rat / SCID mouse chimeras: preferential vß8.2 T cell receptor usage depends on an intact Lewis thymic microenvironment Eur. J. Immunol., 26: 981-988

• Bradl, M., and Linington, C (1996) Animal models of demyelination Brain Pathol, 6: 303-311
• Bradl M (1996) Immune control of the brain Springer Sem Immun, 18: 35-49
• Wekerle, H., Bradl, M., Linington, C., Kääb, G., and Kojima K (1996) The shaping of the brain-specific T lymphocyte repertoire in the thymus Immunol Rev, 149: 231-242

• HainfellnerJA, Pilz P, Lassmann H, Ladurner G, Budka H (1995) Diffuse Lewy body disease as substrate of primary lateral sclerosis J Neurol, 242: 59-63
• Rössler K, Suchanek G, Breitschopf H, Kitz K, Matula C, Lassmann H, Koos WT (1995) Detection of TNFalpha protein and mRNA in human glial brain tumors comparing immunohistochemistry and in situ hybridization with molecular probes J Neurosurg, 83: 291-297
  | Article (PDF) |
• Barac-Latas V, Wege H, Lassmann H (1995) Apoptosis of T Lymphocytes in Coronavirus induced Encephalomyelitis Regional Immunology, 6: 355-357
• Rinner W, Bauer J, Schmidts M, Lassmann H, Hickey W F (1995) Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: an investigation using rat radiation bone marrow chimeras Glia, 14: 257-266
• van Noort J M, van Sechel A C, Bajramovic J, El Ouagmiri M, Polman C H, Lassmann H, Ravid R (1995) A novel candidate autoantigen in multiple sclerosis: alpha-B-crystallin, a small heat shock protein Nature, 798-801
  | Article (PDF) |
• Lorentzen JC, Issazadeh S, Storch M, Mustafa MI, Lassmann H, Linington C, Klareskog L, Olsson T (1995) Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete adjuvant J Neuroimmunol, 63: 193-205
• Brück W, Porada Ph, Poser S, Rieckmann P, Hanefeld F, Kretschmer HA, Lassmann H (1995) Monocyte/macrophage differentiation in early multiple sclerosis Ann Neurol, 38: 788-796
• Bauer J, Huitinga I, Zhao W, Lassmann H, Hickey WF, Dijkstra CE (1995) The role of macrophages, perivascular cells and microglia cells in the pathogenesis of experimental autoimmune encephalomyelitis Glia, 15: 437-446
• Sykova E, Svoboda J, Simonova Z, Lehmenkühler A, Lassmann H (1995) X-irradiation induced changes in the diffusion parameters of the developing brain Neuroscience, 70: 597-610
• Schmitt TL, Steiner E, Klingler P, Lassmann H, Grubeck-Loebenstein B (1995) Thyroid epithelial cells produce amounts of the Alzheimer ß-amyloid precursor protein (APP) and generate potentially amyloidogenic fragments J Clin Endocrinol Metab, 80: 3513-3519

• Bradl M (1995) Autoimmunkrankheiten BiuZ, 25: 374-379

• Lassmann H (1995) Pathology and experimental models. In: Kesselring, J&uuml;rg (ed.), Multiple Sclerosis; 3rd English Edition Kohlhammer, Stuttgart
• Lassmann H, Vass K (1995) Inflammation in the nervous system. In: Mohr, JP and Gauthier, JC (eds), Adult Clinical Neurology Churchill Livingstone

• Larue, L., Dougherty, N., Bradl, M., and Mintz, B. (1993) Melanocyte culture lines from Tyr-SV40E transgenic mice: models for the molecular genetic evolution of malignant melanoma Oncogene, 8: 523-531

• Lassmann H (1993) Pathologische Anatomie und experimentelle Modelle. In: Kesselring, J&uuml;rg (ed.), Multiple Sklerose, 2nd Edition Kohlhammer, Stuttgart: 18-45

• Bradl, M., Klein-Szanto, A., Porter, S., and Mintz, B (1991) Malignant melanoma in transgenic mice Proc Natl Acad Sci USA, 88: 164-168
• Klein-Szanto, A., Bradl, M., Porter, S., and Mintz, B (1991) Melanosis and associated tumors in transgenic mice Proc Natl Acad Sci USA, 88: 169-173
• Mintz, B. and Bradl, M (1991) Mosaic expression of a tyrosinase fusion gene in albino mice yields a heritable striped coat color pattern in transgenic homozygotes Proc Natl Acad Sci USA, 88: 9643-9647
• Bradl, M., Larue, L., and Mintz, B (1991) Clonal coat color variation due to a transforming gene expressed in melanocytes of transgenic mice Proc Natl Acad Sci USA, 88: 6447-6451

• Bradl, M., Schmid, M., and Wekerle, H (1989) Clonotypic chromosomal aberrations in long term lines of myelin specific rat T lymphocytes J Neuroimmunol, 24: 95-104

• Lassmann H (1989) Pathologische Anatomie und experimentelle Modelle. In: Kesselring, J&uuml;rg (ed.), Multiple Sklerose Kohlhammer, Stuttgart: 18-43

• Linington, C., Bradl, M., Lassmann, H., Brunner, C., and Vass, K. (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein Am.J.Pathol., 130: 443-454
  | Article (PDF) |
• Lassmann, H., Brunner, C., Bradl, M., and Linington, C (1988) Experimental allergic encephalomyelitis: The balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions Acta Neuropathol, 75: 566-576

• Kaczanowska J, Ganglberger F, Chernomor O, Kargl D, Galik B, Hess A, Moodley Y, von Haeseler A, Bühler, K, Haubensak W (2022) Molecular archaeology of human cognitive traits Cell Rep, 40
  | Weblink |
• Ganglberger F, Wißmann M, Wu H-Y, Swoboda N, Thum A, Haubensak A, Bühler K (2022) Spatial-data-driven layouting for brain network visualization Computers & Graphics, 105: 12-24
  | Weblink |
• Piszczek L, Constantinescu A, Kargl D, Lazovic J, Pekcec A, Nicholson J, Haubensak W (2022) Dissociation of impulsive traits by subthalamic metabotropic glutamate receptor 4 eLife, 11
  | Weblink |

• Griessner J, Pasieka M, Böhm V, Grössl F, Kaczanowska J, Pliota P, Kargl D, Werner B, Kaouane N, Strobelt S, Kreitz S, Hess A, Haubensak W (2021) Central amygdala circuit dynamics underlying the benzodiazepine anxiolytic effect Mol Psychiatry, 26: 534-544
  | Weblink |
• Ganglberger, F, Kaczanowska, J, Haubensak, W, Bühler, K (2021) Visualising the Transition of Large Networks via Dimensionality Reduction to Illustrate the Evolution of the Human Brain Eurographics, 21-24
  | Weblink |
• Wank I, Pliota P, Badurek S, Kraitsy K, Kaczanowska J, Griessner J, Kreitz S, Hess A, Haubensak W (2021) Central amygdala circuitry modulates nociceptive processing through differential hierarchical interaction with affective network dynamics Commun Biol, 4
  | Weblink |
• Kaouane N, Ada S, Hausleitner M, Haubensak W (2021) Dorsal Bed Nucleus of the Stria Terminalis-Subcortical Output Circuits Encode Positive Bias in Pavlovian Fear and Reward Front Neural Circuits, 15
  | Weblink |
• Peter M, Aschauer D F, Rose R, Sinning A, Grössl F, Kargl D, Kraitsy K, Burkard T R, Luhmann H J, Haubensak W, Rumpel S (2021) Rapid nucleus-scale reorganization of chromatin in neurons enables transcriptional adaptation for memory consolidation PlosOne, 16 (5): e0244038
  | Weblink |

• Orthofer M, Valsesia A, Mägi R, Wang Q, Kaczanowska J, Kozieradzki I, Leopoldi A, Cikes D, Zopf L, Tretiakov E, Demetz E, Hilbe R, Boehm A, Ticevic M, Nõukas M, Jais A, Spirk K, Clark T, Amann S, Lepamets M, Neumayr C, Arnold C, Dou Z, Kuhn V, Novatchkova M, Cronin S, Tietge U, Müller S, Pospisilik J, Nagy V, Hui C, Lazovic J, Esterbauer H, Hagelkruys A, Tancevski I, Kiefer F, Harkany T, Haubensak W, Neely G, Metspalu A, Hager J, Gheldof N, Penninger J (2020) Identification of ALK in Thinness Cell, 181 (6): 1246-1262.e22
  | Weblink |
• Kargl D, Kaczanowska J, Ulonska S, Groessl F, Piszczek L, Lazovic J, Buehler K, Haubensak W (2020) The amygdala instructs insular feedback for affective learning eLife, 9
  | Weblink |

• Ganglberger F, Swoboda N, Frauenstein L, Kaczanowska J, Haubensak W, Bühler K (2019) BrainTrawler: A visual analytics framework for iterative exploration of heterogeneous big brain data Computers & Graphics, 82: 304-320
  | Weblink |
• Ganglberger F, Kaczanowska J, Haubensak W, Bühler K (2019) A Data Structure for Real-Time Aggregation Queries of Big Brain Networks Neuroinform, 18 (1): 131-149
  | Weblink |
• Tröscher A, Werner B, Kaouane N, Haubensak W (2019) Spectral recording of gene expression history by fluorescent timer protein BioTechniques, 67 (4): 154-164
  | Weblink |
• Pfaff D, Tabansky I, Haubensak W (2019) Tinbergen’s challenge for the neuroscience of behavior PNAS, 116 (20): 9704-9710
  | Weblink |

• Ganglberger F, Kaczanowska J, Penninger J, Hess A, Bühler K, Haubensak W (2018) Predicting functional neuroanatomical maps from fusing brain networks with genetic information Neuroimage, 170: 113-120
  | Weblink |
• Groessl F, Munsch T, Meis S, Griessner J, Kaczanowska J, Pliota P, Kargl D, Badurek S, Kraitsy K, Rassoulpour A, Zuber J, Lessmann V, Haubensak W (2018) Dorsal tegmental dopamine neurons gate associative learning of fear Nature Neurosci, 21 (7): 952-962
  | Weblink |

• Groll J, Haubensak W, Ameringer T, Moeller M (2005) Ultrathin Coatings from Isocyanate Terminated Star PEG Prepolymers:  Patterning of Proteins on the Layers Langmuir, 21 (7): 3076-3083
  | Weblink |

• Mussetto V, Teuchmann H, Heinke B, Trofimova L, Sandkühler J, Drdla-Schutting R, Hogri R (2023) Opioids Induce Bidirectional Synaptic Plasticity in a Brainstem Pain Center in the Rat J.Pain, 24 (9): 1664-1680
• Mussetto V, Moen A, Trofimova L, Sandkühler J, Hogri R (2023) Differential activation of spinal and parabrachial glial cells in a neuropathic pain model Front Cell Neurosci, 17: 1-10
• Hogri R, Baltov B, Drdla-Schutting R, Mussetto V, Raphael H, Trofimova L, Sandkühler J (2023) Probing pain aversion in rats with the “Heat Escape Threshold” paradigm Molecular Pain, 19: 174480692311566

• Hogri R, Teuchmann H, Heinke B, Holzinger R, Trofimova L, Sandkühler J (2022) GABAergic CaMKIIα+ Amygdala Output Attenuates Pain and Modulates Emotional-Motivational Behavior via Parabrachial Inhibition J. Neurosci., 42 (27): 5373-5388
• Teuchmann H, Hogri R, Heinke B, Sandkühler J (2022) Anti-Nociceptive and Anti-Aversive Drugs Differentially Modulate Distinct Inputs to the Rat Lateral Parabrachial Nucleus J.Pain, 23 (8): 1410-1426

• Draxler P, Moen A, Galek K, Boghos A, Ramazanova D, Sandkühler J (2021) Spontaneous, Voluntary, and Affective Behaviours in Rat Models of Pathological Pain Front. Pain Res., 2
  | Article (PDF) || Weblink |
• Kronschläger M, Siegert A, Resch F, Rajendran P, Khakh B, Sandkühler J (2021) Lamina‐specific properties of spinal astrocytes Glia, 69 (7): 1749-1766
  | Article (PDF) |

• Hadschieff V, Drdla-Schutting R, Springer D, Siegert A, Schroeder H, Sandkühler J (2020) Fundamental sex differences in morphine withdrawal-induced neuronal plasticity PAIN, 161 (9): 2022-2034
• Reischer G, Heinke B, Sandkühler J (2020) Interferon-γ facilitates the synaptic transmission between primary afferent C-fibres and lamina I neurons in the rat spinal dorsal horn via microglia activation Molecular Pain, 16: 174480692091724
  | Article (PDF) |

• Haider T, Knöpfel T (2020) Voltage-Sensitive Fluorescent Proteins for Optical Electrophysiology. In: Liang Guo, Neural Interface Engineering Springer International Publishing: 383-407

• Drdla-Schutting R, Heinl C, Hadschieff V, Sandkühler J (2019) Withdrawal from an opioid induces a transferable memory trace in the cerebrospinal fluid Pain, 160 (12): 2819-2828
  | Article (PDF) |
• Lobas M, Tao R, Nagai J, Kronschläger MT, Borden P, Marvin J, Looger L, Khakh B (2019) A genetically encoded single-wavelength sensor for imaging cytosolic and cell surface ATP Nat Commun, 10 (1)
  | Article (PDF) |
• Ray S, Salzer I, Kronschläger MT, Boehm S (2019) The paracetamol metabolite NAPQI reduces excitability in first and second order neurons of the pain pathway through actions on KV7 channels Pain, 160 (4): 954-964
  | Article (PDF) |

• Prosenz J, Kloimstein H, Thaler U, Drdla-Schutting R, Sandkühler J, Gustorff B (2017) A brief, high-dose remifentanil infusion partially reverses neuropathic pain in a subgroup of post herpetic neuralgia patients J Clin Neurosci, 40: 195-197
  | Article (PDF) || Weblink |

• Hogri R, Bamford S, Giudice P, Mintz M (2017) Recovery of Brain Function by Neuroprostheses: A Challenge for Neuroscience and Technology. In: Guger C., Allison B., Ushiba J., Brain-Computer Interface Research Springer International Publishing: 81-97
• Sandkühler J (2017) Neuroinflammation and Neuroplasticity in Pain. In: Paul Farquhar-Smith , Pierre Beaulieu, Siân Jagger, Landmark Papers in Pain: Seminal Papers in Pain with Expert Commentaries Oxford University Press
  | Weblink |

• Kronschläger MT, Drdla-Schutting R, Gassner M, Honsek SD, Teuchmann HL, Sandkühler J (2016) Gliogenic LTP spreads widely in nociceptive pathways Science, 354: 1144-1148
  | Article (PDF): 1 2 |

• Gerhold K, Drdla-Schutting R, Honsek S, Forsthuber L, Sandkühler J (2015) Pronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude J Neurosci, 35 (26): 9580-9594
  | Article (PDF) || Weblink |
• Clark A, Gruber-Schoffnegger D, Drdla-Schutting R, Gerhold K, Malcangio M, Sandkühler J (2015) Selective Activation of Microglia Facilitates Synaptic Strength J. Neurosci., 35(11): 4552-4570
  | Article (PDF) || Weblink |
• Honsek SD, Seal RP, Sandkühler J (2015) Presynaptic inhibition of optogenetically identified VGluT3+ sensory fibres by opioids and baclofen Pain, 156 (2): 243-251
  | Article (PDF) || Weblink |

• Jürgen Sandkühler (2015) Translating synaptic plasticity into sensation Brain, 138: 2463-2470
  | Article (PDF) || Weblink |

• Draxler P, Honsek SD, Forsthuber L, Hadschieff V, Sandkühler J. (2014) VGluT3+ Primary Afferents Play Distinct Roles in Mechanical and Cold Hypersensitivity Depending on Pain Etiology J Neurosci, 34(36): 12015-12018
  | Article (PDF) || Weblink |

• Bradl M, Kanamori Y, Nakashima I, Misu T, Fujihara K, Lassmann H, Sandkühler J. (2014) Pain in neuromyelitis optica-prevalence, pathogenesis and therapy Nat Rev Neurol, 10 (9): 529-536
  | Article (PDF) |
• Xanthos D,Sandkühler J (2014) Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity Nat. Rev. Neurosci., 15: 43-53
  | Article (PDF) || Weblink |

• Leitner J, Westerholz S, Heinke B, Forsthuber L, Wunderbaldinger G, Jäger T, Gruber-Schoffnegger D, Braun K, Sandkühler J (2013) Impaired Excitatory Drive to Spinal Gabaergic Neurons of Neuropathic Mice. PLoS.ONE., 8: e73370
  | Article (PDF) || Weblink |
• Naka A, Gruber-Schoffnegger D, Sandkühler J. (2013) Non-Hebbian plasticity at C-fiber synapses in rat spinal cord lamina I neurons. Pain, 154: 1333–1342
  | Article (PDF) || Letter to the Editor || Weblink |
• Gruber-Schoffnegger D, Drdla-Schutting R, Honigsperger C, Wunderbaldinger G, Gassner M, Sandkühler J (2013) Induction of thermal hyperalgesia and synaptic long-term potentiation in the spinal cord lamina I by TNF-α and IL-1β is mediated by glial cells J Neurosci, 33: 6540-6551
  | Article (PDF) || Weblink |
• Gassner M, Leitner J, Gruber-Schoffnegger D, Forsthuber L, Sandkühler J (2013) Properties of spinal lamina III GABAergic neurons in naive and in neuropathic mice. Eur. J. Pain, 17: 1168-1179
  | Article (PDF) || Weblink |

• Sandkühler J, Lee J (2013) How to erase memory traces of pain and fear Trends Neurosci, 36(6): 343-352
  | Article (PDF) || Weblink |

• Sandkühler, J (2013) Spinal Cord Plasticity and Pain. In: McMahon, S.B.; Koltzenburg, M.; Tracey, I.; Turk, D.C., Wall and Melzack´s Textbook of Pain Elsevier Saunders, Philadelphia, PA, USA: 94-110

• Xanthos DN, Püngel I, Wunderbaldinger G, Sandkühler J (2012) Effects of peripheral inflammation on the blood-spinal cord barrier. Molecular Pain, 8: 44
  | Article (PDF) || Weblink |
• Drdla R, Benrath J, Wunderbaldinger G, Sandkühler J (2012) Erasure of a spinal memory trace of pain by a brief, high-dose opioid administration Science, 335: 235-238
  | Article (PDF) || Weblink |

• Sandkühler J, Gruber-Schoffnegger D (2012) Hyperalgesia by synaptic long-term potentiation (LTP): an update Curr. Opin. Pharmacol., 12: 18-27
  | Article (PDF) |

• Fenselau H, Heinke B, Sandkühler J (2011) Heterosynaptic long-term potentiation at GABAergic synapses of spinal lamina I neurons J Neurosci, 31: 17383-17385
  | Article (PDF) || Weblink |
• Heinl C, Drdla-Schutting R, Xanthos D, Sandkühler J (2011) Distinct mechanisms underlying pronociceptive effects of opioids J Neurosci, 31(46): 16748–16756
  | Article (PDF) || Weblink |
• Xanthos DN, Gaderer S, Drdla R, Nuro E, Abramova A, Ellmeier W, Sandkühler J (2011) Central nervous system mast cells in peripheral inflammatory nociception Molecular Pain, 7: 42
  | Article (PDF) || Weblink |
• Heinke,B., Gingl,E., Sandkühler,J. (2011) Multiple targets of µ-opioid receptor mediated presynaptic inhibition at primary afferent Aä- and C-fibers J Neurosci, 31: 1313-1322
  | Article (PDF) || Weblink |

• Ruscheweyh R., Wilder-Smith O., Drdla R., Liu X.-G., Sandkühler J. (2011) Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy Molecular Pain, 7: 20
  | Article (PDF) || Weblink |

• Vessey J.P., Schoderböck L., Gingl E., Luzi E., Riefler J., Di Leva F., Karra D., Thomas S., Kiebler M.A. and Macchi P. (2010) Mammalian Pumilio2 regulates dendrite morphogenesis and synaptic function Proc Natl Acad Sci USA, 107: 3222-7
  | Supplement |

• Sandkühler,J. (2010) Central Sensitization Versus Synaptic Long-Term Potentiation (LTP): A Critical Comment J.Pain, 11: 798-800
  | Article (PDF) |

• Gassner M., Ruscheweyh R., Sandkühler J. (2009) Direct excitation of spinal GABAergic interneurons by noradrenaline Pain, 145: 204-210
  | Article (PDF) |
• Drdla R., Gassner M., Gingl E., Sandkühler J. (2009) Induction of synaptic long-term potentiation after opioid withdrawal Science, 325: 207-210
  | Article (PDF) || Supplement |

• Sandkühler,J. (2009) Models and Mechanisms of Hyperalgesia and Allodynia Physiol.Rev., 89: 707-758
  | Article (PDF) |

• Sandkühler,J. (2009) The role of inhibition in the generation and amplification of pain. In: Castro-Lopes,J., Current Topics in Pain, IASP Press,Seattle: 53-71
  | Article (PDF) |

• Hochmeister S, Zeitelhofer M, Bauer J, Nicolussi EM, Fischer MT, Heinke B, Selzer E, Lassmann H, Bradl M (2008) After injection into the striatum, in vitro-differentiated microglia- and bone marrow-derived dendritic cells can leave the central nervous system via the blood stream Am.J.Pathol., 173(6): 1669-1681
  | Article (PDF) || Supplement |
• Drdla R., Sandkühler J. (2008) Long-term potentiation at C-fibre synapses by low-level presynaptic activity in vivo Molecular Pain, 4: 18
  | Article (PDF) |
• Schoffnegger D., Ruscheweyh R.,Sandkühler J. (2008) Spread of excitation across modality borders in spinal dorsal horn of neuropathic rats Pain, 135: 300-310
  | Article (PDF) |

• Klein T., Magerl W., Nickel U., Hopf J.-H., Sandkühler J., Treede R.-D. (2007) Effects of the NMDA-receptor antagonist ketamine on perceptual correlates of long-term potentiation within the nociceptive system Neuropharmacology, 52: 655-661
  | Article (PDF) |
• Benrath J., Kempf C., Georgieff M., Sandkühler J. (2007) Xenon blocks the induction of synaptic long-term potentiation in pain pathways in the rat spinal cord in vivo Anesth.Pharmacol., 104: 106-111
  | Article (PDF) |
• Heinke B, Sandkühler J. (2007) Group I metabotropic glutamate receptor-induced Ca<SUP>2+</SUP>-gradients in rat superficial spinal dorsal horn neurons Neuropharmacology, 52: 1015-1023
  | Article (PDF) |
• Ruscheweyh R., Forsthuber L., Schoffnegger D., Sandkühler J. (2007) Modification of classical neurochemical markers in identified primary afferent neurons with Abeta-, Adelta-, and C-fibers after chronic constriction injury in mice J. Comp. Neurol., 502: 325-336
  | Article (PDF) |

• Sandkühler J. (2007) Understanding LTP in pain pathways Molecular Pain, 3: 1-9
  | Supplement |

• Sandkühler J. (2007) Long-term potentiation and long-term depression in the spinal cord. In: Schmidt R.F., Willis W.D. , Encyclopedia of Pain Springer Verlag , Heidelberg, Berlin: 1058-1061
  | Article (PDF) |

• Ikeda H., Stark J., Fischer H., Wagner M., Drdla R., Jäger T., Sandkühler J. (2006) Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science, 312: 1659-1662
  | Article (PDF) |
• Ruscheweyh R., Wunderbaldinger G., Goralczyk A.,Schober A.,Sandkühler J. (2006) Possible sources and sites of action of the nitric oxide involved in synaptic plasticity at spinal lamina I projection neurons Neuroscience, 141: 977-988
  | Article (PDF) |
• Schoffnegger D., Heinke B., Sommer C., Sandkühler J. (2006) Physiological properties of spinal lamina II GABAergic neurons in mice following peripheral nerve injury J. Physiol., 577: 869-878
  | Article (PDF) |

• Sandkühler J. (2006) Long-Term Potentiation and Long-Term Depression in the Spinal Cord. In: Schmidt R.F., Willis W.D. , Encyclopedia of Pain Springer Verlag , Heidelberg, Berlin: 1058-1061
  | Article (PDF) |

• Bhattacharya J., Petsche H. (2005) Drawing on mind's canvas: differences in cortical integration patterns between artists and non-artists Human Brain Mapping, 26: 1-14
• Dahlhaus A., Ruscheweyh R., Sandkühler J. (2005) Synaptic input of rat spinal lamina I projection and unidentified neurons in vitro J. Physiol., 566: 355-368
  | Article (PDF) |
• Benrath J., Brechtel C., Stark J., Sandkühler J. (2005) Low dose of S(+)-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo Br.J.Anaesth., 95: 518-523
  | Article (PDF) |
• Heinke B., Sandkühler J. (2005) Signal transduction pathways of group I metabotropic glutamate receptor-induced long-term depression at sensory spinal synapses Pain, 118: 145-154
  | Article (PDF) |
• Ruscheweyh R., Sandkühler J. (2005) Long-range oscillatory Ca<SUP>2+</SUP> waves in rat spinal dorsal horn Eur. J. Neurosci., 22: 1967-1976
  | Article (PDF) |

• Sandkühler J. (2005) Neurobiologische Grundlagen des Schmerzgedächtnisses Psychoneuro, 31: 77-80
  | Article (PDF) |
• Ruscheweyh R., Sandkühler J. (2005) Opioids and central sensitisation: II. Induction and reversal of hyperalgesia Eur. J. Pain, 9: 149-152
  | Article (PDF) |
• Sandkühler J., Ruscheweyh R. (2005) Opioids and central sensitisation: I. Preemptive analgesia Eur. J. Pain, 9: 145-148
  | Article (PDF) |
• Sandkühler J., Kress H.G. (2005) Opioids for chronic nonmalignant and neuropathic pain Eur. J. Pain, 9: 99-100
  | Article (PDF) |

• Sandkühler J. (2005) Das Nozizeptive System von Früh- und Neugeborenen. In: Zernikow B. , Schmerztherapie bei Kindern Springer Verlag, Berlin, Heidelberg, New York: 17-29

• Klein,T.,Magerl,W.,Sandkühler,J.,Treede,R.-D., (2004) Perceptual correlates of nociceptive long-term potentiation and long-term depression in humans J Neurosci, 24: 964-971
  | Article (PDF) |
• Ruscheweyh R., Ikeda H., Heinke B., Sandkühler J. (2004) Distinctive membrane and discharge properties of rat spinal lamina I projection neurones in vitro J. Physiol., 555: 527-543
  | Article (PDF) |
• Heinke B., Balzer E., Sandkühler J. (2004) Pre- and postsynaptic contributions of voltage-dependent Ca<SUP>2+</SUP> channels to nociceptive transmission in rat spinal lamina I neurons Eur. J. Neurosci., 19: 103-111
  | Article (PDF) |
• Benrath J., Brechtel C., Martin E., Sandkühler. (2004) Low doses of fentanyl block central sensitization in the rat spinal cord in vivo Anesthesiology, 100: 1545-1551
  | Article (PDF) |
• Heinke B., Ruscheweyh R., Forsthuber L., Wunderbaldinger G., Sandkühler J. (2004) Physiological, neurochemical and morphological properties of a subgroup of GABAergic spinal lamina II neurones identified by expression of green fluorescent protein in mice J. Physiol., 560: 249-266
  | Article (PDF) |

• Ikeda H., Heinke B., Ruscheweyh R., Sandkühler J. (2003) Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia Science, 299: 1237-1240
  | Article (PDF) |
• Ruscheweyh R., Sandkühler J. (2003) Epileptiform activity in rat spinal dorsal horn in vitro has common features with neuropathic pain Pain, 105: 327-338
  | Article (PDF) |
• Eichler M., Dahlhaus R., Sandkühler J. (2003) Partial correlation analysis for the identification of synaptic connections Biol.Cybern., 89: 289-302
  | Article (PDF) |
• Müller F., Heinke B., Sandkühler J. (2003) Reduction of glycine receptor-mediated miniature inhibitory postsynaptic currents in rat spinal lamina I neurons after peripheral inflammation Neuroscience, 122: 799-805
  | Article (PDF) |
• Azkue J.J., Liu X.G., Zimmermann M., Sandkühler J. (2003) Induction of long-term potentiation of C fibre-evoked spinal field potentials requires recruitiment of group I, but not group II/III metabotropic glutamate receptors Pain, 106: 373-379
  | Article (PDF) |

• Ruscheweyh R., Sandkühler J. (2002) Lamina-specific membrane and discharge properties of rat spinal dorsal horn neurones in vitro J. Physiol., 541: 231-244
  | Article (PDF) |

• Ruscheweyh R., Sandkühler J. (2002) Role of kainate receptors in nociception Brain Res. Brain Res. Rev., 40: 215-22
  | Article (PDF) |
• Sandkühler J. (2002) Fear the pain Lancet, 360: 426
  | Article (PDF) |

• Sandkühler J., Benrath J. (2002) Neurobiologie der Nozizeption. In: Zernikow B. , Schmerztherapie bei Kindern Springer Verlag, Berlin, Heidelberg, New York: 42-50
• Sandkühler J. (2002) Physiologie und Pathophysiologie chronischer Schmerzen - Neue Erkenntnisse zur Chronifizierung. In: , Schmerz Manual BDA: 23-28

• Bhattacharya J., Petsche H., Pereda E. (2001) Interdependencies in the spontaneous EEG while listening to music Int. J. Psychophysiol., 42: 287-301
• Ruscheweyh R., Sandkühler J. (2001) Bidirectional actions of nociceptin/orphanin FQ on Aδ-fibre-evoked responses in rat superficial spinal dorsal horn in vitro Neuroscience, 107: 275-281
  | Article (PDF) |

• Sandkühler J. (2001) Schmerzgedächtnis. Entstehung, Vermeidung und Löschung Deutsches Ärzteblatt, 98: 2725-2730
  | Article (PDF) |

• Chen J., Sandkühler J. (2000) Induction of homosynaptic long-term depression at spinal synapses of sensory Aδ-fibers requires activation of metabotropic glutamate receptors Neuroscience, 98: 141-148
  | Article (PDF) |
• Chen J., Heinke B., Sandkühler J. (2000) Activation of group I metabotropic glutamate receptors induces long-term depression at sensory synapses in superficial spinal dorsal horn Neuropharmacology, 39: 2231-2243
  | Article (PDF) |
• Ruscheweyh R., Sandkühler J. (2000) Differential actions of spinal analgesics on mono-versus polysynaptic Aδ-fibre-evoked field potentials in superficial spinal dorsal horn in vitro Pain, 88: 97-108
  | Article (PDF) |

• Sandkühler J. (2000) Long-lasting analgesia following TENS and acupuncture: Spinal mechanisms beyond gate control Proc. 9th World Congr. Pain, : 359-369
  | Article (PDF) |
• Sandkühler J., Benrath J., Brechtel C., Ruscheweyh R., Heinke B. (2000) Synaptic mechanisms of hyperalgesia Prog.Brain Res., 129: 81-100
  | Article (PDF) |
• Sandkühler J. (2000) Learning and memory in pain pathways Pain, 88: 113-118
  | Article (PDF) |

• Kiprianova I., Sandkühler J., Schwab S., Hoyer S., Spranger M. (1999) Brain-derived neurotrophic factor improves long-term potentiation and cognitive functions after transient forebrain ischemia in the rat Exp. Neurol., 159: 511-519
  | Article (PDF) |
• Gillardon F., Kiprianova I., Sandkühler J., Hossmann K.-A., Spranger M. (1999) Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia. Neuroscience, 93: 1219-1222
  | Article (PDF) |

• Sandkühler J., Jensen T.S. (1999) Inhibition of nociception. In: Olesen,J., Tfelt-Hansen,P.,Welch,K.M.A. , The Headaches Lippincott Williams & Wilkins, Philadelphia: 117-124

• Liu X.-G., Sandkühler J. (1998) Activation of spinal N-methyl-D-aspartate or neurokinin receptors induces long-term potentiation of spinal C-fibre-evoked potentials Neuroscience, 86: 1209-1216
  | Article (PDF) |
• Sandkühler J., Liu X. (1998) Induction of long-term potentiation at spinal synapses b noxious stimulation or nerve injury Eur. J. Neurosci., 10: 2476-2480
  | Article (PDF) |
• Liu X.-G., Morton C.R., Azkue J.J., Zimmermann M., Sandkühler J. (1998) Long-term depression of C-fibre-evoked spinal field potentials by stimulation of primary afferent Aδ-fibres in the adult rat Eur. J. Neurosci., 10: 3069-3075
  | Article (PDF) |
• Jonas P., Bischofberger J., Sandkühler J. (1998) Corelease of two fast neurotransmitters at a central synapse Science, 281: 419-424
  | Article (PDF) |

• Sandkühler J. (1998) Nonlinear dynamics of discharges of sensory neurons in rat spinal dorsal horn in vivo. In: Ito Y., Kawakami I., Konno K., Matunaga Y., Shimada I., Tsubokawa T. , Order & Non-Order World Scientific, Singapore: 33-51
• Sandkühler J. (1998) Long-term potentiation of synaptic strength in nociceptive pathways: a novel target for antihyperalgesic drugs. In: Savage L.M. , IBC Library Series IBC Library Series, Southborough USA: 419-444

• Petsche H., Etlinger S.C. (1998) EEG and Thinking. , Austrian Academy of Sciences

• Liu,X.-G., Sandkühler J. (1997) Characterization of long-term potentiation of C-fiber-evoked potentials in spinal dorsal horn of adult rat: essential role of NK1 and NK2 receptors. J. Neurophysiol., 78: 1973-1982
  | Article (PDF) |
• Dahlhaus R., Eichler M., Sandkühler J. (1997) Identification of synaptic connections in neural ensembles by graphical models J. Neurosci. Methods, 77: 93-107
  | Article (PDF) |
• Eblen-Zajjur A.A., Sandkühler J. (1997) Synchronicity of nociceptive and non-nociceptive adjacent neurons in the spinal dorsal horn of the rat: stimulus-induced plasticity Neuroscience, 76: 39-54
  | Article (PDF) |
• Sandkühler J., Chen J.G., Cheng G., Randic M. (1997) Low-frequency stimulation of afferent Aδ-fibers induces long-term depression at primary afferent synapses with substantia gelatinosa neurons in the rat J. Neurosci., 17: 6483-6491
  | Article (PDF) |

• Sandkühler J. (1997) Neurobiologie des Schmerzsystems. In: Huffmann G., Braune H.-J.,Fritz C., R&ouml;ssy,W. Reinbek , Vegetativum - Schlaf - Schmerz Einhorn-Presse Verlag: 206-213
• Sandkühler J., Randic M. (1997) Long-term depression of primary afferent neurotransmission induced by low frequency stimulation of afferent Aδ -fibers. In: Jensen T.S Turner A.J.; Wiesenfeld-Hallin Z. Progress in Pain Research and Managment Vol. 8, Proceedings of the 8th World Congress on Pain IASP Press: 827-837

• Sandkühler J., Treier A.-C., Liu X.-G., Ohnimus M. (1996) The massive expression of c-Fos protein in spinal dorsal horn neurons is not followed by long-term changes in spinal nociception Neuroscience, 73: 657-666
  | Article (PDF) |
• Debus S., Sandkühler J. (1996) Low dimensional attractors in discharges of sensory neurons of the rat spinal dorsal horn are maintained by supraspinal descending systems Neuroscience, 70: 191-200
  | Article (PDF) |

• Sandkühler J. (1996) Neurobiology of spinal nociception: new concepts Prog.Brain Res., 110: 207
• Sandkühler J. (1996) The organization and function of endogenous antinociceptive systems Prog.Neurobiol., 50: 49-81
  | Article (PDF) |

• Liu X.-G., Sandkühler J. (1995) Long-term potentiation of C-fiber-evoked potentials in the rat spinal dorsal horn is prevented by spinal N-methyl-D-aspartic acid receptor blockage Neurosci Lett, 191: 43-46
  | Article (PDF) |
• Liu X.-G., Sandkühler J. (1995) The effects of extrasynaptic substance P on nociceptive neurons in laminae I and II in rat lumbar spinal dorsal horn Neuroscience, 68: 1207-1218
  | Article (PDF) |
• Sandkühler J., Herdegen T. (1995) Distinct patterns of activated neurons throughout the rat midbrain periaqueductal gray induced by chemical stimulation within its subdivisions J. Comp. Neurol., 357: 546-553
  | Article (PDF) |
• Bett K., Sandkühler J. (1995) Map of spinal neurons activated by chemical stimulation in the nucleus raphe magnus of the unanesthetized rat Neuroscience, 67: 497-504
  | Article (PDF) |
• Helmchen C., Fu Q.-G., Sandkühler J. (1995) Inhibition of spinal nociceptive neurons by microinjections of somatostatin into the nucleus raphe magnus and the midbrain periaqueductal gray of the anesthetized cat Neurosci Lett, 187: 137-141
  | Article (PDF) |
• Beck,H., Schröck,H., Sandkühler J. (1995) Controlled superfusion of the rat spinal cord for studying non-synaptic transmission: an autoradiographic analysis J. Neurosci. Methods, 58: 193-202
  | Article (PDF) |
• Sandkühler J., Eblen-Zajjur A., Fu Q.-G., Forster C. (1995) Differential effects of spinalization on discharge patterns and discharge rates of simultaneously recorded nociceptive and nonnociceptive spinal dorsal horn neurons Pain, 60: 66-65
  | Article (PDF) |

• Sandkühler J. (1995) Volume transmission, synchrony, nonlinear dynamics and gene expression in spinal nociception. In: Carli G., Zimmermann M. , Towards the Neurobiology of Chronic Pain, Progress in Brain Research. Elsevier, Amsterdam

• Sandkühler J., Eblen-Zajjur A.A. (1994) Identification and characterization of rhythmic nociceptive and non-nociceptive spinal dorsal horn neurons in the rat. Neuroscience, 61: 991-1006
• Gillardon F., Beck H., Uhlmann E., Herdegen T., Sandkühler J., Peyman A., Zimmermann M., (1994) Inhibition of c-Fos protein expression in rat spinal cord by antisense oligodeoxynucleotide superfusion. Eur. J. Neurosci., 6: 880-884
  | Article (PDF) |

• Sandkühler J.,Eblen-Zajjur AA.,Liu X-G. (1994) Differential effects of skin inflammation, extrasynaptic substance P and noxious skin heating on rhythmicity, synchrony and nonlinear dynamics in rat spinal dorsal horn. In: Gebhart G.F.,Hammond D.L.,Jensen T.S., Progress in Pain Research and Managment, Vol. 2, Proceedings of the 7th World Congress on Pain IASP,Seattle: 347-358

• Sandkühler J., Fink F.H.A., Lux W. (1993) Vom Ionenkanal zum neuronalen Netz: Computergestützter Physiologieunterricht für fortgeschrittene Mediziner und Naturwissenschaftler. Tierschutz durch Alternativen, Ersatz- und Ergänzungsmethoden zum Tierversuch, : 274-276
• Sandkühler J., Stelzer B., Fu Q.-G. (1993) Characteristics of propriospinal modulation of nocicepti.ve lumbar spinal dorsal horn neurons in the cat. Neuroscience, 54: 957-967
• Herdegen T., Sandkühler J., Gass P., Kiessling M., Bravo R., Zimmermann M. (1993) JUN, FOS, KROX, and CREB transcription factor proteins in the rat cortex: basal expression and induction by spreading depression and epileptic seizures. J. Comp. Neurol., 333: 271-288

• Sandkühler J. (1993) Körpereigene Schmerzabwehr: Neue Konzepte aus der funktionellen Neuroanatomie, Neurophysiologie, Neurobiologie und Chaosforschung. , 7: 250-261
  | Article (PDF) |

• Sandkühler J. (1993) Neuronal mechanisms of endogenous antinociception. In: Sharma K.N., Nayar U., Bhattacharya N. , Current Trends in Pain Research and Therapy. Indian Society for Pain Research and therapy, New Dehli: 1-13

• Leah J.D., Sandkühler J., Herdegen T., Murashov A., Zimmermann M. (1992) Potentiated expression of FOS protein in the rat spinal cord following bilateral noxious cutaneous stimulation Neuroscience, 48: 525-532

• Sandkühler J., Willmann E., Fu Q.-G. (1991) Characteristics of midbrain control of spinal nociceptive neurons and nonsomatosensory parameters in the pentobarbital-anesthetized rat. J. Neurophysiol., 65: 33-48

• Sandkühler J., Fu Q.-G., Stelzer B. (1991) Propriospinal neurones are involved in the descending inhibition of lumbar spinal dorsal horn neurones from the mid-brain. In: Bond M.R., Charlton J.E., Woolf C.J. , Proceedings of the VIth World Congress on Pain Elsevie, Amsterdam: 313-318
• Sandkühler J. (1991) Induction of the proto-oncogene c-fos as a cellular marker of brainstem neurons activated from the PAG. In: Depaulis,A., Bandler,R. , The Midbrain Periaqueductal Gray Matter Plenum Press, New York: 267-286

• Sandkühler J., Fu Q.-G., Helmchen C. (1990) Spinal somatostatin superfusion in vivo affects activity of cat nociceptive dorsal horn neurons: comparison with spinal morphine. Neuroscience, 34: 565-576
• Fu Q.-G., Sandkühler J., Zimmermann M. (1990) B-vitamins enhance afferent inhibitory controls of nociceptive neurons in the rat spinal cord Klin. Wochenschr., 68: 125-128

• Sandkühler J., Willmann E., Fu Q.-G. (1989) Blockade of GABA<SUB>A</SUB> receptors in the midbrain periaqueductal gray abolishes nociceptive spinal dorsal horn neuronal activity. Eur J Pharmacol, 160: 163-166
  | Article (PDF) |

• Sandkühler J., Helmchen C., Fu Q.-G., Zimmermann M. (1988) Inhibition of spinal nociceptive neurons by excitation of cell bodies or fibers of passage at various brainstem sites in the cat Neurosci Lett, 93: 67-72

• Sandkühler J., Zimmermann M. (1988) Neuronal effects of controlled superfusion of the spinal cord with monoaminergic receptor antagonists in the cat Prog.Brain Res., 77: 321-327

• Sandkühler J., Fu Q.-G. , Helmchen C. , Zimmermann M. (1987) Pentobarbital, in subanesthetic doses, depresses spinal transmission of nociceptive information but does not affect stimulation-produced descending inhibition in the cat Pain, 31: 381-390
  | Article (PDF) |
• Sandkühler J., Maisch B., Zimmermann M. (1987) The use of local anaesthetic microinjections to identify central pathways: a quantitative evaluation of the time course and extent of the neuronal block Exp Brain Res, 68: 168-178
  | Article (PDF) |
• Sandkühler J., Fu Q.-G., Zimmermann M. (1987) Spinal pathways mediating tonic or stimulation-produced descending inhibition from the periaqueductal gray or nucleus raphe magnus are separate in the cat J. Neurophysiol., 58: 327-341
• Sandkühler J., Maisch B., Zimmermann M. (1987) Raphe magnus-induced descending inhibition of spinal nociceptive neurons is mediated through contralateral spinal pathways in the cat Neurosci Lett, 76: 168-172

• Siegel J., Morton C.R., Sandkühler J., Xiao H.-M., Zimmermann M. (1986) Spinal neuronal inhibition and EEG synchrony by electrical stimulation in subcortical forebrain regions of the cat Exp Brain Res, 62: 363-372
  | Article (PDF) |

• Petsche H., Pockberger H., Rappelsberger P. (1984) On the search for the sources of the electroencephalogram Neuroscience, 11: 1-27
• Sandkühler J., Gebhart G.F. (1984) Relative contributions of the nucleus raphe magnus and adjacent medullary reticular formation to the inhibition by stimulation in the periaqueductal gray of a spinal nociceptive reflex in the pentobar Brain Res, 305: 77-87
• Sandkühler J., Gebhart G.F. (1984) Characterization of inhibition of a spinal nociceptive reflex by stimulation medially and laterally in the midbrain and medulla in the pentobarbital-anesthetized rat Brain Res, 305: 67-76
• Gebhart G.F., Sandkühler J., Thalhammer J.G., Zimmermann M. (1984) Inhibition in spinal cord of nociceptive information by electrical stimulation and morphine microinjection at identical sites in midbrain of the cat J. Neurophysiol., 51: 75-89
  | Article (PDF) |

• Gebhart G.F., Sandkühler J., Thalhammer J.G., Zimmermann M. (1983) Inhibition of spinal nociceptive information by stimulation in midbrain of the cat is blocked by lidocaine microinjected in nucleus raphe magnus and medullary reticular formation J. Neurophysiol., 50: 1446-1459
  | Article (PDF) |
• Gebhart G.F., Sandkühler J., Thalhammer J.G., Zimmermann M. (1983) Quantitative comparison of inhibition in spinal cord of nociceptive information by stimulation in periaqueductal gray or nucleus raphe magnus of the cat J. Neurophysiol., 50: 1433-1445
  | Article (PDF) |

• Görgülü I, Jagannath V, Pons S, Koniuszewski F, Groszer M, Maskos U, Huck S, Scholze P (2024) The human‐specific nicotinic receptor subunit CHRFAM7A reduces α7 receptor function in human induced pluripotent stem cells‐derived and transgenic mouse neurons Eur J Neurosci, 60 (5): 4893-4906
• Müller V, Ernst M, Baykuchkarova A, Koniuszewski F, Bampali K, Seidel T, Scholze P (2024) Probes for the heterogeneity of muscimol binding sites in rat brain Front. Pharmacol., 15
• Golse M, Weinhofer I, Blanco B, Barbier M, Yazbeck E, Huiban C, Chaumette B, Pichon B, Fatemi A, Pascual S, Martinell M, Berger J, Perlbarg V, Galanaud D, Mochel F (2024) Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy Brain,
• Wang J, Kunze M, Villoria-González A, Weinhofer I, Berger J (2024) Peroxisomal Localization of a Truncated HMG-CoA Reductase under Low Cholesterol Conditions Biomol, 14 (2): 244
• Huber A, Sarne V, Beribisky A, Ackerbauer D, Derdak S, Madritsch S, Etzler J, Huck S, Scholze P, Gorgulu I, Christodoulou J, Studenik C, Neuhaus W, Connor B, Laccone F, Steinkellner H (2024) Generation and Characterization of a Human Neuronal In Vitro Model for Rett Syndrome Using a Direct Reprogramming Method Stem Cells Dev, 33 (5-6): 128-142
  | Article (PDF) |
• Sharmin D, Divović B, Ping X, Cerne R, Smith J, Rezvanian S, Mondal P, Meyer M, Kiley M, Arnold L, Mian M, Pandey K, Jin X, Mitrović J, Djorović D, Lippa A, Cook J, Golani L, Scholze P, Savić M, Witkin J (2024) New Imidazodiazepine Analogue, 5-(8-Bromo-6-(pyridin-2-yl)-4H-benzo-f-imidazo[1,5-a][1,4]diazepin-3-yl)oxazole, Provides a Simplified Synthetic Scheme, High Oral Plasma and Brain Exposures, and Produces Antiseizure Efficacy in Mice, and Antiepileptogenic Activity in Neural Networks in Brain Slices from a Patient with Mesial Temporal Lobe Epilepsy ACS Chem Neurosci, 15 (3): 517-526
  | Article (PDF) |

• Kunze M, Alder N, Hwang I, Roussel G, Karamyshev A (2023) Editorial: Targeting signals in protein trafficking and transport Front Physiol, 14
• Tawbeh A, Raas Q, Tahri-Joutey M, Keime C, Kaiser R, Trompier D, Nasser B, Bellanger E, Dessard M, Hamon Y, Benani A, Di Cara F, Cunha Alves T, Berger J, Weinhofer I, Mandard S, Cherkaoui-Malki M, Andreoletti P, Gondcaille C, Savary S (2023) Immune response of BV-2 microglial cells is impacted by peroxisomal beta-oxidation Front Mol Neurosci, 16
• Villoria-González A, Zierfuss B, Parzer P, Heuböck E, Zujovic V, Waidhofer-Söllner P, Ponleitner M, Rommer P, Göpfert J, Forss-Petter S, Berger J, Weinhofer I (2023) Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders Biomol, 13 (12): 1696
• Milica Gajić Bojić, Marco Treven, Kamal P. Pandey, V.V.N. Phani Babu Tiruveedhula, Anja Santrač, Đorđe Đukanović , Nataša Vojinović, Ljiljana Amidžić,Ranko Škrbić, Petra Scholze, Margot Ernst, James M. Cook,Miroslav M. Savić (2023) Vascular effects of midazolam, flumazenil, and a novel imidazobenzodiazepine MP-III-058 on isolated rat aorta Can.J.Physiol.Pharmacol.,
• Werner E, Swinkels D, Juric V, Dorninger F, Baes M, Keller M, Berger J, Watschinger K (2023) Normal plasmalogen levels are maintained in tissues from mice with hepatocyte-specific deletion in peroxin 5 Brain Res Bull, 193: 158-165
• Dorninger F, Berger J, Honsho M (2023) Editorial: Solving the plasmalogen puzzle—From basic science to clinical application Front Cell Dev Biol, 11
• Weinhofer I, Rommer P, Gleiss A, Ponleitner M, Zierfuss B, Waidhofer-Söllner P, Fourcade S, Grabmeier-Pfistershammer K, Reinert M, Göpfert J, Heine A, Yska H, Casasnovas C, Cantarín V, Bergner C, Mallack E, Forss-Petter S, Aubourg P, Bley A, Engelen M, Eichler F, Lund T, Pujol A, Köhler W, Kühl J, Berger J (2023) Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy EBioMedicine, 96: 104781
• Buda A, Forss-Petter S, Hua R, Jaspers Y, Lassnig M, Waidhofer-Söllner P, Kemp S, Kim P, Weinhofer I, Berger J (2023) ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis Biomol, 13 (9): 1333
• Koniuszewski F, Vogel F, Dajić I, Seidel T, Kunze M, Willeit M, Ernst M (2023) Navigating the complex landscape of benzodiazepine- and Z-drug diversity: insights from comprehensive FDA adverse event reporting system analysis and beyond Front Psychiatry, 14
• Mortensen M, Xu Y, Shehata M, Krall J, Ernst M, Frølund B, Smart T (2023) Pregnenolone sulfate analogues differentially modulate GABA_A receptor closed/desensitised states Br J Pharmacol,
• Bampali K, Koniuszewski F, Vogel F, Fabjan J, Andronis C, Lekka E, Virvillis V, Seidel T, Delaunois A, Royer L, Rolf M, Giuliano C, Traebert M, Roussignol G, Fric-Bordat M, Mazelin-Winum L, Bryant S, Langer T, Ernst M (2023) GABAA receptor-mediated seizure liabilities: a mixed-methods screening approach JCB,
• Martinović K, Bauer J, Kunze M, Berger J, Forss-Petter S (2023) Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy Acta Neuropathologica Communications, 11 (1): 98
• Arias H, De Deurwaerdère P, Scholze P, Sakamoto S, Hamachi I, Di Giovanni G, Chagraoui A (2023) Coronaridine congeners induce sedative and anxiolytic-like activity in naïve and stressed/anxious mice by allosteric mechanisms involving increased GABAA receptor affinity for GABA Eur J Pharmacol, 953: 175854
• Dorninger F, Kiss A, Rothauer P, Stiglbauer-Tscholakoff A, Kummer S, Fallatah W, Perera-Gonzalez M, Hamza O, König T, Bober M, Cavallé-Garrido T, Braverman N, Forss-Petter S, Pifl C, Bauer J, Bittner R, Helbich T, Podesser B, Todt H, Berger J (2023) Overlapping and Distinct Features of Cardiac Pathology in Inherited Human and Murine Ether Lipid Deficiency Int J Mol Sci, 24 (3): 1884

• Kunze M (2023) Computational Evaluation of Peroxisomal Targeting Signals in Metazoa. In: , Methods in Molecular Biology Springer: 391-404
• Bernhard Hochreiter, Johannes A. Schmid, Johannes Berger, Markus Kunze (2023) Estimating the Interaction Strength Between PTS1-Peptides and Their Receptor PEX5 in Living Cells Using Flow-Cytometer-Based FRET (flowFRET) Measurements. In: , Methods in Molecular Biology Springer: 413-434

• Dorninger F, Werner E, Berger J, Watschinger K (2022) Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift Front Cell Dev Biol, 10
• Schmiedhofer P, Vogel F, Koniuszewski F, Ernst M (2022) Cys-loop receptors on cannabinoids: All high? Front Physiol, 13
• Garifulina A, Friesacher T, Stadler M, Zangerl-Plessl E, Ernst M, Stary-Weinzinger A, Willam A, Hering S (2022) β subunits of GABAA receptors form proton-gated chloride channels: Insights into the molecular basis Commun Biol, 5 (1)
• Zierfuss B, Buda A, Villoria-González A, Logist M, Fabjan J, Parzer P, Battin C, Vandersteene S, Dijkstra I, Waidhofer-Söllner P, Grabmeier-Pfistershammer K, Steinberger P, Kemp S, Forss-Petter S, Berger J, Weinhofer I (2022) Saturated very long-chain fatty acids regulate macrophage plasticity and invasiveness J Neuroinflammation, 19 (1)
• Bernhard Hochreiter, Hugo Malagon-Vina, Johannes A. Schmid, Johannes Berger and Markus Kunze (2022) Studying the interaction between PEX5 and its full-length cargo proteins in living cells by a novel Förster´s resonance energy transfer-based competition assay Front Cell Dev Biol,
  | Weblink |
• Eden Yifrach, Markus Rudowitz, Luis Daniel Cruz-Zaragoza, Asa Tirosh , Zohar Gazi , Yoav Peleg , Markus Kunze , Miriam Eisenstein , Wolfgang Schliebs, Maya Schuldiner, Ralf Erdmann and Einat Zalckvar (2022) Determining the targeting specificity of the selective peroxisomal targeting factor Pex9 Biol.Chem.,
• Simeone X, Ernst M, Seidel T, Heider J, Enz D, Monticelli S, Vogel F, Koniuszewski F, Langer T, Scholze P, Pace V, Miele M (2022) Novel alpha6 preferring GABA-A receptor ligands based on loreclezole Bioorg Med Chem, 244: 114780
• Goisis R, Chiavegato A, Gomez-Gonzalo M, Marcon I, Requie L, Scholze P, Carmignoto G, Losi G (2022) GABA tonic currents and glial cells are altered during epileptogenesis in a mouse model of Dravet syndrome Front Cell Neurosci, 16
• Kamoshita M, Kumar R, Anteghini M, Kunze M, Islinger M, Martins dos Santos V, Schrader M (2022) Insights Into the Peroxisomal Protein Inventory of Zebrafish Front Physiol, 13
• Weinhofer I, Buda A, Kunze M, Palfi Z, Traunfellner M, Hesse S, Villoria-Gonzalez A, Hofmann J, Hametner S, Regelsberger G, Moser A, Eichler F, Kemp S, Bauer J, Kühl J, Forss-Petter S, Berger J (2022) Peroxisomal very long-chain fatty acid transport is targeted by herpesviruses and the antiviral host response Commun Biol, 5 (1): 944
• Fallatah W, Cui W, Di Pietro E, Carter G, Pounder B, Dorninger F, Pifl C, Moser A, Berger J, Braverman N (2022) A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1 Front Cell Dev Biol, 10
• Dorninger F, Vaz F, Waterham H, Klinken J, Zeitler G, Forss-Petter S, Berger J, Wiesinger C (2022) Ether lipid transfer across the blood-brain and placental barriers does not improve by inactivation of the most abundant ABC transporters Brain Res Bull, 189: 69-79
• Koniuszewski F, Vogel F, Bampali K, Fabjan J, Seidel T, Scholze P, Schmiedhofer P, Langer T, Ernst M (2022) Molecular Mingling: Multimodal Predictions of Ligand Promiscuity in Pentameric Ligand-Gated Ion Channels MB, 9
• Bampali K, Koniuszewski F, Silva L, Rehman S, Vogel F, Seidel T, Scholze P, Zirpel F, Garon A, Langer T, Willeit M, Ernst M (2022) Tricyclic antipsychotics and antidepressants can inhibit α5‐containing GABA _A receptors by two distinct mechanisms Br J Pharmacol, 0: 1-18
• Vogel F, Krenn M, Westphal D, Graf E, Wagner M, Leiz S, Koniuszewski F, Augé‐Stock M, Kramer G, Scholze P, Ernst M (2022) A de novo missense variant in GABRA4 alters receptor function in an epileptic and neurodevelopmental phenotype Epilepsia, 0: 1-7

• Sieghart W, Chiou LC, Ernst M, Fabjan J, M Savić M, Lee MT (2022) α6-Containing GABAA Receptors: Functional Roles and Therapeutic Potentials Pharmacol Rev, 74(1): 238-270

• Fallatah W, Nimmo G, Yergeau C, Di Pietro E, Dorninger F, Berger J, Braverman N (2021) Molecular, biochemical and neuropathological characterization of novel PEX7 deletion variants in patients with classic (severe) rhizomelic chondrodysplasia punctata type 1 Mol Genet Metab, 132: S286
• Dahan N, Francisco T, Falter C, Rodrigues T, Kalel V, Kunze M, Hansen T, Schliebs W, Erdmann R (2021) Current advances in the function and biogenesis of peroxisomes and their roles in health and disease Histochem Cell Biol, 155 (4): 513-524
• Rodríguez-Pascau L, Vilalta A, Cerrada M, Traver E, Forss-Petter S, Weinhofer I, Bauer J, Kemp S, Pina G, Pascual S, Meya U, Musolino P, Berger J, Martinell M, Pizcueta P (2021) The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy Sci Transl Med, 13 (596): eabc0555
• Fabjan J, Koniuszewski F, Schaar B, Ernst M (2021) Structure-Guided Computational Methods Predict Multiple Distinct Binding Modes for Pyrazoloquinolinones in GABAA Receptors Front Neurosci, 14: 611953
• Raas Q, van de Beek M, Forss-Petter S, Dijkstra I, Deschiffart A, Freshner B, Stevenson T, Jaspers Y, Nagtzaam L, Wanders R, van Weeghel M, Engelen-Lee J, Engelen M, Eichler F, Berger J, Bonkowsky J, Kemp S (2021) Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy J Clin Invest, 131 (8)
• Weinhofer I, Rommer P, Zierfuss B, Altmann P, Foiani M, Heslegrave A, Zetterberg H, Gleiss A, Musolino P, Gong Y, Forss-Petter S, Berger T, Eichler F, Aubourg P, Köhler W, Berger J (2021) Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy Nat Commun, 12 (1)
• Simeone X, Koniuszewski F, Müllegger M, Smetka A, Steudle F, Puthenkalam R, Ernst M, Scholze P (2021) A Benzodiazepine Ligand with Improved GABAA Receptor α5-Subunit Selectivity Driven by Interactions with Loop C Mol Pharmacol, 99 (1): 39-48

• Vilalta, A.; Berger, J; Forss-Petter, S.; Bauer, J.; Weinhofer, I.; Solà, Carme CSIC ORCID; Herrando-Grabulosa, Mireia; Navarro, Xavier; Martinell, M.; Pizcueta, P (2021) Leriglitazone decreases microglia activation and promotes protective phenotypes in several neuroinflammatory models of disease Glia,

• Dorninger F, Zeitler G, Berger J (2020) Nestlet Shredding and Nest Building Tests to Assess Features of Psychiatric Disorders in Mice BioProtoc., 10 (24)
• Farr C, El-Kasaby A, Freissmuth M, Sucic S (2020) The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome Front.Synaptic Neuroscience, 12
• Scholze P, Huck S (2020) The α5 Nicotinic Acetylcholine Receptor Subunit Differentially Modulates α4β2* and α3β4* Receptors Front.Synaptic Neuroscience, 12
• Kumar P, Scholze P, Fronius M, Krasteva‐Christ G, Hollenhorst M (2020) Nicotine stimulates ion transport via metabotropic β4 subunit containing nicotinic ACh receptors Br J Pharmacol, 177 (24): 5595-5608
• Hochreiter B, Chong C, Hartig A, Maurer-Stroh S, Berger J, Schmid J, Kunze M (2020) A Novel FRET Approach Quantifies the Interaction Strength of Peroxisomal Targeting Signals and Their Receptor in Living Cells Cells, 9 (11): 2381
• Zierfuss B, Weinhofer I, Buda A, Popitsch N, Hess L, Moos V, Hametner S, Kemp S, Köhler W, Forss‐Petter S, Seiser C, Berger J (2020) Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS‐275 Ann Clin Transl Neurol,
• Sharp B, Jiang Q, Simeone X, Scholze P (2020) Allosteric Modulation of GABAA Receptors in Rat Basolateral Amygdala Blocks Stress-Enhanced Reacquisition of Nicotine Self-Administration ACS, 3 (6): 1158-1164
• Scholze P, Pökl M, Längle S, Steudle F, Fabjan J, Ernst M (2020) Two Distinct Populations of α1α6-Containing GABAA-Receptors in Rat Cerebellum Front.Synaptic Neuroscience, 12: 1-10
• Todt H, Dorninger F, Rothauer P, Fischer C, Schranz M, Bruegger B, Lüchtenborg C, Ebner J, Hilber K, Koenig X, Erdem F, Gawali V, Berger J (2020) Oral batyl alcohol supplementation rescues decreased cardiac conduction in ether phospholipid‐deficient mice J Inherit Metab Dis., 43: 1046-1055
• Rishi G, Secondes E, Asplett K, Wallace D, Ostini L, Berger J, Subramaniam V (2020) Dysregulated hepcidin response to dietary iron in male mice with reduced Gnpat expression Bio Rep., 40 (8): BSR20201508
• Dorninger F, Forss-Petter S, Wimmer I, Berger J (2020) Plasmalogens, platelet-activating factor and beyond – Ether lipids in signaling and neurodegeneration Neurobiol Dis, 145: 105061
• Dalby N, Falk‐Petersen C, Leurs U, Scholze P, Krall J, Frølund B, Wellendorph P (2020) Silencing of spontaneous activity at α4β1/3δ GABA A receptors in hippocampal granule cells reveals different ligand pharmacology Br J Pharmacol, 177 (17): 3975-3990
  | Article (PDF) |
• Zierfuss B, Weinhofer I, Kühl J, Köhler W, Bley A, Zauner K, Binder J, Martinović K, Seiser C, Hertzberg C, Kemp S, Egger G, Leitner G, Bauer J, Wiesinger C, Kunze M, Forss-Petter S, Berger J (2020) Vorinostat in the acute neuroinflammatory form of X-linked adrenoleukodystrophy Ann Clin Transl Neurol, 7 (5): 639-652
• Perniss A, Latz A, Boseva I, Papadakis T, Dames C, Meisel C, Meisel A, Scholze P, Kummer W, Krasteva-Christ G (2020) Acute nicotine administration stimulates ciliary activity via α3β4 nAChR in the mouse trachea Int. Immunopharmacol., 84: 106496
• Tsymala I, Nigritinou M, Zeka B, Schulz R, Niederschick F, Matković M, Bauer I, Szalay M, Schanda K, Lerch M, Misu T, Fujihara K, Bennett J, Dahle C, Pache F, Rommer P, Leutmezer F, Illes Z, Leite M, Palace J, Scholze P, Reindl M, Lassmann H, Bradl M (2020) Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes Acta Neuropathologica Communications, 15; 8 (1)
  | Supplement |
• Werner E, Keller M, Sailer S, Lackner K, Koch J, Hermann M, Coassin S, Golderer G, Werner-Felmayer G, Zoeller R, Hulo N, Berger J, Watschinger K (2020) TheTMEM189gene encodes plasmanylethanolamine desaturase which introduces the characteristic vinyl ether double bond into plasmalogens Proc Natl Acad Sci USA, 117 (14): 7792-7798
• Arias H, Do Rego J, Do Rego J, Chen Z, Anouar Y, Scholze P, Gonzales E, Huang R, Chagraoui A (2020) Coronaridine congeners potentiate GABAA receptors and induce sedative activity in mice in a benzodiazepine-insensitive manner Prog Neuropsychopharmacol Biol Psychiatry, 101: 109930
• Steudle F, Rehman S, Bampali K, Simeone X, Rona Z, Hauser E, Schmidt W, Scholze P, Ernst M (2020) A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro Sci Rep, 10 (1): 2379
  | Article (PDF) |
• Iorio M, Vogel F, Koniuszewski F, Scholze P, Rehman S, Simeone X, Schnürch M, Mihovilovic M, Ernst M (2020) GABAA Receptor Ligands Often Interact with Binding Sites in the Transmembrane Domain and in the Extracellular Domain—Can the Promiscuity Code Be Cracked? Int J Mol Sci, 21 (1): 334
• Kunze M (2020) The type-2 peroxisomal targeting signal BBA Mol Cell Res, 1867 (2): 118609

• Zarrouk A, Nury T, El Hajj H, Gondcaille C, Andreoletti P, Moreau T, Cherkaoui-Malki M, Berger J, Hammami M, Lizard G, Vejux A (2020) Potential Involvement of Peroxisome in Multiple Sclerosis and Alzheimer’s Disease. In: , Advances in Experimental Medicine and Biology Springer Verlag: 91-104

• Hochreiter B, Kunze M, Moser B, Schmid J (2019) Advanced FRET normalization allows quantitative analysis of protein interactions including stoichiometries and relative affinities in living cells Sci Rep, 9 (1): 8233
  | Article (PDF) |
• Honsho M, Dorninger F, Abe Y, Setoyama D, Ohgi R, Uchiumi T, Kang D, Berger J, Fujiki Y (2019) Impaired plasmalogen synthesis dysregulates liver X receptor-dependent transcription in cerebellum J. Biochem, 166 (4): 353-361
• Chong* , Kunze* , Hochreiter , Krenn , Berger , Maurer-Stroh (*equal contribution) (2019) Rare Human Missense Variants can affect the Function of Disease-Relevant Proteins by Loss and Gain of Peroxisomal Targeting Motifs Int J Mol Sci, 20 (18): 4609
  | Article (PDF) |
• Dorninger F, Gundacker A, Zeitler G, Pollak D, Berger J (2019) Ether Lipid Deficiency in Mice Produces a Complex Behavioral Phenotype Mimicking Aspects of Human Psychiatric Disorders Int J Mol Sci, 20 (16): 3929
• Maleeva G, Wutz D, Rustler K, Nin‐Hill A, Alfonso‐Prieto M, Petukhova E, Bautista‐Barrufet A, Gomila‐Juaneda A, Scholze P, Peiretti F, Rovira C, König B, Gorostiza P, Bregestovski P (2019) A photoswitchable GABA receptor channel blocker Br J Pharmacol, 176(15): 2661-2677
• Simeone X, Karch R, Ciuraszkiewicz A, Orr‐Urtreger A, Lemmens‐Gruber R, Scholze P, Huck S (2019) The role of the nAChR subunit α5, β2, and β4 on synaptic transmission in the mouse superior cervical ganglion Phys Reports, 7 (6): e14023
• Dorninger F, König T, Scholze P, Berger M, Zeitler G, Wiesinger C, Gundacker A, Pollak D, Huck S, Just W, Forss-Petter S, Pifl C, Berger J (2019) Disturbed Neurotransmitter Homeostasis in Ether Lipid Deficiency Hum Mol Genet, 28(12): 2046-2061
• Vasović D, Divović B, Treven M, Knutson D, Steudle F, Scholze P, Obradović A, Fabjan J, Brković B, Sieghart W, Ernst M, Cook J, Savić M (2019) Trigeminal neuropathic pain development and maintenance in rats are suppressed by a positive modulator of α6 GABA A receptors Eur. J. Pain, 23(5): 973-984
• Prevot T, Li G, Vidojevic A, Misquitta K, Fee C, Santrac A, Knutson D, Stephen M, Kodali R, Zahn N, Arnold L, Scholze P, Fisher J, Marković B, Banasr M, Cook J, Savic M, Sibille E (2019) Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles Mol Psychiatry, 5(2): 84-97

• Knutson D, Kodali R, Divović B, Treven M, Stephen M, Zahn N, Dobričić V, Huber A, Meirelles M, Verma R, Wimmer L, Witzigmann C, Arnold L, Chiou L, Ernst M, Mihovilovic M, Savić M, Sieghart W, Cook J (2018) Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABAAR) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability J Med Chem, 61 (6): 2422-2446
• Chiou L, Lee H, Ernst M, Huang W, Chou J, Chen H, Mouri A, Chen L, Treven M, Mamiya T, Fan P, Knutson D, Witzigmann C, Cook J, Sieghart W, Nabeshima T (2018) Cerebellar α6-subunit-containing GABAAreceptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders Br J Pharmacol, 175 (12): 2414-2427
• Fan P, Lai T, Hor C, Lee M, Huang P, Sieghart W, Ernst M, Knutson D, Cook J, Chiou L (2018) The α6 subunit-containing GABAA receptor: A novel drug target for inhibition of trigeminal activation Neuropharmacology, 140: 1-13
• Ricken G, Schwaiger C, De Simoni D, Pichler V, Lang J, Glatter S, Macher S, Rommer P, Scholze P, Kubista H, Koneczny I, Höftberger R (2018) Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis Front Neurol, 9: 841
• Forget B, Scholze P, Langa F, Morel C, Pons S, Mondoloni S, Besson M, Durand-de Cuttoli R, Hay A, Tricoire L, Lambolez B, Mourot A, Faure P, Maskos U (2018) A Human Polymorphism in CHRNA5 Is Linked to Relapse to Nicotine Seeking in Transgenic Rats Curr Biol., 28 (20): 3244-3253.e7
• Siebert D, Bampali K, Puthenkalam R, Varagic Z, Sarto-Jackson I, Scholze P, Sieghart W, Mihovilovic M, Schnürch M, Ernst M (2018) Engineered Flumazenil Recognition Site Provides Mechanistic Insight Governing Benzodiazepine Modulation in GABAA Receptors ACS Chem Biol, 13: 2040-2047
• Siebert D, Wieder M, Schlener L, Scholze P, Boresch S, Langer T, Schnürch M, Mihovilovic M, Richter L, Ernst M, Ecker G (2018) SAR-Guided Scoring Function and Mutational Validation Reveal Binding Mode of CGS-8216 at the α1+/γ2- Benzodiazepine Site J Chem Inf Model., 58 (8): 1682-1696
• Elgarf A, Siebert D, Steudle F, Draxler A, Li G, Huang S, Cook J, Ernst M, Scholze P (2018) Different Benzodiazepines Bind with Distinct Binding Modes to GABAA Receptors ACS Chem Biol, 13 (8): 2033-2039
• Batinić B, Stanković T, Stephen M, Kodali R, Tiruveedhula V, Li G, Scholze P, Marković B, Obradović A, Ernst M, Cook J, Savić M (2018) Attaining in vivo selectivity of positive modulation of α3βγ2 GABA A receptors in rats: A hard task! Eur Neuropsychopharmacol, 28 (8): 903-914
• Weinhofer I, Zierfuss B, Hametner S, Wagner M, Popitsch N, Machacek C, Bartolini B, Zlabinger G, Ohradanova-Repic A, Stockinger H, Köhler W, Höftberger R, Regelsberger G, Forss-Petter S, Lassmann H, Berger J (2018) Impaired plasticity of macrophages in X-linked adrenoleukodystrophy Brain, 141: 2329-2342
  | Article (PDF) |
• Dorninger F, Moser A, Kou J, Wiesinger C, Forss-Petter S, Gleiss A, Hinterberger M, Jungwirth S, Fischer P, Berger J (2018) Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer’s Disease Mimic Accelerated Aging J. Alzheimers Dis., 62 (2): 841-854
  | Article (PDF) |
• Treven M, Siebert D, Holzinger R, Bampali K, Fabjan J, Varagic Z, Wimmer L, Steudle F, Scholze P, Schnürch M, Mihovilovic M, Ernst M (2018) Towards Functional Selectivity for α6β3γ2 GABAA Receptors: A Series of Novel Pyrazoloquinolinones Br J Pharmacol, 175 (3): 419-428

• Kunze M (2018) Predicting Peroxisomal Targeting Signals to Elucidate the Peroxisomal Proteome of Mammals. In: del Río, Luis A. (Ed.), Subcellular Biochemistry Vol. 69: Peroxisomes and their Key Role in Cellular Signaling and Metabolism Springer Verlag, Heidelberg: 157-199

• Wongsamitkul N, Maldifassi M, Simeone X, Baur R, Ernst M, Sigel E (2017) α subunits in GABAA receptors are dispensable for GABA and diazepam action Sci Rep, 7 (1)
• Simeone X, Siebert D, Bampali K, Varagic Z, Treven M, Rehman S, Pyszkowski J, Holzinger R, Steudle F, Scholze P, Mihovilovic M, Schnürch M, Ernst M (2017) Molecular tools for GABAA receptors: High affinity ligands for β1-containing subtypes Sci Rep, 7 (1) : 5674
• Trigueros-Motos L, van Capelleveen J, Torta F, Castaño D, Zhang LH, Chai C, Kang M, Dimova L, Schimmel A, Tietjen I, Radomski C, Tan L, Hwee T, Narayanaswamy P, Wu D, Dorninger F, Yakala G, Barhdadi A, Angeli V, Dubé M, Berger J, Dallinga-Thie G, Tietge U, Wenk M, Hayden M, Hovingh G, Singaraja R (2017) ABCA8 Regulates Cholesterol Efflux and High-Density Lipoprotein Cholesterol Levels Arterioscler Thromb Vasc Biol, 37: 2147-2155
• Ghafari M, Falsafi S, Szodorai E, Kim E, Li L, Höger H, Berger J, Fuchs K, Sieghart W, Lubec G (2017) Formation of GABAA receptor complexes containing α1 and α5 subunits is paralleling a multiple T-maze learning task in mice Brain Struct Funct, 222 (1): 549-561
• Dorninger F, Herbst R, Kravic B, Camurdanoglu B, Macinkovic I, Zeitler G, Forss-Petter S, Strack S, Khan M, Waterham H, Rudolf R, Hashemolhosseini S, Berger J (2017) Reduced Muscle Strength in Ether Lipid-Deficient Mice Is Accompanied by Altered Development and Function of the Neuromuscular Junction J Neurochem, 143: 569-583
  | Article (PDF) |

• Dorninger F, Forss-Petter S, Berger J (2017) From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system FEBS Letters, 591: 2761-2788
  | Article (PDF) |

• Puthenkalam R, Hieckel M, Simeone X, Suwattanasophon C, Feldbauer R, Ecker G, Ernst M (2016) Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What? Front Mol Neurosci, 16;9:44
• Stamenić T, Poe M, Rehman S, Santrač A, Divović B, Scholze P, Ernst M, Cook J, Savić M (2016) Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the α5 subunit Eur J Pharmacol, 791: 433-443
• Mandl P, Hayer S, Karonitsch T, Scholze P, Győri D, Sykoutri D, Blüml S, Mócsai A, Poór G, Huck S, Smolen J, Redlich K (2016) Nicotinic acetylcholine receptors modulate osteoclastogenesis Arthritis Res Ther, 18 (1): 63
  | Article (pdf) |

• Berger J, Dorninger F, Forss-Petter S, Kunze M (2016) Peroxisomes in brain development and function Biochim Biophys Acta, 863: 934-955
  | Article (PDF) |

• Kunze M, Berger J (2015) The similarity between N-terminal targeting signals for protein import into different organelles and its evolutionary relevance Front Physiol, 6: 1-27
• Jung G, Kim E, Cicvaric A, Sase S, Gröger M, Höger H, Sialana F, Berger J, Monje F, Lubec G (2015) Drebrin depletion alters neurotransmitter receptor levels in protein complexes, dendritic spine morphogenesis and memory-related synaptic plasticity in the mouse hippocampus J Neurochem, 134 (2): 327-339
• Mika J, Schwarz K, Wanzenboeck H, Scholze P, Bertagnolli E (2015) Investigation of neurotrophic factor concentrations with a novel in vitro concept for peripheral nerve regeneration J Neurosci Res, 93 (11): 1631-1640
• Dorninger F, Wiesinger C, Braverman N, Forss-Petter S, Berger J (2015) Ether Lipid Deficiency Does Not Cause Neutropenia or Leukopenia in Mice and Men Cell Metab, 21 (5): 650-651
• Xanthos D, Beiersdorf J, Thrun A, Ianosi B, Orr-Urtreger A, Huck S, Scholze P (2015) Role of α5-containing nicotinic receptors in neuropathic pain and response to nicotine Neuropharmacology, 95: 37-49
  | Article (PDF) |
• Kunze M, Malkani N, Maurer-Stroh S, Wiesinger C, Schmid J, Berger J (2015) Mechanistic Insights into PTS2-mediated Peroxisomal Protein Import: The Co-receptor PEX5L drastically increases the Interaction Strength between the Cargo Protein and the Receptor PEX7 J Biol Chem, 290: 4928-4940
  | Article (PDF) |
• Dorninger F, Brodde A, Braverman N.E, Moser A.B, Just W, Forss-Petter S, Brügger B. Berger J, (2015) Homeostasis of Phospholipids – The Level of Phosphatidylethanolamine Tightly Adapts to Changes in Ethanolamine Plasmalogens Biochim Biophys Acta, 1851: 117-128
  | Article (PDF) |
• Ghafari M, Whittle N, Miklósi A, Kotlowsky C, Schmuckermair C, Berger J, Bennett K, Singewald N, Lubec G (2015) Dietary magnesium restriction reduces amygdala–hypothalamic GluN1 receptor complex levels in mice Brain Struct Funct, 220 (4): 2209-2221
  | Article (PDF) |

• Wiesinger C, Eichler F, Berger J, (2015) The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis Appl Clin Genet, 8: 109
  | Article (PDF) |

• Muneer Z, Wiesinger C, Voigtländer T, Werner H, Berger J, Forss-Petter S (2014) Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice PLoS One, 9 (9): e108655
  | Article (PDF) |
• Weber F, Weinhofer I, Einwich A, Forss-Petter S, Muneer Z, Maier H, Weber W, Berger J (2014) Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy PLoS One, 9 (7): e103742
  | Article (PDF) |
• Saroja S, Sase A, Kircher S, Wan J, Berger J, Höger H, Pollak A, Lubec G (2014) Hippocampal proteoglycans brevican and versican are linked to spatial memory of Sprague-Dawley rats in the morris water maze J Neurochem, 130 (6): 797-804
• Beiranvand F, Zlabinger C, Orr-Urtreger A, Ristl R, Huck S, Scholze P (2014) Nicotinic acetylcholine receptors control acetylcholine and noradrenaline release in the rodent habenulo-interpeduncular complex Br J Pharmacol, 171 (23): 5209-5224
  | Article (PDF) |
• Weber F, Wiesinger Ch, Forss-Petter S, Regelsberger G, Einwich A, Weber W, Köhler W, Stockinger H, Berger J, (2014) X-linked adrenoleukodystrophy: Very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes Hum Mol Genet, 23 (10): 2542-2550
  | Article (PDF) |
• Gondcaille C, C.Genin E, E.Lopez T, MM.Dias A, Geillon F, Andreoletti P, Cherkaoui-Malki M, Nury T, Lizard G, Weinhofer-Molisch I, Berger J, T.Kase E, Trompier D, Savary St, (2014) LXR antagonists induce ABCD2 expression Biochim Biophys Acta, 1841(2): 259-266
  | Article (PDF) |
• Mirheydari P, Ramerstorfer J, Varagic Z, Scholze P, Wimmer L, Mihovilovic MM, Sieghart W, Ernst M (2014) Unexpected properties of delta-containing GABA-A receptors in response to ligands interacting with the alpha+beta-site Neurochem Res, 39 (6): 1057-1067

• Berger J, Forss-Petter S, Eichler F.S, (2014) Pathophysiologie of X-linked adrenoleukodystrophy Biochimie, 98: 135-142
  | Article (PDF) |

• Kunze M, Berger J (2014) Single Peroxisomal Enzyme and Transporter Deficiencies in Human Diseases and Mouse Models. In: , Molecular Machines Involved in Peroxisome Biogenesis and Maintenance Springer Vienna: pp 153-184
  | Weblink |

• Wang B, Van Veldhoven P, Brees C, Rubio N, Nordgren M, Apanasets O, Kunze M, Baes M, Agostinis P, Fransen M (2013) Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells FREE RADICAL BIO MED , 65: 882-894
  | Article (PDF) |
• Pei Z, Fraisl P, Shi X, Gabrielson E, Forss-Petter S, Berger J, Watkins P.A (2013) Very Long-Chain Acyl-COA Synthetase 3:Overexpression and Growth Dependence in Lung Cancer PLoS.ONE., 8(7): e69392
  | Article (PDF) |
• Ciuraszkiewicz A, Schreibmayer W, Platzer D, Orr-Urtreger A, Scholze P, Huck S. (2013) Single-channel properties of α3β4, α3β4α5, and α3β4β2 nicotinic ACh receptors in mice lacking specific nAChR subunits J Physiol, 591: 3271-3288
  | Article (PDF) |
• Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J. (2013) Impaired Very Long-Chain Acyl-CoA β-Oxidation in Human X-ALD Fibroblasts Is a Direct Consequence of ABCD1 Transporter Dysfunction J Biol Chem, 288: 19269-19279

• Kunze M, Hartig A, (2013) Permeability of the peroxisomal membrane: lessons from the glyoxylate cycle Front Physiol, 4
  | Article (PDF) |

• Weinhofer I, Kunze M, Forss-Petter S, Berger J (2013) Involvement of Human Peroxisomes in Biosynthesis and Signaling of Steroid and Peptide Hormones. In: del Río, Luis A. (Ed.), Subcellular Biochemistry Vol. 69: Peroxisomes and their Key Role in Cellular Signaling and Metabolism Springer Verlag, Heidelberg: pp 101-110

• Berger ML, Pöhler T, Schadt O, Stanger M, Rebernik P, Scholze P, Noe CR (2012) Exploring the Polyamine Regulatory Site of the NMDA Receptor: a Parallel Synthesis Approach ChemMedChem, 8 (1): 82-94
  | Article (PDF) || Weblink |
• Brodde A, Teigler A, Brugger B, Lehmann WD, Wieland F, Berger J, Just WW. (2012) Impaired neurotransmission in ether lipid-deficient nerve terminals Hum Mol Genet, 21(12): 2713-2724.
  | Article (PDF) |
• Preusser M, Hassler M, Birner P, Rudas M, Acker T, Plate H, Widhalm G, Knosp E, Breitschopf H, Berger J, Marosi C. (2012) Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches Clin Neuropathol, 31(5): 352-360
• Scholze P, Koth G, Orr-Urtreger A, Huck S (2012) Subunit composition of α5-containing nicotinic receptors in the rodent habenula J Neurochem, 121(4): 551-560
  | Article (PDF) |
• Facciotti F, Ramanjaneyulu GS, Lepore M, Sansano S, Cavallari M, Kistowska M, Forss-Petter S, Ni G, Colone A, Singhal A, Berger J, Xia C, Mori L, De Libero G (2012) Peroxisome-derived lipids are self-antigens stimulating invariant Natural Killer T cells in the thymus Nature Immunol, 13(5): 474-480.
• Barbier M, Sabbagh A, Kasper E, Asheuer M, Ahouansou O, Pribill I, Forss-Petter S, Vidaud M, Berger J, Aubourg P (2012) CD1 gene polymorphisms and phenotypic variability in X-linked adrenoleukodystrophy PLoS.ONE., 7(1): e29872
  | Article (PDF) |

• Kemp S, Berger J, Aubourg P (2012) X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects BBA, 1822 (9): 1465-1474

• Wolff P, Weinhofer I, Seguin J, Roszak P, Beisel C, Donoghue MT, Spillane C, Nordborg M, Rehmsmeier M, Köhler C. (2011) High-resolution analysis of parent-of-origin allelic expression in the Arabidopsis Endosperm PLoS Genet, 7(6): e1002126.
• Kunze M, Neuberger G, Maurer-Stroh S, Ma J, Eck T, Braverman N, Schmid J, Eisenhaber F, Berger J. (2011) Structural requirements for the interaction of peroxisomal targeting signal 2 and its receptor PEX7 J Biol Chem, 286(52): 45048-45062
  | Article (PDF) |
• Kou J, Kovacs GG, Höftberger R, Kulik W, Brodde A, Forss-Petter S, Hönigschnabl S, Gleiss A, Brügger B, Wanders R, Just W, Budka H, Jungwirth S, Fischer P, Berger J. (2011) Peroxisomal alterations in Alzheimer's disease Acta Neuropathol, 122: 271-283
  | Article (PDF) |
• Scholze P, Ciuraszkiewicz A, Grössl F, Orr-Urtreger A, McIntosh JM, Huck S (2011) Alpha4beta2 Nicotinic Acetylcholine Receptors n the Early Postnatal Mouse Superior Cervical Ganglion Dev. Neurobiology, 71 (5): 390-399
  | Article (PDF) |
• Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C (2011) Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice Neuroscience, 180: 280-292

• Anzola JM, Sieberer T, Ortbauer M, Butt H, Korbei B, Weinhofer I, Müllner AE, Luschnig C. (2010) Putative Arabidopsis transcriptional adaptor protein (PROPORZ1) is required to modulate histone acetylation in response to auxin Proc Natl Acad Sci USA, 107(22): 10308-13
• Weinhofer I, Hehenberger E, Roszak P, Hennig L, Köhler C. (2010) H3K27me3 profiling of the endosperm implies exclusion of polycomb group protein targeting by DNA methylation PLoS Genet, 6(10): e1001152
• Höftberger R, Kunze M, Voigtländer T, Unterberger U, Regelsberger G, Bauer J, Aboul-Enein F, Garzuly F, Forss-Petter S, Bernheimer H, Berger J, Budka H (2010) Peroxisomal Localization of the Proopiomelanocortin-Derived Peptides β-Lipotropin and β-Endorphin Endocrinology, 151 (10): 4801-4810
  | Article (PDF) |
• Ramerstorfer J, Furtmüller R, Vogel E, Huck S, Sieghart W (2010) The point mutation gamma2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes Eur J Pharmacol, 636: 18-27
  | Article (PDF) |
• David R, Ciuraszkiewicz A, Simeone X, Orr-Urtreger A, Papke RL, McIntosh JM, Huck S, Scholze P (2010) Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes Eur J Neurosci, 6: 978-993
  | Article (PDF): 1 2 |

• Köhler C, I. Weinhofer-Molisch (2010) Mechanisms and evolution of genomic imprinting in plants Heredity, 105: 57-63
• Berger J, Pujol A, Aubourg P, Forss-Petter S (2010) Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy. Brain Pathol, 20: 845-856
  | Article (PDF) |

• Nicolussi EM, Huck S, Lassmann H, Bradl M (2009) The cholinergic anti-inflammatory system limited T cell infiltration into the neurodegenerative CNS, but can not counteract complex CNS inflammation Neurobiol Dis, 35: 24-31

• Savic MM, Clayton T, Furtmüller R, Gavrilovic I, Samardzic J, Savic S, Huck S, Sieghart W, Cook JM (2008) PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA-A receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats Brain Res, 1208: 150-159
  | Article (PDF) |
• Maier EM, Mayerhofer PU, Asheuer M, Köhler W, Rothe M, Muntau AC, Roscher AA, Holzinger A, Aubourg P, Berger J (2008) X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype Biochem Bioph Res Comm, 377: 176-180
  | Article (PDF) |
• Weinhofer I, Kunze M, Rampler H, Forss-Petter S, Samarut J, Plateroti M, Berger J (2008) Distinct modulatory roles for thyroid hormone receptors TR-alpha and TR-beta in SREBP1-activated ABCD2 expression Eur J Cell Biol, 87: 933-945
  | Article (PDF) |
• Furtmüller R, Furtmüller B, Ramerstorfer J, Paladini AC, Wasowski C, Marder M, Huck S, Sieghart W (2008) 6,3'-Dinitroflavone is a low efficacy modulator of GABA(A) receptors Eur J Pharmacol, 591: 142-146
  | Article (PDF) |
• Harris D, Clayton T, Cook J, Sahbaie P, Halliwell RF, Furtmüller R, Huck S, Sieghart W, and DeLorey TM (2008) Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit J Med Chem, 51: 3788-3803
  | Article (PDF) |
• Putz G, Kristufek D, Orr-Urtreger A, Changeux JP, Huck S, Scholze P (2008) Nicotinic acetylcholine receptor-subunit mRNAs in the mouse superior cervical ganglion are regulated by development but not by deletion of distinct subunit genes J Neurosci Res, 86: 972-981
  | Article (PDF) |
• Savic MM, Huang S, Furtmüller R, Clayton T, Huck S, Obradovic DI, Ugresic ND, Sieghart W, Bokonjic DR, Cook JM (2008) Are GABA(A) Receptors Containing alpha5 Subunits Contributing to the Sedative Properties of Benzodiazepine Site Agonists? Neuropsychopharm, 33: 332-339
  | Article (PDF) |

• Scholze P., Orr-Urtreger A., Changeux J.-P., McIntosh J.M. , Huck S (2007) Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation Br J Pharmacol, 151: 414-422
  | Article (PDF) |
• Sarto-Jackson I, Furtmüller R, Ernst M, Huck S, Sieghart W (2007) Spontaneous cross-link of mutated alpha1 subunits during GABA-A receptor assembly J Biol Chem, 282: 4354-4363
  | Article (PDF) |
• Wiese S, Gronemeyer T, Ofmann R, Kunze M, Grou CP, Almeida JA, Eisenacher M, Stephan C, Hayen H, Pawlas M, Bunse C, Schollenberger L, Korosec T, Waterham HR, Schliebs W, Erdmann R, Berger J et al (2007) Proteomic characterization of mouse kidney peroxiosmes by tandem mass spectrometry and protein correlation profiling Mol Cell Proteomics, 6: 2045-2057
• Höftberger R, Kunze M, Weinhofer I, Aboul-Enein F, Voigtländer T, Oezen I, Amann G, Bernheimer H, Budka H, Berger J (2007) Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: Implications for X-linked adrenoleukodystrophy Neurobiol Dis, 28 (2): 165-174
• Barceló-Coblijn G., Golkovko MY., Weinhofer I., Berger J., Murphy E.J. (2007) Brain neutral lipids mass is increased in a-synuclein gene ablated mice J Neurochem, 101: 132-141
• Dumser M, Bauer J, Lassmann H, Berger J, Forss-Petter S (2007) Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency Acta Neuropathol, 114;6: 573-586

• Golovko Y.M., Rosenberger T.A., Fargeman N.J., Feddersen S., Cole N.B, Pribill I., Berger J., Nussbaum R.L., Murphy E.J (2006) Acyl-CoA Synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism Biochemistry, 45: 6956-6966
• Weinhofer I., Kunze M., Stangl H., Porter F.D., Berger J (2006) Peroxisomal cholesterol biosynthesis and Smith-Lemli-Opitz syndrome. Biochem Bioph Res Comm, 345: 205-209
• Fraisl P., Tanaka H., Forss-Petter S, Lassmann H., Nishimune Y., Berger J (2006) A novel mammalian bubblegum-related acyl-CoA synthetase restricted to testes and possibly involved in spermatogenesis Arch Biochem Biophys, 451: 23-33
• Yang J-W., Afjehi-Sadat L., Gelpi E., Kunze M., Höger H., Fleckner J., Berger J., Lubec G (2006) Proteom Profiling in the rat Harderian gland J Proteome Res, 5: 1751-1762
• Rauschka H., Colsch B., Baumann N., Wevers R., Schmidbauer M., Krammer M., Turpin J.C., Lefevre M., Olivier C., Tardieu S., Krivit W., Moser H., Moser A., Gieselmann V,.....Berger J (2006) Late onset metachromatic leukodystrophy: genotype strongly influences phenotype Neurology, 67: 859-863
• Hochmeister S., Grundtner R., Bauer J., Engelhardt B., Lyck R., Gordon G., Korosec T., Kutzelnigg A., Berger J., Bradl M., Bittner R.E., Lassmann H (2006) Dysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis J Neuropath Exp Neurol, 65: 855-865

• Berger J, Gärtner J (2006) X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects BBA Mol Cell Res, 1763: 1721-1732
• Kunze M, Pracharoentwattana I, Smith SM, Hartig A (2006) A central role for the peroxisomal membrane in glyoxylate cycle function BBA Mol Cell Res, 1763: 1441-1452

• Fischer H., Orr-Urtreger A., Role L.W., Huck S (2005) Selective deletion of the alpha 5 subunit differentially affects somatio-dendritic versus axonally targeted nicotinic ACh receptors in mouse J Physiol, 563: 119-137
• DiRusso C. C., Li H, Drwis D, Watkins P, Berger J., Black P.N (2005) Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast J Biol Chem, 280: 16829-16837
• Oezen I., Rossmanith W., Forss-Petter S., Kemp S., Voigtländer T., Moser-Thier., Wanders R., Bittner R., Berger J (2005) Accumulation of very long-chain fatty acids does not affect mitochondrial function in Adrneoleukodystrophy protein deficiency Hum Mol Genet, 14: 1127-1137
• Lugowska A., Berger J., Tylki-Szymanska A., Löschl B., Molzer B., Zobel M., Czartoryska B (2005) Molecular and phenotypic characteristics of metachromatic leukodystrophy patients from Poland Clin Genet, 68: 48-54
• Weinhofer I., Forss-Petter S., Kunze M., Zigman M., Berger J. (2005) X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism FEBS Letters, 579: 5512-5516
• Lugowska A., Amaral O., Berger J., Berna L., Bosshard N.U., Chabas A., Fensom A., Gieselmann V., Gorovenko NG., Lissens W., Mansson J.E., Marcap A., Michelakakis H., Bernheimer H., Olkhovych N.V. et a (2005) Mutations c.459+1G>A and p.P426L in the ARSA gene: prevalence in metachromatic leukodystrophy patients from European countries Mol Genet Metab, 86: 353-359
• Weinhofer I., Kunze M., Rampler H., Bookout A.L., Forss-Petter S., Berger J (2005) LXRalpha interferes with SREBP1c-mediated Abcd2 expression: novel cross-talk in gene regulation J Biol Chem, 280: 41243-41251

• Fraisl P., Forss-Petter S., Zigman M., Berger J. (2004) Murine bubblegum orthologue is a microsomal very long-chain acyl-CoA synthetase Biochemistry, 377: 85-93
• Mashek D.G., Bornfeldt K.E., Coleman R.A., Berger J., Bernlohr D.A., Black P., DiRusso C.C., Farber S.A., Guo W., Hashimoto N., Khodiyar V., Kuypers F.A., Maltais L. J., Nebert D.W., Renieri A., S (2004) Revised nomenclature for the mammalian long chain acyl-CoA synthetase (ACS) gene family J Lipid Res, 45: 1958-1961
• Birner P., Preusser M., Gelpi E., Berger J., Gatterbauer B., Ambros I.M., Ambros P.F., Acker T., Plate K.H., Harris A.L., Hainfellner J.A (2004) Expression of hypoxia-related tissue factors correlates with diminished survival of adjuvantly treated patients with chromosome 1p-aberrant oligodendroglial neoplasms: therapeutic implications Clin Cancer Res, 10: 6567-6571
• Pei Z., Fraisl P., Berger J., Jia Z., Forss-Petter S., Watkins P (2004) Mouse very long-chain acyl-CoA synthetase 3/Fatty Acid Transporter Protein 3 Catalyzes fatty acid activation but not fatty acid transport in MA-10 cells J Biol Chem, 279: 54454-54462
• Neuberger G., Kunze M., Eisenhaber F., Berger J., Hartig A., Brocard C. (2004) Hidden localisation motifs: Naturally occurring peroxisomal targeting signals in non-peroxisomal proteins Genome Biol, 5: R97

• Weinhofer I, Forss-Petter S, Zigman M, Berger J (2003) Cholesterol regulates ABCD2 gene expression: implications for X-linked adrenoleukodstrophy Adv Exp Med Biol, 544: 331-332
• Li X, Cao H, Zhang C, Furtmüller R, Fuchs K, Huck S, Sieghart W, Deschamps J, Cook JM (2003) Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazol[1,5a]- [1,4]benzo-diazepine analogue, the first bivalent alpha5 subtype selective BzR/GABAA antagonist J Med Chem, 46: 5567-5570
• Lassmann H., Reindl M., Rauschka H., Berger J., Aboul-Enein F., Berger T., Zurbriggen A., Luterotti A., Brück W., Weber JR., Ullrich R., Schmidbauer M., Jellinger K., Vanddevelde M. (2003) A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions Brain, 126: 1347-1357
• Fourcade S., Savary S., Gondcaille C., Berger J., Netik A., Cadepond F., Etr ME., Molzer B., Bugaut M (2003) Thyroid hormone induction of the drenoleukodystrophy-related gene (ABCD2) Mol Pharmacol, 63: 1296-1303
• Rampler H., Weinhofer I., Netik A., Forss-Petter S., Brown PJ., Oplinger JA., Bugaut M., Berger J (2003) Evaluation of the therapeutic potential of PPAR alpha agonists for X-linked adrenoleukodystrophy. Mol Genet Metab, 80: 398-407

• Berger J, Kunze M, Forss-Petter S (2003) Lessons from Knockout Mice II: Mouse Models for Peroxisomal Disorders with Single Protein Deficiency. In: , Advances in Experimental Medicine and Biology Springer Verlag: 123-134

• Kunze M, Kragler F, Binder M, Hartig A, Gurvitz A (2002) Targeting of malate synthase 1 to the peroxisomes of Saccharomyces cerevisiae cells depends on growth on oleic acid medium Eur J Biochem, 269 (3): 915-922
  | Article (PDF) |
• Scholze P, Freissmuth M, Sitte H (2002) Mutations within an Intramembrane Leucine Heptad Repeat Disrupt Oligomer Formation of the Rat GABA Transporter 1 J Biol Chem, 277 (46): 43682-43690
  | Article (PDF) |
• Scholze P (2002) The Role of Zinc Ions in Reverse Transport Mediated by Monoamine Transporters J Biol Chem, 277 (24): 21505-21513
  | Article (PDF) |
• Sitte H, Singer E, Scholze P (2002) Bi-directional transport of GABA in human embryonic kidney (HEK-293) cells stably expressing the rat GABA transporter GAT-1 Br J Pharmacol, 135 (1): 93-102
  | Article (PDF) |
• Furtmüller R, Schlag MG, Berger M L, Hopf R, Huck S, Sieghart W, Redl H (2002) Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid-A-receptor antagonistic effect J Pharmacol Exp Ther, 301: 168-173
• Kristufek D, Rudorfer W, Pifl C, Huck S (2002) Organic cation transporter mRNA and function in the rat superior cervical ganglion J Physiol, 543: 117-134
• Lugowska A., Berger J., Tylki-Szymanska A., Czartoryska B., Löschl B., Molzer B (2002) High prevalence of I179S mutation in patients with late-onset metachromatic leukodystrophy Clin Genet, 61: 389-390
• Tylki-Szymanska A., Lugowska A., Chmielik J., Kotowicz J., Winiecka A., Zobel M., Berger J., Molzer B (2002) Investigation into micro-organic brain damage (MOBD) in heterozygotes of metachromatic leukodystrophy Am J Med Genet, 110: 315-319
• Weinhofer I., Forss-Petter S., Zigman M., Berger J (2002) Cholesterol regulates ABCD2 expression: Implication for therapy of X-linked adrenoleukodystrophy Hum Mol Genet, 11: 2701-2708

• Scholze P, Sitte H, Singer E (2001) Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters Neurosci Lett, 309 (3): 173-176
  | Article (PDF) |
• Schmid J, Scholze P, Kudlacek O, Freissmuth M, Singer E, Sitte H (2001) Oligomerization of the Human Serotonin Transporter and of the Rat GABA Transporter 1 Visualized by Fluorescence Resonance Energy Transfer Microscopy in Living Cells J Biol Chem, 276 (6): 3805-3810
  | Article (PDF) |
• Klausberger T, Sarto I, Ehya N, Fuchs K, Furtmüller R, Mayer B, Huck S, Sieghart W (2001) Alternate use of distinct intersubunit contacts controls GABA-A receptor assembly and stoichiometry J Neurosci, 21: 9124-9133
• Sitte HH, Hiptmair B, Zwach J, Pifl C, Singer EA, Scholze P (2001) Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion Mol Pharmacol, 59: 1129-1137
  | Article (PDF) |
• Albet S., Bentejac M., Savary S., Gondcaille C., Netik A., Berger J., Szpirer C., Pineau T., Toiffer-Charlier N., Bugaut M (2001) Rat adrenoleukodystrophy-related (ALDR) gene: full-length cDNA sequence and new insight in expression Biochim Biophys Acta, 1517: 257-269
• Dvoráková L., Štorkánová G., Unterrainer G. , Hujová J., Kmoch S., Zeman J., Høebíèek M., Berger J (2001) Eight novel ABCD1 gene mutations and three polymorphisms in patients with X-linked adrenoleukodystrophy: The first polymorphism causing an amino acid exchange Hum Mut, 18: 52-60
• Fourcade S., Savary S, Albet S, Gauthé D., Gondcaille C., Pineau T., Bellenger J., Bentejac M., Holzinger A., Berger J., Bugaut M (2001) Fibrate induction of the Adrenoleukodystrophy-Related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARa Eur J Biochem, 268: 3490-3500

• Sitte HH, Scholze P, Schloss P, Pifl C, Singer EA (2000) Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study J Neurochem, 74: 1317-1324
• Scholze P, Zwach J, Kattinger A, Pifl V, Singer EA, Sitte HH (2000) Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter J Pharmacol Exp Ther, 293: 870-878p
• Nöhammer C., El Shabrawi Y., Schauer S., Hiden M., Berger J., Forss-Petter S., Winter E., Eferl R., Zechner R., Höfler G. (2000) cDNA cloning and analysis of issue-specific expression of mouse peroxisomal acyl-CoA oxidase Eur J Biochem, 267: 1254-1260
• Lugowska A., Czartoryska B., Tylki-Szymanska A., Bisko M., Zimowski JG., Berger J., Molzer B (2000) Prevalence of arylsulfatase A pseudodeficiency allele in metachromatic leukodystrophy patients from Poland Eur Neurol, 44: 104-107
• Unterrainer G., Molzer B., Forss-Petter S., Berger J (2000) Coexpression of mutated adrenoleukodystrophy protein reduces wild-type protein function: Implication for gene therapy in X-linked adrenoleukodystrophy Hum Mol Genet, 9: 2609-2616
• Netik A., Hobel A., Rauschka H., Molzer B., Forss-Petter S., Berger J (2000) Rolipram does not normalize very long chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice J Inhereted Metab Dis, 23: 615-624
• Berger J., Korosec T., Unterrainer G., Molzer B (2000) A de novo adrenoleukodystrophy gene (ABCD1) mutation S636I without detectable ABCD1 protein and a R104C mutation with normal amount of protein from a Austrian patient collective Hum Mut, 16: 534

• Thomet U, Baur R, Scholze P, Sieghart W, Sigel E (1999) Dual mode of stimulation by the beta-carboline ZK91085 of recombinant GABA-A receptor currents: molecular determinants affecting its action Br J Pharmacol, 127: 1231-1239
• Ebert V, Scholze P, Fuchs K, Sieghart W (1999) Identification of subunits mediating clustering of GABA-A receptors by rapsyn Neurochem Internat, 34: 453-463
• Berger J., Gmach M., Mayr H., Molzer B., Bernheimer H (1999) Coincidence of two novel arylsulfatase A alleles and mutation 459+1G>A within a family with metachromatic leukodystrophy: molecular basis of phenotypic heterogeneity Hum Mut, 13: 61-68
• Netik A., Forss-Petter S., Holzinger A., Molzer B., Unterrainer G., Berger J (1999) Adrenoleukodystrophy-related protein can functionally compensate for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy Hum Mol Genet, 8: 907-913
• Holzinger A., Mayerhofer P., Berger J., Lichtner P., Krammerer S., Roscher A. (1999) Full length cDNA cloning, promoter sequence and genomic organisatin of the human adrenoleukodystrophy related (ALDR) gene functionally redundant to the gene responsible for X-linked adrenoleukodystrop Biochem Bioph Res Comm, 258: 436-442
• Berger J., Albet S., Bentejac M., Netik A., Holzinger A., Roscher A., Bugaut M., Forss-Petter S (1999) The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression Eur J Biochem, 265: 719-727

• Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C (1998) Carrier-mediated release, transport rates and charge transfer induced by amphetamine, tyramine and dopamine in mammalian cells transfected with the human dopamine transporter J Neurochem, 71: 1289-1297
• Berger J., Truppe C., Neumann H., Forss-Petter S (1998) A novel relative of the very long-chain acyl-CoA synthetase and fatty acid transporter protein genes with a distinct expression pattern Biochem Bioph Res Comm, 247: 255-260
• Berger J., Truppe C., Neumann H., Forss-Petter S. (1998) cDNA cloning and mRNA distribution of a mouse very long-chain acyl-CoA synthetase FEBS Letters, 425: 305-309
• Santo-Matsumura K.C., Berger J., Hainfellner J.A., Mazal P., Budka H (1998) Development of HIV encephalitis in AIDS and TNF-a regulatory elements J Neuroimmunol, 91: 89-92
• Lametschwandtner G., Brocard C., Fransen M., Veldhoven P.V., Berger J., Hartig A (1998) The difference in recognition of terminal tripeptides as peroxisomal targeting signal 1 between yeast and human is due to different affinities of their receptor Pex5p to the cognate signal and to resi J Biol Chem, 273: 33635-33643
• Bauer, J., Bradl, M., Hickey, W.F., Forss-Petter, S., Breitschopf, H., Linington, C., Wekerle, H., and Lassmann, H (1998) T cell apoptosis in inflammatory brain lesions. Destruction of T cells does not depend on antigen recognition Am.J.Pathol., 153: 715-724

• Forss-Petter S, Werner H, Berger J, Lassmann H, Molzer B, Schwab MH, Bernheimer H, Zimmermann F, Nave KA (1997) Targeted inactivation of the X-linked adrenoleucodystrophy gene in mice. J Neurosci Res, 50: 829-843
• Weissenböck H., Hainfellner J.A., Berger J., Kasper I., Budka H (1997) Naturally occuring herpes simplex encephalitis in a domestic rabbit (Oryctolagus cuniculus) Vet Pathol, 34: 44-47
• McGuinness M.C., Powers J.M., Bias W.B., Schmeckpeper B.J., Segal A.H., Gowda V.C., Wesselingh S.L., Berger J., Griffin D.E., Smith K.D. (1997) Human leukocyte antigens and cytokine expression in cerebral inflammmatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis J Neuroimmunol, 75: 174-182
• Berger J., Löschl B., Bernheimer H., Lugowska A., Tylki-Szymanska A., Gieselmann V., Molzer B (1997) Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy Am J Med Genet, 69: 335-340
• Lugowska A., Tylki-Szymanska A., Berger J., Molzer B (1997) Elevated sulfatide excretion in compound heterozygotes of metachromatic leukodystrophy and ASA-pseudodeficiency alleles Clin Biochem, 30: 325-331
• Holzinger A., Kammerer S., Berger J., Roscher A.A (1997) cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDR), a peroxisomal ABC-transporter Biochem Bioph Res Comm, 239: 261-264

• Berger J., Bernheimer H., Forss-Petter S (1997) False PCR-based diagnosis: is it avoidable? Am J Med Genet, 72: 241

• Tylki-Szymanska A., Berger J., Löschl B., Lugowska A., Molzer B (1996) Late juvenile metachromatic leukodystrophy (MLD) in three patients with similar clinical course and identical mutation on one allele Clin Genet, 50: 287-292
• Madsen K.M., Hasholt L., Berger J., Sorenson S.A. (1996) SSCP analysis of paraffin embeddes tissues in a family with an atypical form of Fabry disease J Clin Pathol; Mol Pathol, 49: 310-312
• Berger J., Gmach M., Faé I., Molzer B., Bernheimer H (1996) A new polymorphism of arylsulfatase A within the coding region Hum Genet, 98: 348-350

• Berger J., Bernheimer H., Fáe I., Braun A., Roscher A., Molzer B., Fischer G. (1995) Association of X-linced adrenoleukodystrophy with HLA DRB1 alleles Biochem Bioph Res Comm, 216: 447-451

• Berger J., Molzer B., Fáe I., Bernheimer H. (1994) X-linked adrenoleukodystrophy (ALD): A novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes Biochem Bioph Res Comm, 205: 1638-1643

• Berger J., Molzer B., Gieselmann V., Bernheimer H. (1993) Simultaneous detection of the two most frequent metachromatic leukodystrophy mutations Hum Genet, 92: 421-423

• Weichselbraun I., Berger J., Dobrovnik M., Bogerd H., Grassmann R., Greene W.C., Hauber J., Böhnlein E (1992) Dominant-Negative Mutants Are Clustered in a Domain of the Human T-Cell Leukemia Virus Type I Rex Protein: Implications for trans Dominace J Virol, 66: 4540-4545

• Berger J., Aepinus C., Dobrovnik M., Fleckenstein B., Hauber J., Böhnlein E. (1991) Mutational Analysis of Functional Domains in the HIV-1 Rev trans-Regulatory Protein Virology, 183: 630-635
• Böhnlein E., Berger J., Hauber J. (1991) Functional Mapping of the Human Immunodeficiency Virus Type 1 Rev RNA Binding Domain: New Insights into the Domain Structure of Rev and Rex J Virol, 65: 7051-7055

• Sabdyusheva Litschauer I, Becker K, Saghafi S, Ballke S, Bollwein C, Foroughipour M, Gaugeler J, Foroughipour M, Schavelová V, László V, Döme B, Brostjan C, Weichert W, Dodt H (2020) 3D histopathology of human tumours by fast clearing and ultramicroscopy Sci Rep, 10 (1)
• Koch E, Bongrand C, Bennett B, Lawhorn S, Moriano-Gutierrez S, Pende M, Vadiwala K, Dodt H, Raible F, Goldman W, Ruby E, McFall-Ngai M (2020) The cytokine MIF controls daily rhythms of symbiont nutrition in an animal–bacterial association PNAS, : 202016864
• Pende M, Vadiwala K, Schmidbaur H, Stockinger A, Murawala P, Saghafi S, Dekens M, Becker K, Revilla-i-Domingo R, Papadopoulos S, Zurl M, Pasierbek P, Simakov O, Tanaka E, Raible F, Dodt H (2020) A versatile depigmentation, clearing, and labeling method for exploring nervous system diversity Sci Adv, 6 (22): eaba0365
• Ueda H, Dodt H, Osten P, Economo M, Chandrashekar J, Keller P (2020) Whole-Brain Profiling of Cells and Circuits in Mammals by Tissue Clearing and Light-Sheet Microscopy Neuron, 106 (3): 369-387

• K.Becker C. Hahn, N. Jaehrling, M Pende, I. Sabdyusheva-Litschauer, S. Saghafi, M. Wanis, H.U-Dodt (2020) Chemical Clearing of Brains. , CRC Press

• Hahn C, Becker K, Saghafi S, Pende M, Avdibašić A, Foroughipour M, Heinz D, Wotjak C, Dodt H (2019) High‐resolution imaging of fluorescent whole mouse brains using stabilised organic media (sDISCO) J. Biophot., : e201800368

• Mano T, Albanese A, Dodt H, Erturk A, Gradinaru V, Treweek J, Miyawaki A, Chung K, Ueda H (2018) Whole-Brain Analysis of Cells and Circuits by Tissue Clearing and Light-Sheet Microscopy J. Neurosci., 38 (44): 9330-9337
• Pende M, Becker K, Wanis M, Saghafi S, Kaur R, Hahn C, Pende N, Foroughipour M, Hummel T, Dodt H (2018) High-resolution ultramicroscopy of the developing and adult nervous system in optically cleared Drosophila melanogaster Nat Commun, 9 (1)
• Saghafi S, Haghi-Danaloo N, Becker K, Sabdyusheva I, Foroughipour M, Hahn C, Pende M, Wanis M, Bergmann M, Stift J, Hegedus B, Dome B, Dodt H (2018) Reshaping a multimode laser beam into a constructed Gaussian beam for generating a thin light sheet J. Biophot., 11 (6): e201700213

• Jährling N, Becker K, Saghafi S, Dodt H (2017) Light-Sheet Fluorescence Microscopy: Chemical Clearing and Labeling Protocols for Ultramicroscopy. In: , Methods in Molecular Biology Springer: 33-49
  | Supplement |

• Bulantová J, Macháček T, Panská L, Krejčí F, Karch J, Jährling N, Saghafi S, Dodt H, Horák P (2016) Trichobilharzia regenti (Schistosomatidae): 3D imaging techniques in characterization of larval migration through the CNS of vertebrates Micron, 83: 62-71

• Dodt H (2015) The superresolved brain Science, 347 (6221): 474-475
• Jährling N, Becker K, Wegenast-Braun B, Grathwohl S, Jucker M, Dodt H (2015) Cerebral β-Amyloidosis in Mice Investigated by Ultramicroscopy PLoS One, 10 (5): e0125418

• Saghafi S, Becker K, Hahn C, Dodt HU (2014) 3D-ultramicroscopy utilizing aspheric optics J. Biophot., 7: 117-125

• Jährling N, Saghafi S, Becker K, Mauch C, Dodt H (2013) P 227. Ultramicroscopy (UM) in neurobiology Clin Neurophysiol, 124 (10): e174
• Gewies A, Castineiras-Vilarino M, Ferch U, Jährling N, Heinrich K, Hoeckendorf U, Przemeck GK, Munding M, Groß O, Schroeder T, Hrabe de Angelis M, Dodt HU, Peschel C, Förtser I, Dyer MJ, Ruland J. (2013) Prdm6 is essential for cardiovascular development in vivo PLoS.ONE., 8: e81833
• Rozhin Penjweini, Soheila Mokmeli, Klaus Becker, Hans-Ulrich Dodt, and Saghafi (2013) Effects of UV-, Visible-, Near-infrared Beams in Three Therapy Resistance Case Studies of Fungal Skin infections Optics and Photonics Journal, 3: 10.4236/opj.2013.37A001
• Saghafi S, Becker K, Hahn C, Dodt H U (2013) Light Sheet Microscopy: High resolution 3D Microscopic views beneath the surface Imaging & Microscopy, 15: 22-24

• Klaus Becker, Nina Jährling, Saiedeh Saghafi, and Hans-Ulrich Dodt (2013) Dehydration and Clearing of Whole Mouse Brains and Dissected Hippocampi for Ultramicroscopy. In: , Cold Spring Harbor Protocols John Inglis: 10.1101/pdb.prot075820
• Klaus Becker, Nina Jährling, Saiedeh Saghafi, and Hans-Ulrich Dodt (2013) Dehydration and Clearing of Adult Drosophila for Ultramicroscopy. In: , Cold Spring Harbor Protocols John Inglis: doi:10.1101/pdb.prot075812
• Klaus Becker, Nina Jährling, Saiedeh Saghafi, and Hans-Ulrich Dodt (2013) Immunostaining, Dehydration, and Clearing of Mouse Embryos for Ultramicroscopy. In: , Cold Spring Harbor Protocols John Inglis: 743-4
• Klaus Becker, Nina Jährling, Saiedeh Saghafi, and Hans-Ulrich Dodt (2013) Ultramicroscopy: Light-Sheet-Based Microscopy for Imaging Centimeter-Sized Objects with Micrometer Resolution. In: , Cold Spring Harbor Protocols John Inglis: 704-13

• Ertürk A, Becker K, Jährling N, Mauch CP, Hojer C, Egen J, Hellal F, Bradke F, Sheng M, Dodt HU (2012) Three-dimensional imaging of solvent-cleared organs using 3DISCO - pp 1983 - 1995 Nat Protoc, 7: 1983-1995
• Becker K, Jährling N, Saghafi S, Weiler R, Dodt HU (2012) Chemical clearing and dehydration of GFP expressing mouse brains PLoS.ONE., 7(3): e33916
• Becker K, Eder M, Ranft A, von Meyer L, Zieglgansberger W, Kochs E, Dodt HU (2012) Low dose isoflurane exerts opposing effects on neuronal network excitability in neocortex and hippocampus PLoS.ONE., 7(6): e39346
• Ertürk A, Mauch CP, Hellal F, Förstner F, Keck T, Becker K, Jährling N, Steffens H, Richter M, Hübener M, Kramer E, Kirchhoff F, Dodt HU, Bradke F (2012) Three-dimensional imaging of the unsectioned adult spinal cord to assess axon regeneration and glial responses after injury Nat Med, 18: 166-171
  | Supplement |

• Jährling N, Saghafi S (2011) Ultramicroscopy – a novel light sheet based imaging technique created by various research disciplines e&i, 128: 352-358
  | Supplement |
• Schönbauer C, Distler J, Jährling N, Radolf M, Dodt HU, Frasch M, Schnorrer F (2011) Spalt mediates an evolutionarily conserved switch to fibrillar muscle fate in insects. Nature, 479: 406-409
  | Supplement |

• Keller P, Dodt H.-U. (2011) Light sheet microscopy of living or cleared specimens Curr Opin Neurol, 22: 1-6

• Jährling N (2011) Applications of ultramicroscopy to neurobiology and methodological improvements Thesis Work PHD, University of Oldenburg, Germany

• Dodt H.-U., Eder M , Schierloh A, Zieglgänsberger W (2011) Infrared-guided neurotransmitter uncaging on dendrites. In: , Imaging in Neuroscience: A laboratory manual Cold Spring Harbor Press, New York: 387-391
• Becker K, Jährling N, Saghafi S, Dodt H.-U. (2011) Ultramicroscopy: Light-sheet based microscopy for imaging centimeter-sized objects with micrometer resolution.. In: , Imaging: A laboratory manual Cold Spring Harbor Laboratory Press, New York 2011

• Müller M, Jagla M, Bodard LM, Jährling N, Dodt HU, Jagla K, Frasch M (2010) Regulation and functions of the lms homeobox gene during development of embryonic lateral transverse muscles and direct flight muscles in Drosophila PLoS.ONE., 5: 1-16
  | Supplement |
• Ehsani H, Saghafi S, Ghoranneviss M, Hantezadeh M, Hosseini H, Dodt HU (2010) Alteration of optical and morphological properties of polycarbonate illuminated by visible/IR laser beams J. Europ. Opt. Soc. Rap. Public., 5: 100325
• Saghafi S, Penjweini R, Becker K, Kratky W, Dodt HU (2010) Investigating the effects of laser beams (532 and 660nm) in the annihilation of pistachio mould fungus using spectrophotometry J. Europ. Opt. Soc. Rap. Public., 5: 10033s
  | Supplement |
• Saghafi S, Becker K, Jährling N, Richter R, Kramer ER, Dodt HU (2010) Image enhancement in ultramicroscopy by improved laser light sheets J. Biophot., 3: 686-695
  | Supplement |
• Kalchmair S, Jährling N, Becker K, Dodt HU (2010) Image contrast enhancement in confocal ultramicroscopy Optics Letters, 35: 79-81
  | Supplement |
• Becker K, Schneider G, Eder3 M, Ranft A, Kochs EF, Zieglgänsberger W, and Dodt HU (2010) Anaesthesia Monitoring by Recurrence Quantification Analysis of EEG Data PLoS.ONE., 5: e8876
  | Article (PDF) || Supplement |
• Jährling N, Becker K, Schönbauer C, Schnorrer F, and Dodt HU (2010) Three-dimensional reconstruction and segmentation of intact Drosophila by ultramicroscopy Front Syst. Neurosci, 4: 1-5
  | Article (PDF) || Supplement |

• Jährling N, Becker K, and Dodt HU (2009) 3D-reconstruction of blood vessels by ultramicroscopy Organogenesis, 5: 227-230
  | Article (PDF) || Supplement |
• Leischner U, Zieglgänsberger W, Dodt HU (2009) Resolution of ultramicroscopy and field of view analysis PLoS.ONE., 4: e5785

• Deininger K, Eder M, Kramer ER, Zieglgänsberger W, Dodt HU, Dornmair K, Colicelli J, Klein R (2008) The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons Proc Natl Acad Sci USA, 105: 12539-44
  | Article (PDF) |
• Jährling N, Becker K, Kramer ER, Dodt H.-U. (2008) 3D-Visualization of nerve &#64257;ber bundles by ultramicroscopy Med Laser Appl, 23: 209-215
• Becker K, Jährling N, Kramer ER,Schnorrer F,Dodt H.-U. (2008) Ultramicroscopy: 3D reconstruction of large microscopical specimens J. Biophot., 1: 36-42

• Ranft A, Kurz J, Becker K, Dodt H.-U., Zieglgänsberger W, Rammes G, Kochs E, Eder M. (2007) Nitrous oxide (N2O) pre- and postsynaptically attenuates NMDA receptor-mediated neurotransmission in the amygdala Neuropharmacology, 52: 716-723
• Dodt H.-U., Leischner U, Schierloh A, Jährling N, Mauch CP, Deininger K, Deussing JM, Eder M, Zieglgänsberger W, Becker K (2007) Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brain Nat. Methods, 4: 331-6

• Monory K, Massa F, Egertova M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch, R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, Klugmann M, Dodt H.-U., Lutz B (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus Neuron, 51: 455-466
  | Article (PDF) |
• Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt H.-U., Zieglgänsberger W, Lutz B, Rammes G (2006) Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission J Neurosci, 26: 5794-5799

• Becker K, Eder M, Zieglgänsberger W, Dodt H.-U. (2005) WIN 55,212-2 decreases the spatial spread of neocortical excitation in vitro Neuroreport, 16: 993-96

• Azad SC, Eder M, Simon W, Hapfelmeier G, Dodt HU, Zieglgänsberger W, Rammes G (2004) The potassium channel modulator flupirtine shifts the frequency-response function of hippocampal synapses to favour LTD in mice Neurosci Lett, 370: 186-90
• Ranft A, Kurz J, Deuringer M, Haseneder R, Dodt HU, Zieglgänsberger W, Kochs E, Eder M, Hapfelmeier G (2004) Isoflurane modulates glutamatergic and GABAergic neurotransmission in the amygdala Eur J Neurosci, 20: 1276-80
• Schierloh A, Eder M, Zieglgänsberger W, Dodt HU (2004) Effects of sensory deprivation on columnar organization of neuronal circuits in the rat barrel cortex Eur J Neurosci, 20: 1118-24
• Haseneder R, Kurz J, Dodt HU, Kochs E, Zieglgänsberger W, Scheller M, Rammes G, Hapelmeier G (2004) Isoflurane reduces glutamatergic transmission in neurons in the spinal cord superficial dorsal horn – evidence for a presynaptic site of an analgesic action Anesth. Analg., 98: 1718-23

• Kim J, Caine C, Awano T, Herbst R, Monani U (2017) Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice Hum Mol Genet, Epub ahead of print
  | doi:10.1093/hmg/ddx124 |
• Dorninger F, Herbst R, Kravic B, Camurdanoglu B, Macinkovic I, Zeitler G, Forss-Petter S, Strack S, Khan M, Waterham H, Rudolf R, Hashemolhosseini S, Berger J (2017) Reduced Muscle Strength in Ether Lipid-Deficient Mice Is Accompanied by Altered Development and Function of the Neuromuscular Junction J Neurochem, 143: 569-583
  | Article (PDF) |
• Moser B, Hochreiter B, Herbst R, Schmid J (2017) Fluorescence colocalization microscopy analysis can be improved by combining object-recognition with pixel-intensity-correlation Biotechnol J, 12 (1): 1600332
  | Weblink |

• Camurdanoglu BZ, Hrovat C, Dürnberger G, Madalinski M, Mechtler K, Herbst R (2016) MuSK kinase activity is modulated by a serine phosphorylation site in the kinase loop Sci Rep, 6: 33583
  | Weblink |

• Ernst M, Sieghart W (2015) GABAA – Rezeptorsubtypen: Strukturelle Vielfalt gibt Hoffnung auf neue Therapiekonzepte Neuroforum, 21 (4): 144-151
• Ernst M, Sieghart W (2015) GABAA receptor subtypes: structural variety raises hope for new therapy concepts e-Neuroforum, 6 (4): 97-103
• Kudryavtsev D, Shelukhina I, Son L, Ojomoko L, Kryukova E, Lyukmanova E, Zhmak M, Dolgikh D, Ivanov I, Kasheverov I, Starkov V, Ramerstorfer J, Sieghart W, Tsetlin V, Utkin Y (2015) Neurotoxins from Snake Venoms and α-Conotoxin ImI Inhibit Functionally Active Ionotropic γ-Aminobutyric Acid (GABA) Receptors J Biol Chem, 290 (37): 22747-22758
• Sieghart W (2015) Allosteric Modulation of GABAA Receptors via Multiple Drug-Binding Sites Adv Pharmacol, : 53-96

• Obradović A, Joksimović S, Poe M, Ramerstorfer J, Varagic Z, Namjoshi O, Batinić B, Radulović T, Marković B, Roth B, Sieghart W, Cook J, Savić M (2014) Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: The approximated activation of receptor subtypes may explain behavioral effects Brain Res, 1554: 36-48
• Mihailovska E, Raith M, Valencia RG, Fischer I, Banchaabouchi MA, Herbst R, Wiche G (2014) Neuromuscular synapse integrity requires linkage of acetylcholine receptors to postsynaptic intermediate filament networks via rapsyn-plectin 1f complexes Mol Cell Biol, 25 (25): 4130-4149
  | abstract |
• Duernberger G, Camurdanoglu BZ, Tomschik M, Schutzbier M, Roitinger E, Hudecz O, Mechtler K, Herbst R. (2014) Global analysis of muscle-specific kinase signaling by quantitative phosphoproteomics. Mol Cell Proteomics, 13 (8): 1993-2003
  | Weblink |

• Hanada T, Weitzer S, Mair B, Bernreuther C, Wainger BJ, Ichida J, Hanada R, Orthofer M, Cronin SJ, Komnenovic V, Minis A, Mimata H, Yoshimura A, Tamir I, Herbst R, Martinez J, Penninger JM et al. (2013) CLP1 links tRNA metabolism to progressive motor-neuron loss Nature, 495 (7442): 474-480
  | Weblink |
• Luiskandl S, Woller B, Schlauf M, Schmid JA, Herbst R (2013) Endosomal trafficking of the receptor tyrosine kinase MuSK proceeds via clathrin-dependent pathways, Arf6 and actin. FEBS J., 280(14): 3281-97
  | Weblink |
• Ben Ammar A,Soltanzadeh P,Bauché S,Richard P,Goillot E,Herbst R,Gaudon K,Huzé C,Schaeffer L,Yamanashi Y,Higuchi O,Taly A,Koenig J,Leroy JP,Hentati F,Najmabadi H,Kahrizi K,Ilkhani M,Fardeau M et al. (2013) A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia PLoS.ONE., 8: e53826
  | Weblink |

• Mazhar S., Herbst R. (2012) The formation of complex acetylcholine receptor clusters requires MuSK kinase activity and structural information from the MuSK extracellular domain Mol Cell Neurosci, 49: 475-486
  | Article (PDF) |

• Woller B., Luiskandl S., Popovic M., Prieler B.E., Ikonge G., Mutzl M., Rehmann H., Herbst R. (2011) Rin-like, a novel regulator of endocytosis, acts as guanine nucleotide exchange factor for Rab5a and Rab22. BBA Mol Cell Res, 1813: 1198-1210
  | Weblink |

• Herbst R, Iskratsch T, Unger E, Bittner RE (2009) Aberrant development of neuromuscular junctions in glycosylation-defective Large-myd mice. Neuromuscul Disord., 19(5): 366-78
• Ruggiu M, Herbst R, Kim N, Jevsek M, Fak JJ, Mann MA, Fischbach G, Burden SJ, Darnell RB (2009) Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proc Natl Acad Sci USA, 106: 3513-3518

• Galabova-Kovacs, G., Catalanotti, F., Matzen, D., Reyes, G.X., Zezula, J., Herbst, R., Silva, A., Walter, I. and Baccarini, M. (2008) Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal CNS development. JCB, 180: 957-971

• Nishynska, V., Neumüller, R. and Herbst, R (2007) Phosphpinositide 3-kinase acts through the small GTPases Rac and Cdc42 during agrin-induced acetylcholine receptor clustering. Dev. Neurobiology, 67: 1047-1058

• Chevessier F., Faraut B., Ravel-Chapuis A., Richard P., Gaudon K., Bauche S., Prioleau C., Herbst R., Goillot E., Ioos C., Azulay J.P., Attarian S., Leroy J.P., Fournier E., Legay C., Schaeffer L., Ko (2005) Towards the molecular elucidation of congenital myasthenic syndromes: identification of mutations in MuSK. Acta Myol, 24: 55-59

• Chevessier, F., Faraut, B., Ravel-Chapuis, A., Richard, P., Gaudon, K., Bauche, S., Prioleau, C., Herbst, R., Goillot, E., Ioos, C., Azulay, J.P., Attarain, S., Leroy, J.P., Fournier, E., et al. (2004) MuSK, a new target for mutations causing congenital myasthenic syndrome. Hum Mol Genet, 13: 3229-3240

• Herbst, R., Avetisova, E. and Burden, S.J. (2002) Restoration of synapse formation in MuSK mutant mice expressing a MuSK/Trk chimeric receptor. Development, 129: 5449-5460

• Herbst R. (2002) Agrin/MuSK signaling: molecular aspects of neuromuscular synapse formation. Neuroforum, 2/02: 187-192

• Barton, J.L., Herbst, R., Bosisio, D., Higgins, L. and Nicklin, M.J.H. (2000) A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities. Eur. J. Immunol., 30: 3299-3308
• Herbst, R. and Burden, S.J. (2000) The juxtamembrane region of MuSK has a critical role in agrin-mediated signaling. EMBO J., 19: 67-77

• Herbst, R., Barton, J.L. and Nicklin, M.J. (1997) A mammalian homolog of the bacterial monomeric sarcosine oxidases maps to mouse chromosome 11, close to Cryba1. Genomics, 46: 480-482
• Herbst, R. and Nicklin, M.J. (1997) SEZ-6: promoter selectivity, genomic structure and localized expression in the brain Brain Res, 44: 309-322